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Abstract 
Rohan Ambardekar 
Controlled drug release from oriented biodegradable polymers 
Keywords: controlled release, directional release, solid-state orientation, 
biaxial orientation, die drawing, biodegradable, implantable 
This research is the first systematic investigation of solid-state orientation 
as a novel method for controlling drug release from biodegradable polymers. 
The effect of various degrees of polymer orientation was studied in oriented 
Poly (L-lactic acid) (PLA) films containing curcumin and theophylline as model 
drugs. Additionally, direction specific drug release was studied from oriented 
PLA rods containing paracetamol.  
The films oriented to 2X uniaxial constant width (UCW) or 2X2Y biaxial 
draw ratio showed retardation of drug release, when their nematic structure was 
stabilised by the presence of crystalline theophylline. Contrarily, the same films 
when contained solid solution of curcumin, shrunk in the release medium and 
exhibited a release profile similar to the un-oriented films. All films oriented to 
the UCW draw ratio ≥ 3X contained α crystalline form of PLA and showed 
acceleration of drug release proportionate to the draw ratio. According to the 
proposed mechanism augmented formation of water filled channels in these 
films was responsible for faster drug release. 
Similarly, the paracetamol loaded PLA rods die-drawn to uniaxial draw 
ratios ≥ 3X exhibited enhancement of drug release. Importantly, the amount of 
drug released along the oriented chain axis was significantly larger than that in 
the perpendicular direction. Drug release from the die-drawn rods was 
accelerated by a greater degree than that observed from the oriented films. This 
can be correlated to the differences in their size, geometry and the crystalline 
form of PLA. 
In conclusion, the current study provided substantial evidence that solid-
state orientation can offer a control over drug release from PLA. 
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Tg: Glass transition temperature 
(oC) 
λ : Draw ratio  
G' : Storage modulus (Pa) 
G” : Loss modulus (Pa) 
ω : Angular frequency (rad/sec) 
η* : Complex viscosity (Pa.s) 
η0 :Zero shear viscosity (Pa.s) 
m/z : Mass to charge ratio 
Fh: Herman’s orientation function 
γL
D: Dispersive surface tension 
(liquid) (mJ/m2) 
γL
P: Polar surface tension (liquid)  
(mJ/m2) 
γf
D: Dispersive surface energy 
(solid) (mJ/m2) 
γf
P : Polar surface energy (solid) 
(mJ/m2) 
δt : Hansen’s total solubility 
parameter(J1/2. M-3/2) 
Rt : Retention time in a 
chromatography 
E: Young’s modulus or modulus of 
elasticity (N/m2) 
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1. Introduction 
1.1. The hypothesis 
The research reported in this thesis aims to test the hypothesis that 
structuring the morphological domains within a polymer matrix by solid-state 
polymer orientation will offer control over drug release from that matrix.  
1.1.1. Introduction to the hypothesis 
 Spatial and temporal control over the release of a drug, in order to meet 
the specific delivery challenges associated with a particular disease is both 
attractive and challenging. Controlled drug delivery can be achieved through a 
simple dosage form such as tablets or complex nano-formulations, or even 
biomedical devices, e.g. drug loaded biomedical screws. Polymers play a 
critical role in such systems by facilitating (1) the selective release of a drug 
near the target organ, in order to increase bioavailability or to reduce toxicity, 
e.g. implants; (2) the release of a drug in response to a biological stimuli, e.g. 
release of Insulin only when the blood glucose levels are elevated; or 
importantly (3) a rate controlled release necessary to maintain constant drug 
levels in the blood plasma, e.g. in the treatment of chronic diseases such as 
arthritis.  Despite the great potential, there are practical and commercial 
limitations on the number of new polymers synthesised, owing to the 
laboriousness of the process. Similar to drugs, an important barrier preventing 
large investment in search of new biomedical polymers is fear of regulatory 
noncompliance. Such situations can be addressed by exploring the technology 
to modify existing polymers such that the desired properties can be obtained 
without altering their chemical identity.  
Thermal, physical, and mechanical properties of polymers essentially 
depend on their structural features (Brostow, 2007; Ward and Sweeney, 2012). 
Polymers are long chain molecules. Few with stereo-regularity can undergo 
regular chain folding in order to achieve a lower energy state. On the most 
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fundamental level the folded region is referred as lamellar crystals, which are 
connected by amorphous segments. The lamellar crystals are further organised 
into more complex superstructures of different length scales. Such organisation 
provides a platform for increased intramolecular interactions and hence bulk 
properties of a semicrystalline polymer vary according to percentage crystallinity 
and crystal morphology. Owing to the same reason, semicrystalline polymers 
offer a broader margin for altering the polymer properties by changing the 
morphological features. Therefore, this work is focused on orientation of 
semicrystalline polymers for controlled drug delivery applications.  
Solid-state orientation (Coates and Ward, 1981; De Vries et al., 1977) of 
semicrystalline polymers has a significant effect on polymer properties, by virtue 
of its ability to structure the morphological domains within a polymer matrix. The 
term 'orientation', in the case of semicrystalline polymers relates to alignment of 
amorphous and crystalline regions, resulting in development of strong 
anisotropic properties such as enhanced mechanical strength, gas/vapour 
barrier and reduced biodegradability. Such changes may also affect the drug 
release properties of the polymeric matrices. In this work, the effect of polymer 
orientation on drug release has been evaluated.  
The literature survey suggested that there have been no reported 
systematic studies on solid-state orientation, which examine the effect of 
different degrees of orientation on drug release. Moreover, the role played by 
the nature of a drug in influencing polymer orientation and the consequent 
release profile has not been studied. Importantly, orientation of polymers results 
in development of anisotropic properties and hence the rate of drug release in 
the direction parallel to orientation is expected to be different from that in the 
perpendicular direction. Previous reports on drug releasing oriented materials 
have failed to characterise this phenomenon. This work attempts to address 
these gaps and construct a mechanistic understanding of drug release from 
oriented matrices.  
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The effect of the degree and the nature of polymer orientation (e.g. 
uniaxial, biaxial) on drug release was systematically studied here using a simple 
two dimensional geometry, i.e. films (figure 1.1). Poly (lactic acid) – (PLA) films 
loaded with a polymer soluble or a suspended drug were made by melt 
extrusion. They were oriented using a biaxial stretcher. These films also allowed 
investigation of the effect of the physical state of a drug on the release profile 
exhibited by the oriented matrices. The possibility of obtaining anisotropic drug 
release from oriented matrices was studied from a three dimensional cylindrical 
geometry. PLA rods containing a model drug were melt-extruded, followed by 
orientation using the die drawing method. Drug release from the lateral (curved) 
surface and the cross section (base) was studied separately (figure 1.2).    
 
Figure 1.1: Schematic representation of drug release from the oriented films 
 
 
Figure 1.2: Anisotropic drug release from an oriented 3D geometry 
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1.2 Significance of controlled drug release from oriented polymers 
In recent years there has been an increasing interest to use bioresorbable 
polymers in the preparation of implantable medical devices. Hydrolytic or 
enzymatic degradation of these polymers generate by-products which are 
harmless to the human body. Therefore implantable devices made from 
bioresorbable polymers do not require surgical removal. Additionally, they are 
more biocompatible and smoothly transfer the function to the human body as 
they are eroded. For example, a fractured bone that has been fixated with a 
metallic implant bears minimal load in presence of the implant. Consequently, 
there is a risk of re-fracture upon removal of the implant. Contrarily, 
biodegradation of polymeric implant smoothly transfers the load to the healing 
bone and makes it stronger. 
Several researchers have utilised polymer orientation techniques such as 
die-drawing, biaxial drawing for production of self-reinforced polymeric implants 
(Mikkonen et al., 2009; Waris et al., 2003; Ylikontiola et al., 2004). Addition of a 
therapeutic agent to such devices combines the advantages of increased 
mechanical strength and bioresorbability with localised drug delivery. For 
example, Mikkonen et al. (2009) added an anti-proliferative agent to self-
reinforced braided stents, in order to prevent formation of cellular plaque around 
the stent, thereby delaying the requirement for restenosis. Similarly Veiranto et 
al. (2002) added an antibiotic to a die-drawn bone fixation screw, which may aid 
prevention of infections associated with surgical implantation of the screw. 
Despite great potential there is a paucity of research on the effect of polymer 
orientation on drug release from self-reinforced biomedical devices.  
This research attempts to generate a fundamental understanding of the 
effect of various degrees (draw ratio) and nature (uniaxial/ biaxial) of polymer 
orientation on drug release rate. This knowledge will enable creation of a design 
rule by which mechanical properties and drug release rate from a self-reinforced 
implant can be balanced by manipulation of polymer orientation. Based on the 
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outcomes of this research, polymer orientation can be utilised as a novel 
method for controlling drug release from a variety of pharmaceutical polymers.  
Preparation of drug eluting transdermal or wound-care membranes, ocular or 
sub-dermal implants already utilise techniques such as melt-extrusion (Crowley 
et al., 2007), injection moulding (Rothen-Weinhold et al., 1999) , electro 
spinning (Luong-Van et al., 2006) etc. Incidental polymer orientation caused by 
these manufacturing methods may influence the drug release rate to different 
extents. However, this factor has not received considerable attention. The 
results of the current research will highlight the importance of polymer chain 
organisation in affecting drug release. 
It is known that unidirectional polymer orientation leads to generation of 
anisotropic properties (Coates and Ward, 1979; Ward and Sweeney, 2012). The 
research described in this thesis attempts to verify if this correlation also applies 
to drug elution. The outcome of this research will generate a fundamental 
understanding of the influence of anisotropic chain organisation on the 
directionality of drug diffusion. Nevertheless, it may highlight the anisotropic 
percolation of the bathing medium into the oriented polymeric device. 
Importantly, the results will establish if uniaxially oriented materials have an 
isotropic drug release rate or if the observed rate is a combination of two 
anisotropic release rates. This knowledge will provide further insight and control 
over drug release from oriented materials. Based on this information, a novel 
drug delivery system can be designed, where the rate of drug release can be 
simply altered by changing the surface that is exposed to the biological fluid. 
Such drug delivery systems can include cylindrical implants made from 
uniaxially oriented biodegradable polymers; e.g. PLA/ PLGA. Alternatively, 
simple tablets can be generated from a die-drawn billet consisting of fast 
dissolving semicrystalline polymers such as PVA.     
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1.3 Introduction to the thesis 
 This research involves a novel approach to control drug release from 
biodegradable polymers. It attempts to present a fundamental understanding of 
the structure evolution in the drug loaded polymeric matrices, when subjected to 
solid-state orientation and its effect on drug release. 
 This introduction is followed by the aims and objectives of the work 
(chapter 2). The background and literature review chapter (Chapter 3) presents 
an overview of the fundamental knowledge of controlled drug release methods, 
kinetics and the polymers involved. It further discusses various morphological 
features in a semi-crystalline polymer, changes associated with polymer 
orientation and methods of polymer orientation. Biocompatible polymers and 
active agents which are related to this thesis are briefly introduced in this 
chapter. Importantly, existing knowledge about the role of a polymeric 
microstructure in controlling drug release is reviewed and the limitations of the 
reported studies are identified.  
The next part of the thesis is organised such that each chapter represents 
a key stage in the exploration of the hypothesis. Chapter 4 includes discussion 
of the methods used for preparation and solid-state orientation of the drug 
loaded PLA matrices, along with supporting characterisation techniques. 
Precisely, melt compounding of the drug-polymer systems, film extrusion and 
solid-state orientation of the films using a biaxial stretcher, extrusion moulding 
of the drug loaded PLA billets and their die drawing is discussed. 
Chapter 5 reports the findings that formed a basis for the selection of the 
model drug - polymer systems studied further in this thesis. Poly (L-lactic acid) 
(PLA) was selected as a candidate polymer based on the literature survey, 
material availability and initial studies carried out to understand the processing 
suitability. Since biomedical devices made from PLA exploit various polymer 
orientation processes for achieving higher mechanical strength, it was 
considered a good candidate for studying the anisotropic drug release after 
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being subjected to solid-state orientation. Curcumin, theophylline and 
paracetamol were selected as thermostable and inert model drugs. Curcumin 
and paracetamol with PLA represents a solid solution system; whereas 
theophylline represents a model drug that remains in a suspension form.  
The drug loaded PLA matrices utilised in this work were prepared by melt 
extrusion. Rheological studies were used for defining optimum melt processing 
conditions. Changes in the polymorphic state of the experimental materials and 
their degradation during melt extrusion can potential affect solid-state 
orientation process and the resultant drug release profile. Therefore, thermal 
stability of the selected materials and changes in their polymorphic state when 
subjected to melt processing were assessed by various techniques. The results 
of these studies are described in chapter 5. 
 The work discussed in chapter 6, included solid-state orientation of the 
films and studying drug release from the same. The crystalline structure 
developed during solid-state orientation of the films was investigated by 
techniques such as WAXD, DSC and surface energy measurement. Moreover, 
the changes in the molecular weight, crystallinity and morphology of the 
oriented films were monitored during drug release studies. A mechanistic 
understanding of the effect of solid-state orientation on drug release was 
generated by correlating these findings with the drug release profile.  
 Chapter 7 relates to evaluation of anisotropic or direction specific drug 
release from an oriented three dimensional geometry, i.e. rods. The chapter 
reports characterisation of the anisotropic structure of the die-drawn billets by 
WAXD and DSC. Finally, the data obtained from drug release studies is 
discussed in an attempt to understand the role of anisotropic polymer structure 
in shaping the direction specific drug release.  
Chapter 8 presents the conclusions. Additionally, the future work is 
suggested in chapter 9 based on the achievement of set milestones and newly 
identified goals. 
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2. Aims and objectives 
The aim of this work was to investigate the effect of polymer orientation on 
drug release. This ultimate aim was divided into sub-objectives (figure 2.1). 
First, the variation in polymer properties that accompanies solid-state 
orientation was studied. The changes in the oriented matrices during drug 
release were examined in order to comprehend the mechanism of drug release. 
Initially, a mechanistic understanding of the effect of different degrees of 
orientation on drug release was generated, using a two-dimensional geometry, 
i.e. films. The knowledge obtained from these studies was extrapolated to 
assessment of anisotropic drug release from an oriented cylindrical geometry.   
 
Figure 2.1: Objectives of the research 
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3. Background and literature survey 
This chapter presents an overview of the fundamental knowledge about 
controlled drug release systems and polymer orientation. The existing 
knowledge about the role of polymeric microstructure in controlling drug release 
is reviewed. Moreover, the biodegradable polymers and the active agents 
related to this research are briefly introduced in this chapter. 
3.1. Introduction to the materials 
3.1.1. Poly (lactic acid) PLA 
PLA is a semisynthetic thermoplastic polymer with a large number of 
applications in the biomedical industry. It can undergo hydrolytic degradation 
within the body and does not require enzymatic catalysis. The hydrolytic 
products generated, being part of the natural metabolism, attribute 
bioresorbability to PLA. It is usually obtained by polycondensation of lactic acid 
(Maharana et al., 2009) or from ring opening polymerisation of a cyclic dimer of 
lactic acid, i.e. lactide (Okada, 2002) 
 
Figure 3.1: Chemical structure of PLA 
The chemical structure of PLA is depicted in figure 3.1. The presence of 
methyl side groups contributes to the hydrophobicity of PLA due to steric factors 
(Vroman and Tighzert, 2009). The glass transition and the melting temperature 
for PLA homopolymers ranges between 55-65 °C and 170–180 °C respectively 
(Sodergard and Stolt, 2002). It is a hygroscopic polymer and undergoes 
degradation above 200 °C, by hydrolysis, lactide formation or oxidative chain 
scission (Jamshidi et al., 1988). The narrow processing window of PLA puts 
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major limitations on its applicability. The processing window for PLA can be 
broadened by addition of plasticizer or D-isomer, which lowers its melting 
temperature (Blackburn et al., 2006). PLA is soluble in chlorinated 
solvents, tetrahydrofuran, dioxane and hot benzene, while it is insoluble in 
acetonitrile and swells in acetone (Garlotta, 2001).  
Lactic acid exists in two optically active isomers. Controlled polymerisation 
of L- and D- isomers may lead to a certain degree of racemisation in the end 
polymer. The stereological makeup of the end polymer dictates its crystallisation 
behaviour, mechanical properties as well as biodegradability. Commercially 
utilised PLA is a poly (L-lactic acid) variety with different D-isomer content.  
 PLA shows two distinct types of crystal habits. The α Form has a 
pseudo-orthorhombic unit cell with dimensions a = 10.7 Å, b = 6.126 Å and, and 
c = 28.939 Å. On the other hand, the β Form has orthorhombic unit cell having 
dimensions as follows: a = 10.31 Å, b = 18.21 Å, c = 9.0 Å (Hoogsteen et al., 
1990). It was observed that the β Form is associated with a fibrillar morphology, 
while the α crystals signify the presence of lamellar stacks. In a tensile drawing 
process, crystallisation occurs as a bilateral event. When processed at lower 
drawing temperature, formation of α Form is favoured; while the β crystals are 
generated only near the melting temperature, or at significantly higher draw 
ratios (Hoogsteen et al., 1990).  
3.1.2. Curcumin (C21H20O6 | Mol. wt. 368.38 g/mol) 
Curcumin is a yellow pigment found in the dietary spice turmeric (Curcuma 
longa). Chemically it is a linear diphenylheptanoid or specifically (1E, 6E)-1,7-
Bis (4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione. Curcumin exists in 
two tautomeric forms (figure 3.2). The keto form exists in acidic solutions, 
whereas the enol form exists at alkaline pH. Curcumin undergoes photo-
degradation as well as hydrolytic degradation in alkaline pH. Products of 
hydrolytic degradation include feruloyl methane, ferulic acid and vanillin, which 
can be easily detected by HPLC.  
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Figure 3.2: Chemical structure of curcumin (A) The keto form, (B) The enol form of curcumin. 
Curcumin is practically insoluble in water at acidic and neutral pH; it is 
soluble in acetone, methanol, ethanol, DMSO and chlorinated solvents such as 
dichloroethane (Stankovic, 2004). It is a crystalline solid and exhibits three 
different crystal habits (Sanphui et al., 2011). Form I, which is most stable has a 
melting point at 181 °C. Forms II and III are both metastable and their melting 
points are 175 °C and 172 °C respectively. When cooled rapidly from the melt, 
curcumin remains in a glassy amorphous state. Its ability to remain in 
amorphous state after melting and compatibility with PLA formed the basis for 
its selection as a model drug in the current studies. 
3.1.3. Theophylline (C7H8N4O2 | Mol. wt. 180.164 g/mol) 
Theophylline is a bronchodilator and a smooth muscle relaxant, used in 
the treatment of chronic obstructive pulmonary disease and asthma and infant 
apnoea. It is a methyl xanthine derivative with IUPAC name 1,3-dimethyl-7H-
purine-2,6-dione (figure 3.3). 
 
Figure 3.3: Chemical structure of theophylline 
Theophylline melts at approximately 270 °C. It is slightly soluble in water 
and sparingly soluble in ethanol, ether. Theophylline exists in a monohydrate 
form and four anhydrous polymorphs (Khamar et al., 2011). The monohydrate 
form converts to Form II in low humidity conditions or above 80 °C. The Form 
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IV is the most stable followed by Form II. Form I is stable at high temperatures, 
whereas Form III is highly unstable and converts rapidly to Form II. 
Ease of quantification and its non-reactive nature has deemed 
theophylline an excellent model for studying drug release (Bodmeier and Chen, 
1988; Kader and Jalil, 1998; Vargas and Ghaly, 1999; Zhang and McGinity, 
2000). It was selected as a model drug in this study, based on the experimental 
evidence that it remains suspended in the PLA matrix, owing to its lower 
solubility in PLA melt and a significantly high melting point.  
3.1.4. Paracetamol (C8H9NO2 | Mol. wt. 151.2 g/mol) 
Paracetamol, also known as acetaminophen is a popular over-the-counter 
analgesic, antipyretic. It is chemically named as N-acetyl-p-aminophenol and 
has the structure represented in figure 3.4. It is a polar molecule owing to 
presence of a hydroxyl and amide group along with the pi cloud of the benzene 
ring (Bales et al., 1985). Paracetamol exhibits two polymorphs, namely the 
more stable, monoclinic Form I and the orthorhombic Form II. (Espeau et al., 
2005). Quench cooling the paracetamol melt forms an amorphous state, which 
when exposed to temperatures above Tg (22-25 °C), crystallises into Form II 
(Di Martino et al., 2000).  
 
Figure 3.4: Chemical structure of paracetamol 
Paracetamol is a weak acid with Pka 9.38 at 25 °C (Dasmalchi et al., 
1995). Its water solubility is reported to be 17.38 g/ litre. It is practically insoluble 
in nonpolar solvents, but has higher solubility in alcohols and polar solvents due 
to hydrogen bonding (Granberg and Rasmuson, 1999). It melts at 169 °C (Form 
I). A match between the melting temperatures of PLA and paracetamol, coupled 
with the literature reports on successful molecular dispersion after melt 
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extrusion of the paracetamol with PLA (Maniruzzaman et al., 2012; Yang et al., 
2010), formed basis for its selection as a model drug in the current research. 
3.2. Introduction to controlled release drug delivery systems 
The past two and half decades have evidenced an exponential rise in 
applications of synthetic and natural-based polymers in the pharmaceutical and 
biomedical industry. Polymers have been used for making innovative drug 
delivery systems that offer spatiotemporal control on release. Controlled release 
systems can maintain a steady therapeutic level of a drug in the plasma for 
extended duration. This approach prevents therapeutic failure and minimises 
side effects. Moreover, it reduces the frequency of dosing, improves 
bioavailability and prevents dose dumping. Controlled release systems are 
extremely benevolent in the treatment of chronic diseases such as arthritis, 
where a single administration can deliver a dose for long duration. They are 
also promising in the case of paediatric or geriatric patients having difficulty in 
taking normal dosage, or to avoid dose skipping. Considering these factors, 
controlled release systems have demonstrated a greater patient compliance 
and are therefore considered as a better treatment option.  
 
 
Figure 3.5: Plasma concentration Vs. time profile for conventional and controlled 
release systems. 
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A conventional drug treatment involves multiple dosing of the therapeutic 
agent in order to achieve a desired concentration in the plasma for extended 
duration. A typical plasma profile after successive administration of the 
conventional dosage form is represented by the dashed lines in figure 3.5. It 
suggests that the plasma drug concentration in such cases rarely remains 
constant. Moreover, there is always a possibility of drug concentration 
exceeding the maximum safe level or falling below the therapeutic level. Either 
of the events is unwanted but unavoidable in the case of conventional dosage 
forms. Controlled release systems can maintain a steady plasma drug 
concentration, by controlling the rate at which drug becomes available for 
absorption or to the systemic circulation. The solid line in figure 3.5, depicts a 
distinctive blood plasma profile from the controlled release systems. In order to 
achieve such a plasma profile, numerous approaches based on physico-
chemical properties of the drug or a polymer, have been tried.  
 
Figure 3.6: Mechanisms of controlled drug release. 
A controlled release system can be fabricated either by coating a drug 
core by a suitable polymer or by suspending the drug uniformly within a polymer 
matrix. The former is known as the reservoir approach, whereas the latter 
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systems are referred to as matrix/ monolithic carriers. Polymers play a central 
role in controlling drug release by modulating the rate at which they dissolve 
(erosion controlled) or by controlling the rate at which drug diffuses out from the 
polymer matrix (diffusion controlled). A pictorial representation of controlled 
release systems is given in figure 3.6 Reservoir systems 
Ocusert® – a pilocarpine containing polymeric eye implant (Zaffaroni, 
1980) was one of the early reservoir based controlled release systems, used 
clinically.  In this system, a water soluble polymer matrix containing pilocarpine 
is sandwiched between a non-erodible rate controlling membrane and an 
impermeable polymer membrane, in order to achieve a unidirectional controlled 
release. Under ‘steady-state’ conditions, the drug release from such a device 
can be explained by Fick's first law of diffusion. According to this, the rate of 
drug diffusion is defined by the concentration gradient across the rate 
controlling polymer membrane (equation 3.1). 
J =  −D
∂C
H
            (Equation 3.1) 
Where, J is the diffusion flux in dimensions of [(moles of a substance) length−2 time−1] 
      D is the diffusion coefficient or diffusivity in dimensions of [length2 time−1] 
   H is the thickness of the polymer membrane. 
In non-steady state conditions, where diffusion of the drug causes a 
change in the concentration gradient with time, drug release (∂C/∂t) is more 
appropriately explained by Fick’s second law (equation 3.2). 
∂C
𝜕𝑡
=  D
∂2C
∂h2
                  (Equation 3.2) 
 Reservoir systems further include delayed release systems, which are 
made by coating the drug core with an impermeable but erodible polymer. The 
time required for erosion, and consequent delay in the drug release can be 
adjusted by using appropriate polymers or their combination.  
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Examples of polymers used in the reservoir systems include water 
insoluble polymers such as, poly (ethylenevinyl acetate) (EVA), ethyl cellulose, 
silicone and polyacrylates, etc. EVA membranes were popularly used as a rate 
controlling layer in the pilocarpine ocular inserts (Zaffaroni, 1980). Moreover, 
their utility in the transdermal delivery of a variety of drugs (Chen and Lostritto, 
1996; Shin and Lee, 2002) or steroids (Shin and Byun, 1996) has been 
reported. Higuchi et al. (1973a) attempted to reduce the permeability of EVA 
membranes by subjecting them to solid-state orientation.  
3.3. Matrix systems 
Matrix systems are composed of a homogenous dispersion of a drug in a 
non-erodible (diffusion controlled) or an erodible (erosion controlled) polymer 
matrix. Drug release from ‘bioerodible’ systems is shaped by both polymer 
erosion and drug diffusion in a complex way. Matrix systems are generally 
preferred over reservoir systems, since they are easier to manufacture and 
importantly a desired release profile can be easily tuned in such systems 
without involving the risk of dose dumping due to membrane rupture.  
Depending upon the manufacturing method and physicochemical 
properties of the drug and the polymer, matrix systems may have a suspension 
of drug particles in the polymer matrix, a molecular dispersion or a solution. The 
physical form of the drug within the polymer matrix affects the nature and the 
degree of interactions between the drug and the polymer, consequently 
affecting its release profile. 
3.3.1. Diffusion controlled matrix systems 
Kinetics of the drug release from a diffusion controlled matrix system were 
explained by Higuchi (1963), based on following assumptions.  
 Sink conditions are maintained. 
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 Drug release from the matrix occurs in a pseudo-steady state manner, 
where diffusion coefficients for the drug and the polymer remain 
constant throughout. 
 Drug particles must travel distances marginally larger than their particle 
diameter and there is no interaction between the drug and the polymer.  
Bioerodible diffusion controlled matrices may invalidate the second 
assumption. Therefore, to simplify the understanding, diffusion controlled matrix 
systems are defined as those made from non-erodible polymers, and where the 
release occurs by drug diffusion as the only mechanism. Drug release from 
such a matrix system was assumed to be a layer by layer diffusion 
phenomenon. On contact with a biological fluid, the drug contained in the 
outermost layer of the matrix diffuses uncontrollably. Following that, drug 
release is regulated by diffusion of the drug contained in each theoretical plane 
of the device, through several drug depleted planes before it reaches the 
surface of the device. The kinetic contribution from such drug depleted layers 
towards the overall drug release rate was explained by Roseman and Higuchi 
(1970).  
If the drug is present in the dissolved state, its release from a film 
geometry can be described by the approximation given in equations 3.3 and  
3.4 (Roseman and Higuchi, 1970).  
∂M
∂t
= 2M0 (
D
πL2
)
0.5
, for the initial 60% of the release         (Equation 3.3) 
 
∂M
∂t
= 4 (
8DM0
L2
) e−
π2Dt
L2 , for the final portion of the release        (Equation 3.4) 
Where, 
𝝏𝑴
𝝏𝒕
 = rate of drug release/ amount of drug released as a function of time. 
M0 = total amount of drug present in the matrix system. 
D = diffusivity of the drug. 
L = thickness of the film. 
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Ritger et al. (1987) suggested that these equations apply only to the thin 
films, where the assumption of one dimensional diffusion of the drug under 
perfect sink conditions would follow Fick’s second law perfectly. For non-planar 
geometries, Fick’s law must be modified to incorporate deviations from one 
dimensional diffusion and changes in the boundary conditions, due to geometric 
considerations. A mathematical description of drug release from cylindrical and 
spherical geometries based on the Fick’ law modification was deduced by 
Ritger et al. (1987).  
 When a drug is present as a suspension in the polymer matrix, drug 
release kinetics vary according to the level of drug loading. For less than 5% 
w/w drug loading, release occurs mainly by dissolution of the drug into the 
polymer matrix, diffusion of the dissolved drug towards the surface and 
subsequent release into the biological fluid (Higuchi, 1963).  For a film geometry 
having homogenous distribution of a drug, the total amount of drug released 
under sink conditions is given by the Higuchi model (equation 3.5). 
Qt = √Dt (2Q0 − Cs)Cs                    (Equation 3.5) 
Where, Qt = amount of drug release per unit surface area in time ‘t’.  
D = diffusivity of drug in the polymer. 
Cs = saturation solubility of the drug in the polymer matrix. 
Q0 = total amount of drug present in the polymer matrix. 
The term (2Q0 – CS) can be reduced to 2Q0, in the equation 3.5, since the 
saturation solubility of the suspended drug in the polymer matrix is significantly 
lower in comparison to the total drug loading. It was reported that the 
cumulative amount of drug released is inversely proportional to the square root 
of time over the initial 60% release of the drug (Ritger and Peppas, 1987). In the 
later stages, release rate is largely independent of time. 
When the amount of suspended drug exceeds 5% w/w, the physical state 
of the drug – polymer matrix changes from a molecularly mixed to a granular 
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state. Release from such matrices is significantly faster, since it involves 
leaching of the biological fluid through pores, cracks and inter-granular spaces. 
This fluid dissolves the drug and carries it to the external sink. Moreover, 
dissolution of the drug leads to generation of fluid filled pores, which further 
increase the permeability of the matrix. When the drug loading exceeds 15% 
w/w of the polymer, the density of the drug is significant enough to cause a 
particle-particle contact. In such a case, a phenomenon referred as contact 
dissolution takes place; i.e. drug particles in contact with each other dissolve 
when one of them is approached by the leaching fluid. This enhances the 
porosity of the matrix even faster. A mathematical description of the drug 
release kinetics from a granular matrix is given by equation 3.6.  
Qt =  √(
Dε
τ
(2Q0 − ϵCS)CSt), for 5% w/w ≤ A ≤ 15%w/w  (Equation 3.6) 
In addition to the previously mentioned parameters, equation 3.6 takes 
into consideration ε and τ, which are the porosity index and the tortuosity index 
of the polymer matrix respectively.  
3.3.2. Polymers for diffusion controlled matrix systems 
 A preliminary requirement for all diffusion controlled systems is that the 
polymer is non-erodible so that release of a drug is strictly governed by the 
diffusion mechanism. The commonly used polymers include ethyl cellulose 
(Friedman and Golomb, 1982), polyacrylates (Chiang and Tenzel, 1991; Cleary, 
1990; Di Colo and Zambito, 2002) and polyurethanes (Schierholz et al., 1997). 
Ethyl cellulose is extensively used for making diffusion controlled drug delivery 
systems. Ethyl cellulose solvent cast films containing 5, 10 and 20% of 
chlorhexidine diacetate exhibited drug release coherent with the Higuchi model 
discussed previously (Friedman and Golomb, 1982). The influence of 
morphology of the solvent casted ethyl cellulose matrix on drug diffusion was 
described by Jones et al. (1995). They postulated that a good solvent or a 
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solvent having the solubility parameter matching that of the polymer generates 
a dense, homogeneous network of the interpenetrating polymer chains, as the 
solvent is evaporated. Contrastingly, a poor solvent would not fully extend the 
polymer coils, resulting in a heterogeneous matrix with poor intermolecular 
interaction and presence of micro-voids. Release of chlorhexidine was 
augmented as the proportion of the poor solvent in the solvent mixtures 
increased.  An extremely slow release was obtained when drug containing ethyl 
cellulose matrices were melt extruded  (Brabander de et al., 2003). Melt 
extrusion leads to densification of the polymer chains to the extent that extruded 
material has practically zero porosity (Crowley et al., 2004b).  
Drug release from non-erodible matrices is also shaped by the nature of 
the association between a drug and the polymer. At the same level of drug 
loading, gentamycin and flucloxacillin remained homogenously distributed in the 
polyurethane matrices; whereas, ciprofloxacin and fosfomycin matrices 
exhibited a granular structure. This was reciprocated as slow continuous 
release behaviour for the prior two and fast initial release for the latter pair 
(Schierholz et al., 1997).   
3.3.3. Dissolution controlled matrix system 
 Dissolution controlled systems derive their name from the fact that 
release of a drug from such matrices is governed by dissolution of the polymer. 
A demarcation between bioerodible and dissolution controlled systems is that 
the latter are formulated from water soluble polymers such as poly (ethylene 
oxide) – (PEO), polysaccharides, and therefore the erosion mechanism does 
not involve any chemical change in the polymer. The loss of the polymer bulk 
takes place in two steps. First the medium leaches into the matrix, which is 
followed by chain disentanglement. The free drug can subsequently dissolve in 
the surrounding medium and mix with the bulk sink (Narasimhan and Peppas, 
1997).  
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3.3.4. Polymers for dissolution controlled matrix systems 
Poly (ethylene glycol)s (PEG) and their higher molecular weight 
derivatives, referred to as poly (ethylene oxide)s (PEO) are extensively used for 
making dissolution controlled matrices of various geometries (Crowley et al., 
2004a; Prodduturi et al., 2005; Zhang and McGinity, 1999). For lower molecular 
weight PEO (200 – 900kDa), the rate of chain disentanglement marginally 
exceeds the rate of swelling after water uptake. Therefore, drug release follows 
the dissolution controlled mechanism. As the molecular weight increases, the 
rate of swelling increases; while the rate of disentanglement decreases due to 
longer chain reptation time. Consequently, matrices made from PEO having 
molecular weight 2000 kDa or over exhibit an initial diffusion mediated release, 
followed by an erosion phase (Apicella et al., 1993; Colo di et al., 2001).Since 
PEO can be polymerised into a range of molecular weights, their combination 
can be used for balancing the rate of erosion and the rate of swelling, so that a 
constant drug release rate is obtained (Wu et al., 2005).  
Similar to PEO, the water soluble nature of poly (vinyl alcohol) (PVA) and 
polysaccharides makes them suitable for fabrication of dissolution controlled 
matrices (Guohua et al., 2006; Tsukada et al., 1994). The semicrystalline nature 
of PVA offers control over polymer erosion and resultant drug release by 
manipulation of the polymer’s crystallinity. Wan et al. (1992) observed a 
reduction in drug release rate following heat treatment of PVA films above their 
glass transition temperature (Tg).  
3.4. Biodegradable matrix systems 
3.4.1. The concept 
Biodegradable systems are most commonly erodible matrix systems 
consisting of a water insoluble polymer. Erosion mechanism can be as simple 
as hydrolysis, or it may involve polymer degradation by cellular or enzymatic 
pathways. If the degradation products are small molecules normally found in the 
physiological processes, the systems are referred to as ‘bio-resorbable’.  
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Depending upon the diffusivity of the water into the polymer matrix, 
susceptibility of the polymer’s functional group to degradation and matrix 
dimensions, the erosion can be sub-classified as ‘surface erosion’ or ‘bulk 
erosion’ figure 3.7 
 
Figure 3.7: Polymer erosion mechanisms 
 Generally bulk erosion takes place when the rate of water permeation is 
significantly higher than the rate of polymer degradation. Consequently, 
hydrolysis takes place simultaneously throughout the matrix. Hydrolytic 
susceptibility of the bond decreases in order from anhydrides, ortho-esters, 
esters to amides, due to steric factors (Gopferich, 1996). As a result of this, a 
matrix with a constant geometry will exhibit surface erosion if it is made from 
poly-anhydrides or poly-ortho-esters; whereas, it will undergo bulk erosion if it 
has ester or amide linkages. Most biodegradable polymers erode by both 
mechanisms; however, the contribution from each varies depending on the 
chemical structure of the polymer, matrix microstructure, crystallinity, porosity, 
pH of the medium, drug distribution and the level of drug loading, etc. 
Importantly, certain polymers such as poly (lactic acid) undergo crystallisation 
during bulk degradation, which substantially changes the degradation kinetics 
(Wada et al., 1991). A detailed information on these mechanisms can be found 
in the review by Gopferich A. (1996).  
A) Bulk erosion of a drug loaded polymer matrix 
B) Surface erosion of a drug loaded polymer matrix 
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From a drug delivery point of view, surface eroding matrices are preferred 
over bulk eroding ones for the following reasons. Namely, the rate of drug 
release is uniform and predictable, the release rate can be tailored by simply 
varying the geometry of the matrix and importantly, water labile drugs are 
protected from degradation until they are actually released (Uhrich et al., 1999).  
In reality, drug release from bioerodible devices occurs by drug diffusion 
as well as polymer erosion. If the rate of diffusion through such matrices 
significantly exceeds the rate of erosion, the kinetics can be defined by the 
Higuchi model for diffusion controlled non-erodible matrices (equation 3.5). 
Under such circumstances, it is assumed that the change in the diffusivity of the 
polymer due to erosion process is small enough to be ignored. On the contrary, 
if the diffusion rate is equivalent to the erosion rate or if it exceeds the erosion 
rate only by a small margin, The Higuchi equation must be modified to include 
the contribution from polymer erosion (equation 3.7).   
Q𝑡 = √2D𝑄0ektCst    (Equation 3.7) 
Where, Qt = amount of drug release per unit surface area in time ‘t’.  
 D = diffusivity of drug in the polymer. 
 Q0 = total amount of drug present in the polymer matrix. 
 Cs = saturation solubility of the drug in the polymer matrix. 
   ekt  = factor considering the polymer degradation rate. 
When the polymer erosion rate significantly exceeds the diffusion rate, the 
matrix is referred as an ‘erosion controlled’ system. Drug release from an 
erosion controlled system may vary depending on the nature of erosion (surface 
erosion / bulk erosion), and the geometry / surface area of the matrix.  There 
are several mathematical models reported to describe the kinetics of drug 
release from erosion controlled systems. These models were reviewed by Fu et 
al. (2010). Hopfenberg (1976) described the release rate of the drug from 
surface eroding polymers, using the following equations (3.8, 3.9).    
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For a film having initial thickness ‘2a’, the fraction of the drug released (
𝑀𝑡
𝑀∞
) is 
given by, 
Mt
M∞
=
(K0t)
(Ca)
                        (Equation 3.8) 
 
For a cylinder having initial radius ‘a’, the fraction of drug released (
𝑀𝑡
𝑀∞
) is given 
by, 
Mt
M∞
= 1 − (1 − 
K0t
Ca
)
2
                   (Equation 3.9) 
Where, K0 = erosion rate constant  
 C = initial drug loading 
The model by Hofenberg did not confirm the experimental results for drug 
release from a cylindrical geometry, since it did not consider the differential 
erosion rates from radial and axial surfaces (Karasulu et al., 2000). A modified 
equation (eqn. 3.10) was suggested to account for this phenomenon.   
Mt
M∞
= 1 − (1 − 
Kat
Ca
)
2
(1 − 
2Kbt
Cb
)
1
        (Equation 3.10) 
Where, Ka = radial erosion rate constant  
Kb = axial erosion rate constant  
C = initial drug loading 
a = initial radius of the cylinder 
b = initial thickness of the cylinder 
Due to the heterogeneous nature of bulk erosion, few attempts have been 
made to describe such matrices mathematically. A broader model that can be 
applied to surface eroding, bulk eroding or even intermediate systems was 
reported by Rothstein et al. (2009). The model divided the process of drug 
release into three prominent stages. In the first stage, water diffuses into the 
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polymeric matrix and causes hydrolysis of the matrix. The rate of this process is 
dictated by the hydrolysis rate as well as the diffusion gradient for water. 
Following diffusion of the water, water that was not used in the hydrolysis 
dissolves the free drug. Therefore the rate limiting factors in the second stage 
are concentration of the drug, saturation solubility of the drug and the amount of 
dissolution media available. The third stage involves diffusion of the dissolved 
drug out of the matrix. This process depends on the porosity and the diffusion 
path availed by the matrix undergoing degradation. A mathematical derivation 
for drug release kinetics, based on these variables reads as follows (equation 
3.11): 
∂CA
∂t
=  ∇(Deff∇CA) + KdisCSnCAnCWn   (Equation 3.11) 
Where, CA = concentration of the dissolved drug. 
Kdis = intrinsic dissolution rate constant.  
CSn = normalized concentration of solid drug in the polymer matrix. 
CAn= difference between the aqueous drug concentration and its saturation solubility. 
CWn = normalized concentration of water in the polymer matrix. 
Deff = effective diffusivity term. 
3.4.2. Polymers for bioerodible matrix systems 
The four prominent groups of bioerodible/ biodegradable polymers include 
poly (anhydrides) (PAH), poly (ortho-esters) (POE), Poly (esters) of lactic (PLA) 
/ glycolic acid (PGA) and poly (amides) (PA) (Uhrich et al., 1999). Based on the 
erosion mechanism, the prior two are classified as surface eroding polymers, 
whereas the latter are referred to as bulk eroding polymers. Since drug release 
from surface eroding matrices can be easily tailored by changing the geometry, 
PAH and POE have been comprehensively used in controlled drug delivery 
systems. The primary application of bulk eroding polymers involves implantable 
biomedical devices (bone fixation screws, stents), where the bulk erosion 
mechanism allows mechanical strength as well as the shape of the matrix to be 
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maintained for an extended duration. Considering the scope of this report only 
the poly-esters of lactic and glycolic acid are discussed here. 
3.4.2.1. Drug release from poly-esters of lactic and glycolic acid  
Polyesters of α–hydroxy acids have been widely used in the production of 
high strength, high modulus biomedical devices, owing to their semicrystalline 
and bioresorbable nature. Such devices can be designed to release a drug at a 
local site of application for longer durations. Initial approaches to couple a 
therapeutic agent with a biomedical device involved coating the device with a 
drug loaded bioresorbable polymer. Stenberg et al. (2007) utilised this approach 
for coating metallic stents with a PLA matrix containing an anti-proliferative 
agent. In another study, extruded PLA fibres were subjected to tensile drawing 
and then hot compacted to create braided stents (Mikkonen et al., 2009). A drug 
was incorporated by solution coating with an additional polymer layer. Drug 
release in either case followed first order kinetics, where the release rate was 
dependent on the drug loading and the hydrophobicity of the drug. 
 In general, matrices made from PLA show a sigmoidal release pattern 
with an initial lag phase followed by a faster release phase, finally reaching a 
plateau (Miyajima et al., 1997). This is attributed to the fact that the initial stages 
in the bulk erosion of PLA are characterised by water penetration and loss of 
mechanical strength, but no actual erosion takes place. In this stage the drug is 
released mainly by diffusion, according to the Higuchi model (equation 3.5).  
Miyajima et al. (1997) confirmed through DSC and SEM studies that on 
exposure to water an amorphous PLA matrix underwent a transformation into a 
porous semicrystalline structure.  These pores contain crystal defects in the 
form of hydrophilic chain ends, which promote water penetration; consequently 
leading to enhanced drug release. Teupe et al. (1992) obtained a similar three 
phase release pattern for ciprofloxacin from melt extruded PLA cylinders. The 
release profile, however, was evaluated by conducting microbiological inhibition 
assays instead of chemical/ spectroscopic measurement.  
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Similar to PLA, poly (glycolic acid) (PGA) and their lactic acid copolymers 
(PLGA) have witnessed a plethora of applications in controlled release drug 
delivery systems (Grayson et al., 2003; Schmitt and Polistina, 1976; Singh et 
al., 2004). Biodegradation of PGA homopolymer is 6-7 times faster than that of 
PLA. Therefore, copolymerisation of lactic and glycolic acids in different ratios 
yields polymers with a desired biodegradation rate as well as mechanical 
strength (Lewis, 1990). In several independent studies (Li, 1999; Naraharisetti 
et al., 2006), the proportion of the glycolic acid in the oligomer was 
systematically varied, with a common observation that a higher glycolic acid 
content accelerated drug release. Quantitative Nuclear Magnetic Resonance 
(NMR) studies provided further insight into the degradation of PLA/PGA 
matrices; suggesting significantly slower hydrolysis of the PLA backbone, it 
being sterically hindered by the methyl side group (Alexis et al., 2006) 
The drug delivery matrices composed of PGA display a triphasic release 
pattern similar to PLA (Shah et al., 1992). A mechanism for polymer 
degradation and drug release from PGA matrices was explored by Hurrel et al. 
(2001a; 2001b). They evidenced a sigmoidal release pattern, overlapping with a 
four-phase bulk degradation pattern. In the short first stage, a small amount of 
water diffuses into the sample and reaches an equilibrium concentration within 
the polymer. This is followed by the stage II, which is characterised by the 
hydrolysis reaction. The polymer chains become increasingly mobile as the 
molecular weight falls and water plasticises the sample. The mobile chains 
undergo insertion crystallisation. A critical molecular weight is reached at the 
beginning of stage III, and oligomers start to leach out. Water molecules diffuse 
into the space created by the removal of the oligomers, which in turn encourage 
more oligomers to diffuse out. At stage IV, the whole sample is porous and 
highly crystalline. Degradation proceeds homogeneously and more slowly in 
this stage.  
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3.4.2.2. Factors affecting drug release from PLA/ PLGA 
 Hydrolytic degradation and drug release from PLA/ PLGA depends on 
their enantiomeric composition, crystallinity and molecular weight, etc. (Alexis, 
2005). The enantiomeric composition plays a vital role, owing to higher 
susceptibility of the L-isomer of the lactic acid to hydrolysis than the D-isomer 
(Li et al., 2000). Moreover, the enantiomeric composition shapes the crystallinity 
of PLA, which further influences the release of a bioactive agent. The effect of 
crystallinity and the crystalline morphology of PLA on drug release is 
discussed at length, later in this chapter.   
A higher molecular weight indicates higher diffusional resistance or 
slower erosion. Therefore, drug release from the polyesters of alpha hydroxy 
acids exhibits an inverse relationship with their molecular weight (Omelczuk and 
McGinity, 1992; Park, 1994). Contrasting results were obtained by few 
researchers (Cam et al., 1995; Wu and Wang, 2001). They attributed this to the 
lower crystallisation tendency of higher molecular weight PLA, which enhances 
its biodegradation.  
Drug release from PLA/ PLGA matrices is also governed by the nature 
and solubility of the drug, and importantly the size of the matrix. Witt et al. 
(2001) observed the degradation rate decreasing in order from tablets, rods, 
films to microspheres. Although, larger matrices hydrolyse faster, existence of a 
bulk degradation mechanism may restrict the ability of the drug and the 
degraded oligomers to leach out, resulting into heterogeneous drug release (Lu 
et al., 1999; Witt and Kissel, 2001).  
Higher drug loading accelerates the overall drug release with a higher 
initial burst (Sampath et al., 1992; Wada et al., 1990). Moreover, an acidic or a 
basic nature of the compounded drug plays a key role in shaping polymer 
degradation and consequently drug release. Miyajima et al. (1998) reported a 
rise in the Tg of the PLGA rods when they were compounded with basic drugs. 
This was linked to a probable interaction between the basic drug and the 
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carboxyl groups of the polymer, which reduced drug release. Moreover, such an 
interaction may attenuate the autocatalytic effect of the acidic chain ends, 
resulting into slower polymer erosion (Mauduit et al., 1993).  Contrastingly, 
several groups observed higher polymer erosion when a basic drug was 
incorporated. They attributed it to the base catalysed hydrolysis of the ester 
linkages (Cha and Pitt, 1989; Li et al., 1996). Alexis et al. (2006) suggested that 
neutralisation of carboxylic groups by basic drug may occur when the molecular 
weight of the polymer is low enough to have plenty of end groups. In the case of 
a higher molecular weight PLA, they found base catalysed hydrolysis to be the 
predominant mechanism.  
Apart from a drug, other additives such as plasticisers can enhance 
drug release, either by reducing the Tg of the matrix or by creating fluid filled 
channels, following their solubilisation (Andreopoulos, 1994; Kranz et al., 2000). 
Moreover, a change in the in vitro experimental conditions may be reflected 
into the drug release profile. Extreme acidic and alkaline pH of the release 
medium accelerates the hydrolysis by acid catalysis and base catalysis 
respectively (Belbella et al., 1996; Makino et al., 1986). The degradation 
mechanism shows a strong temperature dependence, with temperatures 
above Tg showing a drastic augmentation of degradation (Aso et al., 1994; 
Hakkarainen et al., 1996). Arm et al. (1997) observed faster release of bovine 
albumin from PLGA  (50/50) rods when they were subjected to a cyclic bending 
load. Applied stress leads to elongation of pores into wider cracks, which 
further enhances the release. In vivo, this might correlate to drug release from a 
biomedical device (such a bone fixation screw), which is constantly subjected to 
a stress.  
In summary, it is safer to state that drug release from PLA/ PLGA matrices 
is simultaneously controlled by several factors. A thorough understanding of all 
these factors is necessary before the observed change in release patterns can 
be attributed to a particular one.  
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3.5. Controlled drug release models 
Translation of the drug release data into a mathematical function facilitates 
a quantitative interpretation of the underlying mass transport mechanism. 
Several mathematical models that describe controlled drug release are reported 
in the literature (Costa and Sousa Lobo, 2001). Few are derived by a theoretical 
analysis of the release process, e.g. zero order kinetics; while, the most are 
empirical and correspond to the known release mechanisms, such as diffusion, 
swelling, and erosion. The relevant models are summarised in the table 3.1. 
The drug release data is usually plotted into the mathematical format 
corresponding to the individual model and the best model is selected by 
statistical analysis such as regression or analysis of variance (ANOVA). 
Table 3.1: Mathematical models describing controlled drug release 
The model Mathematical expression 
Applicable if 
the following 
is linear 
Significance 
First order 
kinetics 
Qt = Q0 + e
−kt 
𝐐𝐭 = Cumulative release 
𝐐𝟎 = Original amount of drug 
K = proportionality constant 
t= time 
Y-axis: 
Log(Q0 − Qt) 
X-axis: time 
Drug release rate dependent on the 
concentration of drug available 
Zero order 
kinetics 
Qt = Q0 + Kt Y-axis:Qt 
X-axis: time 
A constant drug release rate 
Higuchi 
Model (1963) 
Qt = √
Dε
τ
(2Q0 − εCS)CS t 
D = diffusivity, 𝛆 = porosity 
𝛕 = tortuosity of the diffusion path 
CS =saturation solubility of the 
drug in the release medium 
Y-axis:Qt 
X-axis:√time 
Describes drug release by diffusion 
through the polymer and the water 
filled pores. 
Drug release follows the Fick’s 
diffusion law. 
Hixson–
Crowell 
(1931) 
Q0
1
3⁄ −  Qt
1
3⁄ = KS t 
KS is a constant accounting for the 
change in the geometry 
Y-axis: 
Q0
1
3⁄ −  Qt
1
3⁄  
X-axis: time 
Describes drug release limited by 
erosion of the matrix. Accounts for 
the change in the geometry of the 
matrix as it is eroded. 
Korsmeyer–
Peppas 
model (1983) 
Qt
Q0
=  Ktn 
 ‘n’ is the release exponent 
predicting the release mechanism 
Y-axis: 
Log(
Qt
Q0
⁄ ) 
X-axis: 
log (time) 
n ≤ 0.5: Fickian diffusion. 
0.5 < n < 1: Non-Fickian transport. 
n = 1: Case II transport responsible 
for the zero order release. 
n ≥ 1: Super case II transport. 
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3.6. Orientation of polymers 
The volume and prospects of research related to oriented polymers are 
continuously growing particularly since the last decade. Examples of polymer 
orientation encountered in day-to-day-life are silk, cobwebs etc. (Christopher, 
1997; Termonia, 1994). Frenkel S (2008) has divided routes of formation of 
oriented structures, principally into three categories. The natural process of 
spinning silk is categorised under 'direct generation'. The second mode of 
orientation involves assemblage of microstructures into a macrostructure, where 
the macrostructure essentially has a similar morphology to that of its 
fundamental units. The phenomenon can be understood through the process of 
organisation of collagen fibres from a solution of tropocollagen or even primary 
gelatine. Assemblage simply involves organisation of existing microstructure 
and hence virtually no energy is required for this thermodynamic event. The 
third mode of orientation in contrast to assemblage requires a great deal of 
energy and is referred to as 'rearrangement'. The existing structure decides the 
statistical possibility of different configurations and the energy barrier involved in 
a jump from one to another. Rearrangement of polymer structure on tensile 
drawing is an example of such a process. To understand the phenomena of 
orientation in synthetic semicrystalline polymers, it is important to know the 
structural/ morphological features present within such polymers. This 
understanding can then be extrapolated to comprehend the changes in oriented 
drug – polymer composites and its implications on drug release. 
3.7. Morphological structures within a semicrystalline polymer 
Ordinarily, polymer chains exhibit an entangled mesh due to secondary 
forces of attraction such as Van der Waal's forces, hydrogen bonds, etc. In the 
case of semicrystalline polymers, stereological constraints imposed by covalent 
bonds within the chain structure give rise to supramolecular structures of 
different dimensions and shapes. In other words, semicrystalline polymers co-
exhibit a randomised chain structure along with some highly ordered regions, 
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commonly referred to as amorphous and crystalline domains respectively. The 
spatial and numeric distribution of these regions depends primarily on the 
average molecular weight, structural features and process history of the 
polymer (Tung and Buckser, 1958). In a molten state, polymer chains are 
randomly distributed. Ideally, if this mass is quenched rapidly, the random 
distribution is frozen in its isotropic state and hence the polymer exhibits an 
amorphous morphology. On the other hand, if the polymer is allowed to cool 
slowly, it provides sufficient time for crystal growth. (Mandelkern, 2002). The 
percentage crystallinity, as well as morphology and organisation of the 
crystalline regions play a vital role in shaping polymer properties. Thus, 
manipulation of polymer morphology offers an enormous potential for tailoring 
its properties according to the designated application. 
3.7.1. Morphology of the amorphous section  
 The amorphous region within a polymer can most conveniently be 
simulated by a random mesh of spaghetti. Amorphous segments act as chains 
that tie and hold together the crystallites, hence are sometimes referred to as tie 
molecules. Configuration of amorphous chains depends on the nature of the 
crystalline region. If the polymer has long needle like crystals, then amorphous 
chains are typically present as overgrowths from either ends of the needle 
(Wenderoth et al., 1985). However if the polymer exhibit lamellar geometry, 
then amorphous chains act as intra-lamellar and inter-lamellar connecting 
molecules (Men et al., 2003). These interconnecting links within the polymer 
structure reduce brittleness and bestow pliability, extensibility and ability to 
recover the structure. 
3.7.2. Morphology of the crystalline section 
The process of crystallisation signifies attempts by the atomic units to 
achieve the lowest possible free energy state. Long polymer chains can achieve 
a lower free energy state by folding upon themselves. Such folding continues 
simultaneously in different regions, leading to several lamellar crystals being 
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spanned by a single polymer chain. The model suggested by Keller (1992) 
explained the folding to be sharp with adjacent re-entry of polymer chains 
(figure 3.8 - A). The previous model considered chain folding to be random 
(Flory, 1962) and was called the switchboard or irregular re-entry model  (figure 
3.8 - B). 
 
Figure 3.8: Lamellar folding models. A) Adjacent re-entry, B) Switchboard model 
3.7.3. Spherulites, shish-kebab and fibre like superstructures 
3.7.3.1. Spherulite 
 A spherulite is a spherical aggregate of polymer crystals (figure 3.9 - A). 
Formation of this birefringent entity can be easily observed in solidifying melt of 
poly (ethylene oxide) (Cheng et al., 1990; Price and Kilb, 1962). A spherulite is 
essentially a high-density packing of lamellae. The presence of a temperature 
gradient in the direction perpendicular to the molecular chain leads to stacking 
of a lamellar arrangement. Whenever such a gradient is absent, lamellar growth 
can occur radially emerging from a single point, hence giving rise to a 
spherulitic structure. In early growth stages, a rod like structure is developed, 
which undergoes branching and expansion to a double inverted umbrella, 
ultimately leading to a sphere (Price, 1961). Formation of spherulites is 
dependent on nucleation density, molecular weight and cooling rate (Barnes et 
al., 1961; Godovsky et al., 1972). Therefore, size of the spherulites vary largely 
from 1µM to 1cm (Silvestre C et al., 2000).  
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3.7.3.2. Shish-Kebab structure 
 Many processing methods such as injection moulding and fibre spinning 
involve application of high shear to the polymer melt and induce extensional 
flow. Consequently, a unique anisotropic microstructure called 'Shish Kebab' 
can be formed (Schultz et al., 2000; Wang et al., 2004). Fundamentally, the 
Shish-Kebab structure is composed of central fibrillar bundles oriented in the 
flow direction with a regular, transverse growth of lamellae, perpendicular to 
chain direction (figure 3.9 - B). The prior is called ‘Shish’ and the latter ‘Kebabs’. 
Such a structure was first investigated and modelled by Penning (1967). The 
shish bundles were thought to be made up of extended polymer chains 
organised in the direction of melt flow. Whereas, the secondary nuclei attached 
to the extended chains give rise to lamellar folding in the perpendicular direction 
(Somani et al., 2005). It has been observed that the presence of the shish-
kebab morphology markedly enhances tensile strength, barrier properties and 
thermal stability of polymers (Pornnimit and Ehrenstein, 1991; Vasile, 2002).  
 
Figure 3.9: Schematic representation of A) the spherulitic crystals and B) the shish-
kebab crystals in a semi-crystalline polymer. 
 [adapted from (Somani et al., 2005) originally from (Meijer-Han, 1997)]. 
3.7.3.3. Fibrils 
Fibrillar crystal structure is a very important morphology developed in 
highly oriented polymers. Fortisan, an ultra-oriented cellulose as well as Nylon 6 
show fibrillar units. Fibrils in Nylon 6 are made up of lamellar folding where the 
Kebab 
Folded lamellar 
region 
(A) (B) 
Inter-lamellar amorphous 
region 
Shish 
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polymer chains lie at right angles to the fibril length. Contrarily, the fortisan 
chains are aligned roughly parallel to the long axis of the fibre. During melt 
crystallisation, if an extended set of nuclei are confined to a plane surface it 
leads to generation of fibrils that does not further develop into spherulites 
(Sharples, 1966). Similarly, tensile drawing of PLA to a significantly higher strain 
and/or near the melting temperature generates a beta crystalline form, having 
fibrillar morphology.  
3.8. Methods to achieve orientation 
 Deliberate orientation can be produced through a variety of methods, 
classified as solid-state and fluid-state orientation processes. Important ones 
are reviewed in figure 3.10. 
 
 
Figure 3.10: Polymer orientation methods. 
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3.8.1. Solid-state processes 
 The term solid-state orientation signifies orientation of a polymer above 
its glass transition but below the melting. The solid-state processes are 
categorised under drawing (tensile/ die drawing), extrusion (ram/ hydrostatic), 
blowing and rolling. Of these, tensile drawing and die drawing will be utilised in 
the current research.  
3.8.1.1. Tensile drawing  
The tensile drawing process for a film like geometry can be easily 
visualised through the simple tensile test, where the sample is clamped at either 
ends and extended, keeping one end fixed. When stretching a film using a 
tensometer, necking may lead to a decrease in the width of the film. In order to 
keep the width constant, equipment such as a biaxial stretcher is used. 
Generally a square film is clamped at multiple positions along all four sides and 
then extended along a single axis. Alternatively, the film can be oriented along 
both of the axes to the same or different extents, either simultaneously or in 
succession. These processes are referred to as Uniaxial Constant Width (UCW) 
orientation and biaxial orientation respectively. The biaxial stretcher is usually 
provided with an oven and can operate at various strain rates. However, such 
an instrument is useful only at a laboratory scale. At an industrial scale, the 
process has to be continuous and therefore a roller system is used in line with a 
film extruder. To achieve uniaxial orientation the extruded film is passed 
between two rollers, the latter rotates at higher speed than the previous. The 
draw ratio (the final length divided by the original length) depends on the ratio of 
the speeds of two rollers. Orientation can also be induced with a single roller, if 
its speed is higher than the exit velocity of the polymeric film, from the melt 
extruder die. In such cases, the draw ratio is the ratio of the chilled roller 
velocity and the exit velocity of the film (Sreenivas et al., 2011b). For producing 
biaxial orientation, a tentering frame is used sideways, along with a roller 
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system. Clamps within the frames grab the film on its lateral edges and 
gradually stretch it to the final width.  
Owing to the methodical variations, entirely different structures are formed 
during various tensile drawing processes (figure 3.12). Uniaxial drawing 
involves deformation of spherulitic or stratified lamellae into an extended chain 
structure (Peterlin, 1965). In simultaneous biax, molecular chains are pulled in 
either direction simultaneously; hence, poor overall orientation is developed 
(figure 3.12). On the contrary, sequential-biax involves development of a strong 
orientation in the primary drawing direction, followed by rotation of crystallites 
and amorphous chains towards the second drawing direction (figure 3.12) 
(Hinrichsen et al., 1981b; Ou and Cakmak, 2008). The uniaxial drawing leads to 
generation of unidirectional anisotropic properties, whereas biaxial orientation 
enhances the film properties in the longitudinal as well as the transverse 
direction (Ajji et al., 1997; Lee et al., 2000; Ng et al., 2000; Penel-Pierron et al., 
2001) 
3.8.1.2. Die drawing  
The ‘die drawing’ process was originally invented by Coates and Ward 
(1980; 1979; 1981), as an energy efficient method, that could significantly 
enhance mechanical properties by reaching a higher draw ratio. In this process, 
the sample is heated within an oven, by dielectric means or by a brief localised 
contact with a heated plate (Kamezawa et al., 1979). The softened sample is 
then pulled through a conical die, leading to orientation of polymer chains in the 
drawing direction. The sample can assume various shapes such as rods, tubes, 
sheets or monofilament, depending on the initial geometry of the sample and 
the die geometry.  
To begin with the die-drawing of rods, a billet is machined into a conical 
shape that fits the die and a tag that protrudes through the die exit. The very 
first reported die drawing process (Coates and Ward, 1979) used a die housed 
in an aluminium heating block. The die housing was drawn upwards using the 
 38 
 
tensile test equipment, keeping the tag of the billet attached to the fixed grips. 
This assembly was later modified into stationary die housing, which had a 
tubular heating chamber. The billet was drawn by pulling the tag end. The latter 
method allowed design of a continuous process (Morath et al., 1993). 
Coates et al. (1979; 1981) described the advantages of die drawing over 
conventional processes as follows: 
1. A rise in the polymer density due to initial compression inside the die 
followed by a slow drop in the density, paralleled with the drawing process 
ensures that the polymer can be drawn to a significantly higher draw ratio.  
2. A higher draw ratio results into a greater production rate.  
3. Lower loads are needed to pull the material through a die than pushing it, 
as in the case of hydrostatic extrusion. 
4. The process can be adapted to a bigger scale, nevertheless can made 
continuous. 
 
 
Figure 3.11: Die-drawing of a polymer billet 
A sample undergoing die drawing can be divided into 5 different zones, as 
represented in figure 3.11. Region A represents an un-deformed billet, which 
follows the die walls as shown by region B. Depending on the strain rate and 
the drawing behaviour of the polymer, it may leave the die wall earlier than the 
exit, due to necking (region C). A change from compression to tensile extension 
takes place while moving from region B to C, followed by a free draw in region 
 39 
 
D. A significant difference between the drawing within region C and region D is 
that the former takes place under isothermal conditions, whereas the latter 
takes place while the sample is cooling down. Finally, the polymer cools down 
below the glass transition temperature and exhibits no change in the geometry 
(region E). The degree of deformation imparted by the die drawing process is 
characterised by a ‘nominal draw ratio, RN’ and an ‘actual draw ratio, RA’; 
Where, RN is the ratio of the initial cross-sectional area to that at the die exit, 
and RA is the ratio of the initial and final cross sectional areas of the product 
(Vgenopoulos, 2012). 
The morphological features developed during the process of drawing 
depend on draw speed, draw ratio, molecular weight of the polymer, and the 
drawing temperature (Bigg, 1976). The drawing transforms the lamellae into 
microfibrils. Microfibrils from the same spherulite or the lamellar stack are 
bundled together into larger fibrils as the draw ratio increases (Tormala, 1992).  
Die drawing of PLA has been utilised to produce biomedical devices such 
as pins, screws (Nordstrom et al., 2001; Saikku-Backstrom et al., 2000) and 
spiral or knitted stents (Petas et al.) with enhanced mechanical properties. 
Compounding a drug with such biomedical devices combines the advantages of 
higher mechanical strength with bioresorbability and controlled drug release 
(Tormala et al., 2003).  
3.8.1.3. Miscellaneous solid-state methods 
A great deal of work has been done using hydrostatic extrusion as a 
method of polymer orientation (Mead et al., 1979; Nakamura et al., 2001; 
Nakayama and Kanetsuna, 1977; Pan et al., 1987). In contrast to die drawing, 
extrusion involves pushing a sample through a suitable die and hence offers a 
better control over the final dimensions of the sample. Moreover, since 
hydrostatic extrusion uses compressive forces (as opposed to the tensile forces 
in die drawing), cavitation is avoided even at higher draw ratios. Therefore 
materials oriented to a higher draw ratio by hydrostatic extrusion have higher 
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mechanical strength than those oriented by die drawing (Mohanraj et al., 2006). 
The properties of the extruded material depend on the extrusion rate, the 
extrusion temperature and the molecular weight of the polymer.  
In die drawing, a visible macro neck is formed which gives rise to 
anisotropic transformation of the structure. Conversely, extrusion involves 
gradual transformation of nearly isotropic matrix into a highly anisotropic one, 
through formation of several invisible micro-necks throughout the matrix. In 
hydrostatic extrusion a fluid filled inside a pressure vessel transmits the 
extrusion force. Alternatively, the force can be generated directly by a piston; 
referred to as ‘the ram extrusion’. Owing to the lubricant action of the fluid in the 
hydrostatic extrusion, homogenously oriented product can be produced at a 
lesser haul-off load as opposed to the ram extrusion (Coates and Ward, 1978).  
 Biaxial orientation can be achieved by extrusion of the molten polymer 
matrix through an annular die (Choi et al., 1982; Kwack et al., 1988) or 
alternatively by passing a softened polymer mass through rollers having 
separation lesser than the polymer mass thickness (Wilchinsky, 1963). The 
prior process is called film blowing and has been widely used in making plastic 
bags. The tubular mass extruded out of annular die is blown by air to form a 
bubble, which is then taken up by rollers in the form of double-layered film.  
3.8.2. Fluid-state processes 
 Fluid-state processes are predominantly used for preparation of fibres. 
The polymer can exist in a fluid-state either as a melt or as a solution. When the 
molten polymer passes through a die or a spinneret onto a chilled roller, the 
process is called as ‘the melt spinning’. The extensional flow of the melt is the 
principal route for orientation of the polymer chains in the spinning direction. 
Thermolabile polymers, which degrade at high temperature, cannot be 
processed using melt spinning; instead, they are spun in the solution form. A 
concentrated, viscous solution of a polymer is similarly passed through the 
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spinnerets into a heated column or an anti-solvent. Such a process is referred 
to as solution spinning.  
3.9. Morphological developments associated with orientation of PLA 
 The deformation behaviour and growth of crystalline morphology in PLA 
matrices, during the process of orientation depends on the strain rate, draw 
ratio, processing temperature, molecular weight and percentage racemisation. 
Tensile deformation of PLA is postulated to happen in a triphasic manner 
(Kokturk et al., 2002). At low draw ratios only the disentanglement and 
orientation of amorphous chains takes place in the drawing direction. This is 
followed by formation of a mesophase with architectural framework for further 
organisation. The last stage involves development of three dimensional 
crystalline structures. No orientation is observed if the draw rate is lower than 
the inverse of chain relaxation time. Nevertheless, the strain rate higher than 
plastic deformation limit of the crystalline region results into fragmentation of 
crystallites and consequent cavitation. Takagi et al. (2004) highlighted the 
correlation between strain induced crystallisation and draw ratio. Films 
stretched to a draw ratio 2 showed higher elongation at failure, primarily due to 
amorphous orientation. From draw ratio 3 onwards, strain induced 
crystallisation restricts further drawability of the matrix, evidenced as a fall in the 
elongation at failure. However this is valid only for lower drawing temperatures. 
At higher temperatures, thermal crystallisation predominates and even films 
drawn to a draw ratio of 2 show crystallisation (Wong et al., 2008). Zhang et al. 
(2011) suggested that, for up to 100% deformations, orientation of amorphous 
phase and strain induced crystallisation occurs. During 100 - 160% deformation, 
critical stress is exceeded and leads to the destruction of formed crystals and 
cavitation. This is accompanied by the formation of new crystals from already 
ordered amorphous chains. This phenomenon continues until cavitation 
dominates the crystal growth, where the sample starts to fail.  
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At lower deformation temperature preferential orientation of amorphous 
chains is followed by strain induced crystallisation of already oriented 
amorphous chains. Therefore a highly oriented matrix is generated, whose 
crystallinity rises with the draw ratio. At higher drawing temperatures, greater 
chain mobility results in copious chain relaxation coupled with enhanced 
thermal crystallisation. Consequently, matrices with higher crystallinity and poor 
orientation are generated (Mulligan and Cakmak, 2005) 
 
 
 
 
 
Figure 3.12: Deformation mechanism in the uniaxial constant width and the biaxial 
drawing modes. (Adapted from: (Ou and Cakmak, 2008)) 
The resultant morphology varies with tensile stretching modes, namely 
uniaxial constant width (UCW), simultaneous biaxial (SB) and sequential biaxial 
(SEQ) stretching (Ou and Cakmak, 2008). UCW stretching leads to orientation 
of polymer chains in the stretching direction (figure 3.12 - A), which is 
accompanied by strain induced crystallisation above a certain strain. Increase in 
degree of orientation and crystallinity accompanies further extension. When 
such a film is sequentially drawn in the transverse direction, the preliminary 
draw ratio plays a key role in deciding the new morphology developed. If the 
first drawing has achieved higher-level crystalline order due to a high draw ratio, 
transverse stretching leads to destruction of the existing lamellae and their 
restructuring into the new drawing direction (figure 3.12 - C). Whereas, if the 
crystalline phase in not well developed in initial drawing direction due to a lower 
draw ratio, simple rotation of the crystallites may occur with little damage to the 
(A)UCW mode (C) SEQ mode  (B) SB mode 
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existing structure. In the SB mode, randomly distributed chains are 
simultaneously extended along two perpendicular axes (figure 3.12 - B). This 
reduces the statistical probability of the like chain interactions; consequently, a 
lower crystallinity is developed in the SB mode than the SEQ mode.   
 
 
Figure 3.13: Spherulite deformation leading to formation of macrofibrils. 
The morphological changes associated with die drawing of PLA are not 
comprehensively reported. However, an understanding can be developed by 
studying the corresponding changes associated with related polymers. Die-
drawing of an amorphous polymer matrix can generate varied crystalline 
morphologies depending upon the draw ratio and the processing conditions. 
Contrarily, a crystalline matrix is gradually transformed from an isotropic 
structure to an anisotropic structure with respect to the draw ratio (figure 3.13). 
A detailed microscopic analysis of high molecular weight polyethylene 
(HMWPE) rods, drawn to different draw ratios, revealed the changes in 
crystalline structure during die-drawing (Li and Lee, 1993). Undrawn material 
showed the presence of spherulites. These were aligned along the drawing 
direction at smaller draw ratios. With a further increment in the draw ratio, the 
spherulitic structure disappeared and oriented sheaf-like lamellae were formed. 
Ultimately, at a draw ratio of about 12, plastic deformation of the lamellae led to 
formation of microfibrils (Ajji et al., 1997; Li and Lee, 1993). Further extension 
would generate spindle like macro-fibrils bundled together from the individual 
micro-fibrils (Peterlin, 1975). The correlation between the draw ratio and 
oriented structure may follow a different scale for PLA. Nevertheless, formation 
Macrofibrils containing 
microfibrils 
Generation of the 
microfibrils Spherulite 
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of the fibrillar structure, from a spherulitic initial morphology has been confirmed 
by several reports (Pohjonen et al., 1997; Tormala, 1992; Tormala, 1993).  
3.10. Methods for deliberate manipulation of PLA crystallinity 
It has been extensively reported in the literature that the level of 
crystallinity and organisation of the crystalline phase plays a significant role in 
affecting drug release from PLA matrices (section 3.12). Strain induced 
crystallisation is an event that invariably accompanies solid state orientation of 
PLA and may have influence on the drug release profile of the oriented 
matrices. Nevertheless, crystallinity of PLA can also be manipulated deliberately 
by various approaches, as described below.  
Crystallization of optically pure PLLA is extremely sluggish. Consequently, 
an amorphous polymer can be obtained by cooling from the melt, at rates as 
low as 5 °C/min (Salmeron Sanchez et al., 2007). Although no crystal growth 
occurs during such cooling, it generates several dormant nuclei (Yasuniwa et 
al., 2006). These subsequently lead to “cold” crystallisation of PLA if the 
temperature is raised above the glass transition. Pyda et al. (2004) confirmed 
that the extent of cold crystallisation can be controlled by varying the heating 
rate; where faster heating rates result in lower degree of crystallinity.   
 
Figure 3.14: Optical micrographs between crossed polars for samples isothermally 
crystallized at various temperatures (adapted from (Yasuniwa et al., 2006)) 
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Crystallisation of PLA from solution, melt state or isothermal crystallisation 
at temperatures exceeding 120 °C results in formation of the α crystalline form 
(Kawai et al., 2007). Contrarily, when isothermally crystallised at temperatures 
below 120 °C, generation of the α’ Form has been reported (Zhang et al., 2006). 
Both the α Form and the α’ Form contain -10/3 helical PLA chains that are 
packed into a pseudo-orthorhombic unit cell. However, the α’ Form lacks 
secondary structural order, which makes such packing, slightly disordered 
(Wasanasuk and Tashiro, 2011). Isothermal crystallisation or annealing 
represents the easiest method to raise crystallinity of previously amorphous 
PLA. Due to the absence of a thermal gradient, spherulitic morphology is 
generated in such a crystallisation process. Here, the nucleation density 
decreases with temperature, while the crystal size increases (figure 3.14) 
(Yasuniwa et al., 2006).   
 
Figure 3.15: Polarized optical photomicrographs of PLLA films containing different 
contents of PDLA crystallized at 135 °C (adapted from (Tsuji et al., 2006)). 
The rate of isothermal crystallisation of poly (L-lactic acid) (PLLA) and the 
size of spherulite can be controlled by addition of a small percentage of poly (D-
lactic acid) (PDLA) (Tsuji et al., 2006). The PDLA forms a stereo-complex with 
PLLA which substantially changes the crystallisation kinetics of the latter, due to 
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short induction period, extremely high growth rate and greater nucleation 
density of stereocomplex spherulites (Tsuji and Ikada, 1996). Here the 
stereocomplex acts as a nucleating agent (figure 3.15). 
Organic and inorganic nucleating agents have been extensively used in 
controlling crystallisation of PLA. Nucleating agents reduce the energy barrier 
for nucleation, by acting as epitaxial templates for polymer crystallization. 
Therefore, efficiency of nucleation depends on the epitaxial match of the 
polymer’s crystalline unit cell with that of the nucleating agent. The organic 
nucleating agents for PLA include chemical nucleating agents such as sodium 
salts of organic acids; e.g. sodium stearate (Li and Huneault, 2007). Such 
nucleating agents induce scission of the ester linkages and transfer sodium 
cations to newly generated carboxyl end groups. This leads to formation of 
polymeric ionomers, which subsequently aggregate and act as nucleation 
templates. Nam et al. (2006) evidenced stronger nucleation of PLA by N-N-
ethylenebis (12-hydroxystearamide) (EBHSA). Addition of 1% EBHSA 
enhanced nucleation density, crystallisation rate and crystallinity; contrarily, the 
spherulite size reduced.  
Among the inorganic nucleating agents, talc is often used as a reference 
to compare the nucleation ability of the physical additives. Use of talc as a 
nucleating agent has shown almost seven fold faster crystallisation in PLA, due 
to 500 times higher nucleation density (Kolstad, 1996). In another study, 
addition of corn-starch exhibited a marked increase in crystallinity as well as 
crystallisation rate of PLA (Park et al., 1999). It was evidenced that the size of 
the starch granule critically influenced the level of crystallinity and crystal size in 
the nucleated polymer.  
Crystallisation of PLA melt in the presence of a temperature gradient leads 
to generation of lamellar stacks instead of spherulites. Similarly, application of 
shear to the molten polymer can result in formation of shish-kebab crystals 
(section 3.7) (Xu et al., 2012; Yamazaki et al., 2010). In the presence of an 
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extensional flow (e.g. injection moulding) the polymer chains stretched along 
the flow direction nucleate into the shish strands, while the relaxed chains 
crystallise as lateral outgrowths (kebabs). 
 
Figure 3.16: Enhanced shear-induced crystallization caused by CNTs in PLA melt 
(adapted from (Tang et al., 2012)) 
 Generation of the shish-kebab morphology is challenging in the case of 
PLA due to its semi-rigid backbone and short chain length. This results in 
breakdown of the shear induced nuclei into random coils once the application of 
shear ceases. Xu et al. (2012) successfully generated shish-kebab crystals in 
injection moulded PLA by utilisation of the oscillation shear injection moulding 
(OSIM) machine. This machine imposes very high shear flow on molten PLLA in 
the mould cavity by reciprocal movement of two pistons during the packing 
stage. The authors confirmed the diameter of shish-kebab PLA crystals to be 
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around 0.7 μm, with a long period of ∼20 nm. Such arrangement further 
contained the α crystalline form of PLA. Tang et al. (2012) generated shish-
kebab PLA crystals by adding carbon nanotubes (CNTs) to the sheared PLA 
melt during injection moulding. The CNTs were thought to provide an anchoring 
surface for the extended set of PLA nuclei and prevent their relaxation (figure 
3.16).  
3.11. Effect of orientation on physical properties of polymers 
 The process of orientation leads to restructuring of a polymer such that 
anisotropic properties are developed. The most prominent effect of polymer 
orientation is improvement of mechanical strength (Baji et al., 2010; Bigg, 
1976). Mechanical properties of films can be augmented in a single or two 
directions, by uniaxial or biaxial drawing respectively (Yu et al., 2008). Another 
orientation induced dynamic change that has tremendous industrial significance 
is improved barrier properties. Decreased gas/ water vapour permeability due to 
orientation can be attributed to densification of the barrier phase of the polymer 
matrix (Liu et al., 2002). For example, chain orientation in PET is accompanied 
by a transformation from the 'Gauche' to the 'Trans' conformation. When in 
'Trans' conformation, polymer chains are densely packed; hence have reduced 
permeability. Additionally, strain induced crystallisation, that accompanies the 
orientation process can also enhance the barrier properties, owing to the 
reduced gas/vapour solubility of the crystalline phase. For similar reasons, 
solid-state orientation also reduces the biodegradability of a polymer (Lee et al., 
1997). Cia et al. (1996) evidenced diminished susceptibility of PLA to enzymatic 
degradation, when subjected to orientation. To sum up, there are several 
prominent changes in the properties oriented polymers. This suggests a 
possibility of engineering drug release by polymer orientation. 
3.12. Correlation between the polymer crystallinity and drug release 
 Solid-state orientation of PLA is usually associated with a rise in the 
crystallinity of the polymer matrix. Therefore, the effect of crystallinity on drug 
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release must be known, for better comprehension of the effect of orientation on 
drug release from the PLA matrices. Release of a bioactive agent from a 
semicrystalline polymer depends on the volume fraction of the amorphous and 
the crystalline phases, their organisation, cross-linking density and size of the 
solute (Barrer, 1957). Here, the crystalline phase act as physical cross-links, 
thereby altering the space distribution of the amorphous phase. Since water 
permeation and drug diffusion occurs through the amorphous phase, a change 
in its distribution further changes the transport properties of the matrix (Barrer, 
1957). In such cases, diffusion of a drug may still be treated as Fickian with the 
effective diffusion coefficient Dim defined as Dim = AD/B. Where D is the 
diffusion coefficient in a completely amorphous polymer, A is the “detour ratio” 
which accounts for reduction in solute mobility due to the tortuosity of diffusion 
paths between crystallites, and B relates to the density of the crystalline cross-
links (Peterlin, 1979).  
Since drug release from PLA/PLGA significantly varies with the polymer 
molecular weight, pH of the bathing fluid and physico-chemical properties of the 
incorporated drug; there are varied opinions in the literature, regarding the 
overall effect of crystallinity on drug release from such matrices.  
While studying release of progesterone from PLA microspheres, 
Izumikawa et al. (1991) observed that the amorphous spheres released the 
drug less rapidly than the crystalline spheres. Authors correlated this to the bulk 
interactions between the drug and the polymer matrix. Lower polymer 
crystallinity suggests better drug dispersion and increased drug–polymer 
interactions, consequently resulting into slower drug release. Withstanding the 
above explanation, Hurrel et al. (2002) observed higher burst release from 
annealed and slow crystallised PGA films than that from quenched films. They 
attributed it to exclusion of the drug from the crystalline phase, which creates a 
supersaturated amorphous phase, resulting in partitioning of the drug towards 
the surface. However, drug release in the later stages was independent of the 
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initial crystallinity. Upon permeation of water, the hydrolysed polymer chains 
undergo insertion crystallisation. Owing to this, all the matrices reached nearly 
the same crystallinity by the end of 10 days. Therefore, the mass loss profile 
was same for all the matrices, irrespective of the initial crystallinity, which further 
resulted into the same drug release profile. 
In another study, Miyajima et al. (1997) observed faster initial drug release 
from crystalline PLA films than amorphous films. For PLA of molecular weight 
4000 g/mol, drug release from the crystallised films was monophasic and 
followed the Higuchi diffusion model.  On the contrary, quenched films showed 
extremely slow initial release superimposed with a rise in the crystallinity. This 
was subsequently followed by a faster release phase (Miyajima et al., 1997).  
Tsuji et al. published a series of papers discussing the effect of initial 
crystallinity, crystalline thickness and spherulite size on hydrolytic degradation 
of higher molecular weight (13,00,000 g/mol) PLLA (Tsuji and Ikada, 1998; Tsuji 
and Ikada, 2000b; Tsuji et al., 2000). For the first time they observed PLLA 
degradation by surface erosion, when the in vitro pH was 10. Under such 
conditions, the rate of weight loss per unit surface area decreased linearly with 
the rise in the initial crystallinity of PLLA ﬁlm (Tsuji and Ikada, 1998). When the 
in vitro pH was changed to a near neutral pH (7.4), the degradation occurred by 
the bulk erosion mechanism. For matrices undergoing homogenous bulk 
erosion, Tsuji et al. (2000b) observed a lag until the weight loss began. The 
length of the lag phase increased as the crystallinity decreased. The overall rate 
of weight loss was higher for the matrices having higher initial crystallinity. The 
size of spherulites had no influence on the hydrolysis rate of PLLA in either 
types of release mechanisms (Tsuji and Ikada, 1998). The characteristics of 
PLA degradation were also reflected in the drug release profiles obtained by 
several other authors (Frank et al., 2005; Hurrell and Cameron, 2001a; Hurrell 
and Cameron, 2002; Zilberman, 2005). 
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3.13. The effect of solid-state polymer orientation on drug release 
The exact effect of polymer orientation on the release of a bioactive agent 
can vary between reservoir and matrix systems. It is well understood that the 
oriented films have enhanced barrier properties (Lee et al., 2000; Liu et al., 
2002). Therefore, a highly oriented membrane can retard drug release from a 
reservoir type of system. The only reported example of this is the use of a 
biaxially oriented, heat shrinkable, rate controlling membrane by Higuchi et al. 
(1973b) for making slower release reservoir systems.  
 
Figure 3.17: Cumulative release profile of ciprofloxacin from the reinforced PLA screws 
(adapted from (Veiranto et al., 2002)) 
The situation is poorly understood in the case of matrix type systems, 
since both diffusion and erosion mechanisms shape drug release. Tormala et 
al. (2009; 2008; 2002) have done the pioneering work in examining drug 
release from the solid-state oriented matrix type systems. The only three reports 
available in the literature are from the same research group. Amongst them, 
Veiranto et al. (2002) explored delivery of ciprofloxacin to an infected bone 
through a fixation screw. The screw was manufactured by co-extrusion of 
ciprofloxacin and PLA into a rod, which was then reinforced by die drawing. The 
rod was finally machined into the screw geometry. The screw showed complete 
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drug release within 44 weeks, in vitro. The release profile was sigmoidal (figure 
3.17) with initial sluggish drug release until the 8th week. Thereafter, drug 
release was accelerated for a few weeks, finally reaching a plateau. Tormala et 
al. (2008) described use of polymer orientation as a method of enhancing drug 
release from a bioresorbable polymer matrix like PLA. Any process where a 
drug is compounded with the polymer and the composite matrix is then drawn at 
temperatures above Tg was believed to accelerate the drug release (figure 
3.18). Nikkola et al. (2009) suggested a novel approach of controlling drug 
release by hot-compressing a melt-extruded, a die-drawn and a radiation 
sterilised billet to form a composite billet. The drug release profile of the 
composite matrix was a combination of drug release from the individual 
components.   
 
Figure 3.18: Acceleration of drug release after solid-state orientation (Tormala et al., 
2008) 
Available literature mentioning the effect of polymer orientation on drug 
release is inadequate, since no attempts have been made to understand the 
mechanism by which polymer orientation may affect drug release. Moreover, 
the effect of different degrees of orientation has not been studied. Orientation of 
polymer leads to development of anisotropic or directionally dependent 
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properties. Consequently, drug release in the direction parallel to polymer chain 
orientation can be different from that in the perpendicular direction. Previous 
reports have failed to characterise this phenomenon and have considered drug 
release as a bulk property. Importantly, a role played by the physical and the 
polymorphic state of a drug in affecting polymer orientation and resultant drug 
release profile has not been considered. The aim of this study is to address 
these limitations and construct a fuller picture about drug release from oriented 
matrices.  
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4. Materials and methods 
4.1. Materials 
 Natureworks PLA, grade 4043D was procured through Resinex, UK. The 
weight-average molecular weight determined by GPC was 133 000 g/mol. The 
D-isomer content was approximately 2% w/w of the polymer (Mulligan and 
Cakmak, 2005). The resin has a melting temperature of 155 °C, crystallisation 
temperature between 100 – 120 °C and glass transition around 58 °C. This was 
also confirmed through DSC. Theophylline (Molecular weight (mol. wt.) = 
180.17 g.mol-1, batch no. - TAM-V/110316, Purity ≥ 99%) was supplied by 
KORES (India) Ltd. Mumbai, India. It has melting point (MP) of 273 °C, however 
starts degrading above 230 °C. Curcumin (Mol. wt. = 368.38 g.mol-1, Batch no. 
ASB-00003927-101) was purchased from ChromaDex, USA (supplied through 
LGC stands, UK). The certificate of analysis stated the purity and melting point 
to be 99.7% and 183 °C respectively.  
Other model compounds namely, paracetamol (Mol. wt. = 151.16 g.mol-1, 
MP = 169 °C, Purity ≥ 99%); aspirin (Mol. wt. = 180.16 g.mol-1, MP = 136 °C, 
Purity ≥ 99.5%); caffeine (Mol. wt. = 194.19 g.mol-1, MP = 235 °C, Purity ≥ 
98.5%), nicotinamide (Mol. wt. =122.12 g.mol-1, MP = 128 °C, Purity ≥ 98.5%), 
citric acid (Mol. wt. = 192.12 g.mol-1, MP = 153 °C, Purity ≥ 99.5%), and 
ascorbic acid (Mol. wt. =176.12 g.mol-1, MP = 190 °C, Purity ≥ 98%) were 
purchased from Sigma-Aldrich, UK; whereas, sodium salicylate (Mol. wt. 
=160.10 g.mol-1, MP > 300 °C , Purity ≥ 99.5%) was purchased from Alfa Aesar.  
 SECTION A: PROCESSING TECHNIQUES 
4.2. Extrusion compounding of PLA with model drugs 
 Twin screw extrusion was used as a scalable blending method in the 
current study (Manas-Zloczower, 2012). The polymer and the model drugs 
(shortlisted after thermo-gravimetric screening) were dried using a vacuum oven 
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set at 80 °C for 4 hours, immediately before processing. Since PLA was 
available as pellets and the model drugs were powders, dry blending prior to 
extrusion was not feasible. Therefore, 5% w/w mixtures of the model drugs with 
PLA were prepared by the following method.  
The Drug and the polymer were fed to the extruder using two different 
feeders, set to operate at different feeding rates. A Movacolor MC Micro12 
feeder was used for the model drugs; whereas, A Brabender DDW-MD0-RT-1.5 
gravimetric feeder was used for PLA pellets. The Movacolor MC Micro12 was 
set to operate at 5% gravimetric output of the Brabender DDW-MD0-RT-1.5. 
Both feeders were calibrated before every compounding operation. Melt 
extrusion was carried out using a ‘Thermo Scientific Pharmalab 16’ twin-screw 
extruder having 16 mm barrel bore diameter, 40:1 barrel length to diameter ratio 
and 15.6 mm screw diameter. The screw configuration and the temperature 
profile were set as listed in table 4.1 (Kulkarni, 2013). The extruder was 
operated at a screw speed of 80 rpm. 
Table 4.1: The screw configuration and the temperature profile used in the twin screw 
extruder, during melt compounding 
Approximate 
zones 
Feeding 2 3 4 5 6 7 8 9 10 Die 
Temperature 
(°C) 2
5 45
 
77
 
10
0 
12
5 
15
0 
17
0 
18
0 
18
0 
18
0 
18
0 
Screw element 
type 
C
 
C
 
C
 
C
 
C
 
C
 
C
 
M
30
 
M
60
 
M
90
 
M
90
 
C
 
C
 
D
 - 
L/D 
(total = 40) 
4 4 4 4 4 4 4 
2.
25
 
1.
25
 
0.
5 
0.
5 
3.
5 
2.
5 
1.
5 - 
*(C = conveying element, D = discharge element, M30 = mixing element arranged at 30° to the previous 
element, M60 = mixing element arranged at 60° to the previous element, M90 = mixing element arranged 
at 90° to the previous element) 
Neat PLA was extruded in a similar fashion in order to evaluate the effect 
of melt compounding on the virgin polymer itself. Moreover, to verify the 
efficiency of the melt compounding operation, samples were withdrawn at 
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regular intervals during the extrusion process (n = 6 /hour). The withdrawn 
samples were dissolved separately in 2:1 - acetone: chloroform, followed by 
drug assay using High Performance Liquid Chromatography (HPLC) *(The 
HPLC methods are separately reported in the drug release studies section). 
4.3. Extrusion of the neat and the drug loaded PLA films 
 The neat and the drug loaded PLA films were prepared by the sheet 
extrusion technique, utilising a single screw extruder. The details of the 
extrusion process are displayed in the table 4.2. 
Table 4.2: Details of the film extrusion process 
Instrument details 
Dr. Collins  
Teach-Line E20T 
Temperature 
profile 
45 °C, 110 °C, 160 °C, 170 °C 
and 170 °C for the feed throat, 
the compression zone, the 
metering zone, the adapter and 
the die respectively 
1 
Screw diameter 
(mm) 
20 Screw speed 50 rpm 
2 
Screw length 
(L/D) 
25 
Take up roll 
temperature 
50 °C 
3 
Width of the slot 
die (mm) 
100 Take up roll speed 0.5 metres/minute 
4 Die gap (mm) 
*variable - 
0.2/0.4/0.6/0.8 
Distance between 
the die exist and 
the take up roll 
150 mm 
 
In brief, the polymeric material (virgin polymer or drug loaded extrudates) 
was dried in a vacuum oven (80 °C for 4 hours), immediately prior to extrusion 
and transferred directly to the extruder hopper. The extruder hopper was 
continuously purged with dry nitrogen during the extrusion process, in order to 
minimise moisture absorption. A cast sheet was extruded through the single 
screw extruder, equipped with a slit die. The die gap was adjusted to produce 
drug loaded PLA films with different thicknesses (0.2 mm, 0.4 mm, 0.6 mm, and 
0.8 mm). The initial thicknesses of the films were selected such that the final 
thickness after tensile stretching remained constant (0.2 mm).  The temperature 
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profile and the screw speed were set as listed in table 4.2. The temperature of 
the uptake roller and its distance from the die exit were decided based on 
preliminary trials to produce uniform films. The speed of the uptake roll was kept 
equivalent to the exit velocity of the polymer sheet from the slit die. This was 
necessary to minimise orientation in the extruded films (Sreenivas et al., 
2011a).  
4.4. Solid-state orientation of PLA films 
 
Figure 4.1: The long stretcher used for orientation of PLA films. 
A) Oven, B) Upper and lower oven plates, C) Clamping pins, D) Heat gun, E) X-arm of the stretcher and 
F) Y-arm of the stretcher. 
Neat and drug loaded PLA films were oriented using a T.M. Long biaxial 
film stretcher (figure 4.1). A square sample (60 mm X 60 mm) was cut from the 
extruded sheets. The sample was gripped from all sides by means of the 
clamping pins within the stretcher. Temperature of the oven (the upper and the 
lower plate) was set to a desired value (table 4.3). Hot air, having the same 
temperature as that of the oven plates was blown at the sample for 120 
seconds from the heat guns positioned above and below the sample. The 
softened sample was extended at a previously decided strain rate (table 4.3), to 
a desired draw ratio (eqn. 4.1) by pneumatic movement of the X and Y arms of 
the stretcher. Details of the oven temperatures, strain rates and the draw ratio 
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are discussed below. On complete extension, the oven was opened and the 
sample was allowed to cool before it was removed from the clamps.  
Draw ratio =  λ =  
Final length along a fixed axis (X or Y)
Original length along the same axis
          (Equation 4.1) 
The experiments focussed on orientation of the PLA films were divided in 
two stages. In the first stage, 30 different samples of the oriented films were 
prepared each from neat extruded PLA films as well as from those containing 
5% w/w theophylline or 5% w/w curcumin. This was achieved by varying the 
oven temperature, strain rate, stretching direction and the draw ratio, as 
summarised in table 4.3. These samples were utilised for studying the effect of 
orientation process variables on organisation of the amorphous-crystalline 
domains (structure) within the resultant films. For simplification of this study, 
films with single initial thickness (0.6 mm) were used. 
Table 4.3: Summary of different variables used in orientation of the PLA films 
Batch 
no. 
Mode of 
orientation 
Variable 1 
Oven 
temperature 
Variable 2 
Strain rate 
Variable 3 
draw ratio 
(λ) 
Total 
samples 
Parameter 
studied 
1 UCW 
70 °C, 80 °C, 
90 °C 
0.12 sec-1, 0.57 
sec-1, 1.2 sec-1 
3X1Y 
(constant) 
3 x 3 = 9  
Effect of 
temperature 
and strain rate 
- 32factorial 2 SB 
70 °C, 80 °C, 
90 °C 
0.12 sec-1, 0.57 
sec-1, 1.2 sec-1 
2X2Y 
(constant) 
3 x 3 = 9 
3 SEQ 
80 °C 
(constant) 
0.57 sec-1 
(constant) 
2X2Y, 3X3Y, 
2X3Y, 3X2Y, 
2X4Y, 4X2Y 
6 
Effect of 
sequential 
stretching 
4 UCW 
80 °C 
(constant) 
0.57 sec-1 
(constant) 
2X1Y, 3X1Y, 
4X1Y, 5X1Y 
4 
Effect of 
uniaxial and 
biaxial draw 
ratio 5 SB 
80 °C 
(constant) 
0.57 sec-1 
(constant) 
2X2Y, 3X3Y 2 
6 
Un-
oriented 
80 °C - 1X1Y 1 
- 
Total 30 + 1  
*(X and Y indicates primary and secondary drawing axis respectively, therefore associated numbers 
indicates the strain along that axis. E.g. 3X1Y means stretched to thrice of the original length along X-axis, 
keeping the width constant). 
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The correlation between the oriented structure and the draw ratio was 
studied in uniaxial and biaxial stretching mode. The uniaxial mode was 
restricted to constant width drawing (UCW), where the samples were stretched 
lengthwise, without allowing any change in their width (figure 4.2 - A). Biaxial 
drawing involved stretching the films either simultaneously along the length and 
the width (simultaneous biaxial -SB) (figure 4.2 - B) or stretching them in a 
single direction at first, followed by stretching in the second direction (sequential 
biaxial - SEQ) (figure 4.2 - C). Samples up to a draw ratio of 5X were prepared 
in the UCW mode; while for the SB and the SEQ mode, samples stretched 
along both the axes to twice and thrice the original dimensions were prepared. 
Moreover, samples with a varied degree of extension along the X and Y axis 
were produced using the SEQ mode (table 4.3, figure 4.2). These included 
2X3Y, 3X2Y, 2X4Y and 4X2Y; where X-axis represents the first drawing 
direction, while Y-axis represents the second drawing direction. All of these 
samples were oriented at 80 °C, using 0.57 sec-1 strain rate. 
 
Figure 4.2: Orientation of PLA films using different stretching modes 
 
The effect of drawing temperature and strain rate on the resultant oriented 
structure was studied in UCW and the SB modes (table 4.3). For each of these 
modes, three temperatures (70 °C, 80 °C and 90 °C), and three strain rates 
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(0.12 sec-1, 0.57 sec-1 and 1.2 sec-1) were studied. The UCW samples were 
stretched to a constant draw ratio of 3X; while, the SB samples were extended 
along two perpendicular axes to twice its original length and width (λ = 2X2Y). 
The second stage of the film orientation experiments was focussed on 
drug release testing. Based on the stage 1 results, UCW films with uniaxial 
draw ratios between 1X – 4X, and SB and SEQ films with the biaxial draw ratio 
of 2X2Y were selected for the drug release studies. Variable thickness of the 
oriented films may present a challenge in quantification of the effect of 
orientation on polymer degradation and drug release. Moreover, such films 
have different drug content per unit surface area, which will in turn affect the 
concentration gradient. In order to minimise an influence of these variables, 
films utilised in drug release and related characterisations were prepared from 
the extruded films with different initial thickness, such that the oriented films will 
have a constant thickness (0.2 mm). 
4.5. Extrusion moulding of rods 
PLA rods containing 5% w/w paracetamol were prepared by single screw 
extrusion using a Dr. Collin Teachline E20T extruder, equipped with a billet 
mould containing four cylindrical cavities (figure 4.3 - C). The diameter and the 
length to diameter ratio of the extruder screw were 20 mm and 25 L/D 
respectively; whereas the length and the diameter of the mould cavities were 
160 mm and 14 mm respectively. Each cavity contained a plunger (figure 4.3 - 
D) which moves towards the rear end, as the polymer melt is filled in the mould 
cavities. The mould was attached to the extruder in a vertical position by means 
of an adapter (figure 4.3 - B). The adapter served to change the flow direction of 
polymer melt from horizontal in the extruder to vertical in the mould. Both 
adapter and the mould were heated by external band heaters, controlled by 
Eurotherm® temperature controllers.  
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Figure 4.3: Billet manufacturing assembly. 
A) Single-screw extruder, B) Adapter, C) Billet mould, D) Plungers, E) Base plate, F) Projection 
tool, G) Pneumatic device used for applying pressure. *(blue arrows indicate polymer flow). 
The PLA extrudates previously compounded with 5% w/w paracetamol 
were dried in a vacuum oven at 45 °C for 24 hours, immediately prior to 
extrusion and filled into the extruder hopper covered with dry nitrogen blanket. 
The temperature profile of the extruder was set to 45 °C, 110 °C, 160 °C, 170 
°C and 170 °C for feed throat, compression zone, metering zone, adapter and 
the mould respectively. The screw speed was 50 rpm. All four cylindrical 
cavities of the mould were allowed to fill completely with the polymer melt 
containing paracetamol. This was indicated by the movement of all four 
plungers to the top end of the mould. Following this, the mould was removed 
from the extruder and the base plate (figure 4.3 - E) was rapidly screwed to the 
bottom end that was previously connected to the adapter. A tool shown in figure 
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4.3 - F was placed on the top end of the die, such that each projection lay on 
the plunger in each of the cylindrical cavity. The assembly was placed in an 
empty water bath and a pneumatic pressure of about 13.79 MPa was applied 
from the top end using the instrument (figure 4.3 - G) built in house. This step 
prevents formation of voids if the polymer undergoes shrinkage while cooling. 
The water bath was slowly filled with cold water and the die assembly was 
allowed to cool. Finally, the water bath was emptied, the pressure was released, 
and the billets were removed.  
4.6. Orientation of rods by die drawing 
4.6.1. The apparatus 
 
Figure 4.4: Die drawing rig used for orientation of PLA rods 
The die-drawing rig (figure 4.4) designed and manufactured at the 
University of Bradford was utilised for unidirectional orientation of paracetamol 
loaded rods. The apparatus comprised of an aluminium oven (figure 4.4 - A), a 
die heating block (figure 4.4 - B) and a converging conical die (figure 4.4 - C) 
with a wall angle of 15°. The diameter of the broader end of the die cavity was 
15 mm, while that of the narrower end was 6.25 mm.  The die had additional 2 
mm long section with the fixed diameter of 6.25 mm (parallel walls) at the 
narrower end. The aluminium oven was heated by blowing hot air (30 litres per 
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minute) through a heating element placed at the back of the oven. The 
temperature of the die heating block was elevated by band heaters. The air 
temperature within the oven was monitored by two independent thermocouples 
placed at the top and the bottom of the oven. The entire assembly was mounted 
on a Messphysik BETA 20-7, 5/8 x 18 universal (tensile) testing machine. 
4.6.2. The method 
From a drug release studies perspective, it was important to have oriented 
rods with different draw ratios, but the same diameter. This was achieved by 
machining the extruded billets to different initial diameters, such that drawing 
them through the 6.25 mm conical die will produce rods with varied draw ratios 
but having a constant final diameter. The draw ratio in the case of rods is given 
by equation 4.2. Preliminary trials revealed that the necking behaviour (sec 
3.8.1.2) resulted in the final rod diameter of 6 mm, when the mentioned billets 
were die-drawn at 40 mm/min crosshead speed. Therefore the initial diameters 
calculated using equation 4.2 were 6 mm, 8.48 mm, 10.4 mm, 12 mm and 13.4 
mm for the draw ratios in an order from 1 to 5 respectively.   
λr =  
A0
Af
                           (Equation 4.2) 
Where, λr is the draw ratio of a drawn billet, A0 is the initial cross sectional area of the 
undrawn billet and Af  is the final cross sectional area of the drawn billet. 
A tag (diameter = 6 mm, parallel length = 18 mm, inclined length = 10 mm, 
inclination = 15°) (figure 4.4 - E) was machined onto every billet. A hole was 
drilled at the centre of the rear end of the billet for inserting a thermocouple. The 
billet was placed in the oven such that the tag will protrude through the die exit 
and can be held between the grips attached to the cross-head of Messphysik. 
The oven controller temperature was set to 85 °C which resulted in the oven air 
temperature and the billet temperature of 70 °C, when incubated for appropriate 
time as per the thickness of the billet. The incubation times were 3 minutes, 5 
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minutes, 8 minutes and 10 minutes for the billets oriented to draw ratio 2, 3, 4 
and 5 respectively (thicknesses 6 mm, 8.48 mm, 10.4 mm, 12 mm and 13.4 mm 
respectively). The die temperature was adjusted to 75 °C.  
When the billet temperature reached 70 °C, it was pulled through the die 
by moving the crosshead of the tensometer. The pulling regime was divided into 
two stages. In the first stage the tag was pulled out slowly. The crosshead 
speed was increased from 1.25 mm/min to 10 mm/min in 4 steps. Each step 
was executed when the load achieved a plateau in the load vs extension curve. 
The rod exiting from the die was constantly sprayed with FRE 400 refrigerant 
spray in order to prevent excessive necking. Once the entire tag was pulled out 
of the die, the process was halted and the section pulled out was re-clamped. In 
the second stage, the speed was increased from 1.25 mm/min to 40 mm/min in 
6 steps, in a manner similar to tag pulling. No freeze spray was used in the 
second stage; instead, cooling was provided 10 mm above the die exit by 
circulating cold water through the assembly shown in figure 4.4 - D.  
 SECTION B: CHARACTERISATION TECHNIQUES 
4.7. Thermal characterisation of the pure model drugs and the polymer 
4.7.1. Thermo-gravimetric analysis  
Thermal stability of virgin PLA and the model drugs listed in the materials 
section was assessed through thermo-gravimetric analysis (Barbooti and Al-
Sammerrai, 1986; Ribeiro et al., 1996), using a TA instruments TGA Q5000 
(V3.13 Build 261). Approximately 5 mg of each sample was loaded onto the 
aluminium pans. Two different experiments were performed; namely, 
temperature ramp TGA and isothermal TGA. In the prior, a ramp rate of 10 
°C/min was used for heating the sample from 25 °C to 250 °C; whereas, in the 
latter, the samples were heated at the rate of 30 °C/min to 180 °C and held 
isothermal for 30 minutes. The sample was maintained under dry nitrogen 
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blanket during the experiment. TA Universal analysis 2000® and Microsoft 
Excel® 2010 were used for data analysis. 
4.7.2. Differential scanning calorimetry (DSC) 
Melting points and the glass transition behaviour of the individual model 
drugs and their melt extruded mixtures with PLA were measured using a TA 
Instruments Q2000 differential scanning calorimeter (with RSC90 cooling unit). 
Approximately 5 mg of the sample was loaded on standard aluminium pans and 
the aluminium lid was crimped over it. A ramp rate of 10 °C/min was selected 
for heating from 0 °C to 300 °C in the case of theophylline and sodium salicylate 
and 30 °C to 250 °C for the rest of the model drugs. TA Universal analysis 
2000® along with Microsoft Excel® 2010 was used for data analysis. 
4.8. Assessment of polymorphic changes in the model drugs after thermal 
treatment. 
 In order to evaluate polymorphic changes during melt extrusion, the pure 
model drugs (further utilised for drug release studies) were subjected to a 
temperature regime similar to melt extrusion. The powdered forms of the model 
drugs (as supplied by the manufacturer) were placed in a crucible and 
equilibrated at 180 °C for 15 minutes in a vacuum oven. The crucibles were 
cooled rapidly by quenching in dry ice. The resultant material along with 
unprocessed pure drugs and melt compounded drug - PLA extrudates were 
further characterised by infra-red spectroscopy (Salari and Young, 1998), x-ray 
diffractometry (Seton et al., 2010) and hot stage microscopy (Sanphui, 2012).   
4.8.1. Fourier Transform Infrared spectroscopy (FTIR) 
The IR spectra of the pure, heat treated and the melt compounded forms 
of the model drugs were collected by a Perkin-Elmer Spectrum 100 
spectrophotometer, equipped with a standard deuterium triglycinesulfate 
(DTGS) detector and a single reflection diamond/ ZnSe universal ATR 
(attenuated total reflectance) accessory. The samples were directly placed on 
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the ATR crystal and pressure was applied using the applicator accessory, to 
ensure intimate contact between the crystal and the sample. Five scans were 
performed in the wavenumber range 4000 cm-1 to 650 cm-1,for each sample (Qi 
et al., 2008; Seton et al., 2010). All measurements were performed in triplicate. 
The raw spectra were further processed using Thermo-scientific Grams® AI 
software. (The same method was used for obtaining the FTIR spectra of the 
oriented films). 
4.8.2. Powder X-ray diffractometry  
X-ray diffractograms of the pure model drugs and their heat treated forms 
were acquired using a Bruker D8 X-ray powder diffractometer. The instrument 
used a Cu Kα radiation source (40 kV voltage and a filament emission of 40 
mA) producing an X-ray wavelength of 1.54 Å. The receiving and the scatter 
slits were 1° and 0.2° respectively. Samples were placed on low background 
silicon holders and were scanned between 2 - 30° (2θ), in 0.01° increments, 
with a scanning speed equivalent to the step width per second. The melt 
compounded material was hot - compressed into thin films and analysed by the 
Wide Angle X-ray Diffraction (WAXD) technique described in the section 4.13. 
4.8.3. Hot stage microscopy 
The solubility status of the shortlisted model drugs in the PLA matrix was 
visualised using a Zeiss Axioplan-2 microscope equipped with an AxioCam 
MRc5 CCD camera and a Linkam 44 hot stage (THMS600) (Tadworth, UK). 
The drug loaded PLA extrudates obtained from melt compounding were 
sectioned (approximately 50 μm thick), using a Leica RM2265 rotary microtome. 
The sections were heated from 25 °C to 180 °C, with an underlying heating rate 
of 30 °C/min and held isothermally for 15 minutes. This was followed by cooling 
back to 25 °C at a rate of 30 °C/min.  The images of all three stages; namely, 
pre-heating (50 °C), isothermal stage (180 °C) and post cooling stage (50 °C) 
were captured by the CCD camera, using Axiovision (4.5) software.  
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4.9. Rheological testing 
 Rheological behaviour of virgin PLA, neat extruded PLA and the 
extruded mixtures with curcumin, paracetamol, theophylline and sodium 
salicylate was investigated on an Anton Paar Physica MCR 501 rheometer. All 
the systems were studied in oscillation mode, using a strain amplitude sweep, 
frequency sweep and time sweep experiments. A parallel plate geometry with 
plate diameter 25 mm was used. The distance between the plates was adjusted 
to 1 mm. Polymer sample was added on the bottom plate and the separation 
between plates was reduced to experimental distance, once the set 
temperature was achieved in the furnace.  
4.9.1. Amplitude sweep 
 A dynamic strain amplitude sweep was performed in order to determine 
the linear viscoelastic region (LVER) for PLA between 160 °C to 210 °C, in 
gradations of 10 °C. The sample was subjected to differential strain amplitudes 
ranging between 0.01 to 100% at a constant angular frequency of 1 rad. sec-1. 
Changes in the storage modulus (G') and the loss modulus (G'’) were 
monitored.  
4.9.2. Frequency sweep 
 Samples were subjected to varied angular frequency (ω), between 0.1 to 
100 rad. sec-1, at a constant strain value of 1% that lies within the LVER of 
studied PLA systems. Temperatures ranging from 160 °C to 210 °C were used 
in steps of 10 °C. Storage modulus (G'), loss modulus (G") and complex 
viscosity (η*) were monitored against angular frequency. 
4.9.3. Time sweep 
 Time dependent stability of the polymer melt at each of the above 
mentioned temperatures was measured by subjecting the melt to a constant 
angular frequency of 1 rad.sec-1, and a constant strain amplitude of 1%, for 30 
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minutes at the desired temperature. Complex viscosity was measured against 
time, with each measurement taken 5 seconds apart. 
4.10. Assessment of PLA molecular weight degradation after thermal 
processing 
Molecular weight degradation of PLA after melt compounding, film 
extrusion and billet extrusion was assessed using a Waters ACQUITY 
advanced polymer chromatography (APC™) system, coupled with an RI 
detector. Separation was achieved by a column bank consisting of Waters 
Aquity XT 125 (Effective molecular weight range 1000 - 30,000 g/mol) and XT 
450 columns (Effective molecular weight range 20000 - 400,000 g/mol), each 
having 4.6 mm internal diameter and 150 mm length. The chromatographic 
conditions were as follows. The isocratic mobile phase was chloroform, injection 
volume was 30 μl, the flow rate was 0.3 ml/min and the temperature of the 
column bank and detector was 30 °C. The calibration curve was obtained by 
using 3 different polystyrene standards (Waters ReadyCal Kit), each containing 
a mixture of four narrow molecular weight fractions (table 4.4). 0.5% w/v 
solution of each of the processed samples was prepared and measured on the 
APC system using the abovementioned parameters. The APC method for PLA 
was developed based on preliminary trials and previous GPC reports (Gerlach, 
1993). The results were processed by Empower 3® software. The calibration 
curve and the equation for the same were obtained using a 5th order polynomial 
fit. This was used for calculation of the molecular weight of the processed PLA 
samples 
Table 4.4: Molecular weight fractions in the ReadyCal calibration kit 
Vial Vial 1 Vial 2 Vial 3 
Mol. Weight (Da) 
2460000 1170000 552000 
271000 125000 62500 
34000 17300 8900 
3460 1250 570 
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4.11. Identification of oligomeric degradation products by gas-
chromatography/ mass-spectrometry (GC/MS) 
The viscosity as well as the molecular weight of PLA significantly dropped 
when processed with sodium salicylate at elevated temperatures. The 
oligomeric degradation products generated during melt extrusion of PLA, with 
and without sodium salicylate were separated and individually identified using 
an Agilent Technologies (USA) 7890A gas chromatographic separation unit 
(GC), coupled with a triple quadrupole 5975 EI/CI mass spectrometric detector 
(MSD). Samples were prepared by dissolving 150 mg of the extrudates in 5 ml 
of 2:1- acetone: chloroform. 1 μl of the sample was injected at 250 °C into a 
capillary column with the following specifications; HP-5-MS, 25 m x 0.25 mm, 
0.25m film thickness. Helium was used as a carrier gas with a flow rate of 
0.66 ml/min. At the beginning of the experiment, the column oven was 
equilibrated at 40 °C for 5 minutes, followed by heating to 350 °C at a rate of 10 
°C /min. Finally it was held isothermally at 350 °C for 10 minutes. The MSD 
source temperature was set to 230 °C while the quadrupoles were held at 150 
°C. The fragmentation patterns were obtained in the scanning mode set to scan 
mode between m/z 50 - 800 amu. Agilent MSD Chem-station® software was 
used for data acquisition and processing. The fragmentation patterns obtained 
for individual species were compared with the NIST database and previous 
reports on thermal degradation of PLA (Kopinke et al., 1996; McNeill and 
Leiper, 1985).   
4.12. Modulated DSC (MDSC) for determination of percentage crystallinity 
A conventional MDSC experiment was performed between the 
temperatures of 35 °C – 220 °C, using a TA instruments Q2000 differential 
scanning calorimeter. Approximately 5mg of the sample was loaded into a 
standard aluminium pan with a crimped aluminium lid. Modulation amplitude 
was set to 0.5 °C with heating rate 5 °C/minute and modulation time of 100 
seconds. Curves for reversible and irreversible heat flow were obtained by TA 
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universal analysis software. Normalised enthalpies of cold crystallisation and re-
crystallisation were calculated from the exotherms visible on the irreversible 
heat flow curve. The normalised enthalpy of melting was obtained from 
integration of the endotherm on the reversible heat flow curve. Percentage 
crystallinity was calculated from the equation 4.3 (Solarski et al., 2005). 
% Crystallinity=  
∆H melting−(∆H cold crystallisation + ∆H recrystallisation)
∆H fusion for 100% crystalline PLA
 
…(Equation 4.3) 
4.13. Characterisation of PLA films using ‘Wide Angle X-ray Diffraction’ 
(WAXD) 
The WAXD patterns were obtained in a flat plane geometry using a 
Rigaku, MicroMax-007hf high intensity microfocus rotating anode x-ray imaging 
system. The diffractomer was operated with monochromatised Cu Kα (1.54 Å) 
radiation, at 40 kV voltage, 30 mA filament current. The sample to detector 
distance was 100 mm. The raw data was obtained as 2 dimensional WAXD 
patterns as well as single dimensional diffractograms, i.e. Intensity Vs 2θ 
(diffraction angle) curves. Crystallinity index was calculated from the 
diffractograms using equation 4.4, without background subtraction (Kawakami 
et al., 2008). *(Refer appendix for 2D WAXD data analysis method) 
% Crystallinity(WAXD) =  
Area under crystalline peaks
Total area under amorphous halo and crystalline peaks
X100 
    …(Equation 4.4) 
Fh  =
3(cos2ɸ)−1
2
                           (Equation 4.5)  
Where,〈cos2ɸ〉hkl =  
∫ I(ɸ)cos2 ɸ sin ɸdɸ
π/2
0
∫ I(ɸ) sin ɸdɸ
π/2
0
           (Equation 4.6) 
ɸ = azimuthal angle and I(ɸ) = scattered intensity along the azimuthal angle ɸ. 
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The molecular orientation of the crystalline phase was quantified through 
Herman’s orientation function. The 2D WAXD patterns were converted into the 
intensity Vs azimuthal angle (ɸ) graphs by integrating the intensity of the 
crystalline reflection in the (200/110) hkl lattice plane over an azimuthal 
semicircle (Kawakami et al., 2008). Herman’s orientation function was 
calculated using the equation 4.5 and 4.6 (Zhang et al., 2011). 
4.14. Mechanical testing of oriented films 
Simple tensile tests (ASTM D638) were performed on dumbbell shaped 
samples (ASTM type V; gauge length = 9.5 mm, width = 3.15 mm, variable 
thickness) cut from oriented films. An Instron® 5900 series mechanical testing 
system was used along with Bluehill2® software for data analysis. The 
experiment was performed at 30 °C, with 1 KN load cell and extension rate of 
100 mm/ minute. Engineering stress (load/ original cross sectional area) vs. 
engineering strain (change in length/ original length) curves were used for 
calculation of the ultimate tensile strength and Young’s modulus. 
4.15. Surface energy determination by static contact angle measurement 
4.15.1. Mathematics 
The change in surface free energy following orientation of blank and drug 
loaded PLA films was calculated by the Owens/Wendt theory (Owens and 
Wendt, 1969).   
                  (y         =       m    .    x     +      c) 
(cos θ+1)γL 
2 (γL
D)
1
2
=  (γf
P)
1
2
(γL
P)
1
2
(γL
D)
1
2
+  (γf
D)
1
2             (Equation 4.7) 
Where, γL= overall surface tension of the probe liquid, γL
D = dispersive component of 
the surface tension of the probe liquid, γL
P = polar component of the surface tension of 
the probe liquid. γf 
D= dispersive component of the surface energy of the film, γf 
P= 
polar component of the surface energy of the film and θ = the contact angle between 
the probe liquid and the film. 
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The overall surface energy for each sample, divided into the contributions 
from the Van-der-Waals dispersive interactions and the dipole or hydrogen 
bonding type polar interactions was obtained using equation 4.7. This equation 
is arranged in ‘y = mx + c’ format. Therefore, plotting x, and y values for a series 
of probe liquids, as per equation 4.7 yields a straight line, the slope of which is 
square root of the polar component of surface free energy and the y-intercept is 
the square root of the dispersive component of the surface energy. The overall 
surface energy (γf) is a sum the polar (γf 
P) and the dispersive component (γf 
D) 
(Riluson, 1999).  In order to calculate the surface energy using equation 4.7, 
surface tensions of the probe liquids (γL, γL
D, γL
P) and their contact angle (θ) 
with the investigated surface must be known. These parameters were 
determined using the following method. 
4.15.2. Instrumentation 
 
 
Figure 4.5: Tensiometer used for measurement of probe liquid surface tension and 
their contact angle with the oriented film surfaces. 
The surface tensions of the probe liquids and their contact angle with the 
reference and the test materials were measured by an FTA188 tensiometer. 
The images were captured by an integrated CCD firewire camera (figure 4.5- D) 
and analysed by FTA32 software. The instrumental setup further consisted of a 
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tensiometer sample stage (figure 4.5 - C) enclosed within an environment 
control chamber and a stainless steel flat-tipped needle (0.47 mm diameter, 
Hamilton, UK) attached to a micrometer syringe (2.5 ml, Hamilton, UK) (figure 
4.5 - B). The syringe was attached to a micromanipulator (figure 4.5 - A), which 
allowed precise movement of the syringe plunger, for accurate formation of a 
pendent drop (figure 4.6 - A) or a sessile drop (figure 4.6 - B).  
4.15.3. Estimation of surface tension of the probe liquids (γL, γL
P, γL
D ) 
Ten probe liquids were selected with varied polar and dispersive nature. 
These included Di-iodomethane, n-hexane, n-octane, n-heptane, cyclohexane, 
toluene, benzyl alcohol, ethylene glycol, glycerol and triple distilled water. All 
probe liquids were procured from Acros chemicals and were >99% pure. The 
overall surface tension of the probe liquids was determined by the pendent drop 
method (Hansen and Rodsrud, 1991). The video camera was focused on the 
needle tip and a pendant drop (figure 4.6 - A) having maximum possible volume 
was formed with the help of the micromanipulator. An image of each drop was 
captured by the camera and the surface tension was calculated by the 
integrated image analysis software with the help of a Young-Laplace fit to the 
contour of a pendant drop. The measurement was performed three times. 
 
 
Figure 4.6: Pictorial representation of A) a pendant drop and B) a sessile drop 
 
A: Pendant drop  
B: Sessile drop  
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The overall surface tension of the probe liquids was divided into their polar 
and dispersive components by the following method reported by Riluson C. 
(1999). The contact angle made by the probe liquids with 
polytetrafluoroethylene (PTFE) were determined by the technique described in 
section 4.15.4. PTFE has a standard surface energy of 18 mJ/m2. Since this is 
entirely contributed by the dispersive component, the ‘mx’ parameter in the 
equation 4.7 becomes zero. Therefore, the only unknown remaining in the 
equation, i.e. the dispersive component of the surface tension (γL
D) was 
obtained and the polar component (γL
P) was calculated by subtracting γL
D from 
the overall surface tension.  
4.15.4. Estimation of the contact angle (θ) 
The static contact angle of the probe liquids with the surface of oriented 
PLA films (or PTFE) was measured at room temperature (25 °C), by the sessile 
drop method. The blank as well as the drug loaded films oriented in the UCW 
mode (λ = 1X to 4X), and those oriented biaxially in the SB and the SEQ mode 
to the draw ratio of 2X2Y were selected as the model systems for this study. 
Each separate film was cleaned with distilled water, dried, grounded to remove 
any static charge and placed on the tensiometer sample stage. A drop of the 
probe liquid was deposited on the film surface through the flat-tipped needle – 
syringe assembly with the help of the micromanipulator. The distance between 
the needle and the sample surface was adjusted for every probe liquid such that 
the drop landed smoothly on the film surface. The images were captured at 20 
fps speed for 90 seconds as soon as the drop touched the film surface. The 
earliest image from which there is no change in the drop shape was considered 
for further analysis. The contact angle from both sides of the drop was 
determined by integrated image analysis software. 6 replicate measurements 
were performed on new surfaces of the same sample (the sample was rotated 
by 90°after every measurement) and the average value was considered for 
calculation of the surface energy.  
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4.16. Drug release studies on oriented PLA films 
Drug loaded films oriented in the UCW mode to draw ratios of 1X to 4X 
and those oriented in the SB and SEQ mode to a draw ratio of 2X2Y were 
selected as model systems for drug release studies. Film samples belonging to 
each model system were cut into several circular sections (5 mm diameter) 
using a hole punch. All circular sections were weighed and an average weight 
was determined. 25 circular sections from each model system (in triplicate) 
were submerged in 5 ml of drug release media, contained in separate glass 
vials. The vials were stored in an incubator-shaker set to operate at 100 rpm 
and 37 °C. The drug release media was composed of 0.5 M sodium phosphate 
buffer (2.29% w/v di-sodium hydrogen phosphate and 3.6% w/v sodium di-
hydrogen phosphate), 0.5% w/v sodium dodecyl sulphate (SDS) and 5% 
acetone. The pH was adjusted to 6.8 using phosphoric acid. Since curcumin 
has poor water solubility, acetone and SDS were added to aid its dissolution 
(Pan et al., 2006; Rahman et al., 2009).  
Different sampling protocols were followed for the curcumin loaded and 
the theophylline loaded films. In the case of theophylline loaded films, the entire 
(5 ml) release media was withdrawn at weekly intervals and replaced with a 
fresh media. The amount of released theophylline was directly quantified from 
the media by the HPLC method reported below.  
The attempts to quantify the release of curcumin using the 
abovementioned method failed due to poor solution stability of curcumin (Wang 
et al., 1997). No release could be detected for up to 4 months; probably 
because the curcumin released in a trace amount was below the detection limit 
of HPLC, when measured at daily intervals; or it degraded before reaching the 
detectable quantity when measured at weekly intervals. Therefore, release of 
curcumin was determined by the residual quantification method; i.e. by 
determination of the amount of curcumin remaining in the films than the amount 
released. A circular section was withdrawn from each model system (in 
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triplicate). The sample was dried, weighed and dissolved in 5 ml chloroform. 
The resulting solution was diluted 10 fold with acetonitrile and analysed by 
HPLC using the method reported below. 
4.16.1. HPLC method for quantification of curcumin 
The amount of curcumin remaining in the films was assayed by reversed-
phase high-performance liquid chromatography (RP-HPLC) method using a 
Waters e-2695 separation unit coupled with a photodiode array detector (PDA-
2998). A Waters Symmetry C18 column with 5 μm particle size and 4.6 mm x 
150 mm column dimensions was used. The mobile phase composed of 60:40 
acetonitrile: water containing 0.1% TFA (pH = 3). The mobile phase flow rate 
was set to 1 ml/min, the detection wavelength was 425 nm and the injection 
volume was 20 μl.  
Standard solutions containing 10 ppm, 20 ppm, 30 ppm, 40 ppm and 50 
ppm curcumin were prepared and a calibration curve was obtained by the 
abovementioned HPLC method. The amount of curcumin in the test solution 
(diluted solution of the circular film section) was determined by comparison to 
the calibration curve. The curcumin standards were measured during every 
HPLC analysis in order to account for the possible sources of error. The 
calibration curve was additionally utilised for calculation of the method linearity, 
the limit of detection (LOD) and the limit of quantification (LOQ). These values 
were R2 = 0.9998, 0.36 μg/ml, and 1.09 μg/ml respectively.  
4.16.2. HPLC method for quantification of theophylline 
The amount of theophylline released was assayed using the same 
instrument, column and the chromatographic conditions as that for curcumin. 
However, the mobile phase, detection wavelength and injection volume were 
varied. The mobile phase for theophylline was composed of 25: 70 methanol : 
0.05M acetate buffer pH 4 (4.1% w/v sodium acetate + 9.8 ml glacial acetic 
acid), while the detection wavelength and injection volume were 273 nm and 
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50.0 μl respectively (Butrimovitz and Raisys, 1979). Calibration curves were 
obtained for theophylline in a manner similar to the curcumin analysis explained 
above. The linear regression coefficient for this method, in the range of 10ppm 
– 50 ppm was 0.99, while LOD and LOQ were 1.14 μg/ml, and 3.46 μg/ml 
respectively. 
4.17. Characterisation of the changes in the polymer properties during 
drug release studies 
Several circular sections belonging to each model system (curcumin and 
theophylline loaded films with UCW draw ratio 1X-4X and SB and SEQ samples 
with biaxial draw ratio 2X2Y) were submerged in 5 ml of drug release medium 
and stored in the incubator-shaker (37 °C, 100 rpm) in parallel with the drug 
release studies. Nine circular sections were withdrawn from each model system 
at the weekly intervals and the release medium was replaced with a fresh 
medium. All the samples were dried and weighed. Three samples were used for 
the crystallinity determination (the same method as section 4.12), three were 
used for estimation of the molecular weight change by gel permeation 
chromatography (GPC) (the same method as section 4.10), while 3 samples 
were used for visualisation of the change in the surface morphology by 
scanning electron microscopy (SEM) (Hurrell and Cameron, 2001a; Hurrell and 
Cameron, 2001b; Hurrell and Cameron, 2002; Jackson et al., 2004).  
4.17.1. Assessment of the change in surface morphology after 
submersion into drug release media 
The circular film samples withdrawn from each model system (in triplicate) 
were dried in a vacuum oven and visualised by a Hitachi TM3030 table-top 
scanning electron microscope (SEM). The microscope was operated in topology 
mode with a working distance of approximately 8.5 mm. An accelerating voltage 
of 5 kV was used for primary focusing and the voltage was increased to 15 kV 
when the final image was captured.  
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4.18. Characterisation of shrinkage in the oriented films 
Curcumin loaded films oriented to a draw ratio of 2X in the UCW mode or 
2X2Y in the SB or the SEQ mode, exhibited shrinkage after submersion in the 
drug release media. In order to rationalise this observation, the following 
experiment was carried out. Several tensile bars (ASTM type V; gauge length = 
9.5 mm, width = 3.15 mm, thickness = 0.2 mm) were obtained from the 
theophylline and curcumin loaded films oriented in the UCW mode to a draw 
ratio of 2X. These were submerged in the release media and stored in an 
incubator shaker at 37 °C, with an agitation speed of 100 rpm. Three samples 
were withdrawn from each type of submerged films at daily intervals for up to 10 
days. The dried samples were tested for changes in dimensions, crystallinity 
(sec. 4.12) and crystalline orientation (by WAXD – sec. 4.13). 
4.19. Characterisation of anisotropic structure in the rods by WAXD 
The rods oriented to different draw ratios were machined into 1 mm thick 
sections along the drawing direction and the perpendicular direction (figure 4.7). 
These sections were analysed by a Rigaku, MicroMax-007hf high intensity 
microfocus rotating anode x-ray imaging system in transmission mode. The 
experimental setup and the data analysis method were similar to that described 
in section 4.13. 
 
Figure 4.7: Sectioning of the rods for WAXD studies 
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4.20. Evaluation of directional drug release from oriented PLA rods 
4.20.1. Sample preparation  
The paracetamol loaded oriented rods representing draw ratios from 1X to 
5X were cut lengthwise into 6 mm long sections. Six such samples representing 
each draw ratio were used for the drug release studies. Out of these, 3 samples 
were coated with a waterproof epoxy resin on the (lateral) curved surface, while 
the remaining 3 were coated on the (transverse) flat surfaces. Buehler 
EpoThin™ resin and hardener were used for this purpose. The resin and the 
hardener were mixed in the ratio 10:3.9 and the mixture was applied onto the 
desired surface of the rod with a brush, followed by curing at room temperature 
for 12 hours. Altogether 3 epoxy coats were applied.  
4.20.2. Drug release studies 
A total of 10 batches of the oriented rods (5 draw ratios curved surface 
coated + 5 draw ratios flat surface coated) were evaluated for drug release, in 
triplicate. The experimental protocol was same as that for the oriented drug 
loaded films. In brief, all samples were stored in separate glass vials containing 
5 ml of the drug release media. The vials were equilibrated at 37 °C in an 
incubator-shaker with an agitation speed of 100 rpm. The entire (5 ml) release 
media was withdrawn at weekly intervals and replaced with a fresh media. The 
amount of released paracetamol was directly quantified from the release media 
by the HPLC method reported below.  
4.20.3. HPLC method for quantification of paracetamol 
The assay of released paracetamol was performed using a Waters e-2695 
HPLC system equipped with a photodiode array detector (PDA-2998). Waters 
µBondapak C18 column (125Å, 10 µm, 3.9 mm X 150 mm) was used as a 
stationary phase; while the isocratic mobile phase composed of 15:85 
acetonitrile: water containing 0.1% TFA (pH = 3). The mobile phase flow rate 
was 1 ml/min, the detection wavelength was 243 nm and the injection volume 
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was 50 μl (Gotelli et al., 1977). The calibration curve for paracetamol was 
obtained in a manner similar to curcumin analysis (section 4.16.1). The linear 
regression coefficient for this method in the range of 10 ppm – 50 ppm was 
0.99; whereas, the LOD and the LOQ were 0.6 μg/ml and 1 μg/ml respectively. 
4.21. Measurement of molecular weight, crystallinity and morphological 
changes in the submerged rods 
The paracetamol loaded oriented PLA rods were assessed for the 
changes in molecular weight, crystallinity and morphology, after being 
submerged in the release media for 16 weeks.   
 
 
Figure 4.8: Schematic representation of (A) the transverse section and (B) the lateral 
section of the PLA rods 
For studying the morphological changes, two distinct sections were 
obtained from the rods remaining at the end of the drug release study. A 
transverse section was obtained by cryo-fracturing a rod parallel to the flat 
surfaces (cross section) (figure 4.8 - A), while a lateral section was obtained by 
cryo-fracturing a rod parallel to the curved surface (figure 4.8 - B). The exposed 
surfaces were visualised by a scanning electron microscope using the 
experimental protocol explained in section 4.17.1. A part of the abovementioned 
rods was utilised for determination of the percentage crystallinity by MDSC 
(section 4.12) and the molecular weight by GPC (section 4.10).  
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4.22. Statistical analysis 
The quantitative data in this thesis is represented as mean ± standard 
deviation of ‘n’ replications. Moreover, such data and associated claims were 
validated by using various statistical analysis techniques as follows.  
To establish a difference between the rheological profile of various drug 
loaded PLA systems, the storage modulus (G’) and loss modulus (G’’) obtained 
from amplitude sweep test, at 1% amplitude were statistically compared paired 
t-tests. A similar comparison was made between the viscosities of the 
investigated model systems (obtained by frequency sweep test) as well as 
between the percentage drop in the viscosity observed during time sweep test. 
Nevertheless, the effect of various concentrations of sodium salicylate on the 
rheological profile and the molecular weight of PLA was validated by the paired 
t-test analysis. This statistical data is discussed at relevant places in chapter 5.  
In chapter 6, the effect of two independent orientation process variables 
(namely draw rate and drawing temperature) on a dependant property variable 
(crystallinity, Tg, Mechanical strength) was studied by multiple regression 
analysis. Moreover, variation in these properties with respect to uniaxial and 
biaxial draw ratios was studied by paired t-test comparison between successive 
draw ratios (except for mechanical properties comparison, where two-way 
ANOVA with replication was used). Likewise, a difference between the surface 
free energy of the oriented films was statistically evaluated by two-way ANOVA 
with replication. The changes in the crystallinity, molecular weight and 
polydispersity of the model PLA films after aqueous submersion were validated 
by one-way ANOVA - Tukey’s test comparison between the draw ratios at 
varied intervals and between the intervals. Wherever a comparison was made 
only between two sets of data, a paired t-test was used. A similar statistical 
analysis was used for establishing the differences in the drug release profiles of 
the investigated PLA films. Moreover, the drug release profiles were fitted to an 
appropriate kinetic model by linear regression analysis. 
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In chapter 7, a rise in the PLA rod crystallinity with respect to uniaxial draw 
ratios was validated by paired t-test comparisons between the successive draw 
ratios. Nevertheless, crystallinity and molecular weights of the investigated rods 
were statistically compared between the draw ratios at the beginning and at the 
end of the drug release study by one-way ANOVA – Tukey’s test. A similar 
comparison was made between the crystallinity and molecular weight values of 
the rods at the beginning and at the end of the study, and between the curved 
surface coated and the cross section coated rods, at a constant draw ratio. The 
anisotropy in the drug release rate between the cross section and the curved 
surface was statistically validated by paired t-test analysis. Nevertheless 
variation in the release rate with respect to the uniaxial draw ratio was 
confirmed by one-way ANOVA followed by Tukey's test. 
The regression analysis was performed using Microsoft Excel®, while the 
rest of the statistical analysis was performed using GraphPad Instat 3® software 
package. 
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5. Understanding the materials and the 
processes: results & discussion 
The following chapter describes the theoretical analysis and the 
experimental work that formed a basis for the selection of the model drugs and 
the model polymer. It includes characterisation of the experimental materials by 
techniques such as rheology, thermal analysis and gel permeation 
chromatography, etc. for establishing efficacy of the melt processing operations 
utilised in this work. The chapter further discusses the assessment of changes 
in the polymorphic state of the experimental materials and their degradation 
during melt processing. Additionally, degradation products generated during 
such processing and degradation mechanism are identified. Knowledge of this 
will ensure that the characteristics of drug release from the oriented films/ rods 
are correctly attributed to the morphological changes imposed solely by solid-
state orientation.  
5.1. Selection of the model polymer 
 The primary aim of this work was to evaluate the effect of solid-state 
polymer orientation on drug release from the polymeric matrices. Various 
polymer orientation methods have been widely used for manufacturing high-
strength, bioresorbable medical devices from synthetic poly-esters of lactic and 
glycolic acid (Pohjonen et al., 1997; Trieu, 2006). A stable oriented morphology 
can be developed in these polymers, by virtue of their semicrystalline nature 
and higher glass transition temperature. Moreover, their biodegradability and 
toxicological safety has enabled their use in controlled drug delivery to an 
internal organ. (Veiranto et al., 2002; Witt and Kissel, 2001). Considering these 
aspects and material availability, poly (L-lactic acid) (PLA) was selected as the 
model polymer.   
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5.2. Screening of model compounds based on the solubility parameter 
As discussed previously in the literature survey, release of a drug from a 
polymer matrix depends on its solubility status in that matrix. Moreover, a 
soluble drug and a suspended drug may influence the solid-state orientation 
process differently. This will in turn affect the drug release profile. In order to 
study such an effect, two separate model drugs were needed; the one that can 
remain in the crystalline suspension form, while the other, which will be soluble 
in the PLA matrix at 5% w/w loading. Nine model small molecules were 
shortlisted on this basis and after thorough consideration to the literature and 
laboratory safety constraints. These molecules included curcumin, theophylline, 
caffeine, paracetamol, aspirin, sodium salicylate, nicotinamide, ascorbic acid 
and citric acid.  
The compatibility between the shortlisted model drugs and PLA was 
theoretically predicted from the reported values of Hansen’s solubility parameter 
(HSP) (Hansen, 1969). HSP takes into consideration the cohesive energy of a 
molecule as a net effect of all inter-atomic and inter-molecular interactions. 
Therefore, when the solubility parameters of two molecules match, they are 
expected to be mutually compatible. Equation 5.1 was utilised for calculation of 
the total solubility parameter (δt). δt is composed of three partial solubility 
parameters, namely δd, δp and δh, which represent the contributions from Van 
der Waals dispersive forces, polar interactions between the induced and the 
existing dipoles and hydrogen bonding respectively. Values of the individual 
solubility parameters for each model drug and PLA are reported in table 5.1 
δ𝑡 =  √(δ𝑑
2 + δ𝑝
2 + δℎ
2)           (Equation 5.1) 
Cohesive energy contribution from the dispersive forces relates to the 
hydrophobic part of a molecule, whereas polar interactions and hydrogen 
bonding are associated with hydrophillicity. It is clear from table 5.1 that PLA is 
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significantly hydrophobic and therefore will accommodate a hydrophobic drug 
very easily. Since all model molecules listed in table 5.1 have a hydrophobic 
(δd) component comparable to PLA, they are expected to be compatible with 
PLA to a greater or lesser extent. Whether they will remain as a solid solution or 
a crystalline suspension (at 5% w/w concentration in PLA), depends on the 
contribution from the remaining solubility parameters. 
Table 5.1: Partial solubility parameters for the shortlisted model compounds 
Material 
Solubility parameter (J1/2 m-2/3) 
Reference 
δd δp δh δt 
Poly lactic acid 17.6 9.7 11.8 23.3 (Liu et al., 2004) 
Curcumin 17.4 6 10.9 21.39 (Fabien and Isabelle, 2009) 
Paracetamol 17.8 10.5 13.9 24.91 (Hansen, 2004) 
Aspirin 20.61 7.56 10.81 24.47 (Roberts et al., 1991) 
Theophylline 19.4 14.2 13.2 27.43 (Huu-Phuoc et al., 1987) 
Caffeine 20.65 7.16 18.61 28.71 (Huu-Phuoc et al., 1987) 
Sodium salicylate 16.55 21.01 16.58 31.47 (Barra et al., 2000) 
Nicotinamide 19.96 13.11 13.08 27.23 (Cutrignelli et al., 2008) 
Ascorbic acid 18 9.8 21.6 29.78 (Hansen, 2004) 
Citric acid 20.9 8.2 21.9 31.36 (Jarvas et al., 2011) 
 
The total solubility parameters of theophylline, caffeine, sodium salicylate, 
nicotinamide, ascorbic acid and citric acid are significantly higher than PLA, 
owing to a higher energy contribution from the hydrophilic interactions. 
Theoretically, these molecules will have low solubility in the PLA matrix and are 
expected to remain as a separate crystalline phase even at low concentrations. 
Therefore, these molecules can represent the class of PLA insoluble model 
drugs. On the contrary, curcumin, paracetamol and aspirin have poor cohesive 
energy contribution from the polar and the hydrogen bonding interaction, which 
makes them predominantly hydrophobic. A close match between the partial as 
well as the total solubility parameters of PLA and the aforementioned three 
molecules suggests higher compatibility. Since all three of them have melting 
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points lower than or within the melt processing window of PLA (figure 5.1) (Lim 
et al., 2008), co-melting in a twin screw extruder followed by instantaneous 
solidification can lead to formation of an glassy solution, where the drug is 
present in a solution state or a molecularly dispersed amorphous state in PLA 
(Greenhalgh et al., 1999; Lakshman et al., 2008).   
 
Figure 5.1: Melting endotherms of the model compounds obtained by DSC. 
Among the PLA insoluble model molecules, theophylline, sodium 
salicylate, ascorbic acid and caffeine have higher melting points than the melt 
processing window for PLA (figure 5.1). Therefore, if present as a suspension in 
the PLA matrix, the size of the suspended particles will be same as that before 
melt compounding. Contrarily, citric acid and nicotinamide melts at 153 °C and 
128 °C respectively. Therefore their particle size will be dictated by the rate at 
which the composite material is cooled from the molten state to the ambient 
conditions.  
5.3. Thermal stability of the model compounds 
The drug loaded PLA matrices further studied in this work were prepared 
by melt extrusion. Therefore, the suitability of the shortlisted drugs was 
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established by studying their thermal stability, through thermo-gravimetric 
analysis. A decomposition temperature was initially determined for the 
shortlisted model drugs, by monitoring the weight loss, as they were heated at 
the rate of 10 °C/min. figure 5.2 presents a comparison of the percent weight 
remaining as a function of temperature. It is clear that sodium salicylate, 
curcumin and theophylline underwent negligible weight loss until 250 °C. A 
slight weight loss was observed for paracetamol starting at 200 °C. The 
remaining model drugs, namely ascorbic acid, aspirin, citric acid, caffeine, and 
nicotinamide underwent significant thermal degradation with decomposition 
temperatures 180 °C, 140 °C, 150 °C, 170 °C and 155 °C respectively. 
Nicotinamide and caffeine showed complete weight loss by 250 °C; whereas 
citric acid lost almost 80% of its original weight due to thermal decarboxylation 
between 150 °C – 212 °C (Barbooti and Al-Sammerrai, 1986). A smaller weight 
loss was exhibited by ascorbic acid and aspirin due to their stepwise 
decomposition (Ribeiro et al., 1996).      
 
 
Figure 5.2: Thermo-gravimetric analysis of the pure model compounds (temperature 
ramp method) 
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The decomposition temperature determined by temperature ramp TGA 
may not be very precise, as the underlying heating rate decides the time for 
which the material is exposed to a particular temperature. A more accurate idea 
can be obtained by exposing the material to a constant temperature for 
prolonged duration. Based on the rheological studies (sec 5.6) 180 °C was 
decided as a suitable melt extrusion temperature. Therefore, thermal stability of 
the model drugs at this temperature was evaluated by rapidly (30 °C/min) 
heating them to 180 °C and holding isothermally for 30 minutes.  Figure 5.3 
represents the percentage weight remaining as a function of time for all of the 
shortlisted model drugs. It is evident that sodium salicylate, curcumin, 
paracetamol, and theophylline were stable for extended durations at 180 °C, 
whereas ascorbic acid, citric acid, caffeine, aspirin and nicotinamide exhibited 
pyrolysis. Although the weight loss shown by ascorbic acid was only about 25%, 
the material was completely charred at the end of the test.  
 
Figure 5.3: Thermo-gravimetric analysis of the pure model compounds            
(isothermal 180 °C) 
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5.4. Selection of the model drugs 
The thermogravimetric analysis results clearly suggested that only sodium 
salicylate, curcumin, paracetamol, and theophylline were suitable for melt 
processing. Considering the thermal stability and the solubility parameters, 
theophylline and sodium salicylate were shortlisted as the thermostable model 
drugs which may remain suspended in PLA at 5% w/w concentration; while, 
curcumin and paracetamol were shortlisted as the thermostable drugs that can 
potentially form a glassy solution in PLA at 5% w/w loading.  
Assessment of the melt compounded model systems by rheology and gel 
permeation chromatography further revealed that sodium salicylate led to 
degradation of PLA, evidenced as a significant fall in viscosity and molecular 
weight (discussed separately in sections 5.7). On the contrary, theophylline 
formed a well dispersed, stable suspension at 5%w/w loading. Therefore, only 
theophylline was utilised as a PLA insoluble model drug that can remain in the 
suspension state within PLA matrices. 
Glass transition temperatures (Tg) of the amorphous forms of curcumin, 
and paracetamol are 69.49 °C (Pawar et al., 2012), and 22.85 °C (Sibik et al., 
2014) respectively. Owing to the similarity between the glass transition 
temperature of curcumin and PLA, curcumin may produce minimal changes in 
the thermal properties of the compounded system. Moreover, the amorphous 
solid solution of curcumin with PLA will have greater stability owing to a higher 
combined Tg than the paracetamol loaded PLA. Therefore, curcumin was 
initially selected as a model drug that can form a glassy solution in PLA. It was 
later realised during the drug release studies that quantification of a minuscule 
amount of curcumin released from the oriented PLA matrices was challenging, 
due to its poor solution stability (irrespective of the pH). This limitation was 
overcome in the case of oriented films by measuring the amount of curcumin 
remaining in the films, rather than the amount released. However, this approach 
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was unsuitable for the rod geometry. Therefore paracetamol was used as a 
model drug for studying the directional drug release from the oriented rods.  
5.5. The effect of melt processing on the physical and polymorphic state 
of the model drugs 
It is important to know the physical and the polymorphic state of an active 
pharmaceutical ingredient (API) in the melt extruded matrix, as this may 
profoundly affect the drug release profile. A drug can be present in the polymer 
matrix as a separate crystalline or amorphous phase. Alternatively, it can form a 
solid solution depending upon its concentration in the polymer phase and the 
degree of interaction between them (Qi et al., 2008). Thermal treatment during 
melt extrusion can potentially alter the polymorphic state as well as the solubility 
of a drug in the polymer phase. Therefore, temperature induced changes in the 
(pure) model drugs were studied by subjecting them to a thermal regime, similar 
to the melt processing conditions utilised in this study (referred as heat 
treatment – isothermal at 180 °C followed by quenching - sec 4.8). The resultant 
material along with the melt extruded ‘drug + PLA’ mixtures were analysed by 
FTIR spectroscopy, X-ray diffractometry and hot-stage microscopy.  
When heated to 180 °C curcumin and paracetamol were molten, while 
theophylline remained in the solid-state (referred as Cht, Pht, Tht respectively 
henceforth). Curcumin turned orange - red on melting and maintained the same 
colour when quench cooled, while paracetamol formed a clear glass following 
quenching. An obvious consequence of quenching from the melt is conversion 
to the amorphous state. Since the melt extruded material is cooled rapidly as 
soon as it leaves the die, it may show a similar change in the polymorphic state 
of the aforementioned drugs. Withstanding this rationale, the melt compounded 
PLA containing 5% w/w curcumin was dark orange in colour; while, the 
paracetamol (5% w/w) containing PLA extrudates were transparent (referred as 
Cext and Pext respectively). Since theophylline was un-molten at the 
compounding temperature, the extrudates (Text) were opaque and white in 
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colour. The change in the polymorphic state of the model drugs, speculated 
above is experimentally confirmed in the following sections. 
5.5.1. Assessment by Fourier Transform Infra-red (FTIR) spectroscopy 
Figure 5.4 displays the FTIR spectra of the unprocessed/ raw 
paracetamol, and the heat treated paracetamol (Pht). Distinct peaks in the 
spectrum of raw paracetamol at the wavenumber 3168 cm-1, a triplet of peaks 
between 1256 -1225 cm-1 and 807.07 cm-1 peak with a shoulder confirmed the 
presence of the polymorphic Form I. Following heat treatment, 3168 cm-1 peak 
corresponding to H-bonded O-H stretching was shifted to 3203 cm-1 and the 
triplet of the peaks corresponding to Aryl-N, C-N and C-O stretching was 
converted to a single broad peak at 1226.83 cm-1 (Moynihan and O'Hare, 2002). 
Moreover, the shoulder to the peak at 807 cm-1 representing out of plane 
bending of C-H, disappeared. These changes confirmed that equilibration at 
180 °C followed by quenching, converted the Form I paracetamol to the 
amorphous state (Zimmermann and Baranovic, 2011).  
 
Figure 5.4: Comparison of ATR-FTIR spectra of raw paracetamol (olive green), heat 
treated paracetamol (pink), neat extruded PLA (purple) and PLA melt compounded with 
paracetamol (red). 
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Figure 5.5: Comparison of ATR-FTIR spectra of raw curcumin (olive green), heat 
treated curcumin (pink), neat extruded PLA (purple) and PLA melt compounded with 
curcumin (red). 
 
 
Figure 5.6: Comparison of ATR-FTIR spectra of raw theophylline (olive green), heat 
treated theophylline (pink), neat extruded PLA (purple) and PLA melt compounded with 
theophylline (red). 
Examination of the IR spectra belonging to the unprocessed and the heat 
treated curcumin (Cht) (figure 5.5) led to a similar set of observations. The 
phenolic O-H stretching peak at 3500.92 cm-1 and the aromatic C=C peak at 
1602 cm-1 in the IR spectrum of raw curcumin became broader and were shifted 
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to 3413.06 cm-1 and 1575.14 cm-1 respectively in the IR spectrum of Cht. 
Moreover the peak corresponding to C-O stretching (1231 cm-1) disappeared 
after heat treatment. The characteristic differences in the IR spectrum of the 
unprocessed curcumin and the Cht suggested that the red-orange material 
generated after heat treatment was the amorphous form of curcumin, while the 
unprocessed yellow coloured curcumin was present in the polymorphic Form I. 
(Sanphui, 2012; Wegiel et al., 2014), Contrarily, the IR spectrum of theophylline 
exhibited no change after heat treatment (figure 5.6). Since the reported (Seton 
et al., 2010) IR spectra for the Form I and the Form II of theophylline match, the 
polymorphic form of theophylline could not be identified from the FTIR studies.    
The IR spectra of the melt compounded matrices were mainly contributed 
to by PLA. The distinguishing PLA peaks were evident at wavenumbers of 1748 
cm-1, 1180.66 cm-1 and 1080.53 cm-1, corresponding to the stretching vibrations 
of aliphatic C=O, asymmetrical stretching of C-O-C and symmetrical stretching  
of C-O-C respectively (figure 5.4 - figure 5.6) (Nikolic et al., 2010). The IR 
spectrum of curcumin loaded PLA (5% w/w) (figure 5.5) showed extra peaks at 
1504.4 cm−1, 1585.41 cm−1 and 1631.2 cm−1, which correspond to the 
amorphous curcumin. Moreover, the peaks at 2849.96 and 2927.4 cm-1 
belonging to PLA were enlarged due to an additive effect of the related peaks in 
the amorphous curcumin spectrum (Thi Thu Trang et al., 2012). Similarly, 
several new peaks appeared in the IR spectrum of paracetamol loaded PLA 
(5% w/w) (figure 5.4), which matched with the IR spectrum of amorphous 
paracetamol. These included peaks at 1655.73 cm-1, 1609.63 cm-1, 1545.55 cm-
1, 1514.24 cm-1, 836.76 cm-1 and 796.48 cm-1. The above mentioned 
observations confirmed that curcumin and paracetamol were present in the 
amorphous state after melt extrusion with PLA. Nevertheless the appearance of 
specific new peaks indicates a possibility of a binding interaction between the 
amorphous drug phase and PLA. Whether the amorphous drug phase was 
molecularly mixed with the polymer phase (solid solution) or it existed as a 
separate phase must be further confirmed by microscopy. The IR spectrum of 
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PLA remained largely unaltered after melt extrusion with 5% w/w theophylline. 
This suggests a poor interaction between PLA and theophylline, the latter being 
present as a separate crystalline phase. 
5.5.2. Assessment by X-ray diffraction techniques 
The polymorphic state of the model drugs was further verified by X-ray 
diffraction studies. The characteristic crystalline reflections observed in the 
PXRD (Powder X-Ray Diffraction) pattern of the unprocessed curcumin, 
paracetamol and theophylline are labelled on the respective diffractograms 
(figure 5.7 - A, B, C respectively). These included the peaks observed at 2θ: 
8.89, 17.24, 18.16, 24.68, 21.20, 25.74, 27.34 ±0.2° for curcumin (figure 5.7 - 
A), at 2θ:12.096, 15.51, 18.17, 23.39, 24.32 and 26.51 ± 0.2° for paracetamol 
(figure 5.7 - B) and those observed at 2θ: 7.08, 12.5, 14.27, 23.96, 25.47 and 
27.28 ± 0.3° for theophylline (figure 5.7 - C).  
Cross referencing with the available literature confirmed that the 
unprocessed curcumin (Sanphui et al., 2011) and the unprocessed paracetamol 
(Wang et al., 2011; Zaki, 2011) were present in their polymorphic Form I, while 
theophylline was present in the Form II (Seton et al., 2010). The diffraction 
pattern of Cht and Pht exhibited a hump, coupled with absence of all crystalline 
diffraction peaks. This observation further established that Cht and Pht were 
present in the amorphous form. On the contrary, the PXRD pattern of Tht was 
unchanged, signifying no polymorphic change in theophylline after heat 
treatment. Among the compounded systems, only the theophylline containing 
PLA matrix showed the presence of a few crystalline peaks matching with the 
diffractogram of theophylline Form II. Therefore it is safe to state that 
theophylline was present as a crystalline suspension in PLA; while, curcumin 
and paracetamol formed a glassy (amorphous) phase.  
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Figure 5.7: X-ray diffractograms for the pure model drugs, heat treated model drugs 
and that melt compounded with PLA. 
A) Curcumin, B) Paracetamol and C) Theophylline 
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Figure 5.8: WAXD- diffractograms of the PLA films with and without model drugs. 
A) Neat PLA film, B) Curcumin loaded PLA film, C) Paracetamol loaded PLA rods and  
D) Theophylline loaded PLA films. 
Drug loaded matrices (films & rods) were prepared by a single-screw 
extruder, which involved re-melting the compounded material followed by 
extrusion into the suitable geometry. Therefore, the drug loaded matrices were 
assessed by Wide Angle X-ray Diffraction (WAXD), in order to confirm the 
polymorphic state of the drug as well as the polymer. The diffraction intensity 
V/s diffraction angle (2θ) curves representing each model system are 
summarised in the figure 5.8. Both paracetamol and curcumin loaded PLA 
matrices showed a single hump similar to neat PLA films.  On the contrary, the 
theophylline loaded films showed a large hump along with a few smaller peaks 
at 2θ: 7.08, 12.5, 23.96, 25.47 and 27.28 ± 0.3° corresponding to the Form II of 
theophylline. Therefore it is clear that the theophylline loaded films contained a 
suspension of the crystalline theophylline (Form II) in amorphous PLA. 
Contrarily, curcumin and paracetamol remained in an amorphous state, either 
molecularly mixed with the amorphous PLA or as a separate phase.  
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5.5.3. Visualisation of the physical state of the model drugs in PLA 
The solubility status of the model drugs in PLA was validated by 
visualisation of the solid and melt phases of the compounded systems by hot-
stage microscopy. Table 5.2 presents three sets of images for each system; the 
first column denotes the solid-state of the compounded matrices at room 
temperature, the second column represents the molten state (t = 180 °C) and 
the third displays the post cooling state.  
Table 5.2: Comparison of the microscopic images of the model drug loaded systems in 
the pre-melting, the molten and the post cooling stage 
 
 
The microscopic images of curcumin (table 5.2 - A) and paracetamol (table 
5.2 - B) loaded systems revealed a complete absence of the crystalline form of 
 98 
 
these model drugs in the pre-melting stage, as well as while cooling from the 
melt.  Moreover, no phase separation was observed in the molten state, 
suggesting that both of these drugs formed a solution with PLA at 5% w/w 
loading. When analysed by DSC, both paracetamol and curcumin loaded PLA 
matrices showed a single glass transition. Moreover, no melting endotherm was 
observed at temperatures corresponding to the melting points of pure 
paracetamol and curcumin. Therefore, the results confirmed formation of a 
glassy solution of paracetamol or curcumin in PLA (Qi et al., 2008). In contrast 
to this, theophylline was present as a crystalline suspension in the un-molten 
composite matrix as well as in the PLA melt (table 5.2 - C). Interestingly, growth 
of theophylline crystals was observed during the cooling stage. This observation 
signifies that a part of the added theophylline was soluble in the PLA melt, 
which crystallised out on cooling, due to the seeding action provided by already 
existing crystals. 
5.6. Rheological testing 
Rheology relates to measurement of flow-induced deformation in the 
material. It is often used as a tool for establishing suitable melt processing 
conditions for various polymers.  Nevertheless, degradation of a polymer after 
being subjected to a thermo-mechanical treatment can be traced using 
rheology. It further helps in understanding the interaction between fillers and 
their interaction with the polymer matrix. Therefore, virgin PLA as well as the 
melt compounded (drug + PLA) material was evaluated by rheology.  
5.6.1. Amplitude sweep analysis 
 In amplitude sweep tests, the storage modulus - G’ and the loss modulus 
- G’’ are measured as a function of strain amplitude, at a constant strain rate.  
For viscoelastic materials such as polymer melts, G’ correlates to the amount of 
energy stored in the form of elastic links, which can be spent in order to regain 
the original structure. Contrarily, G’’ is a measure of the energy barrier for 
initiating a deformation.  
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Figure 5.9: Amplitude sweep analysis of the model PLA systems at 160 °C 
Notes - G’ (dashed) and G” (solid line) against % strain for virgin PLA (blue), neat extruded PLA (red) and 
PLA  compounded with 5% curcumin (green), 5% paracetamol (purple), 5% theophylline (orange). 
The average of 3 replicate measurements is plotted. The error bars (black dots) represent the standard 
deviation. 
Melt extruded PLA (filled and unfilled) exhibited lower G’ and G’’ profiles 
than virgin PLA, at all test temperatures (figure 5.9, figure 5.10). A statistical 
comparison of G’ was made by paired t-tests at 1% strain amplitude. This data 
for 160 °C and 210 °C test temperatures is reviewed in table 5.3. It is clear that 
G’ of the extruded systems was significantly lower than that of virgin PLA. This 
can be attributed to the minor, un-avoidable molecular weight degradation 
incidental to the melt extrusion technique. The statistical difference between G’ 
of the neat extruded PLA and the melt compounded systems was significant at 
all test temperatures, except for that between extruded PLA and theophylline 
loaded PLA at 210 °C (table 5.3). Nevertheless, this difference was 
unsubstantial for the curcumin and theophylline loaded systems. Among the 
extruded systems the paracetamol loaded PLA exhibited the lowest G’ at all 
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studied temperatures (figure 5.9, figure 5.10). The amorphous paracetamol has 
significantly lower glass transition temperature (22 – 23 °C) than PLA (55 – 60 
°C). Moreover, it formed a solid solution with PLA. Therefore, the G’ and G” of 
the paracetamol loaded PLA were reduced by virtue of the plasticisation by 
paracetamol (Pillin et al., 2006). A similar effect was not observed for curcumin 
and theophylline, since curcumin has a glass transition temperature equivalent 
to that of PLA, while theophylline was present as a separate crystalline phase. 
 
 
Figure 5.10: Amplitude sweep analysis of the model PLA systems at 210 °C.  
Notes - Comparison of G’ (dashed) and G” (solid line) against % strain for virgin PLA (blue), neat extruded 
PLA (red) and PLA melt compounded with 5% curcumin (green), 5% paracetamol (purple), 5% 
theophylline (orange).  
The average of 3 replicate measurements is plotted. The error bars (black dots) represent the standard 
deviation. 
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Table 5.3: Statistical analysis of the amplitude sweep test results: comparison of G’ at 
1% strain amplitude 
G' at 1% strain amplitude (and 1 Rad. Sec-1 angular frequency) (Mean ± SD, n = 3) 
 
Virgin PLA 
Extruded Neat 
PLA 
Curcumin 
loaded PLA 
(CPLA) 
Theophylline 
loaded PLA 
(PPLA) 
Paracetamol 
loaded PLA 
(TPLA) 
160 °C 
2770.885 ± 
2.9610 
1809.664 ± 
3.0029 
1972.074 ± 
5.2949 
1864.727 ± 
4.0590 
1432.558 ± 
3.2141 
210 °C 
16371.23 ± 
36.1910 
11410.36 ± 
13.2064 
11873.71 ± 
38.3322 
11428.21 ± 
12.4320 
9503.858 ± 
7.5086 
Statistical comparison by paired t-test 
Significance 
at 160 °C 
Virgin Vs 
Extruded 
P < 0.0001,     
t = 394.78 
Significance 
at 210 °C 
Virgin Vs 
Extruded 
P < 0.0001,     
t = 223.04 
Extruded Vs 
CPLA 
P < 0.0001,     
t = 46.21 
Extruded Vs 
CPLA 
P = 0.0025,     
t = 19.795 
Extruded Vs 
TPLA 
P = 0.0003,     
t = 18.89 
Extruded Vs 
TPLA 
P = 0.1869,     
t = 1.704 
Extruded Vs 
PPLA 
P < 0.0001,     
t = 148.49 
Extruded Vs 
PPLA 
P < 0.0001,     
t = 217.37 
Notes: The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
 
 
One important implication of the amplitude sweep is to determine the 
linear viscoelastic region (LVER). In this region, the storage modulus remains 
constant, irrespective of the applied stress. Since the LVER is correlated to the 
structural integrity of the material under study, it is recommended that the 
viscosity measurement by frequency sweep tests should be carried out within 
the LVER. This ensures a non-destructive testing of the material. A strain 
amplitude of 1% was selected for further studies, as it lies within the LVER for 
all PLA systems under investigation.  
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5.6.2. Frequency sweep test: analysis of the complex viscosity 
 Viscosity of PLA melt depends on its molecular weight, percentage 
racemisation, crystallinity and the presence/ absence of branching (Lim et al., 
2008). The filled as well as the unfilled PLA under investigation exhibited a 
constant ‘zero shear viscosity’ which was followed by shear thinning at higher 
angular frequencies (figure 5.11). Shear thinning was diminished at elevated 
temperatures, owing to a drop in the zero shear viscosity itself. A 10 °C rise in 
the temperature produced 40 ± 3% fall in the value of the complex viscosity. 
This observation was comparable to the previous reports on different grades of 
PLA (Cooper-White and Mackay, 1999). A temperature induced drop in the zero 
shear viscosity coupled with shear thinning, can significantly enhance the flow 
of the molten materials and their mixing, during melt extrusion.  
 
Figure 5.11: Comparison of complex viscosity against angular frequency curves for the 
model drug loaded PLA systems at various test temperatures 
Notes: 160 °C (solid line), 180 °C (dashed line) and 210 °C (dotted line) for virgin PLA (blue), neat 
extruded PLA (red) and PLA melt compounded with 5% curcumin (green), 5% paracetamol (purple), 5% 
theophylline (orange). 
The average of 3 replicate measurements is plotted. The error bars (black dots) represent the standard 
deviation. 
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Figure 5.11 displays a comparison of the ‘complex viscosity Vs angular 
frequency’ curves, for the investigated systems at 160 °C, 180 °C, and 210 °C 
test temperatures. (Only three test temperatures are included here for a clearer 
representation). Figure 5.11 confirms that melt extrusion led to a drop in the 
viscosity of the extruded systems (both filled and un-filled). The viscosities of 
the investigated systems at 1 Rad.sec-1 and 100 Rad.Sec-1 were statistically 
compared by paired t-tests (table 5.4). The statistical treatment confirmed that 
there was a significant difference between the zero shear viscosities (1 
Rad.sec-1) of the investigated systems. Albeit, such a difference between the 
neat extruded PLA and the curcumin loaded PLA was unsubstantial (figure 
5.11).   
As discussed previously in the amplitude sweep section, the lower 
viscosity of the melt-extruded systems can be attributed to the molecular weight 
degradation that could not be avoided, although PLA was pre-dried and 
processed at temperatures not exceeding 180 °C. Extreme susceptibility of PLA 
to thermolysis and hydrolysis during melt extrusion has been previously 
documented (Carrasco et al., 2010; Taubner and Shishoo, 2001; Wang et al., 
2008). In addition to temperature and residual moisture, screw configuration 
and screw speed also influence the molecular weight degradation during melt 
extrusion. Higher screw speed or a configuration that produces a greater shear, 
leads to molecular weight degradation due mechanical impact and localised 
generation of the frictional heat. On the contrary, lower screw speeds enhance 
molecular weight degradation by prolonging the residence time. Wang et al. 
(2008) observed minimal process induced degradation of PLA at 180 °C and 50 
rpm screw speed, using a twin screw extruder with 16 mm diameter and 25 L/D 
ratio. The twin-screw extruder used in the current study was equipped with 16 
mm diameter and 40 L/D ratio screws; therefore a proportionately higher (80 
rpm) screw speed was used.  
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Table 5.4: Statistical analysis of the frequency sweep test results: comparison of the zero shear viscosity and the viscosity at 100 Rad.sec-1 angular 
frequency, between the studied model systems.  
Statistical comparison of the viscosity by paired t-test 
Zero shear viscosity 
(Pa.s)  
160 °C 
Virgin Vs Extruded Neat  P < 0.0001, t = 198.52 
Viscosity at 100 Rad.Sec-1 
(Pa.s)  
160 °C 
Virgin Vs Extruded Neat  P = 0.0003, t = 53.97 
Extruded Neat  Vs CPLA P < 0.0001, t = 81.44 Extruded Neat  Vs CPLA P = 0.0609, t = 3.86 
Extruded Neat Vs PPLA P < 0.0001, t = 99.31 Extruded Neat Vs PPLA P < 0.0001, t = 116.70 
Extruded Neat Vs TPLA P = 0.0022, t = 21.14 Extruded Neat Vs TPLA P = 0.0071, t = 11.78 
180 °C 
Virgin Vs Extruded Neat  P < 0.0001, t = 116.93 
180 °C 
Virgin Vs Extruded Neat  P = 0.0001, t = 85.20 
Extruded Neat  Vs CPLA P = 0.0002, t = 21.32 Extruded Neat  Vs CPLA P = 0.1091, t = 2.77 
Extruded Neat Vs PPLA P = 0.0006, t = 39.72 Extruded Neat Vs PPLA P < 0.0001, t = 278.10 
Extruded Neat Vs TPLA P < 0.0001, t = 198.52 Extruded Neat Vs TPLA P < 0.0001, t = 188.59 
200 °C 
Virgin Vs Extruded Neat  P < 0.0001, t = 135.01 
200 °C 
Virgin Vs Extruded Neat  P < 0.0001, t = 132.81 
Extruded Neat  Vs CPLA P = 0.0012, t = 29.10 Extruded Neat  Vs CPLA P = 0052, t = 13.86 
Extruded Neat Vs PPLA P < 0.0001, t = 242.49 Extruded Neat Vs PPLA P < 0.0001, t = 102.43 
Extruded Neat Vs TPLA P < 0.0001, t = 38.97 Extruded Neat Vs TPLA P = 0.0011, t = 29.70 
Notes: Actual data is represented in figure 5.11 
The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
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The theophylline loaded PLA showed a slightly greater viscosity drop than 
the neat extruded PLA; whereas, the paracetamol loaded PLA showed a 
significantly greater drop in the viscosity, at all test temperatures (figure 5.11, 
table 5.4). Since the molecular weight degradation (sec. 5.8) in the 
abovementioned systems did not exceed that shown by the neat extruded PLA, 
a greater drop in the viscosity relates to a factor other than thermal degradation. 
In the case of paracetamol loaded PLA, this can be attributed to the 
plasticisation action of the molecularly dispersed amorphous paracetamol.  
Owing to the presence of theophylline as a crystalline suspension in PLA, 
the composite system should ideally show a greater viscosity than the neat 
extruded PLA (Pluta et al., 2007). However, the viscosity of the theophylline 
loaded PLA was lower than that of the neat extruded PLA (P < 0.01). Similar 
results were obtained by Gu et al. (2009) when PLA was filled with less than 
10% w/w of calcium carbonate (CaCO3) (the particle size was comparable to 
the theophylline particle size used in this study). The peculiar behaviour of the 
PLA composites was attributed to weakening of the inter-chain interactions by 
the filler particles. At lower loadings, the inter-particulate interactions between 
the filler particles are insufficient to raise the viscosity of the composite material 
(by network formation). Nevertheless, presence of poorly compatible filler 
weakens the particle-matrix interactions as well as the interactions between the 
polymer chains. Theophylline similar to CaCO3 shows poor cohesive 
interactions with PLA (sec. 5.2), which can explain the drop in the G’, G” and 
viscosity of the theophylline loaded PLA. 
5.6.3. Time sweep at a constant temperature 
 Thermal stability of a polymer melt with respect to time can be studied by 
subjecting it to a constant strain amplitude, angular frequency and temperature, 
over an extended duration (Sodergard and Nasman, 1994). Figure 5.12 
displays a comparison of the viscosity changes with time, for virgin PLA and the 
drug loaded PLA, at 160 °C, 180 °C and 210 °C test temperatures.   
 106 
 
 
Figure 5.12: Time sweep test for evaluation of the thermal stability of the model drug 
loaded PLA systems. 
Note: The figure shows a comparison of the complex viscosity  against time, at 160 °C (solid line), 180 °C 
(dashed line) and 210 °C (dotted line) for virgin PLA (blue) and the PLA melt compounded with 5% 
curcumin (green), 5% paracetamol (pink), 5% theophylline (red). 
*The average of 3 replicate measurements is plotted. The error bars (black dots) represent the standard 
deviation.  
It is evident that the viscosity of virgin PLA (blue curves in figure 5.12) 
remained reasonably constant over the 30 minutes duration, when tested 
between 160 °C and 180 °C. At these temperatures the total viscosity drop at 
the end of the test was restricted to less than 15% of the initial value (table 5.5). 
However, the drop in the viscosity was more prominent with a further rise in the 
test temperature, above 180 °C. Thermal degradation of PLA can be minimised 
by removing the trace amount of water and restricting the processing 
temperature and residence time to the minimum possible value (Taubner and 
Shishoo, 2001). Therefore, 180 °C was considered as an appropriate 
temperature for the melt compounding operation, since it can produce a suitable 
viscosity drop without causing significant polymer degradation. As explained 
 107 
 
previously (sec 5.6.2), the screw speed was fixed to 80 rpm in order to balance 
the adverse effects of the prolonged residence time and shear induced 
degradation. This decision was entirely based on the literature reports (Taubner 
and Shishoo, 2001; Wang et al., 2008). Nevertheless, PLA was dried carefully 
before any melt processing. 
Table 5.5: Statistical comparison of the time sweep results represented in figure 5.12 
Percentage drop in the viscosity in 30 minutes (Mean ± SD, n = 3) 
Sample 160 °C 180 °C 200 °C 
Virgin PLA  6.62 ± 0.5855 14.02 ± 0.3846 54.39 ± 0.3154 
Curcumin loaded PLA (CPLA) 12.55 ± 0.1842 39.52 ± 0.1047 70.27 ± 0.0487 
Paracetamol loaded PLA (PPLA) 6.37 ± 0.0277 34.51 ± 0.2076 67.66 ± 0.2009 
Theophylline Loaded PLA (TPLA) 35.16 ± 0.0642 50.86 ± 0.3331 83.77 ± 0.0194 
Statistical comparison by paired t-test 
Virgin Vs CPLA 
160 °C P = 0.0036, t = 16.727 
180 °C P = 0.0001, t = 89.075 
200 °C P = 0.0002, t = 69.928 
Virgin Vs PPLA 
160 °C P = 0.5361, t = 0.7405 
180 °C P < 0.0001, t = 100.99 
200 °C P < 0.0001, t = 75.340 
Virgin Vs TPLA 
160 °C P = 0.0004, t = 48.639 
180 °C P < 0.0001, t = 125.36 
200 °C P < 0.0001, t = 161.04 
 
Note: The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
 
Time sweep studies were performed on the melt compounded systems, in 
order to assess their thermal stability when subjected to further processing; i.e. 
extrusion of sheets and billets. Repeated thermal processing significantly 
reduces thermal stability of PLA. The oligomers generated in the previous 
thermal cycle catalyse the molecular weight reduction by the trans-esterification 
reaction (Jamshidi et al., 1988). Among the compounded systems studied here, 
the paracetamol loaded PLA (purple curves in figure 5.12) displayed the highest 
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thermal stability, whereas the theophylline loaded PLA (orange curves in figure 
5.12) was least stable. The curcumin loaded PLA exhibited an intermediate 
behaviour (orange curves in figure 5.12). This was confirmed statistically by 
comparison of the total viscosity drop over the 30 minutes of the test duration, 
using paired t-tests (table 5.6). At 160 °C test temperature the drop in viscosity 
of the paracetamol loaded PLA was equivalent to that exhibited by virgin PLA (P 
= 0.53). However, at higher test temperature the paracetamol loaded systems 
underwent a greater viscosity reduction (P < 0.001). Similarly, the remaining 
systems showed significantly higher (P < 0.01) viscosity drop than virgin PLA, 
during the time sweep test. The viscosity reduction exhibited by curcumin 
loaded PLA was comparable to the paracetamol loaded PLA; nevertheless that 
in the case of theophylline loaded PLA was substantially higher (table 5.6, figure 
5.12). 
A higher stability in the case of PPLA can be attributed to the plasticisation 
action provided by paracetamol. This may lower the thermal degradation of PLA 
by reducing the mechanical impact and generation of the frictional heat. In the 
case of curcumin, the same can be attributed to the potent antioxidant and free 
radicle scavenging activity (Ak and Gulcin, 2008), which may prevent the 
oxidative thermolysis of PLA. A detailed study focused on understanding these 
mechanisms was beyond the scope of this project. Overall, the results suggest 
that the compounded systems must be processed at lower temperatures than 
the virgin polymer and the residence time should be kept minimal. Therefore, 
the film and billet extrusion was carried out with a temperature profile as follows; 
feeding zone = 45 °C, compression zone = 110 °C, metering zone = 160 °C, 
and the die set to 170 °C, with the screw speed of 50 rpm.  
5.6.4. Summary 
From the above discussion is it clear that PLA melt exhibit a temperature 
dependent, predominantly viscous behaviour at lower shear rates. The glass 
transition of the drug and its solubility in the PLA matrix, significantly affects the 
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rheological behaviour as well as the thermal stability of the PLA melt. A safe 
processing window for PLA lies between 160 °C and 180 °C, with 180 °C being 
the most favourable temperature for compounding operation and 170 °C for 
further extrusion into billets and sheets. Moreover, the screw speed must be 
adjusted such a way to balance the adverse effects of the prolonged residence 
time and the shear induced degradation. This was fixed to 80 rpm for extrusion 
compounding and to 40 rpm for further extrusion into different geometries, 
based on the reviewed literature.  
5.7. Assessment of PLA degradation in the presence of sodium salicylate 
 
 
Figure 5.13: Time sweep test for analysis of thermal stability of PLA in presence of 
sodium salicylate 
Note: The above figure shows a comparison of the complex viscosity against time, at 160 °C (solid line), 
180 °C (dashed line) and 200 °C (dotted line) for virgin PLA (blue) and PLA melt compounded with 0.5% 
(green), 2.5% (pink) and 5% SS (red) sodium salicylate. 
*The average of 3 replicate measurements is plotted. The error bars (black dots) represent the standard 
deviation.   
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Sodium salicylate (SS) was initially selected as a model drug that can 
remain in a crystalline suspension state in PLA. However, rheological studies 
revealed that the storage and the loss moduli of the composite material were 
extremely unstable. Moreover, the zero shear viscosity of the composite PLA 
containing 5% w/w sodium salicylate was only 1/6th of the virgin PLA viscosity at 
160 °C. Since the viscosity of the neat extruded PLA was almost 80% of the 
virgin PLA viscosity (at 160 °C), the effect of SS addition was notably large. To 
evaluate this effect, the following experiments were carried out on the melt 
extruded composite material, containing three different loadings of sodium 
salicylate; i.e. 0.5%, 2.5% and 5%w/w.  
 
Table 5.6: Statistical comparison of the time sweep results represented in figure 5.13 
Percentage drop in the viscosity in 30 minutes (Mean ± SD, n = 3) 
Sample  160 °C 180 °C 200 °C 
Virgin PLA  6.62 ± 0.5855 14.02 ± 0.3846 38.94 ± 0.1367 
PLA + 0.5% Sodium salicylate 
(SS) 80.76 ± 0.649 90.02 ± 0.635 93.52 ± 0.245 
PLA + 2.5% Sodium salicylate 
(SS) 73.48 ± 0.829 91.67 ± 0.493 96.44 ± 0.206 
PLA + 5% Sodium salicylate (SS) 66.05 ± 0.1078 91.01 ± 0.695 94.61 ± 0.516 
Statistical comparison by paired t-test 
Virgin Vs 0.5% SS 
160 °C P < 0.0001, t = 141.91 
180 °C P < 0.0001, t =177.31 
200 °C P < 0.0001, t = 336.96 
0.5% Vs 2.5% SS 
160 °C P = 0.0013, t = 11.977 
180 °C P = 0.0380, t = 3.56 
200 °C P = 0.0006, t = 15.80 
2.5% Vs 5% SS 
160 °C P = 0.0042, t = 15.39 
180 °C P = 0.2722, t = 1.342 
200 °C P = 0.0294, t = 5.71 
Note: The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
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Figure 5.13 summarises the results obtained in the time sweep rheology 
experiments, performed on the composite PLA containing different loadings of 
sodium salicylate. It is clear that the viscosity of the composite material was 
significantly lower than that of virgin PLA at all test temperatures. Moreover, the 
viscosity at a fixed test temperature reduced as the concentration of sodium 
salicylate increased. Figure 5.13 further reveals that the stability of the PLA melt 
was significantly reduced after compounding with sodium salicylate. The 
viscosity of virgin PLA remained stable for 30 minutes at 160 °C test 
temperature; while it started reducing approximately after 14 minutes at 200 °C. 
On the contrary, the viscosity of the composite PLA containing sodium salicylate 
started reducing only after a minute at 160 °C; while at 200 °C it reduced almost 
instantaneously. A plasticiser decreases melt viscosity of a polymer but it rarely 
reduces thermal stability (Ljungberg and Wesslen, 2002). Therefore, the results 
suggest that sodium salicylate might have enhanced thermal degradation of 
PLA.  
Statistical comparison of the total viscosity drop during 30 minutes of the 
test duration (table 5.6), revealed the following. At 160 °C, there was a 
significant (P < 0.001) difference between the viscosity drops produced by 
various loadings of SS. However, the total viscosity drop exhibited an inverse 
relation with the amount of SS at this temperature. This peculiarity could not be 
investigated further. At 180 °C and 200 °C, merely 0.5% of SS produced 90.02 ± 
0.635 % drop in the viscosity. The viscosity drop produced by the higher 
loadings was not substantially different as it ranged between 90 – 96%.  The 
results of time sweep rheological experiments on the SS composite PLA were 
coherent with the molecular weights of these systems. 
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Figure 5.14: Molecular weight degradation of PLA after melt compounding with various 
loading of sodium salicylate. 
*The graph represents the mean ± standard deviation, where n = 3.  
The 0% sodium salicylate loading signifies neat extruded PLA 
Table 5.7: Statistical comparison of the molecular weight of the PLA melt compounded 
with various amounts of sodium salicylate. 
Statistical comparison by paired t-test 
Extruded PLA Vs 0.5% SS P = 0.0018, t = 23.496 
0.5% SS Vs 2.5% SS P = 0197, t = 4.568 
2.5% SS Vs 5% SS P = 0.0785, t = 2.627 
Note: The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
 
The molecular weight degradation of PLA during melt compounding with 
SS was confirmed by GPC (figure 5.14). A substantial (p < 0.01; table 5.7) 
molecular weight reduction was observed at 0.5% SS loading. Statistical 
analysis revealed that the difference between molecular weights of the neat 
extruded PLA and the PLA containing 0.5% SS was highly significant. The 
statistical significance reduced as the SS loading increased (table 5.7). 
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Accordingly, the difference between molecular weights of 2.5% SS loaded PLA 
and 2.5% SS loaded PLA was statistically insignificant (or may be referred to as 
possibly significant based on the P-value) (table 5.7). The results clearly 
suggest that sodium salicylate caused thermal degradation of PLA; however, 
increasing the concentration of sodium salicylate did not substantially enhance 
the degradation.  
Li et al. (2007) reported a 2.5 fold drop in the zero shear viscosity of PLA 
(tested at 180 °C), when it was melt compounded with 0.5% sodium stearate. 
They attributed it to the chain scission induced by sodium stearate. Previous 
reports on the utilisation of organic salts as nucleating agents for polyesters 
such as PET have confirmed that the nucleation mechanism involves a prior 
chemical reaction between the molten polyester and the organic salt (Legras et 
al., 1983; Zhang, 2004). Precisely, organic salts such as sodium stearate 
transfer the sodium ion to random carboxyl oxygen of the polyester, leading to 
extensive scission of the polyester backbone (Legras et al., 1983; Zhang, 
2004). The same mechanism can explain the elevated thermal degradation of 
PLA in the presence of sodium salicylate.  
5.8. Thermal degradation of PLA during melt processing 
A significant limitation associated with melt processing of PLA is its 
tendency to undergo thermal degradation. The extent of degradation depends 
on the processing temperature, presence of moisture, the residence time and 
the mechanical impact resulting from the screw geometry and rotation speed 
(Wang et al., 2008). Taubner et al. (2001) observed 15% reduction in the 
number average molecular weight (Mn) when pre-dried PLA was processed in a 
twin-screw extruder at 210 °C. Lowering the screw speed from 120 rpm to 
20 rpm or increasing the processing temperature to 240 °C, augmented the 
molecular weight loss by 25% and 34% respectively. Moreover, when the resin 
was pre-equilibrated at 20 °C/ 65% RH, merely 0.3%, w/w moisture caused a 
dramatic molecular weight reduction to almost 35% of the original Mn.  
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Table 5.8: Summary of the molecular weight changes in PLA after melt compounding 
with the model drugs and sheet / billet extrusion. 
Compounded system Mw (g.mol-1) Polydispersity 
Virgin PLA 149634 ± 1785 1.66 ± 0.0261 
Neat extruded PLA 141356 ± 1520 1.59 ± 0.0323 
Melt compounded PLA + 5% curcumin (twin-screw) 143758 ± 2607 1.55 ± 0.0659 
PLA + 5% curcumin sheets (single-screw) 142573 ± 2831 1.55 ± 0.0863 
Melt compounded PLA + 5% paracetamol (twin-screw) 141287 ± 2414 1.58 ± 0.0604 
PLA + 5% paracetamol billets (single-screw) 138134 ± 2141 1.54 ± 0.0778 
Melt compounded PLA + 5% theophylline (twin-screw) 139352 ± 2079 1.55 ± 0.0716 
PLA + 5% theophylline sheets (single-screw) 135732 ± 2804 1.55 ± 0.0508 
PLA + 0.5% sodium salicylate 93897 ± 3151 1.52 ± 0.1098 
PLA + 2.5% sodium salicylate 83531 ± 2350 1.46 ± 0.0589 
PLA + 5% sodium salicylate 77485 ± 3219 1.4 ± 0.084 
*The molecular weight and polydispersity values are expressed as mean ± standard deviation, where n=3. 
Knowledge of molecular weight degradation is necessary, since it 
adversely affects the melt strength and the properties of the resulting matrices. 
The oligomers generated as a by-product of the degradation process, catalyse 
further breakdown during another melt processing cycle or even hydrolytic 
degradation during clinical application. Importantly, the effect of degradation can 
be reflected on the tensile deformation behaviour of the drug loaded PLA 
matrices and consequently on the drug release profile.  
Table 5.8 summarises the changes in the molecular weight after each 
processing stage, determined using GPC. It is evident that extrusion of virgin 
PLA through a twin screw extruder at 180 °C led to a drop in the molecular 
weight by approximately 6%. Except sodium salicylate, all other model drugs 
remained inert and therefore a drop in the molecular weight after the 
compounding stage was approximately 4%, 6% and 7% for the curcumin, 
paracetamol and theophylline loaded PLA respectively. A smaller drop in the 
molecular weight of the curcumin loaded PLA might be attributed to the potent 
antioxidant and the radical scavenging activity of curcumin (Ak and Gulcin, 
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2008). This might have lowered the thermal degradation of PLA by the oxidative 
and the radical induced mechanisms. On the contrary, higher degradation 
induced by sodium salicylate correlates to the attack on the carboxyl oxygen of 
PLA by the cationic sodium (Legras et al., 1983). Importantly, the change in the 
molecular weight was negligible (P > 0.05, by paired t-test), when the drug 
loaded PLA was further melt extruded into different geometries (rods/films) 
using a single screw extruder. This can be attributed to lower extrusion 
temperature and lesser shear stress produced by the single screw extruder. 
The reduction in the molecular weight observed in the current study, during both 
single- and twin-screw extrusion was significantly lower than the literature 
reports (Gogolewski et al., 1993; Taubner and Shishoo, 2001; Wang et al., 
2008); which validates the efficiency of the extrusion processes utilised here 
(Lim et al., 2008).  
5.9. Mechanism behind thermal and sodium salicylate induced 
degradation of PLA 
Low molecular weight degradation products generated during thermal 
degradation of PLA may potentially affect its tensile deformation behaviour and 
its hydrolytic degradation in the drug release media (Tsuji and Ikada, 1998). 
Consequently, the drug release profile from oriented matrices can be altered. 
The oligomeric degradation products generated during melt extrusion of PLA 
were identified by gas chromatography/mass spectrometry (GC/MS). This study 
was supplemented by identification of the degradation products generated 
during melt compounding of PLA with sodium salicylate, in order to confirm the 
mechanism of degradation in the presence of such a drug. GC/MS allows 
separation of the individual degradants by gas chromatography. Each 
separated species is subsequently detected by the mass spectrometer. The 
mass spectra obtained in the current study were compared with the NIST 
reference database and with previous reports on pyrolysis of PLA (Kopinke et 
al., 1996; Luderwald, 1979; McNeill and Leiper, 1985).  
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Figure 5.15: GC/MS chromatogram of neat extruded PLA with the individual 
components identified from the corresponding mass spectra.  
*(inset mass spectrum corresponding to the GC peaks observed between 21 to 23 minutes). 
 
Figure 5.16: GC/MS chromatogram of PLA melt compounded with 5% w/w sodium 
salicylate  
*(The individual components were identified from the mass spectra). 
The identified species are displayed on the respective gas-chromatograms 
for the neat extruded PLA (figure 5.15) and the composite system containing 
5% sodium salicylate (figure 5.16). The gas chromatogram of neat extruded 
PLA and composite PLA showed a characteristic series of peaks between the 
retention time (Rt) window of 18 to 28 minutes. The mass spectra corresponding 
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to these peaks contained distinctive bands at m/z (mass to charge ratio) 72.n – 
88, representing the cyclic oligomers of lactic acid (McNeill and Leiper, 1985). 
Here, the m/z = 72 corresponds to the lactic acid monomer unit; whereas, ‘n’ 
signifies the number of monomer units present in an oligomer. Ionisation of the 
lactic acid oligomers in the mass spectrometer leads to rapid elimination of CO2 
(m/z 44) and acetaldehyde (m/z 44). Therefore the fragmentation pattern for the 
lactic acid oligomers is observed at m/z values 72.n - 88 (Kopinke et al., 1996; 
Luderwald, 1979). Oligomers with monomer units between n = 5 to n = 12 were 
identified in the gas chromatogram of the neat extruded and the filled PLA. The 
Rt of the oligomers increased with their molar mass (figure 5.15 & figure 5.16). 
(The same oligomers were also identified by liquid chromatography/mass 
spectrometry, which validates that the oligomers were not generated as a result 
of the GC/MS thermal regime).  Interestingly, the oligomers exhibited a cluster 
of peaks in the gas-chromatogram, which corresponded to the same mass 
spectrum. For the pentamer (n = 5), 4 clear peaks were observed between Rt = 
18 -19 minutes; while the hexamer showed existence of 5 peaks. Kopinke et al. 
(1996) obtained a similar gas-chromatogram, when PLA (mol wt. = 99400 
g/mol) was flash pyrolysed between 400 – 600 °C. The cluster of peaks in the 
gas-chromatogram was attributed to generation of optical isomers of lactic acid 
oligomers during degradation. 
Mcneill et al. (1985) proposed that the thermal degradation of PLA occurs 
primarily by intra- and inter- molecular ester exchange reactions (figure 5.17). If 
the free hydroxyl end of PLA reacts with a carboxyl group of the same lactic 
acid unit, acetaldehyde and carbon monoxide are generated (figure 5.17 - A). 
Nevertheless, depending upon the location of the carboxyl group that faces the 
attack by the hydroxyl oxygen, the resulting product can be a lactide dimer 
(figure 5.17 - B) or a cyclic oligomer with more than two repeat units (figure 5.17 
- C).  
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Figure 5.17: Thermal degradation of PLA by trans-esterification pathway. 
 
 
Figure 5.18: Mechanism for thermal degradation of PLA in presence of sodium 
salicylate. 
The gas chromatogram of neat extruded PLA showed an intense peak at 
Rt = 9 minutes (figure 5.15). The mass spectrum corresponding to this peak 
revealed the presence of a lactide dimer. Since the intensity of this peak was at 
least 2.5 times higher than any other peak, lactide dimer was perhaps the 
largest individual degradation product obtained in the current study. Generation 
of lactide in the neat extruded PLA can be attributed to traces of Sn- catalyst. 
The PLA utilised in the current study was synthesised (by Natureworks LLC) by 
Sn-catalyzed polymerisation of L,L-lactide (Gruber and O'Brien, 2005). It being 
a reversible equilibrium reaction also causes depolymerisation of PLA by the 
 119 
 
traces catalyst left in the polymer (Fan et al., 2004a; Fan et al., 2004b). When 
PLA is present in the molten state, ‘Sn’ can react with the free hydroxyl ends, 
forming Sn-alkoxide anions (figure 5.18). The alkoxide anions further attack the 
carbonyl carbon in the adjacent lactate unit, resulting in the formation of an 
optically pure lactide dimer (Fan et al., 2004b; Gruber and O'Brien, 2005).  
A large lactide peak was also observed in the chromatogram of the 
composite PLA containing 5% sodium salicylate. However, it was split into a 
smaller and a larger peak with Rt = 8.5 minutes and 9.5 minutes respectively 
(figure 5.16). Since both of these peaks correspond to the same mass 
spectrum, they essentially represent optical isomers of lactide. The earlier 
eluting peak represents the meso-lactide, while the latter represents L,L-lactide 
(Fan et al., 2004b) As mentioned above, the Sn catalysed depolymerisation 
leads to formation of optically pure lactide dimers. Therefore, a mechanism 
other than Sn catalysed depolymerisation must be contributing in degradation of 
the sodium salicylate loaded PLA. A possible mechanism may involve transfer 
of Na+ (sodium cations) to the alkoxy end group of PLA chains. The sodium 
alkoxide may subsequently cause unzipping depolymerisation of PLA in a 
manner similar to Sn+2 (tin) ions (figure 5.18). Traces of sodium cations if 
present during polymerisation of isotropically pure lactic acid, are known to 
promote formation of the meso-lactide by the same polymerisation reaction as 
Sn+2 ions (Gruber et al., 1992). Therefore, splitting of the lactide GC peak 
confirms involvement of the sodium cations, generated from sodium salicylate, 
in augmenting the thermal depolymerisation of PLA. In addition to the 
depolymerisation mechanism, literature confirms that the sodium salts of 
organic acids cause scission of the polyester backbone by transferring sodium 
ions to random carboxyl groups. However, this reaction pathway has been only 
observed for PET and not for PLA (Legras et al., 1983). Nevertheless, the 
current GC-MS analysis could not identify the by-products which would validate 
the existence of the random scission reaction.  
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    In summary, it can be concluded that the thermal degradation of PLA 
during melt extrusion simultaneously follows several mechanisms (Kopinke et 
al., 1996). These include depolymerisation into the lactide dimer, inter and 
intramolecular trans-esterification leading to generation of lactide oligomers, etc. 
Sodium salicylate augments thermal degradation of PLA by providing sodium 
cations that react with the carboxyl oxygen and cause depolymerisation (Legras 
et al., 1983; Zhang, 2004).  
5.10. Summary of the materials understanding studies 
This chapter described selection of the model polymer and the model drugs. 
Curcumin, theophylline and paracetamol were selected as thermostable and 
inert model drugs, based on extensive screening of the shortlisted molecules. 
Curcumin and paracetamol at 5% w/w loading represent polymer (PLA) soluble 
model drugs; while theophylline at 5% w/w loading represents an insoluble drug 
that can remain in a suspension state within the polymer matrix. In this 
research, melt extrusion was used a scalable method for compounding model 
drugs with PLA and for preparation of drug loaded films or billets. Changes in 
the polymorphic state of the experimental materials (model drugs & PLA) and 
their degradation during melt extrusion can potential affect solid-state 
deformation behaviour of the composite matrices, their hydrolytic degradation 
and the resultant drug release profile. In order to understand these changes, the 
experimental materials were studied by thermal analysis, X-ray diffraction, IR 
spectroscopy and gel permeation chromatography. This information along with 
rheological characterisation was used for development of an efficient melt 
extrusion process, which will cause minimal degradation of the investigated 
materials. Nevertheless, degradation products generated during melt extrusion 
were identified by gas chromatography - mass spectroscopy (GC-MS). Such a 
comprehensive understanding of the experimental materials will ensure that the 
characteristic features of drug release from oriented materials are correctly 
attributed to polymer orientation.   
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6. Drug release from the oriented PLA 
films: results & discussion 
This chapter relates to solid-state orientation of drug loaded PLA films and 
characterisation of the resultant films for drug release. The initial section is 
dedicated to investigation of the effect of strain rate, drawing temperature, draw 
ratio and the nature of drug on the morphology of oriented films. Development 
of oriented morphology in these films is discussed with respect to WAXD, 
MDSC and mechanical testing results. Based on these results, selected 
samples were further evaluated for changes in the surface polarity and the 
morphological changes underwent by the films after aqueous submersion. 
Finally, the results of drug release testing are discussed with an attempt to 
identify a correlation between the oriented structure of the films and drug 
release.   
6.1. Effect of drawing conditions on the thermal properties of oriented 
PLA films 
 Three important thermal events, namely glass transition (Tg), cold-
crystallisation (Tcc) and enthalpy of melting are closely related to the physical 
structure of a polymer. Since Tg corresponds to the energy required for 
bestowing mobility to the amorphous polymer chains, it is shifted towards higher 
temperatures upon orientation of the amorphous section. On the contrary, Tcc 
shares an inverse relation with the degree of polymer orientation. Finally, the 
normalised enthalpy of melting allows calculation of the percentage crystallinity 
of the oriented matrices. 
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6.1.1. Effect of drawing temperature and strain rate on crystallinity 
 
 
Figure 6.1: Effect of strain rate (X1-axis) and drawing temperature (X2-axis) on 
crystallinity (Z-axis) of (A) curcumin and (B) theophylline loaded films (5% w/w drug 
loading), oriented uniaxially with a constant width (UCW) to a draw ratio 3X. 
* The surface response plots were obtained by multiple regression analysis, details of which are 
represented below the respective plots. The drawing temperatures; namely 70 °C, 80 °C and 90 °C, and 
the strain rates 0.12 sec-1, 0.57 sec-1, 1.2 sec-1 are expressed as -1, 0 and +1 factorial levels respectively.   
Figure 6.1 displays the effect of strain rate and drawing temperature on 
the crystallinity of the uniaxially (uniaxial constant width - UCW – λ = 3X) 
oriented drug loaded films. For simplification the PLA films containing 5% w/w of 
curcumin and 5% w/w theophylline are referred to as CPLA films and TPLA 
films respectively. The Neat PLA films exhibited exactly the same response as 
shown by the CPLA films and therefore it is not separately reported here. It is 
clear that a rise in both strain rate and drawing temperature elevated the 
percent crystallinity of the films. The effect of temperature was significantly 
larger than that of the strain rate. Higher crystallinity at elevated temperatures 
can be attributed to thermally enhanced chain mobility, which increases the 
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probability of them registering into favourable positions (Mahendrasingam et al., 
2005; Mulligan and Cakmak, 2005).  
The lowest values of crystallinity observed for the UCW oriented (λ = 3X) 
neat PLA, CPLA and TPLA films were 0.77 ± 0.69%, 0.43 ± 0.23% and 0.79 ± 
0.82% respectively, when oriented at 70 °C and 0.12 sec-1. Contrastingly, 90 °C 
and 1.2 sec-1 drawing conditions led to significantly higher crystallinity, i.e. 28.91 
± 1.04%, 28.30 ± 1.61% and 25.04 ± 1.67% for the neat PLA, CPLA and the 
TPLA films respectively. The effect of drawing temperature on crystallinity of the 
UCW oriented (λ = 3X) TPLA (figure 6.1 - B) was less prominent than that 
observed with the corresponding neat and the CPLA films. This potentially 
indicates a reduction in the thermally stimulated chain movement and resultant 
inter-chain interactions due to interference by the suspended theophylline 
particles.  
 
 
Figure 6.2: Effect of strain rate (X1-axis) and drawing temperature (X2-axis) on 
crystallinity (Z-axis) of (A) curcumin and (B) theophylline loaded films, oriented in 
simultaneous biaxial mode to a biaxial draw ratio 2X2Y. 
* The surface response plots were obtained by multiple regression analysis, details of which are 
represented below the respective plots. The drawing temperatures; namely 70 °C, 80 °C and 90 °C, and 
the strain rates 0.12 sec-1, 0.57 sec-1, 1.2 sec-1 are expressed as -1, 0 and +1 factorial levels respectively.   
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The crystallinity surface maps for the biaxially oriented films (λ = 2X2Y) 
(figure 6.2) revealed that the effect of drawing temperature and strain rates on 
the crystallinity of such films followed the same correlation observed with the 
UCW oriented films. Albeit, the overall crystallinity was substantially (P< 0.001) 
lower in the biaxially oriented films. A lower crystallinity is developed in 
simultaneous biaxial (SB) mode (figure 6.2), on account of the fact that 
simultaneous stretching in two perpendicular direction makes like-chain 
interactions difficult (Ou and Cakmak, 2008). Similar to the UCW oriented films, 
the effect of drawing temperature on the crystallinity of the SB oriented films 
was substantially greater than that of the strain rate. Nevertheless, the SB 
oriented TPLA films exhibited lower crystallinity than the SB oriented neat and 
the CPLA films at studied drawing conditions (figure 6.2).  
Altogether, it can be said that the drawing temperature is a major 
influencing factor on the crystallinity of the uniaxially (UCW) and biaxially (SB) 
drawn films. The rise in the crystallinity with higher strain rates is due to the 
early onset of strain induced crystallisation (Zhang et al., 2011); whereas in the 
case of temperature it can be attributed to augmented chain mobility 
(Mahendrasingam et al., 2005). Results suggest that the rise in the crystallinity 
is a dynamic phenomenon, which is co-dependent on the underlying 
temperature and strain rate. The results further highlighted the role of the model 
drugs in affecting the drawing behaviour of PLA. The differential effect of the 
model drugs is perhaps attached to their physical form and interaction with the 
polymer chains.   
6.1.2. Effect of drawing temperature and strain rate on glass transition 
temperature 
The glass transition temperature is closly related to the degree of 
orientation.  Therefore, mapping the changes in glass transition temperature 
(Tg) with respect to tensile stretching variables allowed better understanding of 
the effect of these variable on the resultant oriented structure of the films. This 
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data is summerised in figure 6.3. For all the films a rise in the strain rate shifted 
the glass transition towards higher temperatures (figure 6.3), indicating 
improvement in the amorphous orientation. A faster stretching leaves less 
scope for the oriented polymer chains to undergo relaxation during the tensile 
stretching process. Therefore the degree of orientation is augmented with a rise 
in the strain rate (Mahendrasingam et al., 2005). 
In contrast to the effect of strain rate, glass transition temperature of the 
oriented films followed an inverse relationship with drawing temperature (except 
for the UCW oriented TPLA films). At ‘-1’ temperature level, i.e. 70 °C, the glass 
tansition temperature of the oriented films was highest followed by the ‘0 level 
(80 °C)’ and finally the ‘+1 level (90 °C)’. Distinguishingly, the glass transition of 
the films oriented at 70 °C was recognised as a deep endothermic relaxation 
event, suggesting ordering of the amorphous chains (Kokturk et al., 2002; Wong 
et al., 2008). With a rise in drawing temperature, Tg of the oriented films 
reduced. This correlation was also confirmed by the negative value of the 
polynomial constant (X1) representing the effect of drawing temperature (figure 
6.3). At elevated temperatures, the polymer chains can undergo rapid 
relaxation, resulting in a matrix with poor overall orientation (Mahendrasingam 
et al., 2005).  
The regression analysis represented in figure 6.3 further suggested that 
Tg of the UCW and SB oriented CPLA films was also influenced by an 
interaction between the temperature and the strain rate. This was evidenced as 
statistically significant (P < 0.05) coefficient of the interaction term X1X2. 
Moreover, it signifies that one of the independent variables influences the other 
independent variable, consequently affecting the dependent variable (i.e. 
crystallinity) in an indirect manner. An interaction between draw temperature 
and strain can therefore be associated with generation of a frictional heat at 
higher strain rates or faster chain slippage at greater drawing temperature.  
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Figure 6.3: Effect of strain rate (X1-axis) and drawing temperature (X2-axis) on glass 
transition temperature (Z-axis) of oriented films. 
(A) Curcumin loaded films UCW draw ratio 3X, (B) Theophylline loaded films UCW draw ratio 3X,          
(C) Curcumin loaded films SB draw ratio 2X2Y and (D) Theophylline loaded films SB draw ratio 2X2Y. 
* The surface response plots were obtained by multiple regression analysis, details of which are 
represented below the respective plots. The drawing temperatures; namely 70 °C, 80 °C and 90 °C, and 
the strain rates 0.12 sec-1, 0.57 sec-1, 1.2 sec-1 are expressed as -1, 0 and +1 factorial levels respectively.   
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The effect of drawing temperature on the crystallinity of the oriented films 
was opposite to its effect on the glass transition temperature. A combined 
analysis of the changes in glass transition and crystallinity of the oriented films 
suggests that a drawing temperature of 70 °C promoted generation of an 
oriented amorphous matrix with minimal crystallinity. The films processed at 80 
°C contained highly oriented amorphous and crystalline regions; whereas at 90 
°C, highly crystalline matrices with inferior overall orientation were produced. 
The effect of strain rate and drawing temperature was more prominent for UCW 
orientation (figure 6.3 – A, B) compared to the SB mode (figure 6.3 – C, D); 
withstanding the fact that UCW stretching generates highly anisotropic 
structure, while an orthotropic structure is developed in the SB mode. 
The coloured surface map (figure 6.3) clearly established that there was a 
significant difference in the glass transition of the oriented films with respect to 
the added model drug. At all studied strain rate – temperature combinations, 
oriented neat PLA films exhibited the highest Tg, followed by oriented CPLA 
films and finally oriented TPLA films. Tg of the oriented neat and the oriented 
CPLA films showed an inverse relation to drawing temperature (figure 6.3 - A, 
C). Contrarily, the drawing temperature did not produce any significant change 
in the glass transition of the oriented TPLA films (figure 6.3 - C & F). Here the 
coefficient representing the effect of drawing temperature was statistically 
insignificant (P > 0.05) and was excluded from the regression equation. Since 
the Tg of the un-oriented TPLA films was same as that of un-oriented neat PLA 
films, the above observation clearly relates to the effect of suspended 
theophylline on the tensile deformation of PLA. It may alternatively mean that 
the presence of a crystalline drug may interfere with the polymer chain mobility 
(Pukanszky, 1990).  
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6.2. Effect of drawing conditions on the oriented structure of PLA films 
Changes in the crystallinity and glass transition temperature of the 
oriented PLA films confirmed that tensile deformation of PLA films is highly 
sensitive to temperature and strain rate. This correlation was further evaluated 
through WAXD studies.  
2D WAXD patterns representing UCW oriented CPLA and TPLA films are 
displayed in figure 6.4. The oriented structure generated during UCW stretching 
(λ = 3X) of PLA films at 70 °C, was predominantly amorphous in nature. This 
was observed in the WAXD patterns, as the equatorial amorphous halo (figure 
6.4 - C1, T1). When processed at 0.12 sec-1 strain rate, no crystalline bands 
were observed. However, at 0.57 sec-1 /70 °C, faint crystalline reflections 
appeared in the (203) and the mirror crystallographic planes (figure 6.4 - C2, 
T2). These reflections further intensified at 1.2 sec-1 strain rate, indicating a rise 
in crystallinity (figure 6.4 - C3, T3).*(refer to appendix for 2D- WAXD data 
analysis method details) 
 
 
Figure 6.4: Effect of strain rate and drawing temperature on WAXD pattern of drug 
loaded PLA films, oriented uniaxially with a constant width to a draw ratio of 3X. 
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PLA films oriented at 80 °C and 90 °C showed well defined crystalline 
reflections in the (200, 110) and (203) crystallographic planes (figure 6.4 - C4-
C9 & T4-T9). The azimuthal spread of these reflections reduced at higher strain 
rates, signifying improvement in the degree of orientation. Contrary to the effect 
of strain rate, a rise in the drawing temperature from 80 °C to 90 °C increased 
the azimuthal spread of the crystalline reflections. Higher chain mobility at 
elevated temperatures causes relaxation of several oriented chains (Zhang et 
al., 2011). Consequently, when the thermally stimulated chain relaxation 
becomes substantial, an inferior degree of orientation is produced.     
 
 
Figure 6.5: Effect of strain rate and drawing temperature on Herman’s orientation 
function of curcumin loaded PLA films, oriented uniaxially with a constant width to a 
draw ratio 3X. 
* The surface response plot was obtained by multiple regression analysis, details of which are represented 
below the plot. The drawing temperatures; namely 70 °C, 80 °C and 90 °C, and the strain rates 0.12 sec-1, 
0.57 sec-1, 1.2 sec-1 are expressed as -1, 0 and +1 factorial levels respectively.   
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The degree of uniaxial orientation can be quantified by Herman’s 
orientation function (sec 4.13 – eqn. 4.5).  A surface map representing changes 
in the orientation function with respect to drawing temperature and strain rate is 
displayed in figure 6.5. It is evident that the orientation function increased 
almost linearly with strain rate. Contrarily, it shared an inverse relationship with 
drawing temperature.   
 
 
Figure 6.6: Effect of strain rate and drawing temperature on WAXD diffraction pattern 
of drug loaded PLA films, oriented in simultaneous biaxial mode to a biaxial draw ratio 
2X2Y. 
Films oriented in SB mode (λ = 2X2Y) showed peculiar WAXD patterns 
(figure 6.6). When subjected to SB stretching at 70 °C, a diffuse ring 
representing an isotropic amorphous phase was observed (figure 6.6 - C1-C3 & 
T1-T3). Films processed at 80 °C showed faint (110, 200) and (203) crystalline 
reflections overlapping on the sharp amorphous halo. However, they appeared 
as a complete azimuthal ring, suggesting a lack of anisotropy (figure 6.6 - C4-
C6 & T4-T6). Curcumin loaded PLA films exhibited a slightly different behaviour 
at 90 °C drawing temperature. When oriented at 1.2 sec-1 strain rate (at 90 °C), 
the WAXD pattern of the mentioned films displayed a complete crystalline ring 
(figure 6.6. - C7). At 0.57 sec-1 strain rate, the crystalline reflections appeared at 
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approximately 23° angle to the equator (figure 6.6 - C8); while they shifted to 
45°at 0.12 sec-1 strain rate (figure 6.11 - C9). Surprisingly, such a trend was not 
observed in the WAXD patterns belonging to theophylline loaded PLA films 
(figure 6.6 -  T7–T9). The peculiarities of the WAXD data for SB oriented films 
could not be explained at this stage. However the WAXD patterns confirmed the 
role of drawing temperature in enhancing thermal crystallisation of SB oriented 
films. 
Altogether, WAXD data confirmed that the oriented structure of the PLA 
films resulting from the process of solid-state orientation significantly depends 
upon the underlying temperature and strain rate. The PLA films studied here 
developed a predominantly amorphous structure at 70 °C drawing temperature. 
Such structure showed orientation of the amorphous chains in the drawing 
direction, with negligible crystallinity. At 80 °C a crystalline matrix was produced 
which contained highly oriented amorphous PLA chains anchored by oriented 
crystalline links. Raising the temperature augmented the chain mobility 
excessively. Therefore, a highly crystalline matrix with poor orientation was 
generated at 90 °C. It was also evidenced that faster strain rates improved the 
degree of orientation. Nevertheless, they also accelerated the onset of strain 
induced crystallisation. Considering these factors, 80 °C drawing temperature 
and 0.57 sec-1 strain rate were considered as the optimum parameters for 
onward studies. 
6.3. Correlation between draw ratio and thermal properties of oriented 
PLA films 
6.3.1. Effect of draw ratio (λ) on crystallinity 
PLA undergoes complex changes in structure upon tensile drawing. At a 
constant drawing temperature and strain rate, evolution of the crystalline 
structure with respect to draw ratio can be understood by mapping crystallinity 
of the oriented PLA films. Figure 6.7 displays the changes in the crystallinity of 
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drug loaded films following uniaxial constant width (UCW) and sequential biaxial 
(SEQ) stretching to different draw ratios.  
 
 
 
Figure 6.7: Effect of draw ratio on crystallinity of drug loaded PLA films oriented at 80 
°C, using 0.57 sec-1 strain rate. 
Note: A) UCW oriented films, B) Sequentially oriented films (draw ratios are individually labelled.) 
*The red curve represents CPLA films, while the blue curve represents TPLA films. 
**The graph represents the mean ± standard deviation, where n = 3.  
 
 
Table 6.1: Statistical comparison of the crystallinity of UCW oriented PLA films 
Paired t-test - Uniaxial draw ratio comparison 
CPLA 
1X Vs 2X P = 0.0702, t = 3.50 
TPLA 
1X Vs 2X P = 0.0024, t = 20.26 
2X Vs 3X P = 0.0007, t = 19.79 2X Vs 3X P = 0.0032, t = 14.43 
3X Vs 4X P = 0.0037, t = 7.88 3X Vs 4X P = 0.0089, t = 5.08 
4X Vs 5X P = 0.0036, t = 6.24 4X Vs 5X P = 0.2296, t = 1.48 
Paired t-test - model drug comparison 
1X CPLA Vs TPLA P = 0.0152, t = 8.02 
2X (2X1Y) CPLA Vs TPLA P = 0.0046, t = 6.82 
3X (3X1Y) CPLA Vs TPLA P = 0.2157, t = 1.41 
4X (4X1Y) CPLA Vs TPLA P = 0.3375, t = 1.17 
5X (5X1Y) CPLA Vs TPLA P = 0.8683, 0.17 
 
4X1Y 
4X2Y 
2X1Y 
3X1Y 
3X2Y 
3X3Y 
2X1Y 
2X3Y 
2X4Y 
     Solid line = primary draw ratio 2X,  
     Dashed line = primary draw ratio 3X, 
     Dotted line = primary draw ratio 4X 
(A) (B) 
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Table 6.2: Statistical comparison of the crystallinity of SEQ oriented PLA films 
Paired t-test - Sequential biaxial draw ratiocomparison 
CPLA 
2X1Y Vs 2X2Y P = 0.1664, t = 1.97 
TPLA 
2X1Y Vs 2X2Y P = 0.8804, t = 0.16 
2X2Y Vs 2X3Y P = 0.0027, t = 7.242 2X2Y Vs 2X3Y P = 0.0106, t = 7.871 
2X3Y Vs 2X4Y P = 0.0109, t = 4.51  2X3Y Vs 2X4Y P = 0.0097, t = 6.46  
3X1Y Vs 3X2Y P = 0.023, t = 3.590 3X1Y Vs 3X2Y P = 0.0749, t = 2.65 
3X2Y Vs 3X3Y P = 0.0026, t = 6.71 3X2Y Vs 3X3Y P = 0.0021, t = 13.63 
4X1Y Vs 4X2Y P = 0.0029, t = 16.35 4X1Y Vs 4X2Y P = 0.0426, t = 4.08 
Paired t-test - model drug comparison 
2X2Y CPLA Vs TPLA P = 0.7671, t = 0.33 
2X3Y CPLA Vs TPLA P = 0.5069, t = 0.73 
2X4Y CPLA Vs TPLA P = 0.346, t = 1.11 
3X2Y CPLA Vs TPLA P = 0.8629, t = 0.18 
3X3Y CPLA Vs TPLA P = 0.2831, t = 1.41 
4X2Y CPLA Vs TPLA P = 0.1209, t = 2.46 
Note: The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
 
 
During UCW stretching, there was only a minor change in crystallinity of 
the TPLA films drawn to twice their original length (λ = 2X) (figure 6.7 - A). This 
change was statistically insignificant in the case of CPLA films (table 6.1). A 
lack of crystallinity change can be attributed to plastic deformation of the 
amorphous chains without an onset of strain induced crystallisation (Ou and 
Cakmak, 2008; Zhang et al., 2011).  
Crystallinity rapidly increased to 14.3 ± 1.13 % at λ = 3X (figure 6.7 - A), 
followed by a moderate rise to 19.92 ± 0.6% at λ = 4X. On further drawing, there 
was a fall in crystallinity of the CPLA films, while the crystallinity of the TPLA 
films remained statistically the same. An apparent fall in the crystallinity at λ = 
5X can be attributed to fragmentation of the existing crystals (Zhang et al., 
2011). The difference in crystallinity of the PLA films with respect to draw ratio 
was validated by statistical comparison using paired t-tests. This information is 
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summarised in table 6.1. Moreover, a comparison between the oriented CPLA 
and the TPLA films revealed that there was statistically insignificant (P > 0.05) 
difference between the mentioned films when oriented to UCW λ ≥ 5X.   
Sequential biaxial orientation of the films involves primary stretching along 
the main axis (X-axis) followed by secondary stretching along the perpendicular 
axis (Y-axis). Therefore, the oriented structure developed in the primary 
stretching direction shapes the structure evolution in the secondary direction. 
When the draw ratio along the primary stretching axis was low (λ = 2X), no 
crystallinity was developed (figure 6.7 - A). In such a case, extension in the 
perpendicular direction, initially leads to rotation of the existing structure 
(Hinrichsen et al., 1981a). Consequently, crystallinity of the films did not change 
significantly (P > 0.05, table 6.2) up to a draw ratio of 2Y along the secondary 
axis (i.e. biaxial λ = 2X2Y- figure 6.7 - B). Following this, there was a rapid 
growth in the crystallinity with respect to the secondary draw ratio (P < 0.05, 
table 6.2). Films drawn to higher draw ratios along the primary axis already 
have a well-developed crystalline order along that axis (figure 6.7 - A). 
Therefore, secondary drawing along the perpendicular axis disrupts the existing 
structure, perceived as a fall (P < 0.05, table 6.2) in the crystallinity (figure 6.7 – 
B) (Ou and Cakmak, 2008). Further drawing along the secondary axis 
generates newer crystals oriented in the secondary drawing direction. 
Therefore, the films oriented to the biaxial draw ratio of 3X3Y exhibited higher 
crystallinity than the films oriented to the draw ratio of 3X2Y. All the changes in 
the crystallinity of the sequentially oriented films were statistically validated by 
paired t-tests. This information is summarised in table 6.2.  
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6.3.2. Effect of draw ratio on glass transition 
Glass transition temperature is closely related to the degree of orientation 
of the polymeric matrix (Mulligan and Cakmak, 2005). For UCW stretching, Tg 
increased moderately up to a draw ratio 2X (figure 6.8 - A). This difference was 
statistically siginificant for the CPLA films; while it was insignificant for the TPLA 
films (table 6.3). Overall, it suggests that a nematic structure is developed at λ ≥ 
2X. On further drawing to λ ≥ 3X, a rise in the degree of orientation was 
accompanied by generation of crystals that can stabilise the oriented chains. 
Therefore, at UCW draw ratios of 3X and above, a sharp rise in the Tg of the 
oriented PLA films was observed (figure 6.8 - A). The rise in the Tg with respect 
to UCW draw ratio was statistically validated by paired t-tests. This information 
is summarised in table 6.3. Statistical comparison further revealed that there 
was no significant difference between the Tg of the CPLA and the TPLA films 
oriented to a same draw ratio (table 6.3) (except for UCW λ = 4X). 
 
 
 
Figure 6.8: Effect of draw ratio on the glass transition temperature of drug loaded PLA 
films oriented at 80 °C, using 0.57 sec-1 strain rate. 
Note: A) UCW oriented films, B) Sequentially oriented films (draw ratios are individually labelled).  
*The red curve represents CPLA films, while the blue curve represents TPLA films. 
**The graph represents the mean ± standard deviation, where n = 3.  
 
4X1Y 4X2Y 
2X1Y 
3X1Y 3X2Y 
3X3Y 
2X1Y 
2X3Y 
2X4Y 
Solid line = primary draw ratio 2X, 
Dashed line = primary draw ratio 3X, 
Dotted line = primary draw ratio 4X 
(A) (B) 
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Table 6.3: Statistical comparison of the glass transition temperature of UCW oriented 
PLA films 
Paired t-test – UCW draw ratio comparison 
CPLA 
1X Vs 2X P = 0.0052, t = 5.89 
TPLA 
1X Vs 2X P = 0.0852, t = 2.30 
2X Vs 3X P = 0.0034, t = 9.72 2X Vs 3X P = 0.0001, t = 17.26 
3X Vs 4X P = 0.0033, t = 7.69 3X Vs 4X P < 0.0001, t = 17.65 
4X Vs 5X P = 0.0041, t = 6.94  4X Vs 5X P = 0.0004, t = 11.38 
Paired t-test  - model drug comparison. 
1X CPLA Vs TPLA P = 0.8692, t = 0.18 
2X (2X1Y) CPLA Vs TPLA P = 0.0755, t = 2.38 
3X (3X1Y) CPLA Vs TPLA P = 0.1161, t = 2.40 
4X (4X1Y) CPLA Vs TPLA P = 0.0347, t = 3.38 
5X (5X1Y) CPLA Vs TPLA P = 0.0559, t = 2.67 
 
Table 6.4: Statistical comparison of the glass transition temperature of SEQ oriented 
PLA films 
Paired t-test - Sequential biaxial draw ratio comparison 
CPLA 
2X1Y Vs 2X2Y P = 0.0092, t = 5.76 
TPLA 
2X1Y Vs 2X2Y P = 0.0064, t = 5.64 
2X2Y Vs 2X3Y P = 0.006, t = 5.62 2X2Y Vs 2X3Y P = 0.0002, t = 13.26 
2X3Y Vs 2X4Y P = 0.016, t = 7.52 2X3Y Vs 2X4Y P = 0.008, t = 7.87 
3X1Y Vs 3X2Y P = 0.0724, t = 3.41 3X1Y Vs 3X2Y P = 0.016, t = 5.31 
3X2Y Vs 3X3Y P = 0.007, t = 10.75 3X2Y Vs 3X3Y P = 0.0068, t = 5.29 
4X1Y Vs 4X2Y P = 0.1635, t = 1.82 4X1Y Vs 4X2Y P = 0.1838, t = 1.81 
Paired t-test - model drug comparison 
2X2Y CPLA Vs TPLA P = 0.0313, t = 4.18 
2X3Y CPLA Vs TPLA P = 0.0315, t = 4.69 
2X4Y CPLA Vs TPLA P = 0.0174, t = 7.06 
3X2Y CPLA Vs TPLA P = 0.0823, t = 3.11 
3X3Y CPLA Vs TPLA P = 0.0141, t = 4.18 
4X2Y CPLA Vs TPLA P = 0.2637, t = 1.45 
Note: The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
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For films sequentially oriented in the perpendicular direction, Tg increased 
with draw ratio along the secondary axis (figure 6.8 - B). A statistical 
comparison of the Tg change with secondary draw ratio is reported in table 6.4. 
A significant change in Tg was observed when the strain along the primary axis 
was low; alternatively meaning that lower orientation in the primary direction 
leaves a larger scope for structure development in the second stretching 
direction. The glass transition of the films with higher primary draw ratios (λ = 
3X & 4X- fig. 6.8 - A) remained statistically the same with subsequent stretching 
in the perpendicular direction, at a lower secondary draw ratio (3X2Y, 4X2Y). 
Further stretching in the secondary direction lead to a rise in Tg (figure 6.7 - B). 
Surprisingly, the difference between Tg of the sequentially oriented CPLA and 
TPLA films was statistically significant (table 6.4) when the primary draw ratio 
was lower. Overall, the results suggest that secondary stretching in the 
perpendicular direction initially disturbs the order in the first stretching direction. 
However, the resultant chains and the previously un-oriented chains are 
organised in the second direction on subsequent drawing.  
6.4. Evolution of oriented structure during uniaxial constant width and 
sequential biaxial stretching of PLA films 
Oriented structure of the films was predicted from WAXD data based on 
the 2D WAXD patterns, the crystallinity index, and the degree of orientation. 
The crystallinity values obtained by WAXD were within the standard error 
window of those obtained by MDSC and therefore are not separately discussed.  
Development of the oriented structure during UCW and sequential drawing 
of the drug loaded PLA films is summarised in figure 6.9, through WAXD 
patterns. WAXD patterns revealed that PLA films oriented to a UCW draw ratio 
of 2X mainly contained oriented amorphous chains, visible as a concentration of 
the amorphous halo in the equatorial direction (figure 6.9 - 2X1Y). On further 
drawing in the UCW mode (figure 6.9 - 3X1Y), there was a rapid growth of the 
crystalline bands characteristic of the α crystalline form of PLA (Kokturk et al., 
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2002). This observation is in agreement with the findings of Hoogsteen et al. 
(1990) and Wong et al. (2008), who reported that tensile drawing of PLA at 
temperatures significantly below the melting point generates the lamellar α 
crystalline form; whereas at near melting temperatures, complete 
rearrangement into the fibrillar β Form occurs. The α Form has a pseudo-
orthorhombic unit cell, with crystallographic dimensions: a = 10.7 Å, b = 6.45 Å, 
c = 27.8 Å. Here, the PLA chains are organised into a -10/3 helical 
conformation; which is reflected in the scattering pattern, as the bands on (211) 
crystallographic plane having a repeat distance of 3 nm (Mahendrasingam et 
al., 2005).  At a UCW draw ratio of 4X (figure 6.9 - 4X1Y), the azimuthal spread 
of crystalline reflections was reduced, indicating further improvement in the 
crystalline order. In the single dimensional diffractogram, this was reflected as 
intensification of peaks at 2θ = 16.7° and 19.1° representing crystalline 
reflections in the (200, 110) and (203) crystallographic planes respectively. A 
slight broadening of the same crystalline bands in the 2D WAXD pattern along 
with a small drop in their corresponding 1D diffractogram intensities was 
observed at an UCW draw ratio of 5X (figure 6.9 - 5X1Y). This signifies 
fragmentation of the existing crystals due to applied deformation stress; 
however, the structural order remains intact (Kokturk et al., 2002).   
WAXD patterns for films sequentially stretched in the second direction, 
matched with the structure evolution predicted on the basis of crystallinity and 
Tg changes.  When a film with a uniaxial draw ratio of 2X was subsequently 
drawn along the perpendicular axis, the existing scattering bands were rotated 
towards the secondary drawing direction (figure 6.9 - 2X2Y). At this stage no 
significant crystallinity was developed, rather the amorphous halo became 
slightly more diffuse, suggesting that the existing structure was lost during the 
rotation process. On further extension along the secondary axis (λ = 2X3Y) 
(figure 6.9 - 2X3Y), newer population of the oriented crystals developed, giving 
rise to (200), (110) and (203) reflections along the meridian. A diffuse nature of 
these reflections signifies poorer orientation of the crystalline phase in the 
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second direction. Increasing the sequential (Y-axis) draw ratio to 2X4Y resulted 
in the films with higher crystallinity but little improvement in the orientation was 
observed (figure 6.9 - 2X4Y). 
 
 
 
Figure 6.9: Effect of uniaxial and sequential biaxial draw ratio on WAXD diffraction 
patterns of oriented curcumin loaded films. 
*(α – Characteristic reflections of the α crystal form of PLA (Kokturk et al., 2002))  
 Transverse drawing of the samples with UCW/ primary draw ratios of 3X 
and 4X clearly displays splaying of the existing three dimensional order (figure 
6.9 - 3X2Y, 4X2Y). For a lower draw ratio along the secondary axis, the 
azimuthal spread of the characteristic crystalline reflections increased. When 
subjected to additional transverse drawing, a second population of the oriented 
crystals were generated, yielding a cross hatched pattern as displayed in figure 
6.9 - 3X3Y (Ou and Cakmak, 2008). 
Films oriented in simultaneous biaxial mode to a biaxial draw ratio of 2X2Y 
showed development of a diffuse isotropic scatter, resembling an un-oriented 
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amorphous film. At λ = 3X3Y, the (200, 110) and (203) bands appeared in the 
equatorial as well as the meridional planes, generating a cross-hatched pattern 
(similar to figure 6.9 - 3X3Y). The results signified that simultaneous stretching 
in two perpendicular directions in the SB mode leads to the generation of a bi-
directionally equivalent structure (Ou and Cakmak, 2008). 
 
Figure 6.10: Distinctive features of oriented TPLA films 
A) Comparison of the 2D WAXD patterns of the neat PLA and the TPLA films oriented in the UCW mode 
to a draw ratio of 4X1Y, B) SEM image of the cryo-fractured surface of the abovementioned TPLA film. 
A distinctive feature was observed in the WAXD patterns of oriented TPLA 
films (figure 6.10 - A). The azimuthal spread of crystalline reflections 
corresponding to PLA was larger in the case of oriented TPLA films than the 
corresponding neat PLA films. A diffuse WAXD pattern may result from either 
poor orientation of the matrix and/or cavitation (Wang et al., 2014). It was 
previously reported that the presence of poorly cohesive particles in the 
suspension state may restrict the freedom of polymer chain movement during 
tensile drawing (Pukanszky, 1990). This phenomenon may explain the inferior 
orientation in the TPLA films, also evidenced as a lower Tg and a lower 
Herman’s orientation parameter (sec 6.5), compared to neat PLA films having 
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the same draw ratio. Moreover, the SEM images of surfaces of oriented TPLA 
films (figure 6.10 - B) confirmed the presence of voids. Tensile extension of PLA 
may generate voids at the location of suspended theophylline particles, owing to 
a poor cohesive interaction between them (sec. 5.2, 5.6) (Kim et al., 2008). 
Therefore, the diffuse WAXD pattern shown by the oriented TPLA films can be 
attibuted to the combined effect of void formation and inferior orientation. 
6.5. Quantification of the degree of orientation 
The degree of unidirectional orientation can be quantified by Herman’s 
orientation function (sec 4.13 – eqn. 4.5). The orientation function was found to 
increase with the UCW draw ratio for neat as well as drug loaded PLA films 
(figure 6.11). The slope of the curve was highest between the draw ratio of 2X 
and 3X, followed by a less steep rise. A combined analysis of the orientation 
function and the 2D-WAXD patterns suggested that the investigated films 
showed development of an oriented structure in 3 distinguished steps (at 80 °C 
drawing temperature and 0.57 sec-1 strain rate). A nematic phase with 
orientation of the amorphous chains was generated at λ = 2X. The major 
structural changes occurred between λ = 2X and λ = 3X, due to generation of 
an oriented crystalline order. Further drawing merely improved the structural 
order existing at λ = 3, by aligning of the previously un-oriented chains (Mulligan 
and Cakmak, 2005; Wong et al., 2008). In SEQ mode, the orientation function in 
the primary drawing direction (X-axis) reduced sharply, when the films were 
sequentially stretched in the perpendicular direction (Y-axis). Contrarily, the 
orientation function in the secondary direction increased gradually, with respect 
to the secondary (Y-axis) draw ratio.   
Curcumin loaded PLA films showed a higher degree of orientation than 
neat PLA films and theophylline loaded PLA films, at individual draw ratios. The 
degree of orientation was lowest for the theophylline loaded PLA films. This can 
perhaps be attributed to the presence of theophylline in the crystalline 
suspension state, which supposedly hampered the PLA chain movement during 
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tensile deformation (sec. 6.4). No explanation was found for the higher degree 
of orientation in the curcumin loaded films.   
 
 
Figure 6.11: Changes in Herman’s orientation function with respect to the UCW draw 
ratio. 
In summary, drug loaded films showed a systematic evolution of oriented 
structure with respect to the draw ratio. An anisotropic structure was developed 
in UCW stretching, while biaxial stretching generated various morphologies 
depending up on the draw ratio along two perpendicular axes. Since, UCW 
stretching showed the most prominent changes in oriented structure, drug 
loaded films having UCW draw ratio between 1X - 4X, were shortlisted for drug 
release studies. At the current stage, considering the experimental feasibility, 
the drug release study on the biaxially oriented films was restricted to films 
having a biaxial draw ratio of 2X2Y (both SB & SEQ).  
6.6. Mechanical properties of the oriented films 
 Mechanical properties of a material are critically associated with its 
physical structure. These include, Young's modulus - which is a measure of the 
elastic nature of the material; yield strength - representing the inherent strength 
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of the material without any plastic deformation; ultimate tensile strength and 
lastly, the strain or total extension at failure.  
Changes in ultimate tensile strength and Young’s modulus against the 
draw ratio of neat PLA and drug loaded PLA films is summarised in table 6.5. 
The tensile strength of neat and drug loaded PLA films was improved when 
subjected to uniaxial as well as biaxial orientation.  For UCW stretching, the 
tensile properties were enhanced only in the drawing direction; while for the SB 
orientation, they were statistically the same (P > 0.05, paired t-test), in both the 
medional and the transverse directions. The improvement in mechanical 
strength and modulus after UCW orientation was significantly greater than that 
after SB orientation (P < 0.05, paired t-test). Interestingly, the tensile strength 
and the modulus of the films with UCW draw ratio of 2X, even exceeded that of 
the SB oriented films having a biaxial draw ratio of 3X3Y. This can be attributed 
to the preferential unidirectional orientation of the polymer chains in UCW mode 
(sec. 6.4). 
The ultimate tensile strength and Young’s modulus data was statistically 
compared by 2-way ANOVA with replication. The oriented films were analysed 
separately depending upon the mode of orientation (e.g. UCW, SB, SEQ). In 
each mode, the columns represent different model drugs, while the row 
represents increasing draw ratios. The statistical comparison of the tensile 
strength is summerised in table 6.6, while that of Young’s modulus is 
represented in table 6.7.   
Table 6.5 and the ANOVA summary tables (table 6.6, table 6.7) confirmed 
that a continuous enhancement in mechanical strength  and Young’s modulus 
was observed with increasing draw ratios, regardless of the drawing mode. For 
the UCW oriented films the change was more prominent between draw ratios of 
2X and 3X, perhaps due to generation of an oriented crystalline structure at λ = 
3X (sec. 6.4). The yield strength of the oriented films followed the same trend as 
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that displayed by their ultimate tensile strength. Contrarily, the strain at failure 
exhibited an inverse relationship with draw ratio. 
 
Table 6.5: Tensile properties of oriented neat PLA and drug loaded films with respect 
to the uniaxial and biaxial draw ratio. 
S
tr
et
ch
in
g
  
m
o
d
e Draw 
ratio 
Ultimate tensile strength (MPa)   
(Mean ± SD; n = 3) 
Young's modulus (MPa)  
(Mean ± SD; n = 3) 
Neat PLA 
films 
CPLA films TPLA films 
Neat PLA 
films 
CPLA films 
TPLA 
films 
U
C
W
 (
d
ra
w
in
g
 d
ir
ec
ti
o
n
) 
1X1Y 51.87 ± 2.12 50.88 ± 2.36 52.03 ± 4.45 
1502.05 ± 
9.57 
1493.03 ± 
23.33 
1763.42 
± 35.1 
2X1Y 91.55 ± 2.95 96.02 ± 2.76 82.9 ± 0.94 
2070.66 ± 
17.91 
2009.42 ± 
23.49 
2257.17 
± 60.98 
3X1Y 141.94 ± 4.54 146 ± 4.28 130 ± 2.86 
2950.74 ± 
42.27 
3159.16 ± 
46.68 
2865.24 
± 45.88 
4X1Y 171.63 ± 2.24 179.74 ± 6.26 162.1 ± 2.25 
3384.6 ± 
15.84 
3527.78 ± 
26.46 
3234.48 
± 19.58 
5X1Y 200.46 ± 2.28 211.1 ± 3.08 191.93 ± 1.9 
4065 ± 
12.39 
4027.05 ± 
22.74 
3923.48 
± 18.8 
S
eq
u
en
ti
al
  (
se
co
n
d
 d
ir
ec
ti
o
n
) 
2X2Y 80.65 ± 1.27 81.04 ± 0.93 75.31 ± 3.37 
1615.5 ± 
12.27 
1598.6 ± 
54.22 
1896.18 
± 0.88 
2X3Y 102.82 ± 6.42 103.2 ± 2.32 99.36 ±1.92 
1894.31 ± 
15.44 
1804.44 ± 
85.97 
2136.05 
± 36.16 
2X4Y 117.96 ± 3.48 120 ± 2.59 114 ± 1.97 
2702.9 ± 
7.9 
2731.5 ± 
29.31 
2563.62 
± 17.87 
3X2Y 91.24 ± 2.56 97.7 ± 1.93 94.71 ± 4.35 
1933.86 ± 
32.4 
1979.48 ± 
24.06 
1833.54 
± 26.87 
3X3Y 104.49 ± 2.45 112.59 ± 3.18 106.1 ± 1.75 
2511.18 ± 
17.52 
2677.52 ± 
40.85 
2323.02 
± 5.32 
4X2Y 121.53 ± 1.85 121.99 ± 2.99 119.53 ± 1.3 
2925.96 ± 
28.91 
2928.66 ± 
53.35 
2946.44 
± 44.96 
S
B
 
2X2Y 72.76 ± 3.11 74.59 ± 1.53 74.78 ± 1.14 
1726.4 ± 
42.77 
1740.13 ± 
28.92 
1926.18 
± 30.67 
3X3Y 89.18 ± 2.97 92.04 ± 6.62 86.47 ± 2.54 
1915.2 ± 
31.91 
1907.22 ± 
36.35 
2062.99 
± 33.3 
* The mechanical properties of the SEQ oriented films reported here, were measured in the second 
stretching direction. 
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Table 6.6: Two-way ANOVA (with replication) summary tables for tensile strength 
comparison 
1. UCW drawing ultimate tensile strength 
Source of Variation SS df MS F P-value F crit 
Rows 131203 4 32800 3041.95 1.16 X 10-38 2.6896 
Columns 1272.99 2 636.4963 59.02 3.98 X 10-11 3.3156 
Interaction 431.45 8 53.9320 5.00 0.00053 2.2661 
Within 323.48 30 10.7826 
   Total 133231 44 
    
       2. SEQ drawing ultimate tensile strength 
Source of Variation SS df MS F P-value F crit 
Rows 10791.86 5 2158.37 260.30 3.36 X 10-27 2.4771 
Columns 193.9926 2 96.9963 11.69 0.000122 3.2594 
Interaction 132.9324 10 13.2932 1.60 0.145293 2.1060 
Within 298.5006 36 8.2916 
   Total 11417.28 53 
    
       3. SB drawing ultimate tensile strength 
Source of Variation SS df MS F P-value F crit 
Rows 1037.85 1 1037.857 85.99 8.04 X 10-7 4.7472 
Columns 25.7083 2 12.8541 1.06 0.375137 3.8852 
Interaction 28.3057 2 14.1528 1.17 0.342609 3.8852 
Within 144.8190 12 12.0680 
   Total 1236.69 17 
    
* The relevant data is displayed in the table 6.5 
Note: The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
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Table 6.7: Two-way ANOVA (with replication) summary tables for Young’s modulus 
comparison 
1. UCW drawing Young's modulus 
Source of Variation SS df MS F P-value F crit 
Rows 33958939 4 8489735 8553.478 2.2 X 10-45 2.689628 
Columns 18810.17 2 9405.086 9.475702 0.000646 3.31583 
Interaction 521007 8 65125.87 65.61486 6.88 X 10-17 2.266163 
Within 29776.43 30 992.5477 
   Total 34528533 44 
    
       2. SEQ drawing Young's modulus 
Source of Variation SS df MS F P-value F crit 
Rows 10835013 5 2167003 1672.158 1.51 X 10-41 2.477169 
Columns 5390.427 2 2695.214 2.07975 0.139719 3.259446 
Interaction 610041 10 61004.1 47.07355 1.18 X 10-17 2.106054 
Within 46653.53 36 1295.931 
   Total 11497098 53 
    
       3. SB drawing Young's modulus 
Source of Variation SS df MS F P-value F crit 
Rows 121376.6 1 121376.6 103.2297 3.02 X 10-7 4.747225 
Columns 118839.4 2 59419.72 50.53593 1.43 X 10-6 3.885294 
Interaction 2045.581 2 1022.791 0.869874 0.443828 3.885294 
Within 14109.5 12 1175.791 
   Total 256371.2 17 
    
* The relevant data is displayed in the table 6.5 
Note: The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
 
Sequential orientation of the films in the transverse direction showed 
similar improvent in the mechanical properties along the second stretching axis. 
However, the rise in mechanical strength with respect to the transverse draw 
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ratio was smaller than that observed with an increament in the UCW draw ratio 
(P < 0.05, paired t-test). This can be supported by the WAXD findings (sec. 
6.4), which confirmed that previous stretching along the primary axis (X-axis) 
limits the structure development along the perpendicular axis (Y-axis) on 
subsequent stretching. 
The model drugs produced negligible change in the mechanical properties 
of un-oriented PLA films. However, their effect was evident when such films 
were subjected to solid-state orientation (table 6.6 and table 6.7 column 
comparison). The un-oriented TPLA films and the neat PLA films had equivalent 
tensile strength. However, the oriented TPLA films exhibited lower tensile 
strength than the corresponding neat PLA and CPLA films at all UCW draw 
ratios. A similar change was also observed in the SEQ oriented TPLA films. As 
explained in the previous section (sec. 6.4), poor affinity between the 
suspended theophylline particles and the PLA matrix leads to generation of 
voids during tensile extension of the TPLA films (Kim et al., 2008). 
Nevertheless, the overall structural order within oriented TPLA films was inferior 
to the corresponding neat PLA and CPLA films. Therefore, poor mechanical 
properties of the theophylline loaded films at higher draw ratios can be clearly 
correlated with the abovementioned factors. Mechanical strength of the CPLA 
films was higher than both neat PLA films and TPLA films. This observation is 
aligned with the trend in Herman’s orientation factor (figure 6.11), which 
suggested that CPLA films had a higher degree of orientation at a particular 
draw ratio than the corresponding neat and TPLA films. Despite of the 
difference in the mechanical strength, the Young’s moduli of these films did not 
statistically vary with respect to the added drug (table 6.7). A peculiarity was 
observed in the case of SB oriented films. At a constant draw ratio, the 
difference between the mechanical strength of the neat PLA, CPLA and TPLA 
films was statistically insignificant (table 6.6). Nevertheless, the mentioned films 
showed statistically significant difference between their Young’s moduli (table 
6.7). 
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Figure 6.12: Effect of strain rate and drawing temperature on the ultimate tensile 
strength of A) curcumin loaded films uniaxially oriented with a constant width (UCW) to 
λ = 3X and B) curcumin loaded films simultaneous biaxially (SB) oriented to λ = 2X2Y 
* The surface response plots were obtained by multiple regression analysis, details of which are 
represented below the respective plots. The drawing temperatures; namely 70 °C, 80 °C and 90 °C, and 
the strain rates 0.12 sec-1, 0.57 sec-1, 1.2 sec-1 are expressed as -1, 0 and +1 factorial levels respectively.   
 
The mechanical properties closely reflected the changes in the oriented 
structure of the drug loaded PLA films, with respect to the underlying drawing 
conditions. The effect of temperature and strain rate on the tensile strength of 
oriented PLA films is represented in figure 6.12 through an example of the 
oriented CPLA films. Evidently, the films oriented at 70 °C (-1 temperature level) 
had highest mechanical strength, followed by films oriented at 80 °C (0 level) 
and lastly those oriented at 90 °C (+1 level). Moreover, the drawing temperature 
exhibited an inverse relationship with the strain at failure. Higher mechanical 
strength and extensibility of the films stretched at 70 °C can be attributed to 
their strong amorphous orientation. Contrarily, a rise in the crystallinity at higher 
temperatures may have lowered the mechanical strength and extensibility, by 
increasing the brittleness of the matrix. The effect of strain rate was less 
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pronounced than that of the drawing temperature. Nevertheless, higher strain 
rates generated films with higher mechanical strength. The overall effect of 
drawing conditions on the tensile strength was more closely aligned with the 
corresponding degree of orientation. In summary, the mechanical properties of 
oriented films showed a significant correlation to their physical structure. 
Therefore, a similar change may also be expected in the drug release 
properties of the oriented films.  
6.7. Correlation between surface free energy and the oriented structure of 
the films 
 The hydrophobic or the hydrophilic nature of the bulk of an untreated 
polymeric film can be inferred from its surface free energy (Stachewicz et al., 
2012). The surface free energy of PLA films, further utilised in the drug release 
studies was determined here. These included, CPLA and TPLA films oriented in 
UCW mode to 1X ≤ λ ≤ 4X, in SB mode to λ = 2X2Y and in SEQ mode to λ = 
2X2Y. Neat PLA films with corresponding draw ratios were used as a control to 
study the effect of added drug. The surface energy was derived from contact 
angles made by ten diverse probe liquids with the film surface (Owens and 
Wendt, 1969). The mathematical description of the method is detailed in the 
section 4.15.1. 
 The alkane series probe liquids (n-octane, n-heptane, n-hexane, and 
cyclohexane) which are non-polar in nature, completely wetted the PLA film 
surface, exhibiting a zero contact angle. The contact angle did not change after 
orientation of the films; neither was there a difference with respect to the added 
drug. This clearly highlights the hydrophobic nature of PLA. Since, the 
abovementioned probe liquids made a same contact angle with PLA films, only 
one amongst them, i.e. cyclohexane was used further.  
The surface energy of un-oriented neat PLA films, derived from the 
contact angle values for cyclohexane, di-iodomethane and the remaining non-
alkane probe liquids (toluene, benzyl alcohol, ethylene glycol, glycerol and 
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water – ‘7-probe liquids approach’) was 38.37 mJ/m-2. Gruber et al. (1998) 
and Auras et al. (2004) separately reported the total surface energy of PLA films 
(Natureworks, 98% L-isomer) to range between 42 - 44 mJ/m-2. It has been 
previously confirmed that the surface energy measured by any method, 
involving an interaction between the probe liquids and a solid surface is 
sensitive to the liquids used (Cava et al., 2007). Therefore, the lower values of 
the surface energy obtained in this study can be attributed to the selection of 
the probe liquids. The sensitivity of the Owens-Wendt method increases when 
probe liquids with higher surface tension and those making a larger contact 
angle are used. Considering the above fact, a second approach for calculation 
of surface energy was adopted. In this approach, only 3 probe liquids, namely 
water (γL
Dispersive=20.70 mJ/m-2, γL
Polar=52.10 mJ/m-2), Glycerol (γL
Dispersive= 
38.10mJ/m-2, γL
Polar= 25.30mJ/m-2) and di-iodomethane (γL
Dispersive= 50.07mJ/m-
2, γL
Polar=0 mJ/m-2) were used. The surface energy values obtained by the ‘3-
probe liquids approach’ more closely matched with previously reported 
values.   
Table 6.8 and table 6.9 list the surface energy of neat and drug loaded 
PLA films obtained by the ‘7-liquids’ and the ‘3-liquids’ approach respectively. 
The overall surface energy was divided into a polar and a dispersive 
component. Either of the components for the studied systems were separately 
compared by 2-way ANOVA statistical test. In such comparison, the columns 
represented films containing different model drugs, while the rows represented 
different draw ratios. The summary of the statistical analysis is given in table 
6.10 and table 6.11.   
The results confirmed that compounding with curcumin did not produce 
any significant change in the surface energy of both un-oriented and oriented 
PLA films (table 6.8, table 6.9) The difference between the surface energies 
(both polar and dispersive) of the neat and CPLA films was statistically 
insignificant when measured by the ‘7-liquids’ approach (table 6.10 – A, C). 
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Contrarily, such a difference between the surface energies of neat PLA and 
TPLA films was highly significant (table 6.10 – B, D). Surface roughness in the 
theophylline loaded films resulted in a higher contact angle values for the most 
of the probe liquids. The greatest difference was observed in the water contact 
angle, which was approximately 10° higher than that for the corresponding neat 
PLA films. This led to a reduction in the polar component and a small rise in the 
dispersive component of the surface energy of the TPLA films. When measured 
by the ‘3-liquids’ approach, dispersive energies of both CPLA and TPLA were 
statistically similar to the neat PLA films. Nevertheless, a significant difference 
was observed in their polar energies (table 6.11).        
 
Table 6.8: Surface energy of the model PLA films estimated by the Owens-Wendt 
method, using ‘the 7-probe liquids approach’ (cyclohexane, di-iodomethane, toluene, 
benzyl alcohol, ethylene glycol, glycerol and water). 
 
Sample 
Surface energy using 7 probe liquids (mJ.m-2) 
Neat PLA Curcumin loaded PLA Theophylline loaded PLA 
γf D γf P γf D γf P γf D γf P 
Un-oriented 25.5 10.96 25.41 10.77 27.63 5.11 
UCW 2X 25.83 12.54 25.88 11.68 27.86 6.54 
UCW 3X 25.56 16.27 25.72 14.66 27.31 10.1 
UCW 4X 25.28 18.94 25.59 16.7 26.89 13.19 
SB 2X2Y 25.56 10.72 25.39 10.41 27.47 5.09 
SEQ 2X2Y 25.92 10.06 25.98 10.22 27.88 5.42 
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Table 6.9: Surface energy of model PLA films estimated by the Owens-Wendt method, 
using ‘the 3-probe liquids approach’ (di-iodomethane, glycerol and water). 
 
Sample 
Surface energy using 3 probe liquids (mJ.m-2) 
Neat PLA Curcumin loaded PLA Theophylline loaded PLA 
γf D γf P γf D γf P γf D γf P 
Un-oriented 31.84 8.97 31.83 8.97 31.94 3.77 
UCW 2X 33.28 9.94 33.53 9.44 33.66 4.7 
UCW 3X 34.7 12.96 34.44 11.84 35.02 7.35 
UCW 4X 35.43 15.12 35.25 13.39 36.08 9.80 
SB 2X2Y 31.67 9.02 31.88 8.63 31.5 3.24 
SEQ 2X2Y 31.29 8.98 31.53 8.51 31.84 3.78 
 
Notes: The surface energy was calculated from linear regression of the following equation, using the 
contact angle (average from 6 replicates) and the surface tension values (average from 6 replicates) 
obtained for the individual probe liquids (sec. 4.15). R2 for all samples was ≥ 0.99 when measured by 3-
liquid approach, while that was 0.96 ≥ R2 ≥0.94 when measured by 7-liquid approach.    
(𝐜𝐨𝐬 𝛉+𝟏)𝛄𝐋 
𝟐 (𝛄𝐋
𝐃)
𝟏
𝟐
=  (𝛄𝐟
𝐏)
𝟏
𝟐 (𝛄𝐋
𝐏)
𝟏
𝟐
(𝛄𝐋
𝐃)
𝟏
𝟐
+ (𝛄𝐟
𝐃)
𝟏
𝟐                        (Equation. 4.7) 
Where,  γL= overall surface tension of the probe liquid,   
γLD = dispersive component of the surface tension of the probe liquid,  
γLP = polar component of the surface tension of the probe liquid.  
γf D = dispersive component of the surface energy of the film,  
γf P = polar component of the surface energy of the film and   
θ = the contact angle between the probe liquid and the film.  
* The contact angle replicate measurements were performed by rotating the film surface, in order ensure 
that it was same in all directions. All contact angle values showed less than 5% deviation from the mean.  
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Table 6.10: Two-way ANOVA summary table for statistical comparison of the surface 
energy calculated by the ‘7 – probe liquids’ approach. 
A) γf D Comparison Neat PLA Vs CPLA 
Source of Variation SS df MS F P-value F crit 
Rows 0.4913 5 0.0982 6.65 0.028973 5.0503 
Columns 0.0085 1 0.0085 0.57 0.481526 6.6078 
Error 0.0738 5 0.0147 
   Total 0.5737 11 
    
       
B) γf D Comparison Neat PLA Vs TPLA 
Source of Variation SS df MS F P-value F crit 
Rows 0.8801 5 0.1760 9.77 0.012863 5.0503 
Columns 10.8111 1 10.8110 600.33 2.11 X 10-6 6.6078 
Error 0.0900 5 0.0180 
   Total 11.7812 11 
    
       
C) γf p Comparison Neat PLA Vs CPLA 
Source of Variation SS df MS F P-value F crit 
Rows 97.1784 5 19.4357 45.65 0.000357 5.0503 
Columns 2.1252 1 2.1252 4.99 0.075743 6.6078 
Error 2.1283 5 0.4256 
   Total 101.4320 11 
    
       
D) γf P Comparison Neat PLA Vs TPLA 
Source of Variation SS df MS F P-value F crit 
Rows 118.9622 5 23.7924 162.94 1.57 X 10-5 5.0503 
Columns 96.5601 1 96.5601 661.31 1.66 X 10-6 6.6078 
Error 0.7300 5 0.1460 
   Total 216.2524 11 
    
* The relevant data is displayed in the table 6.8 
Note: The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
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Table 6.11: Two-way ANOVA summary table for statistical comparison of the surface 
energy calculated by the ‘3 – probe liquids’ approach. 
A) γf D Comparison Neat PLA Vs CPLA 
Source of Variation SS df MS F P-value F crit 
Rows 26.9435 5 5.3887 212.25 8.14 X 10-6 5.0503 
Columns 0.0052 1 0.0052 0.21 0.669575 6.6078 
Error 0.1269 5 0.0253 
   Total 27.0757 11 
    
       
B) γf D Comparison Neat PLA Vs TPLA 
Source of Variation SS df MS F P-value F crit 
Rows 32.7062 5 6.5412 144.54 2.11 X 10-5 5.0503 
Columns 0.2790 1 0.2790 6.16 0.055616 6.6078 
Error 0.2262 5 0.0452 
   Total 33.2116 11 
    
       
C) γf p Comparison Neat PLA Vs CPLA 
Source of Variation SS df MS F P-value F crit 
Rows 53.1809 5 10.6361 55.50426 0.000222 5.0503 
Columns 1.4770 1 1.4770 7.707672 0.039074 6.6078 
Error 0.9581 5 0.1916 
   Total 55.6161 11 
    
       
D) γf P Comparison Neat PLA Vs TPLA 
Source of Variation SS df MS F P-value F crit 
Rows 67.3310 5 13.4662 448.74 1.26 X 10-6 5.0503 
Columns 87.2102 1 87.2102 2906.20 4.15 X 10-8 6.6078 
Error 0.1500 5 0.0300 
   Total 154.6913 11 
    
* The relevant data is displayed in the table 6.9 
Note: The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
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Figure 6.13: Changes in the water contact angle of A) curcumin loaded PLA films and 
B) theophylline loaded PLA films after subjecting them to UCW stretching. 
*The contact angle values are represented as ‘mean ± SD’ of six replicate measurements 
UCW extension of the films caused a reduction in the contact angle of all 
probe liquids, consequently leading to a rise in the total surface energy (table 
6.8 & table 6.9). Since water exhibited the highest contact angle, a change in its 
value after uniaxial orientation was most prominently visible (figure 6.13). The 
surface energy values obtained by the ‘7-probe liquids’ method (table 6.8) 
showed no variation in the dispersive component after UCW stretching; 
whereas, the polar component increased with respect to UCW draw ratio. 
Results of the ‘3-probe liquids’ method (table 6.9) displayed a greater rise in the 
dispersive component at UCW draw ratio 2X. At λ ≥ 3X, the polar component 
increased by a higher margin than the dispersive component. Overall, both of 
the methods confirmed a rise in the polar surface energy after UCW stretching. 
Such a rise was statistically significant for all studied films regardless of the 
measurement method (table 6.10 and table 6.11) 
Stachewicz et al. (2012) reported similar findings, when polycarbonate 
films were subjected to uniaxial stretching. However, the authors detected no 
change in the surface chemistry of the oriented polycarbonate films. When the 
surface of the oriented PLA films utilised in the current study was analysed by 
ATR-FTIR, a clear indication of the elevated dipole-dipole interaction was 
obtained. The FTIR spectra of the UCW oriented PLA films (λ ≥ 3X) showed the 
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appearance of a small peak at a wavenumber of 923 cm-1 and splitting of 1167 
cm-1 peak (figure 6.14 - B). The prior represents the bending vibrations of the 
lactic acid ‘O-H group’ (figure 6.14 - B), while the latter represents ‘C-O’ 
stretching vibrations of the lactic acid/ ester group. Moreover, the peak at 712 
cm-1 associated with the stretching vibration of the ‘C=O’ group was shifted to 
691 cm-1. All of these events became apparent at the UCW draw ratio 3X and 
intensified at the UCW draw ratio of 4X. The mentioned changes in the FTIR 
spectrum of the PLA films have been previously correlated to higher dipole 
interactions in the α crystalline Form of PLA, due to its -10/3 helical 
conformation (figure 6.14 - A) (Aou and Hsu, 2006; Wasanasuk et al., 2011).  
 
 
Figure 6.14: A) Crystal structure of the α Form of PLA with its c-axis oriented in the 
stretching direction. (Black = carbon, White = Hydrogen, Red = Oxygen) (adapted from 
Wasanasuk et al. (2011)), B) ATR-FTIR spectra of the surfaces of oriented curcumin 
loaded PLA films. 
A B 
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WAXD patterns of the oriented PLA films utilised in this study were 
discussed in the section 6.4. They confirmed that both neat and drug loaded 
PLA films, when subjected to UCW stretching, generated an oriented 
amorphous structure at a draw ratio of 2X. On further stretching, the α 
crystalline form was generated with its c-axis parallel to the stretching direction. 
Nevertheless, the number of chains organised in such a manner increased with 
UCW draw ratio.  The crystal structure of the α Form of PLA with its c-axis 
oriented in the stretching direction was reported by Wasanasuk et al. (2011) 
(figure 6.14 - A). In a homogenous PLA matrix the functional groups are 
organised in a random manner. Contrarily, when the PLA chains are oriented in 
the α crystalline form (figure 6.14), the relative number of functional groups 
facing the surface increases. A rise in the concentration of free hydroxyl groups 
(red dots) augments the polar surface energy, while the dispersive energy is 
enhanced due to higher Van der Waals interaction, between the concentrated 
methyl moieties (3 white dots).  At a uniaxial draw ratio of 2X, exclusive 
amorphous orientation might have enhanced the dispersive surface energy. 
However, the polarity did not increase substantially, owing to the absence of the 
α crystalline form.  
Apparently, no change in the surface energy was observed when the films 
were oriented biaxially to a draw ratio of 2X2Y. Moreover, the characteristic 
changes in the FTIR spectra of UCW oriented films (λ ≥ 3X) were not observed 
in the FTIR spectra of biaxially oriented films (λ ≥ 2X2Y) (figure 6.14 - B). This 
can perhaps be attributed to the amorphous nature of the mentioned films, 
combined with a bi-directionally symmetric chain organisation. However, further 
studies with multiple biaxial draw ratios must be completed before drawing a 
safe conclusion. 
Importantly, the chain organisation depicted in figure 6.14 is also repeated 
in the bulk of the PLA films. Therefore, augmentation of the polar surface 
energy due to formation of the α crystal form at the UCW λ ≥ 3X, can be viewed 
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as, enhancement of the overall hydrophilicity of the oriented PLA films. This 
may accelerate water penetration, formation of the micro-pores and subsequent 
drug release from these films.  
6.8. Dynamic changes in the properties of drug loaded PLA films 
submerged in the release medium 
PLA undergoes rapid hydrolytic degradation in an aqueous environment 
(Cam et al., 1995; Li et al., 1990; Vert et al., 1991). The onset and the kinetics 
of degradation are simultaneously governed by several factors (Codari et al., 
2012) such as crystallinity (Tsuji and Ikada, 1997; Tsuji and Ikada, 2000b; Tsuji 
and Ikarashi, 2004), molecular weight (Belbella et al., 1996), size and shape of 
the matrix (Grizzi et al., 1995), pH and temperature of the aqueous environment 
(Belbella et al., 1996; Cam et al., 1995) and presence of additives (Li et al., 
1996). It is believed that the lower molecular weight PLA undergoes surface 
erosion; whereas at higher molecular weight (> 50KDa), bulk erosion becomes 
a dominant mechanism (Alexis, 2005). When a polyester matrix is undergoing 
bulk degradation, oligomers generated in the degradation process remain 
entrapped within the matrix, unless they are small enough to be soluble in the 
permeated medium. Such oligomers further catalyse the degradation process 
(Li et al., 1990). Nevertheless, it is known that the newly generated oligomers 
undergo crystallisation, being plasticised by the percolated water. This further 
changes the morphology of the polyester matrix and the rate of hydrolytic 
degradation. These changes can critically influence drug release from a PLA 
matrix. Therefore, their prior knowledge is essential. The current study included 
investigation of the changes in the molecular weight, crystallinity and 
morphology of the drug releasing PLA films at regular intervals, after 
submersion into the release medium.       
6.8.1. Shrinkage of oriented amorphous films 
Among the two model drugs utilised in this study, curcumin formed a 
glassy solution in the melt quenched amorphous PLA films. On the contrary, 
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theophylline was present as a suspension of crystalline particles (5-25 μm) in 
the amorphous polymer phase. Orientation of the drug loaded PLA films to a 
UCW draw ratio of 2X or to a biaxial (both SB & SEQ) draw ratio of 2X2Y, led to 
generation of a nematic structure (sec. 6.4). Here the amorphous chains were 
oriented in the drawing direction; however, no strain crystallisation occurred.  
When such films were submerged into the drug release medium (at 37 °C), 
curcumin loaded PLA films (CPLA) underwent shrinkage, while theophylline 
loaded films (TPLA) remained stable. The shrinkage of biaxially oriented films 
occurred in two perpendicular directions. This led to curling of the film samples 
and a non-uniform change in their dimensions. Therefore, only the UCW 
oriented films were selected as a model system for the current study. Shrinkage 
in the mentioned films was characterised by measurement of the dimensional 
changes (in a tensile bar specimen), percentage crystallinity and 2D WAXD 
patterns, for 14 days after submersion in the release medium. This information 
is summarised in figure 6.15. 
 
Figure 6.15: Changes in the length, percentage crystallinity and 2D WAXD patterns of 
UCW 2X oriented curcumin loaded films after submersion into the release medium. 
*The crystallinity and the specimen length values are expressed as mean ± SD, where n = 6.  
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For convenience the TPLA and CPLA films oriented to a UCW draw ratio 
of 2X are referred to here as TPLA-2X and CPLA-2X respectively. Both the 
TPLA-2X and the CPLA-2X films showed a steady rise in crystallinity, when 
submerged in the release medium. Owing to the presence of crystalline 
theophylline particles, the dimensions and the 2D WAXD patterns of the TPLA-
2X films remained unchanged for the current study duration (14 days). 
Conversely, the CPLA-2X films underwent rapid shrinkage between the 4th and 
the 8th day after submersion (figure 6.15). This phase was preceded by an 
induction period, which correlated to the time taken by the release medium to 
percolate into the films and cause plasticisation. The shrinkage plateaued at 
approximately 60% of the original specimen (tensile bar) length, by the 10th day 
(figure 6.15). Perhaps the dimensional change was halted once the film 
crystallinity rose above a critical level. WAXD patterns of the submerged CPLA-
2X films showed intensification of the equatorial amorphous halo and 
appearance of the (203) crystalline reflection, after ageing for 3 days (figure 
6.15). The azimuthal spread of the equatorial halo and the (203) crystalline 
reflection significantly increased between the 4th and the 8th day. CPLA-2X films 
aged for 10 days showed an extremely diffuse halo, nearly forming a complete 
circle. The changes in the 2D WAXD patterns of the submerged CPLA-2X films 
confirmed that the mentioned films lost the majority of their oriented structure as 
they underwent shrinkage.  
These results suggest that the oriented CPLA films having ≤ 5% 
crystallinity (due to lower draw ratios), lost the oriented structure after 
submersion in the release medium (at 37 °C). However, such a nematic 
structure was stabilised in the case of TPLA films, due to the presence of 
theophylline in a crystalline suspension state. Therefore, the effect of 
amorphous orientation on drug release might only be observed in the TPLA 
films. Contrarily, CPLA films which underwent shrinkage will possibly behave 
similar to the un-oriented films.   
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6.8.2. Crystallinity changes 
Figure 6.16 & figure 6.17 illustrate changes in the crystallinity of drug 
loaded PLA matrices with respect to submersion duration. The crystallinity 
change was statistically validated by comparison between different draw ratios 
at certain time-points, and at different time-points. Such comparison was made 
by one-way ANOVA, followed by Tukey’s test. The results of the statistical 
analysis are represented in the following tables: table 6.12, table 6.13, table 
6.14 and table 6.15.  
The crystallinity of drug loaded PLA matrices increased over the first 6 - 8 
weeks and reached a constant value ranging between 35% - 40% by the end of 
the 8th week. As confirmed in the table 6.13 and table 6.15, the difference 
between crystallinity at the beginning and after 8 weeks was highly significant 
for all studied draw ratios, regardless of the model drug. Nevertheless, these 
films displayed statistically equivalent crystallinity (table 6.12, table 6.14) 
between the 8th and 10th weeks.  From the 12th week onwards CPLA films with λ 
= 3X and 4X, showed comparable crystallinity levels (in general the statistical 
difference between them remained insignificant). Similarly, the crystallinity of 
the un-oriented, UCW-2X, SB-2X2Y and SEQ-2X2Y CPLA films remained 
equivalent (table 6.12). In the case of the TPLA films (table 6.14), 1X-2X pair, 
3X-4X pair and SB-2X2Y-SEQ-2X2Y pair showed a statistically equivalent 
change in the crystallinity from the 12th week onwards.     
There was a transient reduction in the crystallinity of the inherently 
amorphous films from the 11th week onwards (i.e. Un-oriented, UCW λ = 2X, SB 
λ = 2X2Y and SEQ λ = 2X2Y. These films are considered practically amorphous 
in the further discussion). Contrarily, films oriented to UCW draw ratios of 3X 
and 4X exhibited a statistically constant crystallinity until the 16th week (table 
6.13, table 6.15). The transient fall in crystallinity can be potentially correlated 
with hydrolytic degradation of the crystalline phase. (Tsuji and Ikada, 1998). 
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Figure 6.16: Changes in the crystallinity of curcumin loaded PLA (CPLA) films after 
submersion in the release medium. 
**The graph represents % crystallinity as the mean ± standard deviation, where n = 6.  
 
 
Figure 6.17: Changes in the crystallinity of theophylline loaded PLA (TPLA) films after 
submersion in the release medium. 
**The graph represents % crystallinity as the mean ± standard deviation, where n = 6.  
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Table 6.12: Statistical comparison of the weekly changes in the crystallinity of CPLA 
films after aqueous submersion – draw ration comparison 
 
Table 6.13: Statistical comparison of the weekly changes in the crystallinity of CPLA 
films after aqueous submersion – duration comparison 
 
Week 0 Week 6 Week 8 Week 10 Week 12 Week 16 Week 24 Week 32
1X Vs 2X
P > 0.05, q 
= 2.21
P > 0.05, 
q = 1.21
P > 0.05, 
q = 1.04
P > 0.05, 
q = 2.42
P < 0.001, 
q = 11.46
P > 0.05, 
q = 0.46
P < 0.01, 
q = 5.39
P > 0.05, 
q = 2.77
1X Vs 3X
P < 0.0001, 
q = 36.70
P < 0.001, 
q = 15.38
P > 0.05, 
q = 0.15
P > 0.05, 
q = 0.72
P < 0.001, 
q = 13.92
P < 0.001, 
q = 13.31
P < 0.001, 
q = 11.87
P < 0.001, 
q = 10.18
1X Vs 4X
P < 0.0001, 
q = 51.35
P < 0.001, 
q = 14.76
P > 0.05, 
q = 0.25
P > 0.05, 
q = 0.72
P > 0.05, 
q = 0.92
P < 0.001, 
q = 15.96
P < 0.001, 
q = 12.95
P < 0.001, 
q = 10.73
1X Vs SB 2X2Y
P < 0.001, 
q = 15.72
P < 0.01, 
q = 6.14
P > 0.05, 
q = 0.28
P > 0.05, 
q = 0.12
P > 0.05, 
q = 1.34
P > 0.05, 
q = 0.04
P < 0.05, 
q = 4.31
P > 0.05, 
q = 1.85
1X Vs SEQ 2X2Y
P < 0.01, q 
= 6.44
P < 0.05, 
q = 5.15
P > 0.05, 
q = 0.55
P > 0.05, 
q = 2.23
P < 0.001, 
q = 11.20
P > 0.05, 
q = 2.40
P > 0.05, 
q = 3.23
P > 0.05, 
q = 0.92
2X Vs 3X
P < 0.001, 
q = 34.48
P < 0.001, 
q = 14.15
P > 0.05, 
q = 1.19
P > 0.05, 
q = 1.69
P > 0.05, 
q = 2.46
P < 0.001, 
q = 12.35
P < 0.001, 
q = 6.47
P < 0.001, 
q = 7.41
2X Vs 4X
P < 0.001, 
q = 49.13
P < 0.001, 
q = 13.53
P > 0.05, 
q = 0.79
P > 0.05, 
q = 1.69
P < 0.001, 
q = 12.38
P < 0.001, 
q = 15.01
P < 0.001, 
q = 7.55
P < 0.001, 
q = 7.96
2X Vs SB 2X2Y
P < 0.001, 
q = 13.50
P < 0.05, 
q = 4.91
P > 0.05, 
q = 1.33
P > 0.05, 
q = 2.29
P < 0.001, 
q = 10.11
P > 0.05, 
q = 0.99
P > 0.05, 
q = 1.07
P > 0.05, 
q = 0.92
2X Vs SEQ 2X2Y
P > 0.05, q 
= 4.22
P > 0.05, 
q = 3.92
P > 0.05, 
q = 1.60
P > 0.05, 
q = 0.18
P > 0.05, 
q = 0.26
P > 0.05, 
q = 1.45
P > 0.05, 
q = 1.63
P > 0.05, 
q = 1.85
3X Vs 4X
P < 0.001, 
q = 14.65
P > 0.05, 
q = 0.61
P > 0.05, 
q = 0.41
P > 0.05, 
q = 0.69
P < 0.001, 
q = 14.84
P > 0.05, 
q = 2.65
P > 0.05, 
q = 1.07
P > 0.05, 
q = 0.55
3X Vs SB 2X2Y
P < 0.001, 
q = 20.98
P < 0.001, 
q = 9.23
P > 0.05, 
q = 0.13
P > 0.05, 
q = 0.60
P < 0.001, 
q = 12.57
P < 0.001, 
q = 13.34
P < 0.001, 
q = 7.55
P < 0.001, 
q = 8.33
3X Vs SEQ 2X2Y
P < 0.001, 
q = 30.26
P < 0.001, 
q = 10.22
P > 0.05, 
q = 0.41
P > 0.05, 
q = 1.51
P > 0.05, 
q = 2.72
P < 0.001, 
q = 10.90
P < 0.001, 
q = 15.10
P < 0.001, 
q = 9.25
4X Vs SB 2X2Y
P < 0.001, 
q = 35.63
P < 0.001, 
q = 8.61
P > 0.05, 
q = 0.54
P > 0.05, 
q = 0.60
P > 0.05, 
q = 2.26
P < 0.001, 
q = 16.00
P < 0.001, 
q = 8.63
P < 0.001, 
q = 8.88
4X Vs SEQ 2X2Y
P < 0.001, 
q = 44.91
P < 0.001, 
q = 9.61
P > 0.05, 
q = 0.81
P > 0.05, 
q = 1.51
P < 0.001, 
q = 12.12
P < 0.001, 
q = 13.55
P < 0.001, 
q = 16.18
P < 0.001, 
q = 9.81
SB 2X2Y Vs SEQ 2X2Y
P < 0.001, 
q = 9.27
P > 0.05, 
q = 0.99
P > 0.05, 
q = 0.27
P > 0.05, 
q = 2.11
P < 0.001, 
q = 9.85
P > 0.05, 
q = 2.44
P > 0.05, 
q = 0.75
P > 0.05, 
q = 0.92
One way ANOVA followed by Tukey's test - Draw ratio comparison
1X 2X 3X 4X SB-2X2Y SEQ-2X2Y
Week 0 Vs Week 8
P < 0.001, 
q = 37.44
P < 0.001, 
q = 41.24
P < 0.001, 
q = 21.96
P < 0.001, 
q = 15.19
P < 0.001, 
q = 31.28
P < 0.001, 
q = 42.73
Week 0 Vs Week 16
P < 0.001, 
q = 18.29
P < 0.001, 
q = 21.49
P < 0.001, 
q = 15.15
P < 0.001, 
q = 11.38
P < 0.001, 
q = 12.23
P < 0.001, 
q = 21.54
Week 0 Vs Week 32
P < 0.001, 
q = 24.04
P < 0.001, 
q = 30.94
P < 0.001, 
q = 20.14
P < 0.001, 
q = 14.51
P < 0.001, 
q = 19.90
P < 0.001, 
q = 27.10
Week 8 Vs Week 16
P < 0.001, 
q = 19.15
P < 0.001, 
q = 19.75
P > 0.05, 
q = 1.82
P > 0.05, 
q = 3.80
P < 0.001, 
q = 19.05
P < 0.001, 
q = 21.18
Week 8 Vs Week 32
P < 0.001, 
q = 13.40
P < 0.001, 
q = 10.30
P < 0.05, 
q = 4.98
P > 0.05, 
q = 0.67
P < 0.001, 
q = 11.37
P < 0.001, 
q = 15.63
Week 16 Vs Week 32
P < 0.01, q 
= 5.74
P < 0.001, 
q = 9.44
P < 0.001, 
q = 6.80
P > 0.05, 
q = 3.13
P < 0.001, 
q = 7.67
P < 0.01, 
q = 5.55
One way ANOVA followed by Tukey's test - Weeks comparison
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figure 6.16 
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Table 6.14: Statistical comparison of the weekly changes in the crystallinity of TPLA 
films after aqueous submersion – draw ration comparison 
 
Table 6.15: Statistical comparison of the weekly changes in the crystallinity of TPLA 
films after aqueous submersion – duration comparison 
 
Week 0 Week 6 Week 8 Week 10 Week 12 Week 16 Week 24 Week 32
1X Vs 2X
P < 0.001, 
q = 20.31
P < 0.001, 
q = 8.11
P > 0.05, 
q = 0.64
P > 0.05, 
q = 1.94
P > 0.05, 
q = 0.70
P > 0.05, 
q = 0.74
P < 0.001, 
q = 6.70
P < 0.01, 
q = 6.03
1X Vs 3X
P < 0.001, 
q = 87.68
P < 0.001, 
q = 15.80
P > 0.05, 
q = 3.28
P > 0.05, 
q = 2.66
P > 0.05, 
q = 3.55
P < 0.05, 
q = 4.73
P < 0.001, 
q = 8.04
P < 0.001, 
q = 13.71
1X Vs 4X
P < 0.001, 
q = 127.02
P < 0.001, 
q = 20.77
P > 0.05, 
q = 4.17
P > 0.05, 
q = 2.37
P < 0.05, 
q = 5.07
P < 0.001, 
q = 8.47
P < 0.001, 
q = 12.18
P < 0.001, 
q = 15.21
1X Vs SB 2X2Y
P < 0.001, 
q = 25.05
P < 0.001, 
q = 9.95
P > 0.05, 
q = 2.13
P > 0.05, 
q = 3.16
P < 0.001, 
q = 7.86
P < 0.001, 
q = 7.91
P < 0.001, 
q = 9.37
P > 0.05, 
q = 1.50
1X Vs SEQ 2X2Y
P < 0.001, 
q = 20.04
P < 0.001, 
q = 14.89
P > 0.05, 
q = 3.35
P < 0.05, 
q = 4.57
P < 0.01, 
q = 5.36
P < 0.001, 
q = 6.74
P < 0.01, 
q = 5.36
P < 0.05, 
q = 4.52
2X Vs 3X
P < 0.001, 
q = 67.36
P < 0.001, 
q = 7.74
P > 0.05, 
q = 2.63
P > 0.05, 
q = 0.72
P > 0.05, 
q = 4.26
P < 0.01, 
q = 5.47
P > 0.05, 
q = 1.34
P < 0.001, 
q = 7.67
2X Vs 4X
P < 0.001, 
q = 106.71
P < 0.001, 
q = 12.66
P > 0.05, 
q = 3.52
P > 0.05, 
q = 0.43
P < 0.01, 
q = 5.78
P < 0.001, 
q = 9.21
P < 0.01, 
q = 5.48
P < 0.001, 
q = 9.18
2X Vs SB 2X2Y
P < 0.05, 
q = 4.73
P > 0.05, 
q = 1.84
P > 0.05, 
q = 1.48
P > 0.05, 
q = 1.22
P < 0.001, 
q = 7.15
P < 0.001, 
q = 7.16
P < 0.001, 
q = 16.07
P < 0.05, 
q = 4.52
2X Vs SEQ 2X2Y
P > 0.05, 
q = 0.27
P < 0.001, 
q = 6.78
P > 0.05, 
q = 2.70
P > 0.05, 
q = 2.63
P < 0.05, 
q = 4.66
P < 0.01, 
q = 5.99
P < 0.001, 
q = 12.05
P > 0.05, 
q = 1.50
3X Vs 4X
P < 0.001, 
q = 39.33
P < 0.05, 
q = 4.92
P > 0.05, 
q = 0.89
P > 0.05, 
q = 0.28
P > 0.05, 
q = 1.52
P > 0.05, 
q = 3.74
P > 0.05, 
q = 4.14
P > 0.05, 
q = 1.50
3X Vs SB 2X2Y
P < 0.001, 
q = 62.62
P < 0.01, 
q = 5.89
P > 0.05, 
q = 1.15
P > 0.05, 
q = 0.50
P < 0.001, 
q = 11.42
P < 0.001, 
q = 12.64
P < 0.001, 
q = 17.41
P < 0.001, 
q = 12.20
3X Vs SEQ 2X2Y
P < 0.001, 
q = 67.63
P > 0.05, 
q = 0.95
P > 0.05, 
q = 0.07
P > 0.05, 
q = 1.91
P < 0.001, 
q = 8.92
P < 0.001, 
q = 11.47
P < 0.001, 
q = 13.39
P < 0.001, 
q = 9.18
4X Vs SB 2X2Y
P < 0.001, 
q = 101.97
P < 0.001, 
q = 10.82
P > 0.05, 
q = 2.04
P > 0.05, 
q = 0.79
P < 0.001, 
q = 12.93
P < 0.001, 
q = 16.38
P < 0.001, 
q = 21.55
P < 0.001, 
q = 13.71
4X Vs SEQ 2X2Y
P < 0.001, 
q = 106.98
P < 0.01, 
q = 5.87
P > 0.05, 
q = 0.82
P > 0.05, 
q = 2.19
P < 0.001, 
q = 10.44
P < 0.001, 
q = 15.21
P < 0.001, 
q = 17.54
P < 0.001, 
q = 10.69
SB 2X2Y Vs SEQ 2X2Y
P < 0.05, 
q = 5.01
P < 0.05, 
q = 4.94
P > 0.05, 
q = 1.22
P > 0.05, 
q = 1.40
P > 0.05, 
q = 2.49
P > 0.05, 
q = 1.16
P > 0.05, 
q = 4.02
P > 0.05, 
q = 3.02
One way ANOVA followed by Tukey's test - Draw ratio comparison
1X 2X 3X 4X SB-2X2Y SEQ-2X2Y
Week 0 Vs Week 8
P < 0.001, 
q = 53.34
P < 0.001, 
q = 64.98
P < 0.001, 
q = 56.96
P < 0.001, 
q = 25.69
P < 0.001, 
q = 88.44
P < 0.001, 
q = 92.33
Week 0 Vs Week 16
P < 0.001, 
q = 44.04
P < 0.001, 
q = 51.35
P < 0.001, 
q = 42.31
P < 0.001, 
q = 18.49
P < 0.001, 
q = 59.79
P < 0.001, 
q = 63.12
Week 0 Vs Week 32
P < 0.001, 
q = 43.33
P < 0.001, 
q = 60.18
P < 0.001, 
q = 61.66
P < 0.001, 
q = 29.37
P < 0.001, 
q = 70.34
P < 0.001, 
q = 78.58
Week 8 Vs Week 16
P < 0.001, 
q = 9.29
P < 0.05, 
q = 4.79
P > 0.05, 
q = 3.70
P > 0.05, 
q = 3.68
P < 0.001, 
q = 28.64
P < 0.001, 
q = 29.20
Week 8 Vs Week 32
P < 0.001, 
q = 10.01
P < 0.001, 
q = 13.62
P < 0.001, 
q = 14.65
P < 0.001, 
q = 7.19
P < 0.001, 
q = 18.09
P < 0.001, 
q = 13.73
Week 16 Vs Week 32
P > 0.05, 
q = 0.71
P < 0.001, 
q = 8.82
P < 0.001, 
q = 19.35
P < 0.001, 
q = 10.88
P < 0.001, 
q = 10.55
P < 0.001, 
q = 15.46
One way ANOVA followed by Tukey's test - Weeks comparison
* Actual data 
displayed in 
figure 6.17 
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Figure 6.16 and figure 6.17 further reveal that the percentage crystallinity 
increased again after the 20th week. There are two possibilities here. Firstly, 
erosion of the degraded amorphous phase may cause a relative rise in the 
percentage crystallinity. Secondly, degraded oligomers may undergo extensive 
crystallisation. Distinguishingly, the crystallinity of the films oriented to UCW λ ≥ 
3X, was higher than the remaining studied films, during this phase.  
When plasticised by water, PLA undergoes ‘insertion crystallisation’ 
(Hurrell and Cameron, 2002; Tsuji et al., 2000). Here the crystallisation occurs 
on templates provided by the existing crystals. Consequently, the inherent 
crystalline structure plays a key role in affecting the crystallisation process. The 
films oriented to UCW draw ratios of 3X and 4X, already have a well-developed 
crystalline order, in the form of lamellar α crystals (sec. 6.4). Therefore insertion 
crystallisation in these films will follow the same structural order. Contrarily, 
insertion crystallisation of the previously amorphous films (i.e. un-oriented, 
UCW λ = 2X, SB λ = 2X2Y and SEQ λ = 2X2Y) will be random, leading to 
generation of large sized, spherulitic crystals (Hurrell and Cameron, 2002; Tsuji 
et al., 2000). Therefore a difference in the length of the plateau crystallinity 
phase and the post-plateau crystallinity of the studied films can be associated 
with the differences in their crystalline structure.   
6.8.3. Molecular weight degradation 
 The drug loaded PLA films investigated here showed a significant 
reduction in molecular weight upon exposure to the release medium. The 
changes in the weight average molecular weight (Mw) of the CPLA and the 
TPLA films (deduced from GPC) are summarised in figure 6.18 and figure 6.19 
respectively. The molecular weight reduction was statistically compared 
between the draw ratios, using one-way ANOVA, followed by Tukey’s test. The 
results of this are presented in table 6.16 and table 6.17. Nevertheless, 
comparison between individual time-points of a same draw ratio was made 
using a paired t-test, wherever suitable. 
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6.8.3.1. The lag in onset of molecular weight degradation 
 Macromolecular degradation of un-oriented PLA films started almost 
instantaneously after submersion into the release medium, and a monotonous 
Mw reduction was observed. Oriented films showed a lag before the loss of 
molecular weight began. The onset of degradation was delayed until the 6th 
week, for TPLA films oriented to a UCW draw ratio of 4X and biaxially oriented 
TPLA films (both SB and SEQ; λ = 2X2Y). Nevertheless, such a phase was 5 
weeks longer for the TPLA films with UCW draw ratios of 2X and 3X. This 
observation was statistically validated by comparison of the molecular weight at 
the beginning of the study and after 5 and 6 weeks, by paired t-tests. Secondly, 
when compared by one-way ANOVA – Tukey’s test (table 6.17), there was a 
statistically insignificant difference in the molecular weight of oriented TPLA 
films for the first 5 weeks. Such a trend continued for another week in the case 
of UCW λ = 4X and biaxially oriented TPLA films. Contrarily, un-oriented TPLA 
films showed a highly significant difference in molecular weight (compared to 
the oriented films) since the beginning of the study. 
Oriented CPLA films showed a slightly different trend. CPLA films oriented 
in UCW mode, to draw ratios of 3X and 4X showed practically no molecular 
weight reduction until the 7th week (paired t-test, P > 0.05, between 0 – 7 
weeks). A similar phase for the SB oriented CPLA films (λ = 2X2Y) lasted for 
approximately 4 weeks (paired t-test, P > 0.05, between 0 – 4 weeks). The lag 
was absent for CPLA films oriented to a UCW draw ratio of 2X and those 
oriented in sequential (SEQ) biaxial mode (λ = 2X2Y). However, the Mw 
reduction for the mentioned films was slower for the initial 6 weeks, followed by 
a rapid fall. Biaxially oriented (λ = 2X2Y) CPLA films and those oriented to a 
UCW draw ratio of 2X clearly exhibited a shorter lag than corresponding TPLA 
films. This can perhaps be attributed to shrinkage of the abovementioned CPLA 
films in the drug release medium, leading to partial loss of their orientation (sec. 
6.8.1). The above observations were also validated in the one-way ANOVA 
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Tukey’s test analysis (table 6.16), which showed a statistically insignificant 
difference in the molecular weights of UCW λ ≥ 3X and SB 2X2Y CPLA films for 
the first 4 weeks. The difference between the molecular weights of UCW λ = 3X 
and λ = 4X CPLA films continued to be insignificant for an additional 2 weeks. 
Contrarily, the remaining films exhibited a highly significant difference in the 
molecular weight when compared to UCW λ ≥ 3X CPLA films and among 
themselves. A delayed onset of molecular weight degradation for PLA matrices 
with higher inherent crystallinity has been reported previously (Pistner et al., 
1993). However, in the current study, oriented films which were practically 
amorphous (UCW – λ = 2X, SB & SEQ – λ = 2X2Y), also showed a lag. 
Therefore the lag observed here correlates more correctly with the structural 
organisation than the crystallinity. Orientation of polymeric matrices enhances 
molecular packing of the polymer chains. This perhaps reduces access of the 
water to the hydrolytic cleavage sites (Qureshi et al., 2000). Consequently, such 
matrices show a delayed onset of degradation or a slower rate of degradation 
(Cho et al., 2003). . 
 
Figure 6.18: Changes in the weight average molecular weight (Mw) of curcumin 
loaded PLA (CPLA) films with respect to aging in the release medium. 
**The graph represents molecular weight as the mean ± standard deviation, where n = 6.  
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Figure 6.19: Changes in the weight average molecular weight (Mw) of theophylline 
loaded PLA (TPLA) films with respect to aging in the release medium. 
A) Uniaxially (UCW) oriented films, B) Biaxially oriented films compared with UCW λ = 4X 
**The graph represents molecular weight as the mean ± standard deviation, where n = 6.  
Table 6.16: Statistical comparison of the molecular weight changes in the CPLA films 
after aqueous submersion (data shown in figure 6.18).  
 
Week 2 Week 3 Week 4 Week 5 Week 6 Week 16 Week 32
1X Vs 2X
P > 0.05 
q = 2.93
P < 0.001 
q = 9.16
P < 0.001 
q = 18.32
P < 0.001 
q = 33.51
P < 0.001 
q = 31.12
P < 0.001 
q = 9.15
P < 0.001 
q = 10.53
1X Vs 3X
P > 0.05 
q = 3.61
P < 0.001 
q = 7.12
P < 0.001 
q = 21.78
P < 0.001 
q = 49.87
P < 0.001 
q = 46.29
P < 0.001 
q = 36.86
P < 0.001 
q = 28.85
1X Vs 4X
P < 0.001 
q = 6.94
P < 0.001 
q = 10.02
P < 0.001 
q = 21.33
P < 0.001 
q = 46.49
P < 0.001 
q = 42.88
P < 0.001 
q = 37.81
P < 0.001 
q = 41.22
1X Vs SB 2X2Y
P < 0.001 
q = 9.18
P < 0.001 
q = 9.44
P < 0.001 
q = 21.27
P < 0.001 
q = 47.84
P < 0.001 
q = 37.03
P < 0.001 
q = 9.68
P > 0.05 
q = 0.55
1X Vs SEQ 2X2Y
P > 0.05 
q = 1.55
P > 0.05 
q = 0.99
P > 0.05 
q = 1.2
P < 0.001 
q = 10.12
P < 0.001 
q = 12.86
P < 0.001 
q = 7.97
P > 0.05 
q = 0.09
2X Vs 3X
P < 0.01 
q = 6.80
P < 0.01 
q = 6.78
P < 0.01 
q = 13.46
P < 0.001 
q = 16.36
P < 0.001 
q = 15.17
P < 0.001 
q = 27.72
P < 0.001 
q = 18.32
2X Vs 4X
P < 0.01 
q = 9.4
P < 0.01 
q = 8.86
P < 0.01 
q = 7.01
P < 0.001 
q = 12.98
P < 0.001 
q = 11.76
P < 0.001 
q = 28.66
P < 0.001 
q = 30.69
2X Vs SB 2X2Y
P < 0.01 
q = 6.25
P < 0.01 
q = 8.27
P < 0.01 
q = 12.95
P < 0.001 
q = 14.33
P < 0.01 
q = 5.91
P > 0.05 
q = 0.53
P < 0.001 
q = 11.08
2X Vs SEQ 2X2Y
P < 0.05 
q = 4.48
P < 0.001 
q = 10.16
P < 0.001 
q = 17.12
P < 0.001 
q = 23.39
P < 0.001 
q = 18.26
P > 0.05 
q = 1.17
P < 0.001 
q = 10.44
3X Vs 4X
P > 0.05 
q = 3.33
P > 0.05 
q = 2.9
P > 0.05 
q = 0.45
P > 0.05 
q = 3.38
P > 0.05 
q = 3.41
P > 0.05 
q = 0.94
P < 0.001 
q = 12.37
3X Vs SB 2X2Y
P < 0.01 
q = 5.57
P > 0.05 
q = 2.31
P > 0.05 
q = 0.51
P > 0.05 
q = 2.03
P < 0.001 
q = 9.26
P < 0.001 
q = 27.19
P < 0.001 
q = 29.4
3X Vs SEQ 2X2Y
P < 0.05 
q = 5.16
P < 0.001 
q = 8.12
P < 0.001 
q = 20.58
P < 0.001 
q = 39.75
P < 0.001 
q = 33.43
P < 0.001 
q = 28.89
P < 0.001 
q = 28.76
4X Vs SB 2X2Y
P > 0.05 
q = 2.25
P > 0.05 
q = 0.59
P > 0.05 
q = 0.06
P > 0.05 
q = 1.35
P < 0.01 
q = 5.85
P < 0.001 
q = 28.13
P < 0.001 
q = 41.77
4X Vs SEQ 2X2Y
P < 0.001 
q = 8.48
P < 0.001 
q = 11.02
P < 0.001 
q = 20.13
P < 0.001 
q = 36.38
P < 0.001 
q = 30.02
P < 0.001 
q = 29.84
P < 0.001 
q = 41.13
SB 2X2Y Vs SEQ 2X2Y
P < 0.001 
q = 10.73
P < 0.001 
q = 10.43
P < 0.001 
q = 20.07
P < 0.001 
q = 37.72
P < 0.001 
q = 24.17
P > 0.05 
q = 1.7
P > 0.05 
q = 0.64
One way ANOVA followed by Tukey's test - Draw ratio comparison
(A) (B) 
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Table 6.17: Statistical comparison of the molecular weight changes in the TPLA films 
after aqueous submersion (data shown in figure 6.19). .  
 
Notes: The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
 
6.8.3.2. The decline phase  
GPC chromatograms revealed that the peaks corresponding to PLA 
shifted towards a higher elution volume as the submersion duration increased. 
However, all the peaks remained monomodal in nature, indicating uniform 
degradation throughout the bulk of the films. Since PLA undergoes bulk 
Week 2 Week 3 Week 4 Week 5 Week 6 Week 16 Week 32
1X Vs 2X
P < 0.001, 
q = 10.62
P < 0.001, 
q = 22.17
P < 0.001, 
q = 28.41
P < 0.001, 
q = 18.18
P < 0.001, 
q = 15.16
P < 0.001, 
q = 21.61
P < 0.001, 
q = 8.14
1X Vs 3X
P < 0.001, 
q = 8.87
P < 0.001, 
q = 23.22
P < 0.001, 
q = 29.91
P < 0.001, 
q = 21.84
P < 0.001, 
q = 24.57
P < 0.001, 
q = 47.60
P < 0.001, 
q = 25.30
1X Vs 4X
P < 0.001, 
q = 12.34
P < 0.001, 
q = 25.66
P < 0.001, 
q = 34.94
P < 0.001, 
q = 23.14
P < 0.001, 
q = 33.83
P < 0.001, 
q = 76.46
P < 0.001, 
q = 37.84
1X Vs SB 2X2Y
P < 0.001, 
q = 8.60
P < 0.001, 
q = 21.91
P < 0.001, 
q = 32.70
P < 0.001, 
q = 19.64
P < 0.001, 
q = 30.14
P < 0.001, 
q = 53.92
P < 0.001, 
q = 22.24
1X Vs SEQ 2X2Y
P < 0.001, 
q = 9.77
P < 0.001, 
q = 24.33
P < 0.001, 
q = 30.30
P < 0.001, 
q = 17.90
P < 0.001, 
q = 28.79
P < 0.001, 
q = 7.89
P < 0.001 
q = 25.94
2X Vs 3X
P > 0.05, 
q = 1.74
P > 0.05,  
q = 1.05
P > 0.05, 
q = 1.50
P > 0.05, 
q = 3.66
P < 0.001, 
q = 9.40
P < 0.001, 
q = 25.98
P < 0.001, 
q = 17.15
2X Vs 4X
P > 0.05, 
q = 1.72
P > 0.05, 
q = 3.48
P < 0.05, 
q = 4.96
P < 0.05, 
q = 4.96
P < 0.001, 
q = 18.67
P < 0.001, 
q = 54.85
P < 0.001, 
q = 29.70
2X Vs SB 2X2Y
P > 0.05, 
q = 2.01
P > 0.05, 
q = 0.26
P > 0.05, 
q = 4.29
P > 0.05, 
q = 1.46
P < 0.001, 
q = 14.98
P < 0.001, 
q = 32.31
P < 0.001, 
q = 30.38
2X Vs SEQ 2X2Y
P > 0.05, 
q = 0.84
P > 0.05, 
q = 2.16
P > 0.05, 
q = 1.88
P > 0.05, 
q = 0.279
P < 0.001, 
q = 13.63
P < 0.001, 
q = 13.71
P < 0.001, 
q = 34.08
3X Vs 4X
P > 0.05, 
q = 3.46
P > 0.05, 
q = 2.43
P < 0.05, 
q = 5.03
P > 0.05, 
q = 1.30
P < 0.001, 
q = 9.26
P < 0.001, 
q = 28.86
P < 0.001, 
q = 12.54
3X Vs SB 2X2Y
P > 0.05, 
q = 0.27
P > 0.05, 
q = 1.31
P > 0.05, 
q = 2.79
P > 0.05, 
q = 2.19
P < 0.01, 
q = 5.57
P < 0.01, 
q = 6.32
P < 0.001, 
q = 47.54
3X Vs SEQ 2X2Y
P > 0.05, 
q = 0.89
P > 0.05, 
q = 1.11
P > 0.05, 
q = 0.38
P > 0.05, 
q = 3.94
P > 0.05, 
q = 4.22
P < 0.001, 
q = 39.70
P < 0.001, 
q = 51.24
4X Vs SB 2X2Y
P > 0.05, 
q = 3.74
P > 0.05, 
q = 3.75
P > 0.05, 
q = 2.24
P > 0.05, 
q = 3.49
P > 0.05, 
q = 3.69
P < 0.001, 
q = 22.53
P < 0.001, 
q = 60.09
4X Vs SEQ 2X2Y
P > 0.05, 
q = 2.57
P > 0.05, 
q = 1.32
P < 0.05, 
q = 4.64
P < 0.05, 
q = 5.24
P < 0.05, 
q = 5.04
P < 0.001, 
q = 68.56
P < 0.001, 
q = 63.78
SB 2X2Y Vs SEQ 2X2Y
P > 0.05, 
q = 1.17
P > 0.05, 
q = 2.42
P > 0.05, 
q = 2.40
P > 0.05, 
q = 1.74
P > 0.05, 
q = 1.34
P < 0.001, 
q = 46.02
P > 0.05, 
q = 3.69
One way ANOVA followed by Tukey's test - Draw ratio comparison
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degradation, the degraded oligomers remain entrapped within the matrix. These 
further catalyse the degradation of the bulk, consequently generating a surface 
to centre differential in the degradation rate. In the case of thin films, such a 
differential is generally insignificant and therefore may not be detected by GPC. 
The current results agree with the findings of Grizzi et al. (1995), who reported 
that thin PLA films (0.3 mm) degraded homogeneously, as opposed to thick 
sheets (2 mm), where surface to centre differential in the hydrolytic degradation 
generated bimodal GPC peaks.  
The molecular weight vs submersion duration curves for UCW oriented 
TPLA films remained nearly parallel to that of the un-oriented films (figure 6.19- 
A), beyond the lag phase. Therefore, if the lag phase was ignored, the 
mentioned films showed practically no difference in the degradation rate. On the 
contrary, biaxially oriented TPLA films showed a slightly higher degradation rate 
(figure 6.19 - B), evidenced as a greater slope of the regression lines 
corresponding to their molecular weight vs submersion duration curves 
(between 7 – 14 weeks). The duration for 50% reduction in molecular weight 
(t1/2) was approximately 12, 15, 17, 19, 17 and 15 weeks for the un-oriented, 
UCW 2X, UCW 3X, UCW 4X, SB 2X2Y and SEQ 2X2Y films respectively. 
Despite the fact that biaxially oriented TPLA films showed a longest lag phase 
amongst the oriented TPLA films, existence of a shorter t1/2 further confirmed 
their faster degradation. Such a trend was not clearly identified in the case of 
biaxially oriented (λ = 2X2Y) CPLA films, perhaps due to their shrinkage. The 
molecular weight vs submersion duration curves (figure 6.18) remained almost 
parallel for all CPLA films, after the initial lag phase. t1/2 for CPLA films with a 
following set of orientation profiles; namely, un-oriented, UCW 2X, UCW 3X, 
UCW 4X, SB 2X2Y and SEQ 2X2Y was 10, 13, 17, 17, 13 and 11 weeks 
respectively. Overall the statistical comparison confirmed that, at a fixed (post - 
lag) submersion duration, both CPLA and TPLA films with different degrees of 
orientation had significantly different molecular weights (table 6.16 and table 
6.17). This factor can significantly impact drug release from these films. 
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Comparison of the molecular weight vs submersion duration curves and 
the t1/2 values for the CPLA and the TPLA films further highlighted that the 
molecular weight degradation was higher in un-oriented and shrunk CPLA films. 
Contrarily films oriented to UCW draw ratios of 3X and 4X exhibited similar 
degradation, irrespective of the added drug. This observation was validated by 
statistical comparison between the percentage molecular weight degradation 
exhibited by CPLA films and TPLA films, following 16 weeks submersion. A 
highly significant (P < 0.001 by a paired t-test) difference was found between 
the molecular weight reduction shown by the un-oriented CPLA and TPLA films. 
Contrarily, the difference between UCW ≥ 3X CPLA and TPLA films was 
statistically insignificant (P > 0.05 by a paired t-test). Molecular weight 
degradation can substantially enhance the diffusivity of a drug through the 
polymer matrix. Nevertheless, the space created by degradation of the polymer 
chains can be occupied by the percolated medium, leading to formation of 
‘water filled channels’. The presence of water filled channels further accelerates 
drug release.  
Overall, the results confirmed that both uniaxial and biaxial orientation of 
the drug loaded PLA films delayed the onset of hydrolytic degradation, in a 
neutral (pH 6.8) bathing medium. After the lag, un-oriented and uniaxially 
oriented TPLA films showed a comparable degradation rate, whereas biaxially 
oriented films exhibited a slightly faster degradation. Such an effect was not 
observed in the biaxially oriented CPLA films as they underwent shrinkage and 
partially lost their oriented structure. Several studies have previously reported 
retardation of hydrolytic degradation of PLA fibres, following uniaxial orientation 
by hot drawing (Cai et al., 1996; Jamshidi et al., 1986). However, studies on 
PLA films have reached largely inadequate conclusions (Burg and Shalaby, 
1998; Lee et al., 2001b; Tsuji et al., 2005).  Tsuji et al. (Tsuji et al., 2005) found 
that enzymatic degradation of PLA, which takes place primarily by a surface 
erosion mechanism was hindered by biaxial orientation. On the contrary, 
hydrolytic bulk degradation was unaffected by orientation; it was rather 
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influenced by the inherent crystallinity of the matrices. Similarly, Burg et al. 
(1998) detected no difference in the weight average molecular weight reduction 
between uniaxially oriented PLA films and un-oriented films from which they 
were obtained.  
6.8.4. Polydispersity changes 
All drug loaded PLA films studied here showed a rise in the polydispersity 
since the beginning of the molecular weight degradation. In the case of TPLA 
films the rise in the polydispersity continued till the 16th week (figure 6.21); while 
CPLA films showed a plateau between the 10th and the 16th week (figure 6.20) 
(P > 0.05, 10th week Vs 12th Vs 14th Vs 16th week by one-way ANOVA followed 
by Tukey’s test). Figure 6.20 and figure 6.21 further suggest that un-oriented 
films exhibited the highest polydispersity amongst the studied films, for the 
entire study duration. A statistical comparison was made (at four different time 
points) between the polydispersity of the films with varied draw ratios, by one-
way ANOVA – Tukey’s test. This data is presented in table 6.18. The 
polydispersity Vs submersion duration curves along with statistical analysis 
confirmed that UCW – 2X films exhibited significantly lower polydispersity than 
un-oriented films for the first 16 weeks (regardless of the model drug). The 
polydispersity of the UCW – 3X and UCW – 4X films was statistically equivalent 
(P > 0.05, table 6.18); nevertheless it was lower than that of the UCW – 2X 
films.  
It was further observed that the polydispersity of SB and SEQ oriented 
TPLA films (λ = 2X2Y) was statistically equivalent to each other and to UCW-
3X/4X films (figure 6.21 – B; table 6.18 - P > 0.05). Conversely, the 
polydispersity of SB oriented CPLA films was statistically equivalent to that of 
the UCW-2X films; and polydispersity of SEQ oriented CPLA films was 
equivalent to that of the un-oriented films (figure 6.20 – B; table 6.18).  Burg and 
Shalaby (1998) reported that the isotropic structure of un-oriented films allows 
hydrolytic chain cleavage to occur at random locations along the chain length. 
 173 
 
Contrarily, a highly ordered structure (sec. 6.4) of the oriented matrices results 
in a more regular chain cleavage. Therefore, lower polydispersity of the oriented 
films can be attributed to this phenomenon.  
 
 
 
Figure 6.20: Changes in the polydispersity (PD) of curcumin loaded PLA (CPLA) films 
with respect to aging in the release medium. 
A) Uniaxially (UCW) oriented films, B) Biaxially oriented films 
**The graph represents polydispersity as the mean ± standard deviation, where n = 6. 
 
 
 
Figure 6.21: Changes in the polydispersity (PD) of the theophylline loaded PLA (TPLA) 
films with respect to aging in the release medium 
A) Uniaxially (UCW) oriented films, B) Biaxially oriented films 
**The graph represents molecular weight as the mean ± standard deviation, where n = 6. 
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Table 6.18: Statistical comparison of the polydispersity changes in the PLA films after 
aqueous submersion  
 
Notes: For actual data refer figure 6.20 and figure 6.21  
The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
 
Week 1 Week 6 Week 12 Week 24 Week 1 Week 6 Week 12 Week 24
1X Vs 2X
P > 0.05, 
q = 0
P < 0.001, 
q = 16.86
P < 0.001, 
q = 9.7
P < 0.001, 
q = 8.91
P < 0.01, 
q = 6.42
P < 0.001, 
q = 21.46
P < 0.01, 
q = 6.23
P < 0.001, 
q = 26.62
1X Vs 3X
P > 0.05, 
q = 2.95
P < 0.001, 
q = 25.71
P < 0.001, 
q = 17.71
P < 0.001, 
q = 13.35
P > 0.05, 
q = 1.11
P < 0.001, 
q = 37.51
P < 0.001, 
q = 8.95
P < 0.001, 
q = 20.94
1X Vs 4X
P > 0.05, 
q = 1.34
P < 0.001, 
q = 35.74
P < 0.001, 
q = 20.61
P < 0.001, 
q = 11.74
P < 0.05, 
q = 5.15
P < 0.001, 
q = 37.39
P < 0.001, 
q = 12.05
P < 0.001, 
q = 26.18
1X Vs SB 
2X2Y
P > 0.05, 
q = 4.03
P < 0.001, 
q = 21.41
P < 0.001, 
q = 18.13
P < 0.001, 
q = 16.6
P > 0.05, 
q = 3.68
P < 0.001, 
q = 22.98
P < 0.001, 
q = 8.84
P < 0.001, 
q = 32.96
1X Vs SEQ 
2X2Y
P < 0.001, 
q = 8.32
P < 0.001, 
q = 27.31
P < 0.001, 
q = 15.07
P < 0.001, 
q = 16.31
P > 0.05, 
q =0.79
P > 0.05,  
q = 1.11
P > 0.05, 
q = 1.06
P < 0.001, 
q = 15.3
2X Vs 3X
P > 0.05, 
q = 2.95
P < 0.001, 
q = 8.85
P < 0.001, 
q = 8.01
P < 0.05, 
q = 4.45
P < 0.01, 
q = 5.31
P < 0.001, 
q = 16.05
P > 0.05, 
q = 2.72
P < 0.01, 
q = 5.69
2X Vs 4X
P > 0.05, 
q = 1.34
P < 0.001, 
q = 18.88
P < 0.001, 
q = 10.9
P > 0.05, 
q = 2.84
P > 0.05, 
q = 1.27
P < 0.001, 
q = 15.93
P < 0.01, 
q = 5.82
P > 0.05, 
q = 0.44
2X Vs SB 
2X2Y
P > 0.05, 
q = 4.03
P < 0.05, 
q = 4.55
P < 0.001, 
q = 8.42
P < 0.001, 
q = 7.7
P > 0.05, 
q = 2.74
P > 0.05, 
q = 1.52
P > 0.05, 
q = 2.61
P < 0.01, 
q = 6.34
2X Vs SEQ 
2X2Y
P < 0.001, 
q = 8.32
P < 0.001, 
q = 10.45
P < 0.01, 
q = 5.37
P < 0.001, 
q = 7.4
P > 0.05, 
q = 0.71
P < 0.001, 
q = 11.35
P < 0.05, 
q = 5.17
P < 0.001, 
q = 11.32
3X Vs 4X
P > 0.05, 
q = 1.61
P > 0.05, 
q = 1.03
P > 0.05, 
q = 2.89
P > 0.05, 
q = 1.61
P > 0.05, 
q = 4.05
P > 0.05, 
q = 0.12
P > 0.05, 
q = 3.1
P < 0.05, 
q = 5.24
3X Vs SB 
2X2Y
P > 0.05, 
q = 1.07
P > 0.05, 
q = 4.3
P > 0.05, 
q = 0.41
P > 0.05, 
q = 3.25
P > 0.05, 
q = 2.58
P < 0.001, 
q = 14.52
P < 0.05, 
q = 5.11
P < 0.001, 
q = 12.02
3X Vs SEQ 
2X2Y
P < 0.01, 
q = 5.37
P > 0.05, 
q = 1.6
P > 0.05, 
q = 2.64
P > 0.05, 
q = 2.96
P < 0.05, 
q = 4.6
P < 0.001, 
q = 27.4
P < 0.001, 
q = 7.89
P < 0.01, 
q = 5.64
4X Vs SB 
2X2Y
P > 0.05, 
q = 2.68
P < 0.001, 
q = 14.33
P > 0.05, 
q = 2.48
P < 0.05, 
q = 4.86
P > 0.05, 
q = 1.47
P < 0.001, 
q = 14.4
P < 0.05, 
q = 5.22
P < 0.001, 
q = 6.78
4X Vs SEQ 
2X2Y
P < 0.001, 
q = 6.98
P < 0.001, 
q = 8.43
P < 0.01, 
q = 5.53
P < 0.05, 
q = 4.57
P > 0.05, 
q = 0.55
P < 0.001, 
q = 27.28
P < 0.001, 
q = 11
P < 0.001, 
q = 10.88
SB 2X2Y 
Vs SEQ 
2X2Y
P > 0.05, 
q = 4.29
P > 0.05, 
q = 3.9
P > 0.05, 
q = 3.06
P > 0.05, 
q = 0.29
P > 0.05, 
q = 2.02
P < 0.001, 
q = 12.88
P < 0.001, 
q = 7.78
P < 0.001, 
q = 17.66
TPLA Films CPLA Films
One way ANOVA followed by Tukey's test
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A sharp decline in polydispersity was observed between the 16th and 24th 
week, followed by another plateau or a sharp rise. This event corresponded to 
dramatic changes in the film properties as listed below. (Note: - after 16 weeks, 
the samples were withdrawn every 4 weeks, and not weekly) 
A. The weight loss shown by drug loaded PLA films was negligible until the 
16th week. By the 24th week, the films lost 10 – 20% of their original weight. 
The weight loss was lower (12 ± 3%) for the uniaxially oriented films with λ 
≥ 3X. Biaxially oriented films lost more weight (17 ± 2%), which was aligned 
with the faster molecular weight degradation exhibited by them. By the 32nd 
week the weight loss for un-oriented and biaxially oriented TPLA films was 
27 ± 4%, while that for UCW 2X, UCW 3X and UCW 4X TPLA films was 21 
± 2.8%, 18 ± 1.44% and 17 ± 2.1% respectively. CPLA films showed a 
slightly higher weight loss during the abovementioned interval. It was within 
the window of 32 ± 6% for the un-oriented, UCW-2X and the biaxially 
oriented films; while that for UCW-3X and UCW-4X films was 22 ± 5.34%. 
B. By the 20th week, a significant reduction in the mechanical strength of the 
circular film sections made them extremely brittle. Samples withdrawn at the 
28th week sampling interval were extremely fragile and easily fractured even 
on delicate handling.   
C. Scanning electron microscopy revealed little change in the surface and the 
cross section of the films until the 16th week. At the 20th week, several large 
cracks appeared on the surface. Samples withdrawn after 28 weeks of 
submersion showed significant degradation of the films. Here the surface 
appeared as a partially degraded crust, exposing the extensively degraded 
inner structure. *(SEM results are summarised in the following section). 
The above results suggest that hydrolytic bulk degradation of PLA reached 
a critical stage by the 20th sampling week, where the outer crust started 
cracking and released the entrapped oligomers. Following this, the matrix 
became highly porous, allowing more water to percolate and cause hydrolysis. 
 176 
 
These events marked the beginning of the erosion phase, where the PLA films 
started breaking apart. Therefore, drug release in this phase will be 
tremendously accelerated.  
6.8.5. Changes in the morphology of drug loaded PLA films 
 Drug loaded PLA films showed little change in their surface morphology 
for 16 weeks after submersion into the drug release medium (figure 6.22). No 
change in the cryo-fractured cross sections of the films (fractured perpendicular 
to the film surface) could be detected for the first 11 weeks. Samples withdrawn 
at the 12th week showed few cracks and several nano-sized pores on the cross 
section (figure 6.23). The number and the size of the pores increased between 
the 11th and the 20th week. However, their distribution appeared random. (Note: 
- after 16 weeks, the samples were withdrawn every 4 weeks and not weekly) 
 
 
Figure 6.22: Transverse surfaces of drug loaded PLA films after 16 weeks of 
submersion in the release medium. 
A) Un-oriented CPLA films representing all CPLA films, B) Un-oriented TPLA films representing all TPLA 
films 
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Figure 6.23: Cryo-fractured cross sections of drug loaded PLA films aged for 12 weeks 
in the release medium. 
A) Un-oriented CPLA films representing all CPLA films, B) Un-oriented TPLA films representing all TPLA 
films 
 
Figure 6.24: Cryo-fractured cross sections of un-oriented drug loaded PLA films aged 
for 20 weeks in the release medium. 
A & C) Un-oriented CPLA films, B & D) Un-oriented TPLA films.  
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Figure 6.25: Cryo-fractured cross sections of oriented TPLA films aged for 20 weeks in 
the release medium. 
A) UCW oriented TPLA films with λ = 4X, B) SB oriented TPLA films with λ = 2X2Y. 
 
 
Figure 6.26: Transverse surfaces of the un-oriented CPLA films A) aged for 24 weeks 
and B) aged for 28 weeks in the release medium. 
*(Represents the transverse surfaces of the following films at corresponding sampling interval; CPLA films 
– un-oriented, UCW-2X, SB-2X2Y, SEQ-2X2Y and TPLA films - un-oriented, UCW-2X, SEQ-2X2Y) 
 
 
A B 
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At the 20th week, the cross section revealed a highly porous structure of 
the degraded matrices. These pores correlate to the channels created by 
permeated water. Therefore, their number and size continuously increases as 
the PLA is degraded further. For films withdrawn after 20 weeks, the shape of 
the pores was uniform circular; while, their diameter varied from approximately 
0.85 to 3.5 μm for TPLA films (figure 6.24 - A & C). CPLA films showed slightly 
smaller pores, ranging between approximately 0.18 – 2.1 μm (figure 6.24 - B & 
D). This indicates variation in the hydrolytic degradation of PLA with respect to 
the added drug (Li et al., 1996). The morphological changes observed until the 
20th week were constant for un-oriented and oriented films (figure 6.25 - A & B).  
 
 
Figure 6.27: Transverse surfaces of oriented drug loaded PLA films aged for 24 weeks 
in the release medium. 
A) UCW oriented TPLA films with λ = 4X, B) SB oriented TPLA films with λ = 2X2Y. 
Few cracks appeared on the transverse surfaces of the films at the 20th 
week. The cracks became wider on further degradation (24th week onwards). 
This overlapped with appearance of white circular spots on the surface of the 
following films; namely, CPLA films – un-oriented, UCW-2X, SB-2X2Y, SEQ-
2X2Y and TPLA films - un-oriented, UCW-2X, SEQ-2X2Y. (figure 6.26 - A). 
These spots were raised above the film surface by the 28th week and few 
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showed a hole in the centre (figure 6.26 - B). Cam et al. (1995) observed a 
similar morphology in hydrolytically degraded PLA films, which they described 
as partially degraded spherulitic crystals. A hole in the centre signifies that 
degradation of spherulites occurs from the centre. No such morphology was 
observed in UCW oriented films with λ ≥ 3X (figure 6.27 - A), perhaps due to the 
presence of α crystals (lamellar stacks). Similarly, the raised white spots were 
also absent in SB oriented TPLA films. Instead, the mentioned films showed 
large (50-150 μm) circular holes on the surface (figure 6.27 - B). Since these 
were not previously observed and their size was significantly larger than the 
size of theophylline particles, they cannot be correlated with the cavitation 
during biaxial stretching of the TPLA films. Tsuji et al. (2005) observed 
formation of such holes when biaxially oriented films were degraded 
enzymatically. They attributed this to detachment of large sized spherulites from 
the surface.  
 
Figure 6.28: SEM images of A) the transverse surface and B) the cross section of un-
oriented TPLA films aged for 32 weeks in the release medium. 
Cross sections of the film samples withdrawn after 24 weeks showed a 
degraded core, sandwiched between two un-degraded thin layers (figure 6.28 - 
B). This distinguishing morphology was also observed on the transverse surface 
of the films, after 32 weeks aging in the release medium. The transverse 
surface of the mentioned films showed a ruptured outer crust at several 
locations, revealing the internal degraded core (figure 6.28 - A). It is known that 
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bulk degradation of PLA causes accumulation of the oligomers within the 
matrix. These oligomers accelerate degradation of the bulk (Burg and Shalaby, 
1998; Grizzi et al., 1995; Tsuji and Ikarashi, 2004). Therefore, a difference 
between the degradation rate of the bulk and the surface generates a 
morphological distinction between them. The less degraded outer layer further 
prevents leaching of the oligomers. When the outer layer is substantially 
degraded, it starts falling apart. At this stage the erosion of PLA is significantly 
enhanced. Perhaps, such a morphological difference was not detected during 
molecular weight determination, owing to the lower thickness (0.2 mm) of the 
studied films (Grizzi et al., 1995).  
6.8.6. Summary 
The overall changes in drug loaded PLA films following aqueous 
submersion are summarised in figure 6.29. These were aligned with the Li et al. 
(1990) model, explaining the hydrolytic degradation of PLA. In brief, water 
penetrates into the films and reaches a saturation concentration within 2 - 3 
weeks duration. The percolated water causes hydrolysis of the polymer chains. 
When the rate of water penetration is higher than the hydrolysis rate, PLA 
undergoes bulk degradation. In the current study, this was evidenced as a 
monotonous fall in the molecular weight of the films. The resultant oligomers 
remain entrapped in the bulk, unless they are small enough to be soluble in the 
permeated medium. The oligomers can either degrade further or undergo 
insertion crystallisation. This event was recognised as a rise in the crystallinity 
of the studied films.  
By the end of the 8th week, all studied films reached a constant crystallinity 
(approximately 35%). Meanwhile, the path followed by percolated water is 
transformed into the water filled channels. The presence of water in these 
channels causes degradation of the surrounding polymer. Consequently the 
size and number of channels increase as the PLA matrix is degraded further. 
Such channels were observed in the cross section of the studied PLA films, as 
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pores with varied diameters (0.18 – 3.5 μm). The smaller size of the channels 
allows transport of the soluble material, but release of the oligomers is 
restricted.  
 
Figure 6.29: Summary of the changes in PLA films after ageing into the release 
medium.  
Accumulation of the oligomers augments degradation of the bulk due to 
elevated concentration of the chain ends. Augmented degradation of the bulk 
compared to the surface creates a morphological distinction between them. In 
the current study this was observed as a thin crust-like layer surrounding the 
bulk. From the 20th week onwards, the crust developed larger cracks, which 
perhaps allowed erosion of the entrapped material (drug and oligomers). This 
phase was characterised by beginning of the weight loss. Finally, the matrix 
Week 0 
Original circular film section 
submerged in the aqueous 
buffer (pH – 6.8) 
Week 2 – week 3 
Water penetrates and reaches 
an equilibrium concentration 
Week 3 – Week 8 
The hydrolytic degradation begins. 
The resulting oligomers undergo 
insertion crystallisation.  
*(lateral view of the film) 
 
 
 
 (rise in the opacity) 
 
Week 20 onwards 
The outer crust breaks down 
and the entrapped drug and 
the oligomers leach out. The 
matrix becomes granular due 
to dissolution of the polymer 
 
Week 10 -16 
Degradation of the entire bulk 
(including crystallites) occurs 
leaving a thin outer crust.  
 
Week 8 – Week 10 
Higher concentration of the acidic 
chain ends entrapped in the bulk 
generates a surface to centre 
differential. The reaction front slowly 
moves towards the periphery. 
 
   
  
 
  200 μM thick  
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started falling apart from the 32nd week onwards. The abovementioned 
mechanism suggests that drug release for the initial 3 weeks will occur 
predominantly by diffusion through the hydrated polymer matrix. Between 3-16 
weeks, degradation of the polymer matrix coupled with formation of the water 
filled channels can augment drug release. Nevertheless, after 16 weeks, 
erosion of the films will cause substantial acceleration of drug release.  
The results confirmed that the nature of the added drug and solid-state 
orientation of the films significantly influenced the hydrolytic degradation of PLA. 
The curcumin loaded films showed higher molecular weight degradation than 
the theophylline loaded films. Uniaxial as well as biaxial orientation delayed the 
onset of degradation, owing to lower hydrolytic susceptibility of the polymer 
chains in their oriented configuration (Lee et al., 2001a). Insertion crystallisation 
of the biaxially oriented films generates large sized, imperfect crystals, which 
can degrade easily, compared to the more perfect lamellar crystals in uniaxially 
oriented films. Consequently, the biaxially oriented films exhibited a sharper fall 
in molecular weight after the onset of degradation. Since the hydrolytic 
degradation of the films varied with respect to the method and the degree of 
orientation, these films can similarly show a difference in the drug release 
profile.     
6.9. Drug release from oriented films  
‘Drug release’ refers to the process of migration of a drug from the bulk of 
a polymeric device to the bulk of the release medium. There has been a 
growing interest to impose a control over this process. This research focuses on 
systematic investigation of the suitability of polymer orientation for achieving the 
same. The previous sections of this thesis have described the changes in drug 
loaded PLA films that occurred during melt-extrusion, solid-state orientation or 
after submersion into the release medium. This knowledge will help in justifying 
the drug release profile of the oriented PLA films. 
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Figure 6.30: Cumulative release of curcumin from oriented and un-oriented CPLA films 
over the study duration.  
*inset – magnified view between 0 – 16 weeks.  
*The graph represents cumulative curcumin release as the mean ± standard deviation; for n = 6 
 
 
Figure 6.31: Cumulative release of theophylline from oriented and un-oriented TPLA 
films over the study duration, after excluding the release during the first week.  
*inset – magnified view between 2 – 16weeks 
The graph represents cumulative theophylline release as the mean ± standard deviation; n = 6. 
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Table 6.19: Statistical comparison of cumulative curcumin release from CPLA films 
oriented to different draw ratios 
 
Notes: For relevant data refer figure 6.30  
The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
Burst Week 4 Week 8 Week 12 Week 16 Week 24 Week 32
1X Vs 2X
P < 0.001, 
q = 46.18
P > 0.05, 
q = 3.6
P > 0.05, 
q = 4.05
P > 0.05, 
q = 2.75
P > 0.05, 
q = 1.26
P > 0.05, 
q = 2.73
P < 0.001, 
q = 14.58
1X Vs 3X
P < 0.001, 
q = 55.23
P < 0.01, 
q = 6.26
P < 0.01, 
q = 5.49
P < 0.001, 
q = 9.87
P < 0.001, 
q = 11.76
P > 0.05, 
q = 4.17
P < 0.001, 
q = 15.01
1X Vs 4X
P < 0.001, 
q = 54.94
P < 0.01, 
q = 5.9
P < 0.001, 
q = 11.78
P < 0.001, 
q = 20.77
P < 0.001, 
q = 22.93
P < 0.001, 
q = 9.04
P < 0.001, 
q = 28.73
1X Vs SB 
2X2Y
P < 0.001, 
q = 42.2
P > 0.05, 
q = 2.98
P > 0.05, 
q = 4.17
P > 0.05, 
q = 3.12
P > 0.05, 
q = 0.89
P > 0.05, 
q = 3.15
P < 0.001, 
q = 8.5
1X Vs SEQ 
2X2Y
P < 0.001, 
q = 39.72
P > 0.05, 
q = 1.52
P > 0.05, 
q = 4.24
P > 0.05, 
q = 3
P > 0.05, 
q = 1.15
P > 0.05, 
q = 1.27
P > 0.05, 
q = 0.56
2X Vs 3X
P < 0.001, 
q = 9.05
P < 0.01, 
q = 12.51
P < 0.001, 
q = 7.65
P < 0.001, 
q = 12.62
P < 0.001, 
q = 13.03
P < 0.001, 
q = 6.9
P < 0.001, 
q = 29.59
2X Vs 4X
P < 0.001, 
q = 8.77
P < 0.001, 
q = 7.01
P < 0.001, 
q = 15.83
P < 0.001, 
q = 23.52
P < 0.001, 
q = 24.2
P < 0.001, 
q = 11.77
P < 0.001, 
q = 43.31
2X Vs SB 
2X2Y
P > 0.05, 
q = 3.97
P > 0.05, 
q = 0.77
P > 0.05, 
q = 0.12
P > 0.05, 
q = 0.37
P > 0.05, 
q = 0.37
P < 0.01, 
q = 5.88
P < 0.001, 
q = 23.08
2X Vs SEQ 
2X2Y
P > 0.05, 
q = 3.46
P > 0.05, 
q = 0.41
P > 0.05, 
q = 0.2
P > 0.05, 
q = 0.25
P > 0.05, 
q = 0.12
P > 0.05, 
q = 1.46
P < 0.001, 
q = 14.03
3X Vs 4X
P > 0.05, 
q = 0.29
P < 0.05, 
q = 4.49
P < 0.001, 
q = 8.18
P < 0.001, 
q = 10.9
P < 0.001, 
q = 11.17
P < 0.05, 
q = 4.87
P < 0.001, 
q = 13.72
3X Vs SB 
2X2Y
P < 0.001, 
q = 13.03
P < 0.05, 
q = 5.29
P < 0.001, 
q = 7.77
P < 0.001, 
q = 12.99
P < 0.001, 
q = 12.65
P > 0.05, 
q = 1.01
P < 0.001, 
q = 6.51
3X Vs SEQ 
2X2Y
P < 0.001, 
q = 15.51
P < 0.05, 
q = 4.92
P < 0.001, 
q = 7.85
P < 0.001, 
q = 12.88
P < 0.001, 
q = 12.91
P < 0.01, 
q = 5.43
P < 0.001, 
q = 15.56
4X Vs SB 
2X2Y
P < 0.001, 
q = 12.74
P < 0.001, 
q = 7.78
P < 0.001, 
q = 15.95
P < 0.001, 
q = 23.89
P < 0.001, 
q = 23.82
P < 0.01, 
q = 5.88
P < 0.001, 
q = 20.23
4X Vs SEQ 
2X2Y
P < 0.001, 
q = 15.22
P < 0.001, 
q = 7.42
P < 0.001, 
q = 16.03
P < 0.001, 
q = 23.78
P < 0.001, 
q = 24.08
P < 0.001, 
q = 10.3
P < 0.001, 
q = 29.29
SB 2X2Y 
Vs SEQ 
2X2Y
P > 0.05, 
q = 2.48
P > 0.05, 
q = 0.36
P > 0.05, 
q = 0.07
P > 0.05, 
q = 0.12
P > 0.05, 
q = 0.26
P < 0.05, 
q = 4.42
P < 0.001, 
q = 9.06
One way ANOVA followed by Tukey's test - curcumin release
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Table 6.20: Statistical comparison of cumulative theophylline release from TPLA films 
oriented to different draw ratios 
 
Notes: For relevant data refer figure 6.31  
The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
Burst Week 4 Week 8 Week 12 Week 16 Week 24 Week 32
1X Vs 2X
P < 0.001, 
q = 22.93
P < 0.001, 
q = 15.33
P < 0.001, 
q = 31.89
P < 0.001, 
q = 52.37
P < 0.001, 
q = 89.66
P < 0.001, 
q = 20.64
P < 0.001, 
q = 52.41
1X Vs 3X
P < 0.001, 
q = 30.91
P < 0.001, 
q = 22.55
P < 0.001, 
q = 45.17
P < 0.001, 
q = 94.31
P < 0.001, 
q = 186.36
P < 0.001, 
q = 21.62
P < 0.001, 
q = 37.07
1X Vs 4X
P < 0.001, 
q = 41.13
P < 0.001, 
q = 70.93
P < 0.001, 
q = 124.76
P < 0.001, 
q = 230.27
P < 0.001, 
q = 424.62
P < 0.001, 
q = 87.88
P < 0.001, 
q = 90.08
1X Vs SB 
2X2Y
P < 0.001, 
q = 53.96
P < 0.001, 
q = 76.4
P < 0.001, 
q = 147.87
P < 0.001, 
q = 260.06
P < 0.001, 
q = 451.34
P > 0.05, 
q = 3.49
P < 0.001, 
q = 34.02
1X Vs SEQ 
2X2Y
P < 0.001, 
q = 42.58
P < 0.001, 
q = 32.41
P < 0.001, 
q = 67.99
P < 0.001, 
q = 115.02
P < 0.001, 
q = 187.78
P < 0.001, 
q = 44.36
P < 0.001, 
q = 96.97
2X Vs 3X
P < 0.001, 
q = 7.98
P < 0.001, 
q = 37.88
P < 0.001, 
q = 77.06
P < 0.001, 
q = 146.68
P < 0.001, 
q = 276.03
P < 0.001, 
q = 42.26
P < 0.001, 
q = 89.49
2X Vs 4X
P < 0.001, 
q = 18.2
P < 0.001, 
q = 86.26
P < 0.001, 
q = 156.64
P < 0.001, 
q = 282.63
P < 0.001, 
q = 514.28
P < 0.001, 
q = 108.51
P < 0.001, 
q = 142.49
2X Vs SB 
2X2Y
P < 0.001, 
q = 31.03
P < 0.001, 
q = 61.07
P < 0.001, 
q = 115.98
P < 0.001, 
q = 207.69
P < 0.001, 
q = 361.68
P < 0.001, 
q = 24.13
P < 0.001, 
q = 86.43
2X Vs SEQ 
2X2Y
P < 0.001, 
q = 19.66
P < 0.001, 
q = 17.07
P < 0.001, 
q = 36.1
P < 0.001, 
q = 62.65
P < 0.001, 
q = 98.12
P < 0.001, 
q = 65
P < 0.001, 
q = 149.38
3X Vs 4X
P < 0.001, 
q = 10.22
P < 0.001, 
q = 48.38
P < 0.001, 
q = 79.58
P < 0.001, 
q = 135.96
P < 0.001, 
q = 238.25
P < 0.001, 
q = 66.26
P < 0.001, 
q = 53
3X Vs SB 
2X2Y
P < 0.001, 
q = 23.04
P < 0.001, 
q = 98.95
P < 0.001, 
q = 193.05
P < 0.001, 
q = 354.37
P < 0.001, 
q = 637.71
P < 0.001, 
q = 18.13
P > 0.05, 
q = 3.06
3X Vs SEQ 
2X2Y
P < 0.001, 
q = 11.67
P < 0.001, 
q = 54.96
P < 0.001, 
q = 113.16
P < 0.001, 
q = 209.33
P < 0.001, 
q = 374.15
P < 0.001, 
q = 22.74
P < 0.001, 
q = 59.9
4X Vs SB 
2X2Y
P < 0.001, 
q = 12.83
P < 0.001, 
q = 147.33
P < 0.001, 
q = 272.63
P < 0.001, 
q = 490.32
P < 0.001, 
q = 875.96
P < 0.001, 
q = 84.39
P < 0.001, 
q = 56.06
4X Vs SEQ 
2X2Y
P > 0.05, 
q = 1.45
P < 0.001, 
q = 103.34
P < 0.001, 
q = 192.74
P < 0.001, 
q = 345.29
P < 0.001, 
q = 612.4
P < 0.001, 
q = 43.52
P < 0.001, 
q = 6.89
SB 2X2Y 
Vs SEQ 
2X2Y
P < 0.001, 
q = 11.37
P < 0.001, 
q = 43.99
P < 0.001, 
q = 79.89
P < 0.001, 
q = 145.04
P < 0.001, 
q = 263.56
P < 0.001, 
q = 40.87
P < 0.001, 
q = 62.96
One way ANOVA followed by Tukey's test - Draw ratio comparison
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Theophylline release from oriented and un-oriented PLA (TPLA) films 
followed a tri-phasic release pattern (figure 6.31). The initial phase was 
characterised by burst release of a large fraction of theophylline. The drug 
release slowed down gradually until the 16th week, following which there was a 
rapid surge again. Contrarily, the curcumin loaded PLA films (CPLA) exhibited 
negligible burst release. The amount of curcumin released between the weekly 
sampling intervals increased gradually until the 16th week and then continued as 
an exponential release phase (figure 6.30). The difference in the release profile 
exhibited by the mentioned model systems can be attributed to the physical 
state of the respective drugs within the PLA matrix. 
The overall drug release profiles displayed in figure 6.30 and figure 6.31 
did not show a large visual difference between the draw ratios. However a 
statistical comparison at different time points by one-way ANOVA – Tukey’s test 
(table 6.19, table 6.20) revealed a significant difference between the draw ratios 
(except for the shrunken CPLA films). This can be attributed to the uncontrolled 
release of a large amount of drug after 16 weeks, which masked individual 
differences between the films prior to 16 weeks (in the overall drug release 
profile). Therefore the effect of different draw ratios on drug release from 
oriented PLA films was studied by dividing the total drug release in three distinct 
phases. These included the initial burst release phase, the second slow release 
phase and the final exponential release phase. Drug release in each of these 
phases was analysed separately.   
6.9.1. Phase I: the burst release 
   The term ‘burst release’ here refers to the amount of drug released 
uncontrollably during the first day, after submersion into the release medium. 
The phenomenon is usually associated with rapid dissolution of the drug located 
at or near the surface. Therefore, the nature of the burst phase varies 
substantially with the physical state of the drug in the polymer matrix. The 
results of hot-stage microscopy (sec. 5.5.3) confirmed that only a small fraction 
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of the compounded theophylline was soluble in the molten PLA; nevertheless, it 
crystallised out, upon cooling the composite melt. This alternatively means that 
theophylline was present as a supersaturated solution in PLA, along with 
numerous suspended crystalline particles. Such matrices show a prominent 
burst release phase due to the following reasons.  
A. Firstly, the drug present as a supersaturated solution can migrate towards 
the surface and crystallise out (Ahmed et al., 2008; Tzafriri, 2000).  
B. The crystalline drug already located at the surface, along with the newly 
crystallised drug can readily dissolve instantaneously into the bathing 
medium (Hurrell and Cameron, 2002). 
C. Dissolution of the phase separated drug creates voids, which accelerate 
water penetration and further dissolution of the drug particles located near 
the surface (Huang and Brazel, 2001).  
It was previously confirmed that curcumin remained in a molecularly 
dispersed state within the PLA matrix (chapter 5). Moreover, the PLA extrudates 
containing 5% w/w curcumin showed no phase separation, when re-molten on 
the hot-stage microscope or while cooling from the melt state. These findings 
indicate that the concentration of curcumin utilised here (i.e. 5% w/w) was below 
its saturation solubility in PLA. Owing to a higher cohesiveness between the 
curcumin and PLA, its migration towards the surface can be negligible (at 5% 
w/w loading). Perhaps as a result of this, the burst release exhibited by the 
curcumin loaded PLA films was significantly lower than that observed with the 
theophylline loaded PLA films (figure 6.32). 
Orientation of the drug loaded films diminished the amount of drug 
released in a burst manner (figure 6.32). For the uniaxial constant width (UCW) 
orientation, the burst release of theophylline decreased systematically as the 
uniaxial draw ratio increased. This observation was statistically validated by 
one-way ANOVA – Tukey’s test. A highly significant (P < 0.001) difference was 
observed in the burst release from TPLA films, when individual UCW draw 
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ratios were compared (table 6.20). Among the biaxially oriented TPLA films, 
simultaneous biaxial stretching lowered the burst theophylline release to a 
greater extent than that observed with the sequential biaxial stretching (SEQ). 
The burst release from SEQ oriented (λ = 2X2Y) TPLA films was statistically 
equivalent to that from the UCW – 4X films (table 6.20).  
 
Figure 6.32: Burst release from oriented PLA films containing A) curcumin and B) 
theophylline as model drugs. 
*The amount of drug released is expressed as mean ± SD, where n = 6. 
Orientation of the CPLA films similarly reduced the burst release of 
curcumin. A substantially lower burst release was observed at the UCW draw 
ratio of 2X. Further extension to the UCW draw ratio of 3X progressively 
reduced the burst release. The statistical difference between the burst release 
from un-oriented, UCW-2X and UCW-3X CPLA films was highly significant (P < 
0.001; table 6.19). The CPLA films oriented to a UCW draw ratio of 4X showed 
statistically equivalent burst release to that from UCW-3X films. Nevertheless, 
drug release from the biaxially (both SB and SEQ) oriented CPLA films was 
statistically equivalent to that from the UCW-2X films (table 6.19). 
Burst release from the matrix type drug delivery systems (sec. 3.4) has 
been previously attributed to migration of the drug towards the matrix surface, 
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during storage (Huang and Brazel, 2001). Densification of the polymer chains 
after solid-state orientation of the films may hinder drug migration perpendicular 
to the film plane, during storage. Consequently, a lesser amount of free drug 
may be available on the film surface for instantaneous dissolution. Burst release 
can be a desired mechanism when a faster onset followed by a prolonged 
release of a constant drug amount is needed. However, it is unpredictable and 
the amount of burst can be rarely controlled. Therefore, a reduction in the burst 
release following orientation of the polymeric films is advantageous.  
6.9.2. Phase II: diffusion driven release 
6.9.2.1. Mechanism 
 
Figure 6.33: Principle mechanisms responsible for drug release from PLA 
(A) Diffusion through the polymer, (B) Transport through the water-filled channels, (C) Erosion  
Numerous mechanisms have been proposed for elucidating the release of 
a bioactive agent from PLA matrices. Among them, i) diffusion through the 
polymeric amorphous phase, ii) transport through the water filled channels, and 
iii) release due to polymer erosion have been evidenced as the principle 
mechanisms (figure 6.33) (Fredenberg et al., 2011).  The drug loaded PLA films 
studied here underwent bulk hydrolytic degradation when submerged in the 
release medium (sec. 6.8). The oligomers generated in this process remained 
entrapped within the PLA matrix, without being eroded away. The path followed 
by the percolated medium was transformed into the fluid/water filled channels, 
whose number and size increased as the PLA matrix degraded further. 
However, weight loss due to erosion was observed only from the 20th week. 
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(After 16 weeks, the samples were withdrawn every 4 weeks and not weekly, 
therefore the 20th week was the earliest sampling time-point after the 16th 
week). A common trend coherent with the bulk degradation profile was 
evidenced in the cumulative release profile of curcumin and theophylline from 
CPLA and TPLA films respectively. The drug release rate was considerably 
slower for the first 16 weeks, compared to that from the 20th week onwards. The 
four weeks duration between the 16th and the 20th week perhaps represented a 
transition phase, following which there was an exponential rise in drug release. 
A similarity between the drug release profile and the degradation profile 
suggests that drug release up to the 16th week may have occurred by diffusion 
through the polymer (figure 6.33 - A) and/or transport through water filled 
channels (figure 6.33 - B). Nevertheless, a substantial acceleration of drug 
release from the 20th week onwards, correlates with erosion of the films (figure 
6.33 - C). 
The relative importance of the mass transport mechanisms (in phase II) 
may vary depending upon the physical state of a drug within the PLA matrix. 
Since the crystalline theophylline formed a suspension in PLA, its release in 
‘phase II’ may predominantly occur by transport through the water filled 
channels. On the contrary, curcumin may equally follow both mass transport 
mechanisms, it being present in the solution state (sec. 5.5.3). 
6.9.2.2. Kinetic expression of drug release 
The primary aim of kinetic model fitting was to understand the mass 
transport mechanisms responsible for controlling drug release from the 
investigated films. Additionally, this approach allowed for the quantitative 
prediction of the effects of solid-state orientation on the resulting drug release 
kinetics (sec. 6.9.2.4). 
The drug is transported from the bulk of the delivery device to the external 
sink by different types of mass transport processes. These include drug 
diffusion through the polymer phase, transport through the water filled channels, 
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and erosion of the polymer. Nevertheless, certain polymeric matrices exhibit 
osmotic movement of water into the matrix followed by diffusion of the drug 
through the swollen polymer or transport by dissolution in the permeated water. 
Drug release from a biodegradable polymer matrix simultaneously involves 
several of these mass transport processes. However, one of them usually plays 
a substantially greater role than others, and consequently acts as a principle 
mechanism behind drug release. In order to identify this, the drug release data 
is plotted as per the mathematical functions described by various empirical 
models (sec. 3.5). The empirical kinetic models reported in the literature 
describe separate mass transport mechanisms (Dash et al., 2010). Therefore, 
the model which yields the highest regression coefficient and the F – value (by 
ANOVA or the lowest P value) represents the most substantial mass transport 
process responsible for the overall drug release. Control over this process can 
therefore result in a control over entire drug release. 
Selection of one model alternatively invalidates the other models, since 
each describe different mass transport process as the main drug release 
mechanism. However, it is not unusual that the drug release data does not 
agree with any of the reported models. Such situation arises due to a number of 
reasons as follows:  
a. A mass transport mechanism, which has not been yet considered in 
drug release modelling, is involved. For example, pore closing – 
pore opening phenomena responsible for drug release from PLGA 
microparticles (Fredenberg et al., 2011). 
b. There are far too many processes involved in the overall drug 
release. Several of these processes alter the fate/rate of the other 
process. For example, drug release from low molecular weight 
PLA/PLGA involves surface erosion as well as bulk degradation of 
the polymer, swelling due to osmosis and drug diffusion (Hurrell and 
Cameron, 2001b).  
 193 
 
c. The principle mass transport mechanism changes from time to time. 
For example, depending upon the molecular weight of the drug 
loaded PEO matrix, the rate limiting process changes between 
erosion of the polymer and diffusion of the drug through swollen 
polymer matrix (Colo di et al., 2001). 
d. The drug delivery device disobeys one of the fundamental 
assumptions made while deriving the model. For example, the 
Higuchi model (Higuchi, 1963), describes those systems where 
drug diffusion is the rate limiting step. This model assumes that the 
diffusivity of the drug/ polymer matrix remains constant throughout 
(sec. 3.4). Therefore, if a bioerodible system exhibits a change in 
the diffusivity due to erosion, the drug release may not conform to 
the Higuchi model, even if drug diffusion was the principle process.  
Similar to the empirical models, drug release can be expressed by 
theoretical models such as the first order release and the zero order release 
models. The prior signifies that the drug release rate decreases progressively 
due to a gradual fall in the drug concentration gradient. Nevertheless, the latter 
indicates that irrespective of the underlying mass transport processes, the drug 
release rate remains constant. In the current study, the drug release data 
between the 2nd and the 16th week was fitted into the following models (sec. 
3.6); namely, zero order, first order, Hixson–Crowell model, Higuchi model, and 
Korsmeyer–Peppas model (Dash et al., 2010; Higuchi, 1961; Korsmeyer et al., 
1983; Korsmeyer and Peppas, 1981; Ritger and Peppas, 1987). Since the 
overall drug release from the studied PLA films was extremely low, and 
because multiple mass transport processes are involved in drug release from 
PLA, most models yielded a high R2 value. There the most appropriate model 
(that can identify the principle transport mechanism) was selected based on the 
highest regression coefficient, highest F- value and the lowest P – value 
obtained from ANOVA (table 6.21). 
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Table 6.21: Testing suitability of the controlled drug release models by regression 
analysis 
The Model 
The Linearity criteria 
*(What was plotted) 
TPLA Films 
λ = 4X 
CPLA Films 
λ = 4X 
R2 F P R2 F P 
First order 
kinetics 
Y-axis: Log(Q0 − Qt), 
X-axis: time 
0.9076 127 4.28 X 10-8 0.9628 336 1.13 X 10-10 
Zero order 
kinetics 
Y-axis: Qt, 
X-axis: time 
0.9058 125 4.84 X 10-8 0.9971 4525 6.43 X 10-18 
Higuchi 
Model 
Y-axis: Qt, 
X-axis: √time 
0.9958 2883 1.19 X 10-16 0.8994 116 7.47 X 10-8 
Hixson–
Crowell 
Y-axis: Q0
1
3⁄ − Qt
1
3⁄ , 
X-axis: time 
0.804 53 5.98 X 10-6 0.9513 254 6.52 X 10-10 
Korsmeyer–
Peppas 
model 
Y-axis: Log(
Qt
Q0
⁄ ), 
X-axis: log (time) 
0.9881 798 2.4 X 10-12 0.9881 1546 4.72 X 10-14 
Note: Q0 = Original amount of drug present in the films, Qt = Cumulative drug release in time ‘t’. The ‘p’ 
value was calculated with α = 0.05. 
In the case of TPLA films, the theophylline release data showed highest 
agreement with the Higuchi model. The regression coefficient for the release 
data when plotted according to the Higuchi model was highest. Nevertheless 
the F- value was substantially higher than other models. To visualise this 
graphically, the predicted theophylline release obtained from regression 
analysis, for each model was plotted along with the actual release data (figure 
6.34). It can be clearly seen from figure 6.34 that theophylline release can be 
best explained by the Higuchi and the Korsmeyer-Peppas model (Korsmeyer et 
al., 1983). The Peppas model is the only empirical model which describes 
various mass transport mechanisms depending on the value of the Peppas 
exponent. This model is based on equation 6.1.  
𝐌𝟎
𝐌∞
 = 𝐊𝐭𝐧                            (Equation 6.1) 
 
 195 
 
In equation 6.1, ‘M0/M∞’ signifies the fraction of the drug released; ‘K’ is the 
proportionality constant, ‘t’ is time and ‘n’ is the exponent used for 
characterising the diffusion mechanism. For film geometry, 0.5 ≤ n corresponds 
to the Higuchi model, 0.5 < n < 1 to non-Fickian anomalous transport, n = 1 
relates to the zero order Case II transport and n > 1 to the super case II 
transport. In the current study, the values of the Peppas exponent for all TPLA 
films were less than 0.5. This further confirmed that theophylline release 
occurred according to the Higuchi model. Here the plot of the percent 
cumulative release of theophylline between the 2nd and the 16th week, against 
the square root of time yielded straight lines (figure 6.35). The proportionality 
between the fraction of drug released and the square root of time signified that 
the theophylline release during this phase followed the Fickian diffusion 
mechanism (as explained by the Higuchi model) (Higuchi, 1963; Ritger and 
Peppas, 1987). Therefore, it can be safely stated that diffusion of theophylline 
was the rate limiting step in overall drug release.  
 
Figure 6.34: Comparison between actual theophylline release and predicted 
theophylline release by various models for TPLA films oriented to λ = 4X. 
*The actual data is plotted here as mean of 6 replicates. The errors bars represent the standard deviation.  
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Figure 6.35: Fraction of theophylline released against the square root of time from 
oriented TPLA films between 2nd and 16th week – Higuchi model. 
*Note: The X-axis utilises (t-t*) values signifying that the second week sampling point was considered as 
the starting point. Here ‘t’ represents the individual time-point, while ‘t* = 2 week’. Similarly, the Y–axis 
utilises the cumulative (C – C*) values; where ‘C’ represents the cumulative drug release till the respective 
time-point, while ‘C*’ represents the cumulative drug released during the first two weeks.  
*The graph represents theophylline release as the mean ± standard deviation; for n = 6 
As reported in section 3.4.1, the Higuchi model was originally developed 
for matrix type systems made from non-erodible polymers. It was later found 
that the biodegradable systems, where the drug diffusion is substantially faster 
than polymer erosion may exhibit drug release according to the Higuchi model 
(Fu and Kao, 2010). The PLA films studied here underwent significant 
molecular weight degradation following aqueous submersion. However, due to 
bulk degradation, no actual erosion was observed until the 20th week. Therefore 
diffusion of theophylline through PLA can be considered as the principle mass 
transport mechanism responsible for theophylline release. According to the 
Higuchi model the cumulative drug release from a non-biodegradable matrix 
can be explained by equation 6.2, when the drug is present in the suspension 
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state and the total drug loading is less than 5% w/w. If the drug loading exceeds 
5% w/w, the matrix becomes granular, where water percolation creates fluid 
filled channels. Although theophylline loading in the current study was 5% w/w, 
it was confirmed that similar channels were formed due to bulk degradation of 
the PLA films (section 6.8.5). Here theophylline can either diffuse to the external 
sink or towards the nearest channel (figure 6.33). Therefore theophylline 
release should be expressed by the modified Higuchi equation (eqn. 6.3), which 
takes into consideration the porosity of the matrix and the tortuosity of the fluid 
filled channels.      
𝑄𝑡 = √𝐷𝑡 (2𝑄0 − 𝐶𝑠)𝐶𝑠              (Equation 6.2) 
Q =  √(
Dε
τ
(2Q0 − ϵCS)CSt)                      (Equation 6.3) 
Where, Q = amount of drug release per unit surface area in time ‘t’. 
Q0 = the total drug loading 
D = combined diffusivity of theophylline through the polymer matrix and through 
the water filled channels. 
Since, the theophylline release is expected to occur predominantly through the percolated medium, Cs is 
considered here as the saturation solubility of theophylline in the release medium. ‘ε’ represents the 
volume fraction of the fluid filled channels and ‘τ’ is the tortuosity index of such channels. 
The Higuchi model considers drug release to be a layer by layer diffusion 
phenomenon. Upon water penetration into the system drug release initially 
occurs only from the outermost layers that are in direct contact with water. 
These include the exterior surface of the delivery device (in direct contact with 
the release medium) or the internal surfaces of the water filled channels (in 
contact with the permeated water). Firstly, the drug that is located on these 
surfaces in the undissolved/precipitated state solubilises in the surrounding 
medium. Only after the undissolved drug is completely exhausted, the drug 
present in the solution state within these layers is released. Once the drug 
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concentration in the outermost layers falls below the drug’s saturation solubility, 
the drug in the adjacent layer starts to diffuse due to presence of a 
concentration gradient between these layers. Depletion of the drug in each 
successive layer causes solubilisation of the excess drug located in the vicinity, 
and its diffusion towards the depleted layers. The Higuchi model assumes that 
the dissolution of drug particles into the polymer phase is substantially rapid 
compared to the diffusion of the dissolved drug molecules through the polymer 
phase. Therefore, the drug diffusion acts as a rate limiting step, which depends 
on the concentration gradient. Since depletion of the drug from the polymer 
matrix causes a fall in the concentration gradient, drug release rate decreases 
gradually with time. The proportionality between the cumulative theophylline 
release and the square root of time observed in the current study explains the 
same phenomenon (Roseman and Higuchi, 1970).  
A substantial difference between the theophylline loaded and the curcumin 
loaded PLA films was that the theophylline release rate reduced progressively, 
while the curcumin release rate remained nearly constant throughout. 
Therefore, the percent cumulative release of curcumin exhibited a linear 
relationship with time and not with the square root of it (figure 6.37). Such 
proportionality indicated that the release of curcumin followed zero order 
kinetics. This was further confirmed by comparison of R2 and the F-values 
obtained for curcumin release data by various models (table 6.21). The R2 
according to the zero order model was highest for all CPLA films. Nevertheless, 
the F- value obtained by this model was significantly higher than any other 
model considered here. When the predicted curcumin release according to the 
selected models was plotted along with the actual data (figure 6.36), it 
highlighted that curcumin release more closely agreed with the zero order 
model and the Peppas model.  The Peppas exponent for all CPLA films was 
1.00 ± 0.15, which further established that curcumin released occurred 
according to the zero order model.  
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Figure 6.36: Comparison between actual curcumin release and predicted curcumin 
release by various models for CPLA films oriented to λ = 4X. 
*The actual data is plotted here as mean of 6 replicates. The errors bars represent the standard deviation.  
Although the curcumin release data was within the 95% confidence 
intervals of the Hixon-Crowell model the overall trend showed a poorer fit than 
the zero order and Peppas models. Moreover, it was found that the investigated 
PLA films underwent bulk erosion in water, without losing the weight and 
geometry for approximately 20 weeks. The Hixson-Crowell model explains drug 
release from a surface of a drug delivery device, where erosion of the surface 
causes a change in the geometry. Therefore, this model will be clearly 
inapplicable to the studied films. 
The material investigation studies confirmed that curcumin was present in 
the solution state within PLA. Importantly, it did not phase separate during 
cooling, suggesting that its concentration was below its saturation solubility in 
PLA. In such cases, diffusion is invariably involved in the mass transport of the 
drug out of the dosage form (Siepmann and Siepmann, 2012). Moreover, the 
layer by layer diffusion of a solution state drug does not require dissolution of 
the excess drug in each theoretical layer before the drug in the next layer can 
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start to diffuse. Despite this, the cumulative curcumin release could not be 
explained by the Higuchi model, perhaps due to the reasons listed in the 
beginning of this section. The Higuchi model claims that the drug diffusion rate 
remains constant at least over the first 60% of drug release. Therefore, it can be 
assumed that bulk degradation of the PLA films in the course of drug release, 
did not affect the diffusion rate of theophylline (suspended drug); however, it 
augmented that of curcumin (drug in the solution state). Increased diffusion of 
curcumin (along with several unknown factors) may have balanced the 
reduction in the release rate due to depletion of the concentration gradient. 
Consequently, a nearly constant release rate was evidenced.  
 
 
 
Figure 6.37: Fraction of curcumin released against time from oriented CPLA films 
between 2nd and 16th week – zero order kinetics. 
*The graph represents cumulative curcumin release as the mean ± standard deviation; for n = 6 
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The zero order release profile is usually observed in polymeric drug 
delivery devices, where the polymer undergoes swelling. As water percolates 
into the polymer it hydrates the polymer chains, which subsequently swell. A 
clear boundary separates the swollen outer region and the glassy polymer core. 
The boundary slowly moves towards the centre. The rate of drug diffusion is 
faster in the swollen polymer than in the glassy core. Although the diffusion rate 
in the glassy core reduces gradually due to drug depletion, this can be balanced 
by the inward movement of the boundary at an appropriate speed. 
Consequently, the overall drug release rate remains constant. The films studied 
here neither showed any visible swelling, nor substantial weight gain due to 
water absorption. Therefore, a mechanism other than swelling must have 
contributed in the augmentation/ balancing of the diffusion rate. The studied 
films progressively underwent molecular weight reduction and the resultant 
oligomers remained entrapped within the bulk of the matrix, this might have 
contributed in enhancing the diffusivity of curcumin, which may subsequently 
balance the effect of concentration depletion.     
This work highlighted that the release of a solution state drug from PLA 
substantially varied from that of a suspension state drug. Finding a justification 
for the observed differences would require significantly more experiments and 
separate mathematical modelling, which was beyond the scope of this work.    
6.9.2.3. The effect of solid-state orientation 
Solid-state orientation of the drug loaded PLA films significantly altered the 
phase II drug release (figure 6.35 & figure 6.37). Theophylline release from 
TPLA films was suppressed when they were subjected to simultaneous biaxial 
or sequential biaxial stretching to λ = 2X2Y or UCW stretching to a uniaxial 
draw ratio of 2X. Further stretching in UCW mode in fact accelerated drug 
release (figure 6.35). Since only a small percentage of drug was released 
between 2 – 16 weeks, the difference between individual draw ratios was 
statistically validated by one-way ANOVA followed by Tukey’s test (table 6.20). 
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The results of statistical analysis confirmed that at selected time-points the 
cumulative theophylline release from TPLA films was highly significant (P < 
0.001) between the studied draw ratios. Contrarily, the cumulative curcumin 
release from CPLA films followed a slightly different trend. At the same time-
points, throughout the study duration, the cumulative curcumin release from 
biaxially oriented CPLA films and those oriented to UCW draw ratio of 2X was 
statistically equivalent (P > 0.05) to that from the un-oriented CPLA films (table 
6.19, figure 6.37). This can be attributed to shrinkage of the mentioned films, 
which resulted in a partial loss of the oriented structure (sec. 6.8.1). Similar to 
TPLA films, curcumin release was accelerated from CPLA films oriented to 
UCW draw ratios of 3X and 4X (figure 6.37). These films showed a statistically 
significant difference in the cumulative drug release compared to un-oriented 
films and even between themselves (table 6.19).  
Orientation of the TPLA films by tensile stretching created several voids, 
owing to the poor affinity between PLA and suspended theophylline particles 
(sec 6.4). Theoretically, pore size will increase as films are stretched to a higher 
draw ratio. A greater pore size may augment water permeation and 
consequently the theophylline release. However, the faster drug release from 
UCW oriented (λ ≥ 3X) TPLA films cannot be entirely attributed to void 
formation; since it fails to justify the following findings. Firstly, biaxial orientation 
of TPLA films as well as orientation to a UCW draw ratio of 2X also exhibited 
formation of voids; however, drug release from these films was slower than that 
from the un-oriented films (figure 6.35). Secondly, such voids were absent in 
oriented CPLA films. Albeit, curcumin release from the CPLA films was 
accelerated after orienting them to UCW draw ratios of 3X and 4X (figure 6.37).  
The characteristic differences in drug release patterns displayed by 
oriented PLA films can be correlated with their molecular organisation. It was 
derived from MDSC and WAXD studies that films oriented to a UCW draw ratio 
of 2X exhibited no strain induced crystallisation. Strain induced crystallisation in 
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the biaxially oriented films (λ = 2X2Y) was practically insignificant. These films 
contained merely amorphous chains oriented in the drawing direction/s. On the 
contrary, UCW stretching to draw ratios of 3X and above produced a three 
dimensional α crystalline order. Several studies have previously confirmed that 
drug elution is faster from crystalline PLA matrices than from the amorphous 
matrices (Hurrell and Cameron, 2001b; Hurrell and Cameron, 2002; Izumikawa 
et al., 1991; Miyajima et al., 1997). A rise in polymer crystallinity increases drug 
concentration in the polymer’s amorphous phase. Consequently, an elevated 
concentration gradient augments drug release by Fickian diffusion mechanisms 
(Miyajima et al., 1997).  
It was earlier confirmed that oriented as well as un-oriented films 
underwent insertion crystallisation after submersion in the release medium (sec. 
6.8.1). The crystallinity of all studied films reached a constant level of about 
35% by the 6th week after aqueous submersion. If the percentage crystallinity 
was the sole influencing factor, the drug release from all of the films should 
have been similar after 6 weeks. However, a higher drug release from films 
oriented to UCW draw ratios of 3X and 4X, highlights the importance of 
structural order rather than mere crystallinity.  
Insertion crystallisation is essentially a template crystallisation 
phenomenon. Therefore, new crystal growth follows the existing crystalline 
arrangement (Hurrell and Cameron, 2002). Tsuji et al. (2000b) reported that 
insertion crystallisation in a previously amorphous polymer matrix generates 
largely imperfect crystals (figure 6.38). In such crystals the inter-crystalline and 
intra-crystalline amorphous phase is loosely arranged (refer sec. 3.8 for lamellar 
polymer crystals). Contrastingly, the polymer matrices, which have a well-
developed crystalline order, already contain the amorphous phase as tie 
molecules and chain ends interspaced between the crystalline folds. Insertion 
crystallisation of such a structure may pull the inter/intra- crystalline amorphous 
chains into the crystalline folds. Consequently, the free (unmasked) chain ends 
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may create a defect zone (figure 6.38). Since such a defect zone contains 
hydrophilic chain ends (carboxylic acid groups), they can augment percolation 
of water and degradation of the surrounding amorphous phase. Subsequently, 
this region is transformed into a water filled channel. The medium / water 
present in these channels can dissolve the surrounding drug molecules, and 
transport them to the outside medium by virtue of the concentration gradient 
(Miyajima et al., 1998; Ritger and Peppas, 1987).   
Films oriented to UCW draw ratios of 3X and 4X contained a highly 
ordered α crystalline phase. This may augment drug release owing to the 
following possibilities. 
A. Due to a greater crystalline order, the oriented α crystalline phase may 
already contain several chain ends concentrated in the inter / intra-lamellar 
region. Insertion crystallisation of such matrices will further enhance the 
number of defect zones, Therefore, formation of water filled channels and 
associated drug release can be higher from the oriented crystalline films. 
B. Presence of an ordered α crystalline form led to a rise in the polar surface 
energy of oriented PLA films (UCW λ ≥ 3X). This was attributed to a relative 
increase in the concentration of polar functional groups (hydroxyl) on the 
film surface. Since such an order is repeated in the bulk of the oriented films 
(UCW λ ≥ 3X), the overall hydrophilicity of the bulk might be enhanced. This 
may augment percolation of water and consequently, drug release. 
C. The α crystalline form has a lamellar structure; where, the lamellar stacks 
are aligned in the drawing direction (figure 6.38). Percolation of water might 
be easier in such a structure in contrast to a spherulitic structure (generated 
in the previously amorphous matrices, due to insertion crystallisation). 
Alternatively, it can be said that a continuous channel formed due to 
permeation of water might be longer/deeper and less tortuous in oriented 
crystalline films, owing to the regular chain organisation. Consequently, the 
drug release from such films was higher than from un-oriented films.  
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Figure 6.38: A model explaining concentration of chain defects in the inter-lamellar 
region of highly oriented PLA films containing a 3-dimensional crystalline order 
(Tsuji et al., 2000) 
Interestingly, biaxially oriented TPLA films (both SB – 2X2Y and SEQ-
2X2Y) and films with a UCW draw ratio of 2X, exhibited slower drug release 
than the un-oriented films. An important difference in the structure of these films 
and the films with higher UCW draw ratio was that the former films contained 
amorphous PLA chains aligned in the drawing direction, with negligible 
crystallisation.  In such films, increased packing of the amorphous chains may 
reduce the diffusivity of the matrix. Nevertheless, insertion crystallisation in such 
matrices may occur randomly, resulting into a structure which has fewer defects 
and highly convoluted fluid filled channels. Therefore, the reduction in the drug 
release in the mentioned films can be attributed to the increased orientation of 
the amorphous chains without generation of the α crystalline phase.  
Drug release reduced in order from UCW-2X films to SEQ-2X2Y and 
finally to SB-2X2Y films. This can be correlated with the oriented structure of the 
mentioned films. As explained in section 6.4, UCW stretching to λ = 2X, 
produced uniaxially oriented amorphous chains. The sequential stretching of 
such films in the perpendicular direction rotated a part of the already oriented 
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chains; whereas, biaxial orientation generated an oriented orthotropic structure 
(organisation of the chains almost parallel to the two orthogonal stretch 
directions but in the film plane). The orthotropic biaxial structure has been found 
to reduce diffusivity of the polymer matrices to a greater extent (Delpouve et al., 
2012; Jang and Lee, 2004) by substantially increasing the matrix tortuosity, than 
that observed with uniaxially oriented matrices (Delpouve et al., 2012; 
McGonigle et al., 2001). This may explain the reduction in drug release rate in 
an order from UCW (λ = 2X) TPLA films, SEQ (λ = 2X2Y) TPLA films and finally 
SB (λ = 2X2Y) TPLA films. 
CPLA films oriented to UCW draw ratio of 2X or biaxial draw ratio of 2X2Y 
(both SB and SEQ) underwent shrinkage, after incubation (at 37 °C) in the 
release medium. Consequently, these films showed little difference in the 
curcumin release profile (figure 6.37) than that obtained from un-oriented CPLA 
films. This observation further emphasizes the importance of amorphous 
orientation in reducing drug release rate from oriented films. 
6.9.2.4. Effect of orientation of the kinetics of the phase II drug release 
The kinetic models explained in the section 6.9.2.2 confirmed that 
curcumin release from oriented as well as un-oriented CPLA films followed the 
zero order kinetics. Similarly, theophylline release from TPLA films was 
confined to the Higuchi model, regardless of the degree and the nature of 
orientation. Therefore, it is safe to state that solid-state orientation of PLA films 
did not alter the mechanism of drug release. Despite of this, the slope of the 
kinetic curves (cumulative drug release Vs time or cumulative drug release Vs 
time1/2) changed after solid-state orientation of PLA films (figure 6.35 and figure 
6.37). For theophylline the slope represented the rate of diffusion, while for 
curcumin it represented the release rate.  
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Figure 6.39: Effect of solid state orientation on kinetics of drug release. 
* The theophylline diffusion rate was calculated from the slope of the cumulative release Vs time1/2 curves 
(regression lines), which were linear in the case of TPLA films. Similarly, the curcumin release rate in μg.g 
-1.week -1 units was calculated by plotting cumulative μg of curcumin released per gram of CPLA films 
against time in weeks. The cumulative curcumin release exhibited a linear relationship with time, instead 
of with the square root of it. Therefore the slope of such curves represented the curcumin release rate. 
**The error bars in both cases represent the standard error obtained by regression analysis of the 
respective data. 
 
The change in slope with respect to draw ratio is represented in figure 
6.39. It is evident that UCW orientation to the draw ratio of 2X led to a slight 
reduction in the diffusivity; while a larger difference was observed after biaxial 
orientation to the 2X2Y draw ratio. Contrarily orientation to UCW λ ≥ 3X, 
progressively increased the diffusivity. A regression analysis of the diffusivities 
of TPLA-1X, TPLA-3X and TPLA-4X films confirmed that there was a possibly 
significant (P = 0.09, F = 45.73) linear (R2 = 0.9786) correlation between the 
diffusivities and the draw ratios of these films. This relationship is graphically 
represented in figure 8.4. It is believed that once a drug molecule is released 
from a polymeric matrix, it still has to diffuse through a thin, unstirred layer of 
the release medium that immediately surrounds the matrix. This layer therefore 
contributes to the overall diffusivity of the drug. According to the drug release 
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study protocol utilised here, the release medium was replaced at weekly 
intervals. This can potentially disturb the unstirred liquid layer. Consequently, 
the theophylline diffusivity values obtained from the slope of the Higuchi curves 
will have a small error. Therefore, it can be assumed that in the absence of 
such an error, the linear relationship between theophylline diffusivity and draw 
ratios (λ ≥ 3X) can be highly significant.  
In contrast to TPLA films, the biaxially oriented (λ = 2X2Y) CPLA films and 
those oriented to UCW draw ratio of 2X, showed release rates comparable to 
un-oriented CPLA films. As discussed previously, this can be attributed to 
shrinkage of the mentioned CPLA films, resulting in loss of their orientation. 
This difference between the CPLA and the TPLA films highlighted that 
orientation had an influence on drug release. The CPLA films drawn to UCW 
draw ratios of 3X and 4X displayed enhancement of curcumin release rate, 
similar to the TPLA films oriented to the same draw ratios. Regression analysis 
of the release rates from CPLA-1X, CPLA-3X and CPLA-4X films suggested 
that there existed a statistically significant (P < 0.05, F = 197.02) linear (R2 = 
0.9950) correlation between curcumin release rates and draw ratios of these 
films. This relationship is graphically represented in figure 8.4.  
Overall, the results of kinetic analysis emphasised that control of drug 
release rate can be imposed by controlling the draw ratio. Nevertheless, 
retardation of drug release from oriented amorphous matrices was reported 
here for the first time. The current study also highlighted the importance of the 
incorporated drug in affecting its elution from the oriented films  
6.9.3. Phase 3: Erosion controlled release 
The diffusion mediated release phase lasted for approximately 16 weeks, 
following which the drug release from all the films increased in an exponential 
manner (figure 6.30, figure 6.31 & figure 6.40). The exponential drug release 
overlapped with dramatic changes in the film properties that are summarised in 
section 6.8. By the 20th week molecular weight of the films reduced significantly. 
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The fall in molecular weight was accompanied by a sharp decline in the 
polydispersity of the films between the 16th and 20th week (sec. 6.8.4). The 
mechanical strength of the smaller circular sections was lost by the 20th week 
and they could be easily crushed between the fingers. Scanning electron 
microscopy revealed formation of cracks on the transverse surface; while cryo-
fractured sections showed a highly porous internal structure (sec. 6.8.5). 
Moreover, the films exhibited weight loss and the pH of the release medium 
became more acidic. These changes clearly indicate erosion of the films. 
Consequently, an exponential upsurge in drug release was evidenced.   
 
 
Figure 6.40: Percentage cumulative drug release during the erosion phase 
(A) Release of curcumin from CPLA films, (B) Release of theophylline from TPLA films 
*The graph represents cumulative drug release as the mean ± standard deviation; for n = 6 
Surprisingly, the onset of the erosion phase was similar for all studied films 
regardless of whether and how the films were oriented. (The exact onset could 
not be detected because sampling after the 16th week was carried out every 4 
weeks. However the erosion of all studied films started between the 16th and the 
20th week). Since the films started falling apart in the erosion phase, drug 
release occurred in an uncontrolled manner. Consequently, there was not a 
characteristic correlation between drug release from the studied films and their 
degree and nature of orientation.  
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6.10. Summary 
This chapter reported changes in the crystalline structure of drug loaded 
PLA films, with respect to drawing temperature, strain rate, draw ratio and mode 
of drawing; i.e. uniaxial or biaxial. A comprehensive understanding of the 
structural changes associated with orientation of drug loaded PLA films, can be 
later used for creating a design rule for controlled drug delivery through oriented 
biodegradable polymers.  
In the current study, few samples were shortlisted for drug release and 
related characterisations. The films oriented to a uniaxial constant width (UCW) 
draw ratio (λ) of 2X (using selected conditions), exhibited anisotropic alignment 
of amorphous chains with negligible strain induced crystallisation. At λ = 3X an 
oriented α PLA crystals were generated; whereas, further drawing led to 
additional improvement in the structural order and crystallinity. Films oriented 
biaxially to a draw ratio of 2X2Y (in the simultaneous biaxial mode as well 
sequential biaxial mode), were predominantly amorphous and contained 
orthotropic organisation of PLA chains. UCW orientation of the films resulted in 
an overall rise in the surface energy, perhaps due to regular arrangement of the 
PLA chains. When a rise in draw ratio produced α crystalline order, the polar 
component of surface energy was enhanced.  
The investigated PLA matrices underwent hydrolytic degradation by the 
bulk erosion mechanism. A monotonous fall in molecular weight was observed 
after submerging the PLA films in the drug release medium. However, 
oligomers generated in this process remained entrapped within the bulk of the 
films for the first 16 weeks. Path followed by the percolating medium was 
transformed into fluid filled channels, whose size and number increased 
gradually. Actual erosion of the films started from the 20th week. Withstanding 
this degradation pattern, all studied films showed biphasic drug release. For the 
first 16 weeks the model drugs were predominantly released by diffusion 
through the polymer matrix and transport through fluid filled channels. From the 
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16th week onwards, drug release was progressively accelerated due to onset of 
polymer erosion. Orientation of drug loaded PLA films mainly influenced drug 
release in the prior phase. Oriented films which were predominantly amorphous 
in nature (UCW λ = 2X & Biaxial λ = 2XY) showed retardation of drug release 
only when the amorphous orientation was stabilised by the presence of a 
crystalline drug (i.e. theophylline). Contrarily, oriented amorphous films 
containing a drug in a glassy solution state (i.e. curcumin), shrunk after 
submersion into the release medium. Consequently, such films showed a drug 
release profile similar to un-oriented films. All UCW oriented films, which 
contained oriented α crystalline form showed acceleration of drug release with 
respect to draw ratio. A probable mechanism was predicted, according to which 
augmented formation of fluid filled channels in oriented crystalline films may be 
held responsible for acceleration of drug release. The proposed mechanism can 
be confirmed in the future by quantifying porosity of oriented drug releasing 
matrices and studying changes in their crystalline/ porous structure as they are 
aged to in the release medium.                                 
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7. Directional drug release from 
oriented rods: results and discussion 
The previous chapter systematically reported the effect of the degree and 
nature of polymer orientation (e.g. uniaxial, biaxial) on drug release, using a 
simple two dimensional geometry, i.e. films. It was evidenced that the structural 
organisation within the oriented films significantly influenced the drug release 
profile. Based on this finding, it was hypothesised that anisotropic structural 
organisation after uniaxial orientation, may produce a direction specific drug 
release pattern. This chapter discusses the results that validate this hypothesis. 
The initial section of the chapter includes WAXD and MDSC results that 
establish development of the uniaxially oriented anisotropic structure in the die-
drawn, paracetamol loaded PLA rods. In the later sections assessment of 
morphological changes in the oriented rods following aqueous submersion and 
drug release profiles exhibited by these rods is discussed, with an attempt to 
identify the directionality in drug release rate and its correlation with draw ratio. 
7.1. Uniaxial structure evolution in die-drawn PLA rods 
The paracetamol loaded PLA (PPLA) rods studied here were oriented 
using the die-drawing method. The technique originally invented by Coates et 
al. (1979; 1981), relies upon pulling a heated polymer billet through a heated 
converging die. The compressive stress exerted by the conical die walls 
combined with the tensile stress, promotes polymer chain organisation in the 
drawing direction. Therefore, an anisotropic structure is developed following die 
drawing (section 3.8.1.2).  
 
 
 
 
 213 
 
7.1.1. Anisotropic structure 
 
Figure 7.1: WAXD diffraction patterns of paracetamol loaded rods oriented to different 
draw ratios. 
(A) Cross section/ transverse section, (B) Lateral section 
Development of an anisotropic structure in the die drawn PPLA rods is 
depicted in figure 7.1, through WAXD diffraction patterns. Cross sections of the 
oriented rods (sectioned perpendicular to the drawing direction) showed 
homogenous 2D WAXD patterns, indicating an absence of structural anisotropy 
in the transverse plane. Samples oriented to a draw ratio of 2X exhibited a 
diffuse isotropic scatter, resembling the un-oriented amorphous rods. 
Nevertheless, the brightness of the amorphous halo was higher at λ = 2X, 
indicating densification of the amorphous chains. Further orientation to draw 
ratios of 3X, 4X and 5X led to strain crystallisation. The cross sections of the 
mentioned samples showed crystalline reflections in the (200, 110) and (203) 
crystallographic planes, appearing as a complete azimuthal ring.  
In contrary to above observation, the lateral sections (sectioned parallel to 
the drawing direction) of the PPLA rods exhibited a clear evolution of the 
anisotropic structure, with respect to the draw ratio. The un-oriented samples 
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showed an isotropic halo, suggesting existence of a homogenous amorphous 
matrix. At a draw ratio of 2X, organisation of amorphous chains along the 
drawing direction resulted in concentration of the amorphous halo towards the 
equator. A three dimensional crystalline order was developed at λ = 3X. The 
azimuthal spread of the crystalline reflections ((203) and (200, 110)) 
progressively reduced on further drawing, signifying further refinement of the 
structure in the drawing direction. Altogether, the 2D WAXD patterns confirmed 
that the oriented PPLA rods had an anisotropic structure, where the PLA chains 
were exclusively oriented in the drawing direction.   
7.1.2. Evolution of the oriented structure with respect to draw ratio 
The changes in 2D WAXD patterns (sec 7.1.1) of the oriented PPLA rods 
were closely aligned with the trend in their percentage crystallinity (figure 7.2). 
The extrusion moulding process involved rapid quenching of the mould in a 
water bath. Consequently, the un-oriented rods were practically amorphous in 
nature (figure 7.2). 
 
  
Figure 7.2: Changes in percentage crystallinity and glass transition temperature of the 
die-drawn rods, with respect to uniaxial draw ratio. 
*The glass transition temperature and % crystallinity values are expressed as mean ± SD, where n = 6. 
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Table 7.1: Statistical comparison of crystallinity of the die drawn rods by paired t-test 
Property Draw ratio Paired t-test comparison 
% Crystallinity 
1X Vs 2X P = 0.1524, t = 2.259 
2X Vs 3X P = 0.0112, t = 9.374 
3X Vs 4X P = 0.0024, t = 20.509 
4X Vs 5X P = 0.8112, t = 0.2718 
Notes: For relevant data refer figure 7.2.  
The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
 
At a draw ratio of 2X, the crystallinity of the rods remained statistically 
equivalent to un-oriented rods (table 7.1). This can be attributed to alignment of 
the amorphous chains, generating a nematic phase (figure 7.1 – λ = 2 & figure 
7.4). Further stretching to a draw ratio of 3X results in strain induced 
crystallisation. The deformation stress aligns the newly generated crystals in the 
drawing direction. Moreover, such crystals stabilise the remaining amorphous 
chains in their oriented state. Therefore at λ = 3X, a sharp rise in the crystallinity 
was observed, along with generation of a WAXD pattern characteristic of an 
oriented semicrystalline PLA (figure 7.1 – λ = 3X). The crystallinity increased 
almost linearly between draw ratios of 3X and 4X, suggesting further 
reinforcement of the oriented structure. The rise in crystallinity at both of these 
draw ratios was statistically validated by a paired t-test comparison to the 
preceding draw ratio (table 7.1). On extension to λ = 5X, crystallinity of the 
oriented PPLA rods remained practically constant (P = 0.8, table 7.1). This can 
be attributed to fragmentation of the existing crystals, accompanied by 
orientation of amorphous chains leading to strain crystallisation (Zhang et al., 
2011).  Evolution of an anisotropic chain organisation in the die drawn rods is 
depicted in figure 7.3 
 216 
 
 
Figure 7.3: Evolution of an anisotropic chain organisation in the die drawn rods 
(Adapted from (Ou and Cakmak, 2008)) 
Strain induced fragmentation of crystals in the oriented PLA matrices 
leads to a lateral broadening of the crystalline reflections (Kokturk et al., 2002). 
Nevertheless, such broadening is also associated with the presence of a 
disordered α crystal form, alternatively known as the α’ Form or the δ Form 
(Wasanasuk and Tashiro, 2011). Similar to the α crystal form observed in 
oriented PLA films (sec. 6.4), the α’ Form has a -10/3 helical conformation and 
packs into the orthorhombic or pseudo-orthorhombic unit cell (Zhang et al., 
2008).  However, the -10/3 helix of the α Form assumes a 21 screw symmetry 
along the chain axis; while such a symmetry is absent in the α’ Form 
(Wasanasuk and Tashiro, 2011). Consequently, the molecular chains of the α’ 
Form are considerably disordered. This further changes the unit cell parameters 
of the α’ Form as well as the arrangement of the higher order domains (Pan et 
al., 2008; Wasanasuk and Tashiro, 2011).  
Due to common fundamental chain organisation, the spectral profiles of 
both the α and the α’ Form look similar. However, in the case of the α’ Form, the 
2D WAXD bands are thicker and Bragg’s angle (2θ) position of certain bands is 
slightly altered. WAXD patterns of oriented rods showed characteristic 
reflections at the (200/110), (203), (206) and (018) crystallographic planes 
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(figure 7.1), corresponding to the Bragg’s angle (2θ) of 16.4°, 18.8°, 24.5°, 
32.6°. Here the Bragg’s position of the (200/110), (203) and (206) reflections 
was shifted by 0.3° with respect to the α Form. Moreover, the reflection in the 
(020) plane shown by the α Form was replaced by the (018) reflection, which 
appeared at 32.6° Bragg’s angle in the one dimensional diffractogram. These 
characteristic features of the WAXD data were consistent with the literature 
reports on the α’ Form of PLA (Chen et al., 2011; Pan et al., 2008; Wasanasuk 
and Tashiro, 2011; Zhang et al., 2008). Therefore, the results confirmed 
development of the α’ crystalline form of PLA during die drawing of the PPLA 
rods. 
 
 
 
Figure 7.4: Changes in Herman’s orientation function calculated for die-drawn rods, 
with respect to the uniaxial draw ratio. 
A further insight into the structural organisation of oriented PPLA rods was 
obtained by deriving Herman’s orientation function (sec 4.13 – eqn. 4.5), from 
the WAXD data. This allows a quantitative expression of the degree of 
unidirectional orientation. Die drawing of the PPLA rods augmented the 
orientation function in three distinguishing steps (figure 7.4), coherent with 2D 
WAXD patterns and the crystallinity data (figure 7.1, figure 7.2). Up to a draw 
ratio of 2X, plastic deformation of the amorphous chains without strain 
crystallisation only enhanced the orientation function by a smaller margin. A 
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major improvement in the structural order occurred between draw ratios of 2X 
and 3X, due to the onset of strain crystallisation. Following this stage, previously 
un-oriented chains or chains resulting from the fragmentation of strained 
crystals are merely inserted in to the existing three dimensional order. 
Therefore, the orientation function increased gradually between λ = 3X and λ = 
5X (Mulligan and Cakmak, 2005, Wong et al., 2008). Evolution of an oriented 
structure in the die-drawn PPLA rods, significantly matched with that observed 
in UCW orientation of PLA films (sec. 6.4). This suggests a similarity between 
the mentioned orientation methods under the processing conditions utilised in 
this study. Nevertheless, it highlights the importance of polymer composition 
(grade) in affecting the structure development.  
7.2. State of the PLA matrix during drug release 
Due to a limited number of samples, changes in the molecular weight, 
crystallinity and microscopic changes in the morphology of the PPLA rods were 
evaluated only at the end of the drug release study. During the release study, 
PPLA rods were monitored for the visual alterations. This information is 
summarised below. In the following section the oriented PPLA rods with draw 
ratios of λ = 2X, λ = 3X, λ = 4X and λ = 5X are referred as PPLA-2X, PPLA-3X, 
PPLA-4X and PPLA-5X respectively for simplification. 
7.2.1. Visual changes 
 
Figure 7.5: Visual changes in PPLA rods during drug release study 
*(The above representative image was captured at the end of the study; i.e. 16 weeks) 
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Two prominent visual changes were detected in the PPLA rods during the 
drug release studies. Firstly, between the 10th and the 20th day, the PPLA-2X 
rods progressively expanded to 89% of their cross sectional area before die-
drawing (i.e. 178% of their cross sectional area after die drawing or equivalent 
to λ =1.12) (figure 7.5). This signifies that the mentioned rods lost a large 
proportion of the oriented structure, by the end of the third week, when 
submerged in the drug release media (at 37 °C). As discussed previously, the 
PPLA-2X rods contained oriented amorphous chains with a negligible 
crystallinity. When such rods are submerged in the drug release media, the 
permeated water plasticises the polymer matrix, allowing the amorphous chains 
to recoil back to the homogenous state. Here the extent of recovery is limited by 
insertion crystallisation of the matrix in presence of water.  
The second important observation was that the colour of the PPLA rods 
darkened as the study progressed. The most prominent change was observed 
with un-oriented and PPLA-2X (expanded) rods, which turned amber brown 
after about 10 weeks (figure 7.5). This was initially attributed to higher 
degradation of the un-orientated rods compared to the oriented rods (similar to 
the PLA films – sec 6.8.3). However, molecular weight determination at the end 
of the study revealed that the reverse was true. Therefore, the exact reason for 
such a colour change could not be identified at the present stage.  
7.2.2. The molecular weight changes 
Un-oriented PPLA rods showed molecular weight degradation (table 7.1) 
comparable to the un-oriented drug loaded PLA films (sec. 6.8.3), after 16 
weeks of aqueous submersion. Surprisingly a monotonous GPC peak was 
obtained; suggesting that the rods left at the end of the 16th week were 
homogenously degraded throughout the bulk.  The PPLA-2X rods underwent 
expansion and lost the majority of their oriented structure. Therefore, the 
degradation profile of PPLA-2X rods matched with that of the un-oriented rods.  
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Figure 7.6: Molecular weight (Mw) of PPLA rods at the end of the drug release studies 
*The values of molecular weight and polydispersity are expressed as mean ± SD, where n = 6. 
  
Table 7.2: Statistical analysis of the molecular weight at the end of the release study 
by one-way ANOVA - Tukey’s test comparison between draw ratios. 
Comparison 
Molecular weight 
Cross section coated Curved surface coated 
1X vs 2X P > 0.05, q = 1.77 P > 0.05, q = 1.13 
1X vs 3X P < 0.001, q = 64.41 P < 0.001, q = 19.25 
1X vs 4X P < 0.001, q = 71.58 P < 0.001, q = 17.63 
1X vs 5X P < 0.001, q = 76.34 P < 0.001, q = 15.1 
2X vs 3X P < 0.001, q = 62.64 P < 0.001, q = 18.12 
2X vs 4X P < 0.001, q = 69.81 P < 0.001, q = 16.5 
2X vs 5X P < 0.001, q = 74.57 P < 0.001, q = 13.96 
3X vs 4X P < 0.001, q = 7.17 P > 0.05, q = 1.62 
3X vs 5X P < 0.001, q = 11.93 P > 0.05, q = 1.16 
4X vs 5X P < 0.05, q = 4.76 P > 0.05, q = 2.54 
 
0
10000
20000
30000
40000
50000
1X 2X 3X 4X 5X
W
e
ig
h
t 
av
g.
 M
o
le
cu
la
r 
W
e
ig
h
t 
(D
a)
 
Uniaxial draw ratio 
Mw - Curved surface coated Mw - Cross section coated
 221 
 
Table 7.3: Statistical comparison of molecular weights of PPLA rods before and after 
completion of the release study, by one-way ANOVA followed by Tukey’s test. 
Comparison 
Molecular weight 
1X 2X 3X 4X 5X 
0 week Vs 16 weeks cross 
section coated 
P < 0.001, 
q = 86.59 
P < 0.001, 
q = 75 
P < 0.001, 
q = 325 
P < 0.001, 
q = 358 
P < 0.001, 
q = 421 
0 week Vs 16 weeks curved 
surface coated 
P < 0.001, 
q = 87.22 
P < 0.001, 
q = 76.16 
P < 0.001, 
q = 333 
P < 0.001, 
q = 354 
P < 0.001, 
q = 398 
16 weeks cross section coated 
Vs 16 weeks curved surface 
coated 
P > 0.05, q 
= 0.63 
P > 0.05, q 
= 1.16 
P < 0.001, 
q = 8.46 
P < 0.05, q 
= 4.27 
P < 0.001, 
q = 22.32 
 
The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
 
A remarkable difference was found between the hydrolytic degradation of 
oriented drug loaded PLA films (λ ≥ 3X) and oriented PPLA rods (λ ≥ 3X). 
Tensile drawing of the PLA films above a draw ratio of 3X hindered their 
hydrolytic degradation. On the contrary, degradation was significantly higher in 
the oriented PPLA rods (λ ≥ 3X). It is evident from figure 7.6 that the molecular 
weight of the PPLA-3X, PPLA-4X and PPLA-5X rods was nearly half as much 
as the molecular weight of the un-oriented rods, after 16 weeks of submersion. 
This can perhaps be attributed to formation of macroscopic cracks in the 
mentioned rods (figure 7.9). The presence of large cracks might have enhanced 
water uptake by the rods, thereby accelerating their degradation. An augmented 
degradation of the oriented PPLA rods (λ ≥ 3X), can further enhance the drug 
release by increasing mass transport by several mechanisms. 
The difference between molecular weights of the rods oriented to various 
draw ratios was statistically validated by one-way ANOVA – Tukey’s test (table 
7.2).  All rods had statistically equivalent molecular weight regardless of the 
draw ratio, at the beginning of drug release study. At the end of the study un-
oriented and PPLA-2X rods displayed comparable (P > 0.05) molecular weight, 
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which was significantly higher than that of the remaining rods. When the curved 
surface was coated, the molecular weight of the PPLA-3X, PPLA-4X and PPLA-
5X rods showed an absence of any statistically significant difference. Contrarily, 
when the cross section was coated, the rods oriented to higher draw ratios 
showed progressively lower degradation (or progressively higher molecular 
weights). Higher anisotropic orientation may lower water permeation 
perpendicular to the chain orientation due to increased chain packing. However, 
this may not greatly affect water permeation in the chain orientation direction 
(curved surface coated).  
Molecular weights of the rods with coated curved surface and coated 
cross sections were statistically compared at the end of the study. The results of 
such analysis (table 7.3) confirmed that the un-oriented and PPLA-2X 
(expanded) rods showed no statistical difference between their molecular 
weights, regardless of which surface was exposed to the medium. Contrarily, a 
statistically significant difference was observed between the molecular weights 
of the curved surface coated and cross section coated rods, whose draw ratio 
was greater than or equal to 3X. This observation highlighted a possibility that 
water permeation can be anisotropic in the uniaxially oriented rods. If true, drug 
release can also be expected to have a directional dependency.  
7.2.3. Crystallinity changes 
Submersion of the PPLA rods in the release medium resulted in a 
crystallinity rise due to insertion crystallisation of PLA. All PPLA rods showed 
substantially higher crystallinity after 16 weeks of aqueous submersion than 
their original crystallinity (figure 7.7, table 7.5). A statistical comparison between 
the crystallinity values obtained at the end of the release study revealed the 
following (table 7.4). When cross-sections of the rods were protected from direct 
contact with water, all rods oriented to λ ≥ 3X, exhibited the same crystallinity at 
the end of the release study. Similarly, when the curved surface of the rods was 
protected from water, the PPLA-3X and PPLA-4X rods exhibited statistically 
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equivalent crystallinity, but the crystallinity of PPLA-5X rods was slightly lower. 
Although statistically significant, this difference was unsubstantial; 
consequently, it was ignored. A highly significant difference existed between the 
crystallinity values of un-oriented, PPLA-2X rods and the rods oriented to 
greater draw ratios (λ ≥ 3X) (table 7.4). The expanded PPLA-2X and un-
oriented rods, which were initially amorphous, showed progressively lower 
crystallinity of 24.93% and 14.52% respectively than the λ ≥ 3X rods (figure 
7.7).  
A similar change in crystallinity was detected while studying drug release 
from oriented curcumin loaded films (sec. 6.8.2). All curcumin loaded films 
reached the same level of crystallinity by the 6th week after submersion into the 
release medium. However, towards 16 weeks the initially amorphous films (i.e. 
λ = 1X, 2X) exhibited a significantly lower crystallinity than the films which were 
inherently crystalline (λ = 3X, 4X). As explained previously, this can be 
attributed to differences in the organisation of the crystalline phase, between the 
two kinds of matrices mentioned above.  
 
 
Figure 7.7: The percentage crystallinity of the PPLA rods before and after the drug 
release studies. 
*The % crystallinity values are expressed as mean ± SD; where n = 6. 
-5
0
5
10
15
20
25
30
35
40
0 2 4 6
P
e
rc
e
n
ta
ge
 c
ry
st
al
lin
it
y 
Draw ratio 
After 16 weeks -
curved surface
coated
After 16 weeks -
cross section coated
Original rods
 224 
 
Table 7.4: Statistical analysis of the percentage crystallinity at the end of the release 
study by one-way ANOVA - Tukey’s test comparison between draw ratios. 
Comparison 
% Crystallinity 
Cross section coated Curved surface coated 
1X vs 2X P < 0.001 q = 17.26 P < 0.001 q = 20.65 
1X vs 3X P < 0.001 q = 38.93 P < 0.001 q = 42.55 
1X vs 4X P < 0.001 q = 35.88 P < 0.001 q = 41.92 
1X vs 5X P < 0.001 q = 39.14 P < 0.001 q = 37.6 
2X vs 3X P < 0.001 q = 21.67 P < 0.001 q = 21.9 
2X vs 4X P < 0.001 q = 18.62 P < 0.001 q = 21.27 
2X vs 5X P < 0.001 q = 21.88 P < 0.001 q = 16.95 
3X vs 4X P > 0.05 q = 3.05 P > 0.05 q = 0.64 
3X vs 5X P > 0.05 q = 0.21 P < 0.05 q = 4.96 
4X vs 5X P > 0.05 q = 3.26 P < 0.05 q = 4.32 
 
Table 7.5: Statistical comparison of the percentage crystallinity values before and after 
completion of the release study, by one-way ANOVA followed by Tukey’s test. 
Comparison 
% crystallinity 
1X 2X 3X 4X 5X 
0 week Vs 16 weeks cross 
section coated 
P < 0.001, 
q = 25.69 
P < 0.001, 
q = 90.15 
P < 0.001, 
q = 35.93 
P < 0.001, 
q = 34.92 
P < 0.001, 
q = 27.26 
0 week Vs 16 weeks curved 
surface coated 
P < 0.001, 
q = 27.09 
P < 0.001, 
q = 94.61 
P < 0.001, 
q = 35.36 
P < 0.001, 
q = 37.46 
P < 0.001, 
q = 22.04 
16 weeks cross section coated 
Vs 16 weeks curved surface 
coated 
P > 0.05, q 
= 1.4 
P > 0.05, q 
= 2.72 
P > 0.05, q 
= 0.57 
P > 0.05, q 
= 2.54 
P < 0.05, q 
= 4.46 
The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
 
The crystallinity values obtained at the end of the study were regardless of 
whether the PPLA rods were coated on the curved surface or on the cross 
section (table 7.5). (PPLA-5X rods showed slightly anomalous behaviour). A 
difference in diffusion of water from the curved surface (diffusion direction 
 225 
 
perpendicular to the orientation direction) and from the cross section (diffusion 
direction parallel to the orientation direction) may vary crystallisation of oriented 
PPLA rods. However, such a difference can only be detected in the early 
stages, before water saturates the entire rod. In the future, the differential 
movement of the crystallisation front from the curved surface and from the cross 
section will be traced using an XRD mapping technique. 
7.2.4. Microscopic changes 
 
 
Figure 7.8: Microscopic changes in the fractured lateral surface (X) and cross section 
(Y) of un-oriented (A, B) and PPLA-2X rods (C, D). 
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Figure 7.9: Microscopic changes in the fractured lateral surface (X) and                 
cross section (Y) of PPLA-3X (A, B), PPLA-4X (C, D) and PPLA-5X rods (E, F). 
In order to understand the microscopic changes in PPLA rods two distinct 
sections were obtained from samples remaining at the end of the drug release 
study. A transverse section was obtained by cryo-fracturing the rod parallel to 
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the base / cross section (figure 7.8 - Y), while a lateral section was obtained by 
cryo-fracturing the rod parallel to the curved surface (figure 7.8 - X). Irrespective 
of whether the rods were coated on the curved surface or on the cross section, 
they showed similar microscopic features at the end of the drug release study. 
These are represented below in figure 7.8 and figure 7.9 
Un-oriented rods exhibited a homogenously degraded structure in both the 
lateral section and the cross section (figure 7.8 - A & B). The lateral section of 
PPLA-2X rods showed few striations, which were aligned parallel to the drawing 
direction (figure 7.8 - C). Since such striations were absent in the cross section 
(figure 7.8 - D), these might be considered as imprints of the residual 
orientation, in the expanded PPLA-2X rods. Both the lateral surface and cross 
section of the un-oriented and the PPLA-2X rods displayed minute cavities (1-2 
μm). The presence of such cavities on either of the surfaces suggests that 
water-filled channels in the isotropic PPLA rods were formed randomly.  
 
 
Figure 7.10: Postulated structural difference between the α’ and the α Form of PLA. 
(Wasanasuk and Tashiro, 2011) 
*(U and D signify up and down arrangement of 5 monomeric units in a 21 screw geometry) 
Quite contrarily, the lateral sections of PPLA-3X, PPLA-4X and PPLA-5X 
rods showed formation of large crevices parallel to the drawing direction (figure 
7.9). For PPLA-3X rods, the average width of the crevices was less than a 
micrometre; however their length was over 100 μm. The crevices became wider 
as the uniaxial draw ratio increased but their number reduced significantly. 
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WAXD studies on the die-drawn PPLA rods had confirmed that the rods 
oriented to the draw ratio of 3X and above, contained the α’ crystalline form of 
PLA (sec. 7.1). The α’ Form has a structural disorder at the unit cell level as well 
as between the macroscopic domains (figure 7.10) (Wasanasuk and Tashiro, 
2011). Nevertheless, it has a sheaf-like structure in contrast to the lamellar 
structure of the α Form (Pan et al., 2008). All of the above factors clearly justify 
formation of the large crevices in the PPLA-3X, PPLA-4X and PPLA-5X rods. 
The crevices observed in the lateral sections were detected as voids in the 
cross sections. The presence of such morphology can perhaps explain higher 
degradation of the oriented rods. Nevertheless, it may lead to an extreme 
enhancement of the drug release, due to easy permeation of the release media.  
7.3. Drug release from oriented rods 
Uniaxial orientation of the polymeric matrices has been known to produce 
directionally dependent properties such as mechanical strength, refractive 
index, thermal conductivity, etc. (Kurabayashi, 2001; Ward, 1997; Ward and 
Sweeney, 2012). Since drug release from the oriented PLA matrices is 
influenced by the organisation of the polymer chains (chapter 6), an anisotropic 
chain orientation may produce a direction specific drug release. In this research, 
a possibility of obtaining direction specific drug release from the oriented PLA 
rods was evaluated for the first time. 
7.3.1. Differential paracetamol release from the cross section and the 
curved surface 
 
 
Figure 7.11: Crystallisation of paracetamol on the uncoated surface of a PPLA rod 
*(When the submerged rod was subjected to drying) 
Clear coated 
surface 
Opaque un-coated 
surface 
 229 
 
In order to separately evaluate paracetamol release from the cross 
section, the curved surface of the PPLA rods was coated with a water 
impermeable epoxy polymer. Similarly, paracetamol release from the curved 
surface was studied by coating the cross section of the rods. The intactness of 
the coat was verified at weekly sampling intervals by microscopy. Nevertheless, 
a thin coat was reapplied at monthly intervals. If a submerged rod was 
withdrawn and allowed to dry, only the uncoated surface showed crystallisation 
of the drug, while the coated surface remained clear (figure 7.11). This 
observation further confirmed that the coated surface was protected from direct 
contact with water.  
Preliminary drug release studies on the oriented films had revealed that 
the thickness of the films played a significant role by affecting the diffusional 
path-length and relative concentration gradient per unit film surface area. 
Therefore, the rods utilised in the drug release study were cut into 6 mm 
lengths, equivalent to their diameter. This way the diffusional path-length from 
the centre to the curved surface and from the centre to the cross sectional ends 
remained constant. However, with this approach the curved surface area 
became twice as large as the total cross sectional surface area. When drug 
release was not normalised against the surface area, un-oriented rods showed 
higher release from the curved surface than from the cross section. Since the 
un-oriented rods had an isotropic structure, differential release of paracetamol 
from the cross section and the curved surface can perhaps be attributed the 
difference in the respective surface areas. In order to avoid this effect, the 
amount of paracetamol released from the cross section and from the curved 
surface was divided by the respective surface areas.    
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Figure 7.12: Comparison of the amount of paracetamol released on individual days per 
gram of the PPLA rods, from the curved surface and the cross section per cm2 surface 
area. (A: λ = 1X, B: λ = 2X, C: λ = 3X, D: λ = 4X, E: λ = 5X) 
*The cumulative drug release data is expressed as mean ± SD; where n = 6. 
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Table 7.6: Statistical comparison between paracetamol release (day-1.g-1.cm-1) from 
the cross section and the curved surface of the PPLA rods by paired t-test 
Intervals 
Cross section Vs curved surface 
1X 2X 3X 4X 5X 
Week 4 
P = 0.2287, 
t = 1.291 
P = 0.1615, 
t = 1.642 
P < 0.0001, 
t = 57.611 
P < 0.0001, 
t = 48.183 
P < 0.0001, 
t = 43.580 
Week 8 
P = 0.0472, 
t = 2.490 
P = 0.2587, 
t = 1.247 
P < 0.0001, 
t = 17.337 
P < 0.0001, 
t = 177.29 
P < 0.0001, 
t = 21.332 
Week 12 
P = 0.0658, 
t = 2.093 
P = 0.005, t 
= 4.031 
P < 0.0001, 
t = 18.788 
P < 0.0001, 
t = 64.689 
P < 0.0001, 
t = 70.741 
Week 16 
P = 0.07, t 
= 2.201 
P = 0.0864, 
t = 1.924 
P < 0.0001, 
t = 128.66 
P < 0.0001, 
t = 70.534 
P < 0.0001, 
t = 8.605 
Notes: For relevant data refer figure 7.12.  
The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
 
   
Figure 7.12 displays a comparison between paracetamol release from the 
cross section and from the curved surface of the oriented PPLA rods. It is 
evident that un-oriented rods released the same amount of paracetamol from 
the cross section and from the curved surface, when normalised with respect to 
the surface area (figure 7.12 - A). A similar drug release profile was shown by 
rods oriented to a draw ratio of 2X (figure 7.12 - B). This can be attributed to 
loss of the oriented structure, when the mentioned rods underwent expansion 
whilst ageing in the release media (sec. 7.2.1, figure 7.5). An absence of a 
statistical difference between paracetamol release (day-1.g-1.cm-1) from the 
curved surface and the cross section of the un-oriented and PPLA-2X rods was 
validated by a paired t-test carried out at four different submersion intervals 
(table 7.6). 
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Contrary to un-oriented and PPLA-2X rods, the rods oriented to draw 
ratios of 3X, 4X and 5X exhibited a highly significant (P < 0.0001, table 7.6) 
difference in paracetamol release from the cross section and from the curved 
surface (figure 7.12 - C, D, E). Such a difference existed at all stages of drug 
release. However, because the drug release after 8 weeks was substantially 
higher, the difference before 8 weeks is masked in the overall drug release 
profile. For all of these samples, paracetamol release from the cross section 
exceeded that from the curved surface by a margin of 10-20 μg.g-1.cm-2 for the 
initial 60 days. From the 60th day till the end of the study (112th day = 16 
weeks), paracetamol release from the cross section (per cm2 surface area) was 
notably higher than that from the curved surface. Figure 7.12 further highlights 
that orientation of PPLA rods to λ ≥ 3X significantly accelerated the overall 
release. This aspect is discussed separately in a later section. Nevertheless, it 
is important to note that an augmented drug release from the mentioned rods 
rapidly depleted the amount of drug remaining in them. This may explain the 
decline in the drug release observed from the 13th week (91 days) onwards.    
Overall, the results suggest that unidirectional orientation of the rods 
enhanced paracetamol release in the drawing direction as well as in the 
perpendicular direction. When the drug release was normalised for the surface 
area, the augmentation effect was found to be more prominent along the PLA 
chain orientation direction.  
 
Figure 7.13: ‘Run and jump model’ explaining diffusion of small molecules through the 
polymer matrix. (Adapted from (Wesselingh, 1993)) 
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Diffusion of small molecules through the polymeric matrices can occur 
either parallel to the chain axis (Brandt, 1955) or perpendicular to it 
(DiBenedetto, 1963). Pace et al. (1979) proposed that the small molecules ‘run’ 
along the chain axis, through the tubular surrounding created by the polymer 
chains (figure 7.13). Once they encounter a region of high entanglement, the 
molecules have to ‘jump’ from one tube to another. Contrarily, diffusion 
perpendicular to the chain axis would require numerous ‘jumps’ from one 
surrounding to the adjacent surrounding. Since, jumps require higher energy 
than the movement through the tubular channels, the latter is favoured.  
Considering this theory, uniaxial orientation of the rods should accelerate 
the drug release through the cross section by aligning the polymer chains in a 
single direction (sec. 7.1). Contrarily, increased chain packing after orientation 
should retard the drug diffusion perpendicular to the drawing direction. 
However, the drug release was enhanced from both the curved surface and the 
cross section; which suggests that a process in addition to directional diffusion 
of the drug through the polymer matrix might have played a role here. If the 
mechanism proposed from the studies on the oriented films was true, this can 
be attributed to augmented formation of water-filled channels. In order to make 
a safe conclusion on mechanism behind directional drug release, the changes 
in the oriented polymer matrix following aqueous submersion must be traced 
using a technique such as micro-CT.      
7.3.2. The effect of uniaxial draw ratio   
 The cumulative drug release from uniaxially oriented rods displayed a 
sigmoidal pattern (figure 7.14 & figure 7.15). The initial slow release phase was 
followed by a rapid release phase, ultimately leading to a plateau. Such a trend 
was constant, regardless of whether the drug release occurred from the cross 
section (figure 7.14) or from the curved surface (figure 7.15).  
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Figure 7.14: Cumulative paracetamol release from the cross section of oriented PPLA 
rods per cm2 surface area (inset: magnified view between 0 to 6 weeks). 
*The cumulative paracetamol release is expressed as mean ± SD; where n = 6. 
 
 
Figure 7.15: Cumulative paracetamol release from the curved surface of oriented 
PPLA rods per cm2 surface area (inset: magnified view between 0 to 6 weeks). 
*The cumulative paracetamol release is expressed as mean ± SD; where n = 6. 
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Table 7.7: Statistical comparison between cumulative paracetamol release (μg.cm-1) 
from the cross section of the PPLA rods drawn to different draw ratios 
One-way ANOVA followed by Tukey's test 
Comparison Week 4 Week 8 Week 12 Week 16 
1X Vs 2X 
P < 0.001, 
q = 34.11 
P < 0.001, 
q = 46.3 
P < 0.05,  
q = 7.17 
P < 0.001, 
q = 7.04 
1X Vs 3X 
P < 0.001, 
q = 60.37 
P < 0.001, 
q = 223.46 
P < 0.001, 
q = 139.25 
P < 0.001, 
q = 316.74 
1X Vs 4X 
P < 0.001, 
q = 112.22 
P < 0.001, 
q = 335.2 
P < 0.001, 
q = 174.52 
P < 0.001, 
q = 435.86 
1X Vs 5X 
P < 0.001, 
q = 89.3 
P < 0.001, 
q = 299.58 
P < 0.001, 
q = 181.69 
P < 0.001, 
q = 352.66 
2X Vs 3X 
P < 0.001, 
q = 26.26 
P < 0.001, 
q = 177.16 
P < 0.001, 
q = 135.63 
P < 0.001, 
q = 309.71 
2X Vs 4X 
P < 0.001, 
q = 78.11 
P < 0.001, 
q = 288.9 
P < 0.001, 
q = 170.9 
P < 0.001, 
q = 428.82 
2X Vs 5X 
P < 0.001, 
q = 55.19 
P < 0.001, 
q = 253.28 
P < 0.001, 
q = 178.07 
P < 0.001, 
q = 345.62 
3X Vs 4X 
P < 0.001, 
q = 51.85 
P < 0.001, 
q = 111.74 
P < 0.001, 
q = 35.27 
P < 0.001, 
q = 119.11 
3X Vs 5X 
P < 0.001, 
q = 28.93 
P < 0.001, 
q = 76.12 
P < 0.001, 
q = 42.44 
P < 0.001, 
q = 35.92 
4X Vs 5X 
P < 0.001, 
q = 22.93 
P < 0.001, 
q = 35.62 
P > 0.05,  
q = 3.62 
P < 0.001, 
q = 83.2 
Notes: The associated release data can be found in figure 7.14  
The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
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Table 7.8: Statistical comparison between cumulative paracetamol release (μg.cm-1) 
from the curved surface of the PPLA rods drawn to different draw ratios. 
One-way ANOVA followed by Tukey's test 
Comparison Week 4 Week 8 Week 12 Week 16 
1X Vs 2X 
P < 0.001, 
q = 89.92 
P < 0.001, 
q = 73.14 
P < 0.001, 
q = 18.01 
P < 0.001, 
q = 24.37 
1X Vs 3X 
P < 0.001, 
q = 105.31 
P < 0.001, 
q = 299.37 
P < 0.001, 
q = 386.71 
P < 0.001, 
q = 526.66 
1X Vs 4X 
P < 0.001, 
q = 120.16 
P < 0.001, 
q = 583.29 
P < 0.001, 
q = 483.98 
P < 0.001, 
q = 729.39 
1X Vs 5X 
P < 0.001, 
q = 71.1 
P < 0.001, 
q = 271.42 
P < 0.001, 
q = 265.74 
P < 0.001, 
q = 646.17 
2X Vs 3X 
P < 0.001, 
q = 15.39 
P < 0.001, 
q = 226.23 
P < 0.001, 
q = 368.7 
P < 0.001, 
q = 502.29 
2X Vs 4X 
P < 0.001, 
q = 30.23 
P < 0.001, 
q = 510.16 
P < 0.001, 
q = 465.97 
P < 0.001, 
q = 705.02 
2X Vs 5X 
P < 0.001, 
q = 18.82 
P < 0.001, 
q = 198.29 
P < 0.001, 
q = 247.73 
P < 0.001, 
q = 621.8 
3X Vs 4X 
P < 0.001, 
q = 14.84 
P < 0.001, 
q = 283.93 
P < 0.001, 
q = 97.27 
P < 0.001, 
q = 202.73 
3X Vs 5X 
P < 0.001, 
q = 34.21 
P < 0.001, 
q = 27.95 
P < 0.001, 
q = 120.97 
P < 0.001, 
q = 119.51 
4X Vs 5X 
P < 0.001, 
q = 49.05 
P < 0.001, 
q = 311.87 
P < 0.001, 
q = 218.24 
P < 0.001, 
q = 83.22 
Notes: The associated release data can be found in figure 7.15  
The null hypothesis was that the compared samples were statistically the same 
  P > 0.05 = The difference between the compared samples is not statistically significant  
  0.05 > P > 0.01 = The difference between the compared samples is statistically significant  
  0.01 > P = The difference between the compared samples is highly significant  
 
A sigmoidal release pattern was observed by Miyajima et al. (1997) when 
studying release of papaverine from un-oriented melt compressed PLA rods. 
They proposed that the initial slower release occurred predominantly by 
diffusion of the drug through the hydrated polymer matrix. A faster drug release 
in the second stage was attributed to formation of water filled channels; 
following which the drug release declined due to a progressive fall in the 
concentration gradient.  
 237 
 
A similar drug release profile was also obtained by Vieranto et al. (2002) 
and Tormala et al. (2008) from die drawn PLA matrices containing a drug in a 
suspension form. Vieranto et al. (2002), prepared self-reinforced screws by 
machining a die drawn PLA billet (Mw = 910 000 g/mol), containing 
ciprofloxacin. Surprisingly, no mention of the draw ratio or the drug loading was 
found. The authors observed that less than 10% of the drug was released in the 
first 9 weeks. Between the 10th and the 20th week a rapid release of about 60% 
ciprofloxacin occurred, followed by a plateau phase. Tormala et al. (2008) 
compared ciprofloxacin release from isotropic polyester (PLA/PGA) rods and 
polyester rods die drawn to λ = 4.4X. The initial slow release phase for the 
isotropic rods lasted for approximately 220 days, whereas that in the case of the 
die-drawn rods was only about 100 days longer. An early onset of the 
exponential release phase in the die-drawn rods resulted in greater overall 
release of ciprofloxacin from such rods.  
In the present study, drug release was divided into three distinct phases, 
namely the slow release phase (until the 5th week), the transition phase (from 
5th to the 8th week) and the exponential phase (8th week onwards) (figure 7.14, 
figure 7.15). During the first two phases, the amount of paracetamol released 
daily, from the cross section or from the curved surface of an un-oriented PPLA 
rod did not exceed 1.5 µg.cm-2. The PPLA-2X rods showed anomalously higher 
drug release for the initial 2 weeks; however, drug release reduced from the 
third week onwards. A statistical comparison revealed that there was a 
significant difference between paracetamol release from un-oriented rods and 
PPLA-2X rods (both surface and cross section) throughout the drug release 
study (table 7.7, table 7.8). If the initial anomalous release from PPLA-2X rods 
was subtracted, the cumulative paracetamol release from the cross section of 
PPLA-2X rods was 1.5 to 1.7 fold higher than that from the cross-section of the 
un-oriented rods. Similarly, the cumulative paracetamol release from the curved 
surface of PPLA-2X rods was 2.0 to 2.2 fold higher than that from the curved 
surface of the un-oriented rods. These results were surprising as the PPLA-2X 
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rods underwent expansion (sec. 7.2.1), which can result in loss of the oriented 
structure. Contrary to shrinkage of the oriented amorphous films, expansion of 
the PPLA-2X rods may induce substantial changes in the microstructure as well 
as macrostructure. This needs to be investigated in order to find a logical 
explanation for higher drug release from PPLA-2X rods. Despite a difference in 
the amount of drug release, PPLA-2X rods showed a very similar release 
pattern to that exhibited by un-oriented rods. The overall drug release from 
these rods continued to be slower and never lead to an exponential phase. 
Therefore, the maximum amount of paracetamol released from the un-oriented 
and the PPLA-2X rods merely reached 5 μg.cm-2.day-1 and 11.5 μg.cm-2.day-1 
respectively. 
PPLA rods oriented to λ ≥ 3X, showed a marked enhancement of drug 
elution, during all three phases mentioned above. Between the 2nd and 5th 
week, the curved surface of PPLA-3X rods released 5-6 fold higher paracetamol 
than the curved surface of un-oriented PPLA rods. Similarly, drug release from 
the cross section of PPLA-3X rods was 10-12 fold higher than the 
corresponding release from un-oriented rods. The aforementioned difference 
between the paracetamol release from PPLA- 3X and un-oriented rods almost 
doubled in the transition phase. Nevertheless, this difference increased 
exponentially from the 8th week onwards. The maximum amount of paracetamol 
released per day by the PPLA-3X rods was 184.89 μg.cm-2 from the curved 
surface and 346.66 μg.cm-2 from the cross section. Quite remarkably, this 
amount was 60 and 134 times higher than the corresponding drug release from 
un-oriented rods. 
PPLA-5X rods exhibited an intermediate drug release between PPLA-3X 
and PPLA-4X rods during the slow release phase. Drug release from the cross 
section of PPLA-5X rods increased during the exponential phase, and became 
comparable to the PPLA-4X rods. Contrarily, drug release from the curved 
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surface of PPLA-5X rods remained significantly lower than the corresponding 
release from PPLA-4X and even PPLA-3X rods.  
Altogether, drug release from PPLA rods was significantly (P < 0.001) 
enhanced at λ ≥ 3X. A statistical comparison by one-way ANOVA – Tukey’s test 
validated that the difference in the cumulative paracetamol release between the 
PPLA-3X, PPLA-4X and PPLA-5X rods was highly significant (table 7.7, table 
7.8). However, a definite proportionality was not observed between the drug 
release rate and the draw ratio (λ ≥ 3X); perhaps because the enhancement at 
λ = 3X itself was large. Orientation of the films produced a maximum threefold 
rise in the drug release, while the maximum acceleration in the case of PPLA 
rods was 175-fold (PPLA-5X cross section, week 12). Such a difference can be 
attributed to formation of large cracks (sec. 7.2.4, figure 7.9) in the oriented 
PPLA rods, after 8-9 weeks of water submersion. These cracks when filled by 
the bathing medium can accelerate the drug release as well as polymer 
degradation. 
Strain crystallisation of PLA during solid-state orientation enhances the 
concentration of the drug in the remaining amorphous phase. Nevertheless, 
drug can also be excluded from the highly organised amorphous sections, 
where augmented inter-chain interactions may reduce the number of functional 
groups available for the drug molecules to attach. Both of these factors can 
generate a higher concentration gradient, thereby enhancing diffusion mediated 
drug release from the oriented PLA. Based on the hypothesis proposed 
previously (section 6.9.2.3, figure 6.37), concentration of the chain defects in 
the inter-lamellar regions of the highly oriented matrices supposedly augments 
formation of water filled channels. In the case of PPLA rods, even the 
macroscopic crevices were formed due the presence of the disordered α’ 
crystalline form. Therefore, a higher drug release from the oriented (λ ≥ 3X) 
PPLA rods in the exponential release phase can be attributed to the 
abovementioned morphological changes.   
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7.4. Summary 
This is the first study reporting release of a polymer soluble drug from the 
oriented polymer rods. Nevertheless, directional dependency of drug release 
was evaluated for the first time. The paracetamol release from oriented PPLA 
rods followed a sigmoidal pattern. Drug release was divided into three phases 
as follows; a slower release phase – from the 2nd to the 5th week, a transition 
phase – from the 5th to the 8th week and an exponential phase - from the 8th 
week onwards. Uniaxial orientation of the PPLA rods generated an oriented 
crystalline structure, which significantly enhanced the paracetamol release. The 
effect of orientation was most prominent in the exponential phase due to 
formation of the microscopic and then macroscopic water filled-channels. 
Normalisation of drug release with respect to the surface area confirmed that 
the augmentation of the drug release was superior along the chain orientation 
direction than in the perpendicular direction.  
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8. Comparison of the distinctive findings 
between drug release from oriented PLA 
films and die-drawn PLA rods  
8.1. The structural distinction between oriented rods and oriented films 
The uniaxial constant width (UCW) oriented PLA films and die drawn PLA 
rods showed analogous changes in their oriented structure with respect to 
uniaxial draw ratio. At uniaxial λ = 2X, both geometries developed a nematic 
organisation of the amorphous PLA chains in the drawing direction. Negligible 
strain crystallisation was observed up to this level of extension. At λ = 3X, PLA 
films exhibited generation of α PLA crystals with their c-axis oriented parallel to 
the drawing direction (figure 6.9). Conversely, die-drawn rods showed the 
presence of α’ PLA crystals with similar orientation (figure 7.1). On further 
extension, an increasing number of PLA chains were recruited into the oriented 
crystalline arrangement. However, the respective crystalline forms remained the 
same.  
 
 
 
Figure 8.1: Postulated structural difference between the α’ and the α Form of PLA. 
(Wasanasuk and Tashiro, 2011)  
*(U and D signify up and down arrangement of 5 monomeric units in a 21 screw geometry) 
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The characteristic differences between the α and the α’ Form of PLA are 
summarised in section 7.1.2 and through figure 7.10 (shown here as figure 8.1). 
In brief, the α’ Form possesses slightly disordered molecular chains compared 
with the α Form (Zhang et al., 2008). Such a disorder alters the unit cell 
parameters of the α’ Form and consequently, organisation of the higher order 
domains becomes imperfect (figure 8.1) (Pan et al., 2008; Wasanasuk and 
Tashiro, 2011). A boundary is created between the disordered crystalline 
domains, which perhaps possesses crystal defects in the form of chain ends. 
Such macroscopic defects are absent in the α Form of PLA due to existence of 
a 21 screw symmetry (figure 8.1). The mentioned distinction between the 
crystalline organisation of PLA in the oriented films and rods, along with the 
other differences such as that in the geometry, size, model drug and overall 
chain orientation resulted in largely dissimilar drug release profile from the two 
systems.  
8.2. Difference in the biphasic nature of drug release profiles 
 If the initial burst release was ignored, the drug loaded PLA films 
exhibited a biphasic drug release. A similar release profile was displayed by the 
paracetamol loaded PLA rods following die-drawing (λ ≥ 3X). However, the rods 
exhibited a plateau towards the end of the drug release testing due to a 
substantial depletion of the drug concentration (figure 8.2). Although both kinds 
of systems exhibited a biphasic release pattern, the nature of the two phases 
was substantially different in the oriented films and the die-drawn rods (λ ≥ 3X). 
Figure 8.2 summarises these differences through comparison of the drug 
release profiles of curcumin loaded oriented PLA films (UCW λ = 3X) and 
paracetamol loaded die drawn rods (λ = 3X).  
 As displayed in figure 8.2, the slow release phase in the oriented rods 
relates to diffusion of the drug through the hydrated polymer matrix. This phase 
lasted approximately for 4-6 weeks, following which there was a smooth 
transition to the exponential release phase between 6th and the 10th week. 
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Since, no weight loss (reduction in the dried weight) was detected in the 
oriented rods for the entire study duration; acceleration of drug release in the 
exponential phase can be attributed to formation of several microscopic and 
macroscopic water filled channels. The exponential release phase in the case of 
oriented rods continued approximately from the 10th week onwards. Due to 
substantially faster drug release in this phase (sec. 7.3.2), the oriented rods 
were progressively depleted of the drug. The falling concentration gradient 
subsequently lowered the release rate. 
 
 
Figure 8.2: Distinction between biphasic release of (X) paracetamol from oriented rods 
and that of (Y) curcumin from the oriented films 
* The cumulative release is represented as Mean ± SD, where n = 6.  
The percentage cumulative paracetamol release represented here is the release from the curved surface 
of the rods, without area normalisation. 
Due to the larger size of the rods (6 mm diameter X 6 mm thickness) 
compared to the films (5 mm diameter X 0.2 mm thickness), percolation of 
water is extremely slow and requires a longer duration before the rod is 
X: Paracetamol release from 
oriented rods 
Y: Curcumin release from 
oriented films 
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completely saturated by the water. As water starts percolating in the rods, it 
gradually hydrates numerous successive layers from the periphery towards the 
centre. Drug present in a hydrated layer diffuses towards the surface of the rods 
and it is subsequently released in the bathing medium. In parallel to this, the 
percolated water causes hydrolytic degradation of the surrounding polymer 
phase and promotes formation of the water filled channels. Drug release is 
accelerated as the number of channels gradually increases and they are 
transformed from the microscopic to macroscopic dimensions. Once the matrix 
is significantly porous, drug release predominantly occurs through such 
channels (figure 7.9).  
Diffusion through the hydrated polymer and through water filled channels 
could not be distinguished in the drug release profile of the oriented films. Lower 
thickness of the films can result in faster equilibration by the release medium 
and an earlier onset of channel formation. Nevertheless, the network of the 
connected channels can grow faster in the films due to significantly higher 
surface area to volume ratio compared to the rods. Due to lower thickness of 
the films (0.2 mm), drug diffusion in the films is virtually one dimensional. 
Consequently, diffusion through the hydrated polymer phase plays a 
substantially greater role in drug release from films than from the rods. All these 
factors perhaps resulted in a monophasic drug release from the oriented PLA 
films until the 16th week after aqueous submersion.  
These mass transport mechanisms play a key role in affecting drug elution 
from PLA matrices only till the onset of erosion. Study of the molecular weight 
degradation and morphological changes in the submerged films revealed that 
the films started to disintegrate from the 20th week onwards. This led to 
uncontrolled release of the remaining drug from the films. Therefore, the 
exponential phase observed in the release profile of the PLA films relates to 
erosion mediated drug release. The erosion of the paracetamol loaded PLA 
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rods could not be observed in the current study, which was restricted to 16 
weeks (due to drug depletion). 
8.3. Difference in the effects of solid state orientation 
 
 
Figure 8.3: Distinction between the effect of solid state orientation on the biphasic drug 
release profiles of (A) curcumin and (B) paracetamol from the oriented films and the 
rods respectively 
* The cumulative release is represented as Mean ± SD, where n = 6.  
The percentage cumulative paracetamol release represented here is the release from the curved surface 
of the rods, without area normalisation. 
The effect of solid-state orientation on drug release from the PLA films 
was quite distinct from that observed in the case of oriented PLA rods (figure 
8.3). The biphasic nature of the drug release profile was not altered after solid-
state orientation of the PLA films. All PLA films irrespective of their degree of 
orientation and the compounded model drug exhibited slower drug release until 
the 16th week, followed by an erosion induced acceleration of drug release. 
Conversely, the un-oriented PLA rods (and the λ = 2X rods that shrunk after 
aqueous submersion) exhibited a monophasic drug release for the entire study 
duration (16 weeks). Orientation of the rods to UCW draw ratios of 3X and 
above, transformed the drug release profile from monophasic to biphasic. Here 
the initial phase represented drug release by diffusion through the hydrated 
polymer; while the later phase represented substantial acceleration of drug 
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release due to formation of microscopic and macroscopic water filled channels. 
Importantly, orientation of the films to the draw ratio of 4X produced a maximum 
two fold rise in the cumulative curcumin release before the onset of erosion 
(during the first 16 weeks). Contrastingly, the maximum difference between the 
cumulative paracetamol release from PPLA-4X rods and that from the un-
oriented rods was 52-fold (at the end of the 13th week). Such a difference 
predominantly relates to formation of macroscopic channels in the oriented rods 
(sec. 7.2.4); along with other factors such as differences in their size, geometry, 
model drug and oriented morphology.  
The presence of macroscopic channels in the oriented rods (λ ≥ 3X) was 
confirmed by SEM at the end of the release study. For the rods oriented to λ = 
3X, the average width of the channels was less than a micrometre and they 
were approximately 100 μm long. The width of the channels increased with the 
draw ratio, but their number reduced significantly. Importantly, all such channels 
were aligned parallel to the drawing direction. They were absent in the un-
oriented and the λ = 2X rods. A key difference between the un-oriented (and λ = 
2X) and the oriented (λ ≥ 3X) rods was that the former were amorphous in 
nature while the latter contained α’ crystalline form of PLA. The α’ Form has a 
sheaf like structure where PLA chains are loosely bundled together (Pan et al., 
2008). Therefore, formation of macroscopic channels quite clearly relates to 
existence of the α’ Form of PLA. This further explains transformation of 
monophasic drug release profile to a biphasic profile after orientation of the PLA 
rods (λ ≥ 3X).  As explained in section 8.1, oriented PLA films also underwent 
strain crystallisation at the draw ratio of 3X and above. However, they contained 
the α crystalline form of PLA. Since the α crystals have lamellar structure and a 
higher order symmetry than the α’ Form (figure 8.1), formation of macroscopic 
channels was not observed in the case of oriented films. Consequently, the 
nature of drug release profile remained constant, although the overall drug 
release was accelerated after orientation of the films.   
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Figure 8.4: Effect of solid state orientation on kinetics of drug release from oriented 
films. 
A: Theophylline diffusivity/ diffusion rate, B: Curcumin release rate  
* The theophylline diffusivity was calculated from the slope of the cumulative release Vs time1/2 curves 
(regression lines), which were linear in the case of TPLA films. Similarly, the curcumin release rate in μg.g 
-1.week -1 units was calculated by plotting cumulative μg of curcumin released per gram of CPLA films 
against time in weeks. The cumulative curcumin release exhibited a linear relationship with time, instead 
of with the square root of it. Therefore the slope of such curves represented the curcumin release rate. 
**The error bars in both cases represent the standard error obtained by regression analysis of the 
respective data. 
 
Orientation of the films to UCW draw ratios of 3X and 4X resulted in 
acceleration of the release of both model drugs, despite difference in their 
release mechanisms. Theophylline was predominantly released by a Fickian 
diffusion mechanism. This signifies that the rate of theophylline release reduced 
gradually, in response to the falling concentration gradient; however, the 
diffusivity remained constant. Here the diffusivity of theophylline was calculated 
from the slope of the cumulative drug release Vs time1/2 curves. A linear (R2 = 
0.9786) rise in the diffusivity of theophylline was observed with respect to UCW 
draw ratio ≥ 3X (figure 8.4 - A).  
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It was previously confirmed that curcumin (at 5% w/w loading) formed a 
solid-solution in PLA. Therefore, hydrolytic degradation of the polymer matrix 
resulted in a gradual rise in the diffusivity of curcumin as the drug release study 
progressed. This perhaps balanced the effect of falling concentration gradient 
and the overall release rate remained constant until the 16th week. The 
curcumin release rate was therefore obtained from the slope of the cumulative 
drug release Vs time curves. A linear rise (R2 = 0.9950) in the release rate of 
curcumin was observed with respect to UCW draw ratio ≥ 3X (figure 8.4 - B).  
In the case of oriented rods (λ ≥ 3X), no proportionality between the draw 
ratio and the release rate or diffusivity was observed, since neither the release 
rate nor diffusivity remained constant during the drug release study. Moreover, 
the enhancement of drug release due to formation of macroscopic channels 
was so high that it masked the effect of individual draw ratios.  
8.4. Summary 
In summary, the comparison between the drug release profiles of the 
oriented films and the oriented rods emphasised the role played by microscopic 
and macroscopic channels in enhancing drug release from orientated materials. 
The importance of the crystalline form of PLA in influencing this process was 
also highlighted. It was confirmed that presence of the α Form can offer a better 
control over the drug release rate than the α’ Form. Since strain crystallisation 
of PLA generates varied crystalline polymorphs depending upon the drawing 
temperature, strain rate, draw ratio and the method of drawing; manipulation of 
these conditions can offer a control over the crystalline form of PLA and 
consequently drug release from oriented semicrystalline PLA.    
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9. Conclusions 
This study represents the first systematic exploration of polymer 
orientation as a novel method for controlling drug release from biodegradable 
polymers. The effect of the degree and nature of polymer orientation (e.g. 
uniaxial, biaxial) on the release of model drugs was studied, using oriented Poly 
(lactic acid) – (PLA) films. Importantly, anisotropy in the drug release rate 
following uniaxial orientation of PLA rods was also evaluated for the first time. 
From the work performed here the following conclusions could be drawn: 
 An efficient melt processing method was developed, which caused 
minimal thermal degradation of the experimental materials (model drugs & 
PLA) during melt compounding and during extrusion into sheets or rods. 
This ensured that the characteristics of drug release from oriented PLA 
matrices were solely attributable to the structural changes caused by solid-
state orientation.  
 Changes in the polymorphic and physical state of the experimental 
materials due to melt processing were identified. When melt compounded 
with PLA, curcumin and paracetamol at 5% w/w loading formed a solid 
solution, while theophylline remained in a crystalline suspension state at 
the same loading.  
 The physical state of the model drug critically influenced the stability and 
consequent drug release profile of the oriented amorphous PLA matrices. 
When the nematic orientation of amorphous PLA chains was stabilised by 
the presence of a crystalline model drug, it caused retardation of drug 
release. Contrarily, oriented amorphous PLA matrices (rods and films) 
containing a model drug in a solution state lost their oriented structure 
after submersion in the release medium at 37 °C. Drug release from such 
matrices became equivalent to that from the un-oriented PLA matrices. 
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 Morphology of the amorphous and crystalline regions in oriented PLA 
matrices played a pivotal role in affecting drug release prior to the onset of 
erosion.  
 PLA films oriented to a lower draw ratio (uniaxial constant width λ = 2X, 
biaxial λ = 2X2Y), which contained a nematic alignment of the amorphous 
chains and negligible crystallinity (<1%) showed retardation of drug 
release. Among these, biaxially oriented films exhibited a greater release 
retardation effect due to higher tortuosity. 
 Uniaxial orientation of the PLA matrices (both films and rods) enhanced 
drug release when accompanied by strain induced crystallisation at draw 
ratios of 3X and above. 
 Generation of α crystalline form with its c-axis parallel to the drawing 
direction led to enhancement of polarity of the PLA films, which were 
oriented to uniaxial constant width (UCW) draw ratios of 3X or greater.  
 Based on the above finding, a mechanism was proposed for explaining 
higher drug release from oriented crystalline PLA matrices (films UCW λ ≥ 
3X, rods λ ≥ 3X). According to it, augmented formation of water filled 
channels in such matrices was responsible for acceleration of drug 
release. 
 The polymorphic form of PLA generated during solid-state orientation was 
of equivalent importance to the degree of orientation, in influencing drug 
release from oriented PLA matrices. The disordered α’ Form of PLA 
(generated during die drawing of PLA rods; UCW λ ≥ 3X) accelerated drug 
release to a much greater extent than that exhibited by the α crystalline 
form (present in the oriented PLA films; UCW λ ≥ 3X). This resulted due to 
the formation of cracks between disordered domains of the α’ Form. 
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 Importantly, the anisotropic morphology of uniaxially oriented PLA rods 
resulted in direction specific drug release. Drug release was faster along 
the polymer chain orientation direction, than that in the perpendicular 
direction.  
 This work provided substantial evidence that the rate of drug release from 
oriented PLA matrices significantly depends on the morphology of such 
matrices. Results described in chapter 6 confirmed that various oriented 
morphologies could be generated by varying the strain rate, drawing 
temperature, and draw ratio during solid-state orientation of PLA. 
Therefore, it was established that polymer orientation can serve as a novel 
method of controlling drug release from biodegradable polymers.  
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10. Future work 
The current findings highlighted the following aspects to be studied in the future 
 Effect of drug concentration: 
Effect of orientation was studied here keeping the drug loading constant 
at 5% w/w. As explained in section 3.4.1, different drug loadings may change 
the distribution of drug in the polymer matrix and drug – polymer interactions. 
This may subsequently affect solid-state deformation behaviour of PLA and 
resultant release profile. Nevertheless, increasing the drug loading will 
enhance the concentration gradient between the polymer phase and the 
bathing medium. In such a case, correlation between the drug release rate 
and the degree of orientation may vary. Therefore, it will be interesting to 
study drug release from PLA matrices oriented to a constant draw ratio but 
containing varied drug loading. 
 Effect of amorphous orientation: 
This work confirmed that PLA films oriented to different draw ratios but 
containing a predominantly amorphous structure can be prepared at lower 
drawing temperatures (70 °C using the selected grade). Drug elution studies 
on these films will generate an understanding of whether release retardation 
observed in the current study was due to amorphous orientation or due to a 
lower draw ratio. 
 Additional biaxial draw ratios: 
In the current work, a single biaxial draw ratio of 2X2Y was studied due 
to technical limitations. In the future, PLA films oriented to higher biaxial draw 
ratios can be generated. Nevertheless, the films can be oriented to different 
extents along the perpendicular directions (e.g. λ = 2X3Y, 2X4Y, 3X4Y, etc.) 
in sequential biaxial mode. Drug release studies on these films will provide 
further insight into the effect of biaxial orientation on drug release.  
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 The mechanism by which drug release is altered in oriented PLA: 
A mechanism proposed in this research explained augmented formation 
of water filled channels as a probable cause of accelerated drug release from 
oriented crystalline matrices. In order to verify this mechanism, changes in 
the connected porosity and crystalline structure of the oriented PLA matrices 
can be studied periodically during drug release studies. The prior can be 
achieved by a micro-computed tomography measurement, while the latter 
can be determined by WAXD. Such a study in the case of biaxially oriented 
PLA films (currently studied λ = 2X2Y) and oriented amorphous films 
(currently studied UCW λ = 2X) will highlight the cause of drug release 
retardation exhibited by these films.  
 Anisotropic drug release from a cube geometry: 
It was established that drug release from uniaxially oriented rods was 
anisotropic in nature. Drug release in the drawing direction was studied from 
a flat cross section, while that in the perpendicular direction was studied from 
a curved surface. Moreover, oriented rods with equivalent length and 
diameter were used in the drug release studies, so as to keep the diffusional 
path-length from the centre to the curved surface and from the centre to the 
cross section constant. However, with this approach the curved surface area 
became twice as much as the total cross sectional surface area. In order to 
eliminate these geometric variables, drug release can be studied from 
different surfaces of a cube specimen obtained from an oriented square billet.  
 Creating a design rule: 
Various oriented morphologies can be generated in PLA and related 
bulk eroding biodegradable polymers, by varying drawing temperature, strain 
rate and draw ratios. Drug release studies on such matrices will allow 
formulation of a design rule for controlling drug release from oriented bulk 
eroding biodegradable polymers. 
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12. Appendix 
12.1. Brief description of 2D-WAXD analysis 
A crystal is made up of a periodic, symmetrical arrangement of individual 
atoms or groups of atoms. Such an arrangement is referred to as a crystal 
lattice.  Depending upon the relative lengths of the unit vectors connecting such 
atoms and angles between them, a unit cell of the lattice may exhibit 14 
different geometries. These are known as the Bravais lattices. The principle 
geometries are monoclinic, triclinic, orthorhombic, rhombohedral, tetragonal, 
hexagonal and cubic, which further have their own variants.  
 
Figure 12.1: Typical crystallographic planes in a cubic crystal lattice. 
Adapted from: (http://www.chem.qmul.ac.uk/surfaces, 2015) 
A crystal lattice can be divided into several lattice planes. The orientation 
of a lattice plane is usually denoted by the Miller indices. These relate to how 
the lattice plane intersects the main crystallographic axes of that solid. Figure 
12.1 displays the most common planes in a cubic crystal and corresponding 
Miller indices. When irradiated by X-rays, each crystal plane scatters the X-rays 
at a unique Bragg’s angle. If the sample is rotated in a complete azimuthal circle 
the scattered rays can be detected on a 2D detector, giving rise to a 2D X-ray 
pattern. Depending upon the crystal plane orientation, these appear on 
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characteristic locations within the 2D X-ray pattern. Therefore, their positions 
help in identification of the crystal type (Alexander, 1971).  
 
Figure 12.2: Prototype 2D-WAXD patterns of the oriented and un-oriented PLA films 
In figure 12.2 (A & B), the characteristic reflections for α crystals of PLA 
are identified. When the crystalline reflections of a polymeric sample are 
present as a complete azimuthal circle (figure 12.2 - A), they signify that the 
crystalline phase is isotropic. If the crystals are oriented uniaxially along the 
meridian, the azimuthal spread of the crystalline reflections reduces and they 
appear as concentrated spots near the equator (figure 12.2 - B). Biaxially 
oriented crystalline polymeric matrices contain the crystalline phase aligned in 
two orthogonal directions. Consequently, crystalline reflections appear on 
meridian as well as equator (figure 12.2 - C).  In an amorphous polymer, the 
scattered X-rays appear as a diffuse halo (figure 12.2 - D, E). When such a 
pattern is translated to an ‘intensity Vs Brag’s angle’ diffractogram, no 
crystalline peaks are observed. The presence of an amorphous halo as a 
complete azimuthal circle signifies isotropic organisation of the amorphous 
phase (figure 12.2 - D).  Similar to the crystalline pattern, orientation of the 
amorphous phase results in concentration of the halo along the perpendicular 
axis (figure 12.2 - E).  
